index,company_name,industry_code,symbol,industry,quarter,year,entry_label,entry_concept,entry_unit,entry_value,statement
1,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Short-term investments,OtherShortTermInvestments,usd,17000000,bs
2,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Trade receivables, net",AccountsReceivableNetCurrent,usd,1749000000,bs
3,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Current portion of net investment in sales-type leases,CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent,usd,35000000,bs
4,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Materials,InventoryRawMaterialsNetOfReserves,usd,320000000,bs
5,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Work in process,InventoryWorkInProcessNetOfReserves,usd,293000000,bs
6,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1216000000,bs
7,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Inventories:,InventoryNet,usd,1829000000,bs
8,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
9,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Prepaid expenses and other,OtherAssetsCurrent,usd,731000000,bs
10,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Current Assets:,AssetsCurrent,usd,18212000000,bs
11,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,8975000000,bs
12,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,4565000000,bs
13,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,4410000000,bs
14,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,7513000000,bs
15,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2867000000,bs
16,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,2533000000,bs
17,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,588000000,bs
18,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Capitalized Software, Net",CapitalizedComputerSoftwareNet,usd,61000000,bs
19,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Net Investment in Sales-Type Leases, Less Current Portion",CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent,usd,43000000,bs
20,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Other Assets,OtherAssetsNoncurrent,usd,938000000,bs
21,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Assets,Assets,usd,37166000000,bs
22,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Short-term debt,DebtCurrent,usd,453000000,bs
23,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,2820000000,bs
24,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Liabilities held for sale,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
25,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Current Liabilities:,LiabilitiesCurrent,usd,3273000000,bs
26,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Long-Term Debt,LongTermDebtNoncurrent,usd,18563000000,bs
27,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1337000000,bs
28,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,1406000000,bs
29,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
30,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Preferred stock,PreferredStockValue,usd,2000000,bs
31,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Common stock,CommonStockValue,usd,347000000,bs
32,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,9586000000,bs
33,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12989000000,bs
34,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,22000000,bs
35,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Common stock in treasury - at cost,TreasuryStockValue,usd,8437000000,bs
36,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1923000000,bs
37,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Shareholders’ Equity,StockholdersEquity,usd,12587000000,bs
38,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,37166000000,bs
39,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Net (Loss) Income,NetIncomeLoss,usd,773000000,cf
40,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,802000000,cf
41,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Equity Award [Domain],ShareBasedCompensation,usd,138000000,cf
42,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,339000000,cf
43,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,665000000,cf
44,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,56000000,cf
45,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Excess Tax Benefit from Share-based Compensation, Operating Activities",ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-60000000,cf
46,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Lease contract modification-related charge,bdx:LeaseContractModificationRelatedCharge,usd,741000000,cf
47,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,142000000,cf
48,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1424000000,cf
49,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,467000000,cf
50,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-17000000,cf
51,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,158000000,cf
52,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,165000000,cf
53,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,94000000,cf
54,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-536000000,cf
55,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Change in short-term debt,ProceedsFromRepaymentsOfShortTermDebt,usd,50000000,cf
56,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,11462000000,cf
57,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Payments of debt,RepaymentsOfLongTermDebt,usd,3980000000,cf
58,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,4827000000,cf
59,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,220000000,cf
60,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
61,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Dividends paid,PaymentsOfDividendsCommonStock,usd,478000000,cf
62,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-229000000,cf
63,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,11433000000,cf
64,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-11000000,cf
65,Becton Dickson,0000010795,BDX,Medical Products,Q3,2017,Net increase in cash and equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,12310000000,cf
66,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,14179000000,bs
67,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Short-term investments,OtherShortTermInvestments,usd,21000000,bs
68,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Accounts Receivable, Net, Current",AccountsReceivableNetCurrent,usd,1744000000,bs
69,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Current portion of net investment in sales-type leases,CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent,usd,16000000,bs
70,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Inventories,InventoryNet,usd,1818000000,bs
71,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Disposal Group, Including Discontinued Operation, Assets",AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
72,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Prepaid expenses and other,OtherAssetsCurrent,usd,856000000,bs
73,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Current Assets,AssetsCurrent,usd,18633000000,bs
74,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,4638000000,bs
75,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,7563000000,bs
76,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2830000000,bs
77,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,2478000000,bs
78,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,585000000,bs
79,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Net Investment in Sales-Type Leases, Less Current Portion",CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent,usd,38000000,bs
80,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Other Assets,OtherAssetsNoncurrent,usd,968000000,bs
81,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Total Assets,Assets,usd,37734000000,bs
82,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Short-term debt,DebtCurrent,usd,203000000,bs
83,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Accounts payable,AccountsPayableCurrent,usd,797000000,bs
84,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Accrued expenses,AccruedLiabilitiesCurrent,usd,1393000000,bs
85,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Salaries, wages and related items",EmployeeRelatedLiabilitiesCurrent,usd,773000000,bs
86,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Income taxes,AccruedIncomeTaxesCurrent,usd,176000000,bs
87,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Liabilities held for sale,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
88,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Current Liabilities,LiabilitiesCurrent,usd,3342000000,bs
89,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Long-Term Debt,LongTermDebtNoncurrent,usd,18667000000,bs
90,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1168000000,bs
91,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,1609000000,bs
92,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
93,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Preferred Stock, Value, Issued",PreferredStockValue,usd,2000000,bs
94,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Common stock — $1 par value: authorized — 640,000,000 shares; issued — 346,687,160 shares in 2017 and 332,662,160 shares in 2016.",CommonStockValue,usd,347000000,bs
95,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,9619000000,bs
96,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13111000000,bs
97,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,19000000,bs
98,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Common stock in treasury — at cost — 118,744,758 shares in 2017 and 119,370,934 shares in 2016.",TreasuryStockValue,usd,8427000000,bs
99,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Accumulated other comprehensive (loss) income, beginning balance",AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1723000000,bs
100,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,12948000000,bs
101,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,37734000000,bs
102,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Net Income,NetIncomeLoss,usd,1100000000,cf
103,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Total Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,1088000000,cf
104,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Equity Award [Domain],ShareBasedCompensation,usd,174000000,cf
105,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,236000000,cf
106,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Trade receivables, net",IncreaseDecreaseInAccountsAndOtherReceivables,usd,93000000,cf
107,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Net investment in sales-type leases,IncreaseDecreaseInFinanceReceivables,usd,-14000000,cf
108,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Inventories,IncreaseDecreaseInInventories,usd,46000000,cf
109,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Prepaid expenses and other,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,usd,380000000,cf
110,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Accounts payable, income taxes and other liabilities",IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,usd,134000000,cf
111,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,84000000,cf
112,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Excess Tax Benefit from Share-based Compensation, Operating Activities",ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-77000000,cf
113,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Lease Contract Modification Related Charge,bdx:LeaseContractModificationRelatedCharge,usd,748000000,cf
114,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,114000000,cf
115,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,2550000000,cf
116,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Total Capital Expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,727000000,cf
117,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Proceeds from (purchases of) investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-13000000,cf
118,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,174000000,cf
119,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Divestitures of businesses, net",ProceedsFromDivestitureOfBusinesses,usd,165000000,cf
120,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,161000000,cf
121,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-883000000,cf
122,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Change in short-term debt,ProceedsFromRepaymentsOfShortTermDebt,usd,-200000000,cf
123,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,11462000000,cf
124,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Payments of debt,RepaymentsOfLongTermDebt,usd,3980000000,cf
125,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,4827000000,cf
126,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,220000000,cf
127,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Excess tax benefit from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
128,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Dividends paid,PaymentsOfDividendsCommonStock,usd,677000000,cf
129,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-234000000,cf
130,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,10977000000,cf
131,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-6000000,cf
132,Becton Dickson,0000010795,BDX,Medical Products,FY,2017,Net Increase (Decrease) in Cash and Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,12638000000,cf
133,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Opening Cash and Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1124000000,bs
134,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Restricted Cash and Investments, Current",RestrictedCashAndInvestmentsCurrent,usd,113000000,bs
135,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Short-term investments,OtherShortTermInvestments,usd,84000000,bs
136,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2000000000,bs
137,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Materials,InventoryRawMaterialsNetOfReserves,usd,520000000,bs
138,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Work in process,InventoryWorkInProcessNetOfReserves,usd,424000000,bs
139,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Finished products,InventoryFinishedGoodsNetOfReserves,usd,2022000000,bs
140,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Inventories:,InventoryNet,usd,2967000000,bs
141,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Prepaid expenses and other,OtherAssetsCurrent,usd,1255000000,bs
142,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Current Assets:,AssetsCurrent,usd,7542000000,bs
143,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,10109000000,bs
144,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,4848000000,bs
145,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5262000000,bs
146,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,22699000000,bs
147,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3938000000,bs
148,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,14173000000,bs
149,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,565000000,bs
150,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Other Assets,OtherAssetsNoncurrent,usd,1184000000,bs
151,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Assets,Assets,usd,55363000000,bs
152,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Short-term debt,DebtCurrent,usd,703000000,bs
153,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,4193000000,bs
154,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Current Liabilities:,LiabilitiesCurrent,usd,4895000000,bs
155,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Long-Term Debt,LongTermDebtNoncurrent,usd,22095000000,bs
156,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1164000000,bs
157,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5961000000,bs
158,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
159,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Preferred stock,PreferredStockValue,usd,2000000,bs
160,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Common stock,CommonStockValue,usd,347000000,bs
161,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16197000000,bs
162,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12765000000,bs
163,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,19000000,bs
164,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Common stock in treasury - at cost,TreasuryStockValue,usd,6343000000,bs
165,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1740000000,bs
166,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Shareholders’ Equity,StockholdersEquity,usd,21247000000,bs
167,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,55363000000,bs
168,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Net (Loss) Income,NetIncomeLoss,usd,-136000000,cf
169,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,291000000,cf
170,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Share-based compensation,ShareBasedCompensation,usd,141000000,cf
171,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,324000000,cf
172,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-409000000,cf
173,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-101000000,cf
174,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-38000000,cf
175,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,-3000000,cf
176,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,320000000,cf
177,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,178000000,cf
178,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"(Purchases of) proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,63000000,cf
179,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,15013000000,cf
180,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,0,cf
181,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,62000000,cf
182,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-15315000000,cf
183,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Change in short-term debt,ProceedsFromRepaymentsOfShortTermDebt,usd,0,cf
184,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,2250000000,cf
185,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Payments of debt,RepaymentsOfLongTermDebt,usd,0,cf
186,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,0,cf
187,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Dividends paid,PaymentsOfDividends,usd,210000000,cf
188,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-101000000,cf
189,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1938000000,cf
190,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,2000000,cf
191,Becton Dickson,0000010795,BDX,Medical Products,Q1,2018,Net decrease in cash and equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-13055000000,cf
192,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Opening Cash and Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1251000000,bs
193,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Restricted Cash and Investments, Current",RestrictedCashAndInvestmentsCurrent,usd,167000000,bs
194,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Short-term investments,OtherShortTermInvestments,usd,16000000,bs
195,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2293000000,bs
196,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Materials,InventoryRawMaterialsNetOfReserves,usd,498000000,bs
197,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Work in process,InventoryWorkInProcessNetOfReserves,usd,355000000,bs
198,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1691000000,bs
199,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Inventories:,InventoryNet,usd,2543000000,bs
200,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Prepaid expenses and other,OtherAssetsCurrent,usd,1241000000,bs
201,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Current Assets:,AssetsCurrent,usd,7512000000,bs
202,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,10460000000,bs
203,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5049000000,bs
204,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5411000000,bs
205,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23491000000,bs
206,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3865000000,bs
207,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,12562000000,bs
208,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,573000000,bs
209,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Other Assets,OtherAssetsNoncurrent,usd,1159000000,bs
210,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Assets,Assets,usd,54573000000,bs
211,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Short-term debt,DebtCurrent,usd,202000000,bs
212,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,4224000000,bs
213,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Current Liabilities:,LiabilitiesCurrent,usd,4426000000,bs
214,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Long-term Debt, Excluding Current Maturities",LongTermDebtNoncurrent,usd,22589000000,bs
215,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1172000000,bs
216,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5233000000,bs
217,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
218,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Preferred stock,PreferredStockValue,usd,2000000,bs
219,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Common stock,CommonStockValue,usd,347000000,bs
220,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16170000000,bs
221,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12616000000,bs
222,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,21000000,bs
223,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Common stock in treasury - at cost,TreasuryStockValue,usd,6300000000,bs
224,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Balance at September 30, 2017",AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1704000000,bs
225,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Shareholders’ Equity,StockholdersEquity,usd,21152000000,bs
226,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54573000000,bs
227,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Net (Loss) Income,NetIncomeLoss,usd,-148000000,cf
228,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,844000000,cf
229,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Share-based compensation,ShareBasedCompensation,usd,207000000,cf
230,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,400000000,cf
231,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-702000000,cf
232,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-72000000,cf
233,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-56000000,cf
234,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,172000000,cf
235,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1017000000,cf
236,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,391000000,cf
237,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-7000000,cf
238,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,15118000000,cf
239,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,100000000,cf
240,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,138000000,cf
241,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-15540000000,cf
242,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Change in credit facility borrowings,ProceedsFromRepaymentsOfOtherLongTermDebt,usd,380000000,cf
243,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,3622000000,cf
244,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Payments of debt,RepaymentsOfLongTermDebt,usd,1833000000,cf
245,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,0,cf
246,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Dividends paid,PaymentsOfDividends,usd,449000000,cf
247,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-155000000,cf
248,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1565000000,cf
249,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,29000000,cf
250,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Net decrease in cash and equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-12929000000,cf
251,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Non-cash consideration-fair value of shares issued,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,8004000000,cf
252,Becton Dickson,0000010795,BDX,Medical Products,Q2,2018,Non-cash consideration-fair value of equity awards issued,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,613000000,cf
253,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1384000000,bs
254,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Restricted Cash and Investments, Current",RestrictedCashAndInvestmentsCurrent,usd,125000000,bs
255,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Short-term investments,OtherShortTermInvestments,usd,15000000,bs
256,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2243000000,bs
257,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Materials,InventoryRawMaterialsNetOfReserves,usd,514000000,bs
258,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Work in process,InventoryWorkInProcessNetOfReserves,usd,330000000,bs
259,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1718000000,bs
260,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Inventories:,InventoryNet,usd,2562000000,bs
261,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Prepaid expenses and other,OtherAssetsCurrent,usd,1196000000,bs
262,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Current Assets:,AssetsCurrent,usd,7525000000,bs
263,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,10384000000,bs
264,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5063000000,bs
265,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5321000000,bs
266,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Goodwill,Goodwill,usd,23505000000,bs
267,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3804000000,bs
268,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,12301000000,bs
269,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,537000000,bs
270,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Other Assets,OtherAssetsNoncurrent,usd,984000000,bs
271,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Assets,Assets,usd,53977000000,bs
272,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Short-term debt,DebtCurrent,usd,1900000000,bs
273,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,4207000000,bs
274,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Current Liabilities:,LiabilitiesCurrent,usd,6106000000,bs
275,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Long-Term Debt,LongTermDebtNoncurrent,usd,20350000000,bs
276,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1075000000,bs
277,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5088000000,bs
278,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
279,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Preferred stock,PreferredStockValue,usd,2000000,bs
280,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Common stock,CommonStockValue,usd,347000000,bs
281,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16193000000,bs
282,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12971000000,bs
283,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,22000000,bs
284,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Common stock in treasury - at cost,TreasuryStockValue,usd,6275000000,bs
285,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1902000000,bs
286,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Shareholders’ Equity,StockholdersEquity,usd,21357000000,bs
287,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53977000000,bs
288,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Net Income (Loss),NetIncomeLoss,usd,446000000,cf
289,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1412000000,cf
290,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Share-based compensation,ShareBasedCompensation,usd,261000000,cf
291,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,472000000,cf
292,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-430000000,cf
293,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-228000000,cf
294,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-63000000,cf
295,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Lease Contract Modification Related Charge,bdx:LeaseContractModificationRelatedCharge,usd,0,cf
296,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Gain on Sale of Investments,GainOnSaleOfInvestments,usd,308000000,cf
297,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,45000000,cf
298,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1559000000,cf
299,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,588000000,cf
300,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-13000000,cf
301,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,15111000000,cf
302,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,534000000,cf
303,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,145000000,cf
304,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-15298000000,cf
305,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Change in credit facility borrowings,ProceedsFromRepaymentsOfOtherLongTermDebt,usd,200000000,cf
306,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,4335000000,cf
307,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Payments of debt,RepaymentsOfLongTermDebt,usd,2723000000,cf
308,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,0,cf
309,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,0,cf
310,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Dividends paid,PaymentsOfDividends,usd,687000000,cf
311,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-176000000,cf
312,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,949000000,cf
313,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-5000000,cf
314,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Net (decrease) increase in cash and equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-12795000000,cf
315,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Fair value of the Company’s issued shares,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,8004000000,cf
316,Becton Dickson,0000010795,BDX,Medical Products,Q3,2018,Non-cash consideration-fair value of equity awards issued,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,613000000,cf
317,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Opening Cash and Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1140000000,bs
318,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,96000000,bs
319,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Short-term investments,OtherShortTermInvestments,usd,17000000,bs
320,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2319000000,bs
321,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Inventories,InventoryNet,usd,2451000000,bs
322,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,137000000,bs
323,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Prepaid expenses and other,OtherAssetsCurrent,usd,1251000000,bs
324,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Current Assets,AssetsCurrent,usd,7411000000,bs
325,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5375000000,bs
326,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23600000000,bs
327,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,12184000000,bs
328,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3723000000,bs
329,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,534000000,bs
330,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Other Assets,OtherAssetsNoncurrent,usd,1078000000,bs
331,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Assets held for sale,Assets,usd,53904000000,bs
332,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Short-term debt,DebtCurrent,usd,2601000000,bs
333,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Accounts payable,AccountsPayableCurrent,usd,1106000000,bs
334,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Accrued expenses,AccruedLiabilitiesCurrent,usd,2255000000,bs
335,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Salaries, wages and related items",EmployeeRelatedLiabilitiesCurrent,usd,910000000,bs
336,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Income taxes,AccruedIncomeTaxesCurrent,usd,343000000,bs
337,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Current Liabilities,LiabilitiesCurrent,usd,7216000000,bs
338,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Long-Term Debt,LongTermDebtNoncurrent,usd,18894000000,bs
339,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Long-term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1056000000,bs
340,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5743000000,bs
341,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
342,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Preferred stock,PreferredStockValue,usd,2000000,bs
343,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Common stock — $1 par value: authorized — 640,000,000 shares; issued — 346,687,160 shares in 2018 and 2017.",CommonStockValue,usd,347000000,bs
344,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16179000000,bs
345,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12596000000,bs
346,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,22000000,bs
347,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Repurchase of common stock,TreasuryStockValue,usd,6243000000,bs
348,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Accumulated other comprehensive (loss) income, beginning balance",AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1909000000,bs
349,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,20994000000,bs
350,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53904000000,bs
351,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Net Income,NetIncomeLoss,usd,311000000,cf
352,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1978000000,cf
353,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Share-based Compensation Arrangement by Share-based Payment Award [Line Items],ShareBasedCompensation,usd,322000000,cf
354,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,240000000,cf
355,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Trade receivables, net",IncreaseDecreaseInAccountsAndOtherReceivables,usd,170000000,cf
356,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Inventories,IncreaseDecreaseInInventories,usd,-246000000,cf
357,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Prepaid expenses and other,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,usd,46000000,cf
358,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Accounts payable, income taxes and other liabilities",IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,usd,867000000,cf
359,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-263000000,cf
360,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-78000000,cf
361,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Lease contract modification-related charge,bdx:LeaseContractModificationRelatedCharge,usd,0,cf
362,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Gain on sale of Vyaire interest,GainOnSaleOfInvestments,usd,303000000,cf
363,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,-85000000,cf
364,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,2865000000,cf
365,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,895000000,cf
366,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Proceeds from (purchases of) investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-11000000,cf
367,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,15281000000,cf
368,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,534000000,cf
369,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,198000000,cf
370,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-15829000000,cf
371,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,0,cf
372,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,5086000000,cf
373,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,3996000000,cf
374,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,0,cf
375,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,0,cf
376,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Excess tax benefit from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
377,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Dividends paid,PaymentsOfDividendsCommonStock,usd,927000000,cf
378,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-220000000,cf
379,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-58000000,cf
380,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Effect of exchange rate changes on cash and equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-17000000,cf
381,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Net (Decrease) Increase in Cash and Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-13039000000,cf
382,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Noncash consideration-fair value of shares issued,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,8004000000,cf
383,Becton Dickson,0000010795,BDX,Medical Products,FY,2018,Noncash consideration-fair value of stock options and other equity awards,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,613000000,cf
384,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,943000000,bs
385,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,98000000,bs
386,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Short-term investments,OtherShortTermInvestments,usd,5000000,bs
387,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2216000000,bs
388,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Materials,InventoryRawMaterialsNetOfReserves,usd,552000000,bs
389,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Work in process,InventoryWorkInProcessNetOfReserves,usd,296000000,bs
390,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1674000000,bs
391,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Inventories:,InventoryNet,usd,2522000000,bs
392,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
393,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Prepaid expenses and other,OtherAssetsCurrent,usd,1157000000,bs
394,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Current Assets:,AssetsCurrent,usd,6941000000,bs
395,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,10585000000,bs
396,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5223000000,bs
397,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5362000000,bs
398,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23505000000,bs
399,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3644000000,bs
400,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,11893000000,bs
401,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,525000000,bs
402,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Other Assets,OtherAssetsNoncurrent,usd,1062000000,bs
403,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Assets held for sale,Assets,usd,52932000000,bs
404,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Short-term debt,DebtCurrent,usd,3254000000,bs
405,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,3891000000,bs
406,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Current Liabilities:,LiabilitiesCurrent,usd,7145000000,bs
407,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Long-Term Debt,LongTermDebtNoncurrent,usd,17817000000,bs
408,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,805000000,bs
409,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5762000000,bs
410,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
411,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Preferred stock,PreferredStockValue,usd,2000000,bs
412,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Common stock,CommonStockValue,usd,347000000,bs
413,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16174000000,bs
414,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13018000000,bs
415,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,24000000,bs
416,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Common stock in treasury - at cost,TreasuryStockValue,usd,6235000000,bs
417,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Accumulated other comprehensive income (loss), net of tax, beginning balance",AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1927000000,bs
418,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,21404000000,bs
419,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,52932000000,bs
420,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Net income (loss),NetIncomeLoss,usd,599000000,cf
421,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,563000000,cf
422,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Share-based compensation,ShareBasedCompensation,usd,93000000,cf
423,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,28000000,cf
424,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,473000000,cf
425,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-225000000,cf
426,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-23000000,cf
427,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Gain on sale of business,GainOnSaleOfInvestments,usd,335000000,cf
428,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,-29000000,cf
429,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,245000000,cf
430,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,167000000,cf
431,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Proceeds from (purchases of) sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-11000000,cf
432,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
433,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,476000000,cf
434,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,20000000,cf
435,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,299000000,cf
436,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,50000000,cf
437,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,0,cf
438,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,453000000,cf
439,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Dividends paid,PaymentsOfDividends,usd,245000000,cf
440,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-86000000,cf
441,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-734000000,cf
442,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-5000000,cf
443,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Net decrease in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-195000000,cf
444,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Fair value of the Company’s issued shares,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,0,cf
445,Becton Dickson,0000010795,BDX,Medical Products,Q1,2019,Non-cash consideration-fair value of equity awards issued,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,0,cf
446,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,686000000,bs
447,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,81000000,bs
448,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Short-term investments,OtherShortTermInvestments,usd,10000000,bs
449,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2279000000,bs
450,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Materials,InventoryRawMaterialsNetOfReserves,usd,555000000,bs
451,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Work in process,InventoryWorkInProcessNetOfReserves,usd,325000000,bs
452,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1748000000,bs
453,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Inventories:,InventoryNet,usd,2627000000,bs
454,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,0,bs
455,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Prepaid expenses and other,OtherAssetsCurrent,usd,1161000000,bs
456,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Current Assets:,AssetsCurrent,usd,6844000000,bs
457,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,10875000000,bs
458,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5402000000,bs
459,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5473000000,bs
460,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Goodwill,Goodwill,usd,23513000000,bs
461,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,11625000000,bs
462,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3564000000,bs
463,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,518000000,bs
464,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Other Assets,OtherAssetsNoncurrent,usd,1061000000,bs
465,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Assets held for sale,Assets,usd,52598000000,bs
466,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Short-term debt,DebtCurrent,usd,3057000000,bs
467,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,4050000000,bs
468,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Current Liabilities:,LiabilitiesCurrent,usd,7108000000,bs
469,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Long-Term Debt,LongTermDebtNoncurrent,usd,17556000000,bs
470,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,815000000,bs
471,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5810000000,bs
472,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
473,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Preferred stock,PreferredStockValue,usd,2000000,bs
474,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Common stock,CommonStockValue,usd,347000000,bs
475,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16177000000,bs
476,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12792000000,bs
477,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
478,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Common stock in treasury - at cost,TreasuryStockValue,usd,6192000000,bs
479,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1839000000,bs
480,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,21309000000,bs
481,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,52598000000,bs
482,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Net Income (Loss),NetIncomeLoss,usd,619000000,cf
483,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1126000000,cf
484,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Share-based compensation,ShareBasedCompensation,usd,152000000,cf
485,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,109000000,cf
486,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,531000000,cf
487,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-202000000,cf
488,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-38000000,cf
489,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Gain on sale of business,GainOnSaleOfInvestments,usd,335000000,cf
490,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Product liability-related charge,LossContingencyLossInPeriod,usd,331000000,cf
491,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,63000000,cf
492,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1027000000,cf
493,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,362000000,cf
494,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-5000000,cf
495,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
496,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,477000000,cf
497,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,90000000,cf
498,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,30000000,cf
499,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,0,cf
500,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,0,cf
501,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,905000000,cf
502,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Dividends paid,PaymentsOfDividends,usd,491000000,cf
503,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-135000000,cf
504,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-1532000000,cf
505,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,5000000,cf
506,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Net decrease in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-469000000,cf
507,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Fair value of shares issued as acquisition consideration,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,0,cf
508,Becton Dickson,0000010795,BDX,Medical Products,Q2,2019,Fair value of equity awards issued as acquisition consideration,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,0,cf
509,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,523000000,bs
510,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,71000000,bs
511,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Short-term investments,OtherShortTermInvestments,usd,12000000,bs
512,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2220000000,bs
513,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Materials,InventoryRawMaterialsNetOfReserves,usd,569000000,bs
514,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Work in process,InventoryWorkInProcessNetOfReserves,usd,317000000,bs
515,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1743000000,bs
516,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Inventories:,InventoryNet,usd,2629000000,bs
517,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
518,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Prepaid expenses and other,OtherAssetsCurrent,usd,1326000000,bs
519,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Current Assets:,AssetsCurrent,usd,6781000000,bs
520,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,11040000000,bs
521,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5491000000,bs
522,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5550000000,bs
523,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Goodwill,Goodwill,usd,23498000000,bs
524,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,11334000000,bs
525,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3507000000,bs
526,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,500000000,bs
527,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Other Assets,OtherAssetsNoncurrent,usd,1063000000,bs
528,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Assets,Assets,usd,52233000000,bs
529,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Short-term debt,DebtCurrent,usd,2168000000,bs
530,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Payables and accrued expenses,AccountsPayableAndAccruedLiabilitiesCurrent,usd,4069000000,bs
531,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Current Liabilities:,LiabilitiesCurrent,usd,6237000000,bs
532,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Long-Term Debt,LongTermDebtNoncurrent,usd,18016000000,bs
533,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,862000000,bs
534,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5621000000,bs
535,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
536,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Preferred stock,PreferredStockValue,usd,2000000,bs
537,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Common stock,CommonStockValue,usd,347000000,bs
538,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16227000000,bs
539,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12997000000,bs
540,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
541,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Common stock in treasury - at cost,TreasuryStockValue,usd,6201000000,bs
542,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1897000000,bs
543,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Shareholders’ Equity,StockholdersEquity,usd,21497000000,bs
544,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,52233000000,bs
545,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Net income,NetIncomeLoss,usd,1071000000,cf
546,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1700000000,cf
547,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Share-based compensation,ShareBasedCompensation,usd,208000000,cf
548,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,172000000,cf
549,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,661000000,cf
550,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-150000000,cf
551,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-45000000,cf
552,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Gain on Sale of Investments,GainOnSaleOfInvestments,usd,N/A,cf
553,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Gain (loss) on disposition of business,GainLossOnSaleOfBusiness,usd,336000000,cf
554,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Product liability-related charge,LossContingencyLossInPeriod,usd,331000000,cf
555,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,77000000,cf
556,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1959000000,cf
557,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,599000000,cf
558,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Proceeds from sale of investments, net",PaymentsForProceedsFromShortTermInvestments,usd,-4000000,cf
559,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
560,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,477000000,cf
561,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,182000000,cf
562,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-300000000,cf
563,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,300000000,cf
564,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,2224000000,cf
565,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,3882000000,cf
566,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Dividends paid,PaymentsOfDividends,usd,737000000,cf
567,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-204000000,cf
568,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-2300000000,cf
569,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-1000000,cf
570,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Net decrease in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-642000000,cf
571,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Fair value of shares issued as acquisition consideration,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,N/A,cf
572,Becton Dickson,0000010795,BDX,Medical Products,Q3,2019,Fair value of equity awards issued as acquisition consideration,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,N/A,cf
573,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,536000000,bs
574,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,54000000,bs
575,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Short-term investments,OtherShortTermInvestments,usd,30000000,bs
576,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2345000000,bs
577,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Inventories,InventoryNet,usd,2579000000,bs
578,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Assets held for sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
579,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Prepaid expenses and other,OtherAssetsCurrent,usd,1119000000,bs
580,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Current Assets,AssetsCurrent,usd,6664000000,bs
581,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5659000000,bs
582,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23376000000,bs
583,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,11054000000,bs
584,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3424000000,bs
585,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,500000000,bs
586,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Other Assets,OtherAssetsNoncurrent,usd,1088000000,bs
587,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Assets,Assets,usd,51765000000,bs
588,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Short-term debt,DebtCurrent,usd,1309000000,bs
589,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Accounts payable,AccountsPayableCurrent,usd,1092000000,bs
590,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Accrued expenses,AccruedLiabilitiesCurrent,usd,2127000000,bs
591,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Salaries, wages and related items",EmployeeRelatedLiabilitiesCurrent,usd,987000000,bs
592,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Income taxes,AccruedIncomeTaxesCurrent,usd,140000000,bs
593,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Current Liabilities,LiabilitiesCurrent,usd,5655000000,bs
594,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Long-Term Debt,LongTermDebtNoncurrent,usd,18081000000,bs
595,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1272000000,bs
596,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Deferred Income Taxes and Other,OtherLiabilitiesNoncurrent,usd,5676000000,bs
597,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Commitments and Contingencies (See Note 5),CommitmentsAndContingencies,usd,N/A,bs
598,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Preferred stock,PreferredStockValue,usd,2000000,bs
599,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Common stock — $1 par value: authorized — 640,000,000 shares; issued — 346,687,160 shares in 2019 and 2018.",CommonStockValue,usd,347000000,bs
600,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16270000000,bs
601,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12913000000,bs
602,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
603,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Common stock in treasury — at cost — 76,259,835 shares in 2019 and 78,462,971 shares in 2018.",TreasuryStockValue,usd,6190000000,bs
604,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2283000000,bs
605,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Shareholders’ Equity,StockholdersEquity,usd,21081000000,bs
606,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,51765000000,bs
607,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Net Income,NetIncomeLoss,usd,1233000000,cf
608,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,2253000000,cf
609,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",ShareBasedCompensation,usd,261000000,cf
610,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,381000000,cf
611,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Trade receivables, net",IncreaseDecreaseInAccountsAndOtherReceivables,usd,51000000,cf
612,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Inventories,IncreaseDecreaseInInventories,usd,149000000,cf
613,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Prepaid expenses and other,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,usd,-299000000,cf
614,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Accounts payable, income taxes and other liabilities",IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,usd,-470000000,cf
615,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,-123000000,cf
616,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-55000000,cf
617,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Lease contract modification-related charge,bdx:LeaseContractModificationRelatedCharge,usd,N/A,cf
618,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Gain on sale of Vyaire interest,GainOnSaleOfInvestments,usd,N/A,cf
619,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Gain on sale of business,GainLossOnSaleOfBusiness,usd,336000000,cf
620,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Product liability-related charges,LossContingencyLossInPeriod,usd,914000000,cf
621,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,177000000,cf
622,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,3330000000,cf
623,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,957000000,cf
624,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Acquisitions of businesses, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
625,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,477000000,cf
626,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,261000000,cf
627,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-741000000,cf
628,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,485000000,cf
629,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,2224000000,cf
630,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,4744000000,cf
631,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,N/A,cf
632,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
633,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Dividends paid,PaymentsOfDividendsCommonStock,usd,984000000,cf
634,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-205000000,cf
635,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-3223000000,cf
636,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-12000000,cf
637,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Net (Decrease) Increase in Cash and Equivalents and Restricted Cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-646000000,cf
638,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Fair value of the Company’s issued shares,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,N/A,cf
639,Becton Dickson,0000010795,BDX,Medical Products,FY,2019,Noncash consideration-fair value of stock options and other equity awards,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,N/A,cf
640,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,560000000,bs
641,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,49000000,bs
642,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Short-term investments,OtherShortTermInvestments,usd,8000000,bs
643,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2074000000,bs
644,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Materials,InventoryRawMaterialsNetOfReserves,usd,599000000,bs
645,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Work in process,InventoryWorkInProcessNetOfReserves,usd,350000000,bs
646,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1811000000,bs
647,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Inventories:,InventoryNet,usd,2760000000,bs
648,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Prepaid expenses and other,OtherAssetsCurrent,usd,987000000,bs
649,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Current Assets:,AssetsCurrent,usd,6438000000,bs
650,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,11425000000,bs
651,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5643000000,bs
652,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5782000000,bs
653,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23435000000,bs
654,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,10848000000,bs
655,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3345000000,bs
656,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,532000000,bs
657,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Other Assets,OtherAssetsNoncurrent,usd,1573000000,bs
658,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Assets,Assets,usd,51952000000,bs
659,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Short-term debt,DebtCurrent,usd,2456000000,bs
660,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,4269000000,bs
661,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Current Liabilities:,LiabilitiesCurrent,usd,6726000000,bs
662,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Long-Term Debt,LongTermDebtNoncurrent,usd,16949000000,bs
663,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1290000000,bs
664,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5785000000,bs
665,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
666,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Preferred stock,PreferredStockValue,usd,2000000,bs
667,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Common stock,CommonStockValue,usd,347000000,bs
668,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16320000000,bs
669,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12938000000,bs
670,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,24000000,bs
671,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Common stock in treasury - at cost,TreasuryStockValue,usd,6228000000,bs
672,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Accumulated other comprehensive income (loss), net of tax, beginning balance",AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2202000000,bs
673,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,21202000000,bs
674,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,51952000000,bs
675,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Net income,NetIncomeLoss,usd,278000000,cf
676,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,530000000,cf
677,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Share-based compensation,ShareBasedCompensation,usd,82000000,cf
678,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Deferred income taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,71000000,cf
679,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-102000000,cf
680,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Pension obligation,IncreaseDecreaseInPensionPlanObligations,usd,24000000,cf
681,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Gain on sale of business,GainLossOnSaleOfBusiness,usd,N/A,cf
682,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,231000000,cf
683,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,713000000,cf
684,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,173000000,cf
685,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
686,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,114000000,cf
687,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-287000000,cf
688,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,210000000,cf
689,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,303000000,cf
690,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Dividends paid,PaymentsOfDividends,usd,252000000,cf
691,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-68000000,cf
692,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-413000000,cf
693,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,6000000,cf
694,Becton Dickson,0000010795,BDX,Medical Products,Q1,2020,Net increase (decrease) in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,18000000,cf
695,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2351000000,bs
696,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,88000000,bs
697,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Short-term investments,OtherShortTermInvestments,usd,6000000,bs
698,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2160000000,bs
699,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Materials,InventoryRawMaterialsNetOfReserves,usd,601000000,bs
700,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Work in process,InventoryWorkInProcessNetOfReserves,usd,357000000,bs
701,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1836000000,bs
702,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Inventories:,InventoryNet,usd,2793000000,bs
703,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Prepaid expenses and other,OtherAssetsCurrent,usd,1156000000,bs
704,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Current Assets:,AssetsCurrent,usd,8555000000,bs
705,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,11262000000,bs
706,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5598000000,bs
707,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5664000000,bs
708,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,23415000000,bs
709,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,10545000000,bs
710,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3261000000,bs
711,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,567000000,bs
712,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Other Assets,OtherAssetsNoncurrent,usd,1509000000,bs
713,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Assets,Assets,usd,53516000000,bs
714,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Short-term debt,DebtCurrent,usd,4357000000,bs
715,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,4398000000,bs
716,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Current Liabilities:,LiabilitiesCurrent,usd,8755000000,bs
717,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Long-Term Debt,LongTermDebtNoncurrent,usd,16809000000,bs
718,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1253000000,bs
719,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5747000000,bs
720,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
721,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Preferred stock,PreferredStockValue,usd,2000000,bs
722,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Common stock,CommonStockValue,usd,347000000,bs
723,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,16288000000,bs
724,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12868000000,bs
725,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
726,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Common stock in treasury - at cost,TreasuryStockValue,usd,6158000000,bs
727,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2419000000,bs
728,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,20951000000,bs
729,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53516000000,bs
730,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Net income,NetIncomeLoss,usd,461000000,cf
731,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1067000000,cf
732,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Share-based compensation,ShareBasedCompensation,usd,141000000,cf
733,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Deferred income taxes,DeferredIncomeTaxExpenseBenefit,usd,-136000000,cf
734,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,258000000,cf
735,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,49000000,cf
736,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Gain on sale of business,GainLossOnSaleOfBusiness,usd,N/A,cf
737,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Product liability-related charge,LossContingencyLossInPeriod,usd,N/A,cf
738,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-128000000,cf
739,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1196000000,cf
740,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,395000000,cf
741,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
742,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,147000000,cf
743,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-542000000,cf
744,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,210000000,cf
745,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Proceeds from long-term debt and term loans,bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans,usd,1900000000,cf
746,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,305000000,cf
747,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Dividends paid,PaymentsOfDividends,usd,505000000,cf
748,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-90000000,cf
749,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1210000000,cf
750,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-15000000,cf
751,Becton Dickson,0000010795,BDX,Medical Products,Q2,2020,Net increase (decrease) in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,1849000000,cf
752,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2882000000,bs
753,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,82000000,bs
754,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Short-term investments,OtherShortTermInvestments,usd,22000000,bs
755,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Trade receivables, net",AccountsReceivableNetCurrent,usd,1993000000,bs
756,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Materials,InventoryRawMaterialsNetOfReserves,usd,627000000,bs
757,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Work in process,InventoryWorkInProcessNetOfReserves,usd,336000000,bs
758,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1983000000,bs
759,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Inventories,InventoryNet,usd,2945000000,bs
760,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Prepaid expenses and other,OtherAssetsCurrent,usd,903000000,bs
761,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Current Assets:,AssetsCurrent,usd,8827000000,bs
762,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,11660000000,bs
763,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,5819000000,bs
764,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5841000000,bs
765,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Goodwill, Purchase Accounting Adjustments",Goodwill,usd,23549000000,bs
766,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,10356000000,bs
767,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3186000000,bs
768,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,567000000,bs
769,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Other Assets,OtherAssetsNoncurrent,usd,1632000000,bs
770,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Assets,Assets,usd,53959000000,bs
771,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Short-term debt,DebtCurrent,usd,1630000000,bs
772,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,4437000000,bs
773,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Total Current Liabilities,LiabilitiesCurrent,usd,6067000000,bs
774,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Long-Term Debt,LongTermDebtNoncurrent,usd,17090000000,bs
775,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1297000000,bs
776,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5483000000,bs
777,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
778,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Preferred stock,PreferredStockValue,usd,2000000,bs
779,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Common stock,CommonStockValue,usd,365000000,bs
780,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19228000000,bs
781,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12916000000,bs
782,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
783,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Common stock in treasury - at cost,TreasuryStockValue,usd,6145000000,bs
784,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2367000000,bs
785,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,24022000000,bs
786,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53959000000,bs
787,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Net income applicable to common shareholders,NetIncomeLoss,usd,746000000,cf
788,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1601000000,cf
789,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Share-based compensation,ShareBasedCompensation,usd,193000000,cf
790,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-203000000,cf
791,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,248000000,cf
792,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,77000000,cf
793,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Gain on sale of business,GainLossOnSaleOfBusiness,usd,N/A,cf
794,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Product liability-related charge,LossContingencyLossInPeriod,usd,N/A,cf
795,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-107000000,cf
796,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,2058000000,cf
797,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,597000000,cf
798,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Payments to Acquire Businesses, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,139000000,cf
799,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
800,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,169000000,cf
801,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-905000000,cf
802,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-485000000,cf
803,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Proceeds from long-term debt and term loans,bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans,usd,3389000000,cf
804,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,3711000000,cf
805,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Proceeds from Issuance or Sale of Equity,ProceedsFromIssuanceOrSaleOfEquity,usd,2917000000,cf
806,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Dividends paid,PaymentsOfDividends,usd,773000000,cf
807,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-106000000,cf
808,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Net Cash Provided by (Used for) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1230000000,cf
809,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-9000000,cf
810,Becton Dickson,0000010795,BDX,Medical Products,Q3,2020,Net increase (decrease) in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,2374000000,cf
811,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Short-term debt,DebtCurrent,usd,707000000,bs
812,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Short-term debt,DebtCurrent,usd,707000000,bs
813,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5753000000,bs
814,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2825000000,bs
815,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2825000000,bs
816,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,560000000,bs
817,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19270000000,bs
818,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Current Liabilities,LiabilitiesCurrent,usd,5836000000,bs
819,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2548000000,bs
820,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2548000000,bs
821,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Income taxes,AccruedIncomeTaxesCurrent,usd,144000000,bs
822,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
823,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Goodwill,Goodwill,usd,23620000000,bs
824,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Goodwill,Goodwill,usd,23620000000,bs
825,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2398000000,bs
826,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Common stock, shares issued (shares)",CommonStockSharesIssued,shares,364639901,bs
827,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Short-term investments,OtherShortTermInvestments,usd,20000000,bs
828,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,92000000,bs
829,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,92000000,bs
830,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Current Assets,AssetsCurrent,usd,8969000000,bs
831,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Commitments and Contingencies (See Note 5),CommitmentsAndContingencies,usd,N/A,bs
832,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Inventories,InventoryNet,usd,2743000000,bs
833,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Inventories,InventoryNet,usd,2743000000,bs
834,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Prepaid expenses and other,OtherAssetsCurrent,usd,891000000,bs
835,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Preferred stock,PreferredStockValue,usd,2000000,bs
836,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Common stock, shares authorized (shares)",CommonStockSharesAuthorized,shares,N/A,bs
837,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Salaries, wages and related items",EmployeeRelatedLiabilitiesCurrent,usd,993000000,bs
838,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1435000000,bs
839,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Assets,Assets,usd,54012000000,bs
840,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Assets,Assets,usd,54012000000,bs
841,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Accounts payable,AccountsPayableCurrent,usd,1355000000,bs
842,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Long-Term Debt,LongTermDebtNoncurrent,usd,17224000000,bs
843,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Long-Term Debt,LongTermDebtNoncurrent,usd,17224000000,bs
844,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Common stock — $1 par value: authorized — 640,000,000 shares; issued — 364,639,901 shares in 2020 and 346,687,160 shares in 2019.",CommonStockValue,usd,365000000,bs
845,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Other Assets,OtherAssetsNoncurrent,usd,1687000000,bs
846,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12791000000,bs
847,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Shareholders’ Equity,StockholdersEquity,usd,23765000000,bs
848,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,10146000000,bs
849,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3107000000,bs
850,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54012000000,bs
851,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Common stock, par value (USD per share)",CommonStockParOrStatedValuePerShare,usd/shares,1,bs
852,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5923000000,bs
853,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,5923000000,bs
854,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Common stock in treasury — at cost — 74,622,657 shares in 2020 and 76,259,835 shares in 2019.",TreasuryStockValue,usd,6138000000,bs
855,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Accrued expenses,AccruedLiabilitiesCurrent,usd,2638000000,bs
856,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Income,NetIncomeLoss,usd,874000000,cf
857,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Income,NetIncomeLoss,usd,874000000,cf
858,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Income,NetIncomeLoss,usd,874000000,cf
859,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Income,NetIncomeLoss,usd,874000000,cf
860,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Increase (Decrease) in Other Operating Assets and Liabilities, Net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,68000000,cf
861,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,810000000,cf
862,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,810000000,cf
863,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Dividends paid,PaymentsOfDividendsCommonStock,usd,1026000000,cf
864,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,3389000000,cf
865,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Cash Used for Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-1232000000,cf
866,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,4664000000,cf
867,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Noncash consideration-fair value of stock options and other equity awards,bdx:BusinessCombinationConsiderationTransferredStockOptionsAndAwards,usd,N/A,cf
868,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Gain on sale of business,GainLossOnSaleOfBusiness,usd,N/A,cf
869,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Trade receivables, net",IncreaseDecreaseInAccountsAndOtherReceivables,usd,48000000,cf
870,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Share-based compensation,ShareBasedCompensation,usd,244000000,cf
871,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-52000000,cf
872,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Gain on sale of Vyaire interest,GainOnSaleOfInvestments,usd,N/A,cf
873,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-302000000,cf
874,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Noncash consideration-fair value of shares issued,BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable,usd,N/A,cf
875,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Inventories,IncreaseDecreaseInInventories,usd,125000000,cf
876,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-485000000,cf
877,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,2154000000,cf
878,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,2154000000,cf
879,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,2917000000,cf
880,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
881,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Increase (Decrease) in Cash and Equivalents and Restricted Cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,2326000000,cf
882,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,95000000,cf
883,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Product liability-related charges,LossContingencyLossInPeriod,usd,378000000,cf
884,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,164000000,cf
885,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,257000000,cf
886,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Cash Provided by (Used for) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,22000000,cf
887,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-3000000,cf
888,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Accounts payable, income taxes and other liabilities",IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,usd,205000000,cf
889,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Prepaid expenses and other,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,usd,-81000000,cf
890,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-109000000,cf
891,Becton Dickson,0000010795,BDX,Medical Products,FY,2020,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,3539000000,cf
892,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3248000000,bs
893,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,199000000,bs
894,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Short-term investments,OtherShortTermInvestments,usd,17000000,bs
895,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2370000000,bs
896,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Materials,InventoryRawMaterialsNetOfReserves,usd,651000000,bs
897,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Work in process,InventoryWorkInProcessNetOfReserves,usd,366000000,bs
898,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1798000000,bs
899,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Inventories,InventoryNet,usd,2814000000,bs
900,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Prepaid expenses and other,OtherAssetsCurrent,usd,889000000,bs
901,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Total Current Assets,AssetsCurrent,usd,9537000000,bs
902,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,12273000000,bs
903,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,6177000000,bs
904,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6096000000,bs
905,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Goodwill [Line Items],Goodwill,usd,23758000000,bs
906,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9940000000,bs
907,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,3053000000,bs
908,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,564000000,bs
909,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Other Assets,OtherAssetsNoncurrent,usd,1801000000,bs
910,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Assets,Assets,usd,54748000000,bs
911,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Short-term debt,DebtCurrent,usd,1737000000,bs
912,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,5284000000,bs
913,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Total Current Liabilities,LiabilitiesCurrent,usd,7021000000,bs
914,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Long-Term Debt,LongTermDebtNoncurrent,usd,16082000000,bs
915,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1434000000,bs
916,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5549000000,bs
917,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
918,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Preferred stock,PreferredStockValue,usd,2000000,bs
919,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Common stock,CommonStockValue,usd,365000000,bs
920,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19301000000,bs
921,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13522000000,bs
922,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
923,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Common stock in treasury - at cost,TreasuryStockValue,usd,6136000000,bs
924,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2414000000,bs
925,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Shareholders' Equity,StockholdersEquity,usd,24663000000,bs
926,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54748000000,bs
927,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Net Income,NetIncomeLoss,usd,1003000000,cf
928,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,555000000,cf
929,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Share-based compensation,ShareBasedCompensation,usd,83000000,cf
930,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-66000000,cf
931,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-24000000,cf
932,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,26000000,cf
933,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-91000000,cf
934,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1533000000,cf
935,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,246000000,cf
936,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Payments to Acquire Businesses, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,67000000,cf
937,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,116000000,cf
938,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-430000000,cf
939,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,N/A,cf
940,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,267000000,cf
941,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Dividends paid,PaymentsOfDividends,usd,264000000,cf
942,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-61000000,cf
943,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Net Cash Used for Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-592000000,cf
944,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,18000000,cf
945,Becton Dickson,0000010795,BDX,Medical Products,Q1,2021,Net increase in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,530000000,cf
946,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3734000000,bs
947,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,164000000,bs
948,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Short-term investments,OtherShortTermInvestments,usd,24000000,bs
949,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2118000000,bs
950,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Materials,InventoryRawMaterialsNetOfReserves,usd,642000000,bs
951,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Work in process,InventoryWorkInProcessNetOfReserves,usd,392000000,bs
952,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1861000000,bs
953,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Inventories,InventoryNet,usd,2895000000,bs
954,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Prepaid expenses and other,OtherAssetsCurrent,usd,1065000000,bs
955,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Current Assets:,AssetsCurrent,usd,10000000000,bs
956,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,12420000000,bs
957,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,6277000000,bs
958,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6142000000,bs
959,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Goodwill, Purchase Accounting Adjustments",Goodwill,usd,23772000000,bs
960,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9710000000,bs
961,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2977000000,bs
962,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,561000000,bs
963,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Other Assets,OtherAssetsNoncurrent,usd,1758000000,bs
964,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Assets,Assets,usd,54921000000,bs
965,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Short-term debt,DebtCurrent,usd,1000000,bs
966,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,5375000000,bs
967,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Total Current Liabilities,LiabilitiesCurrent,usd,5376000000,bs
968,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Long-Term Debt,LongTermDebtNoncurrent,usd,17718000000,bs
969,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1425000000,bs
970,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5575000000,bs
971,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
972,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Preferred stock,PreferredStockValue,usd,2000000,bs
973,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Common stock,CommonStockValue,usd,365000000,bs
974,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19341000000,bs
975,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13557000000,bs
976,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
977,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Common stock in treasury - at cost,TreasuryStockValue,usd,6132000000,bs
978,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2329000000,bs
979,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,24826000000,bs
980,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54921000000,bs
981,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Net income applicable to common shareholders,NetIncomeLoss,usd,1302000000,cf
982,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1113000000,cf
983,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Share-based compensation,ShareBasedCompensation,usd,138000000,cf
984,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-120000000,cf
985,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-55000000,cf
986,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,45000000,cf
987,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Product liability-related charge,LossContingencyLossInPeriod,usd,296000000,cf
988,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-109000000,cf
989,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,2721000000,cf
990,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,499000000,cf
991,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,179000000,cf
992,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,186000000,cf
993,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-863000000,cf
994,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,N/A,cf
995,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Proceeds from long-term debt and term loans,bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans,usd,1715000000,cf
996,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,1998000000,cf
997,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Dividends paid,PaymentsOfDividends,usd,528000000,cf
998,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-82000000,cf
999,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Net Cash (Used for) Provided by Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-893000000,cf
1000,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,17000000,cf
1001,Becton Dickson,0000010795,BDX,Medical Products,Q2,2021,Net increase in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,981000000,cf
1002,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6164000000,bs
1003,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1922000000,bs
1004,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2899000000,bs
1005,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Short-term debt,DebtCurrent,usd,2033000000,bs
1006,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Total Assets,Assets,usd,54333000000,bs
1007,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Total Shareholders’ Equity,StockholdersEquity,usd,24135000000,bs
1008,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,12651000000,bs
1009,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Work in process,InventoryWorkInProcessNetOfReserves,usd,388000000,bs
1010,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2078000000,bs
1011,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19282000000,bs
1012,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Goodwill,Goodwill,usd,23814000000,bs
1013,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Goodwill,Goodwill,usd,23814000000,bs
1014,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Materials,InventoryRawMaterialsNetOfReserves,usd,636000000,bs
1015,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Long-Term Debt,LongTermDebtNoncurrent,usd,15700000000,bs
1016,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
1017,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,128000000,bs
1018,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,128000000,bs
1019,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Preferred stock,PreferredStockValue,usd,2000000,bs
1020,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Total Current Assets,AssetsCurrent,usd,9538000000,bs
1021,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Prepaid expenses and other,OtherAssetsCurrent,usd,1207000000,bs
1022,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
1023,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Short-term investments,OtherShortTermInvestments,usd,24000000,bs
1024,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Other Assets,OtherAssetsNoncurrent,usd,1821000000,bs
1025,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13821000000,bs
1026,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Common stock,CommonStockValue,usd,365000000,bs
1027,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,6487000000,bs
1028,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1421000000,bs
1029,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2330000000,bs
1030,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2330000000,bs
1031,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54333000000,bs
1032,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5329000000,bs
1033,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,5716000000,bs
1034,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,557000000,bs
1035,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Inventories,InventoryNet,usd,2947000000,bs
1036,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Common stock in treasury - at cost,TreasuryStockValue,usd,7027000000,bs
1037,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9541000000,bs
1038,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Total Current Liabilities,LiabilitiesCurrent,usd,7749000000,bs
1039,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3153000000,bs
1040,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3153000000,bs
1041,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-95000000,cf
1042,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net Cash Used for Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-1186000000,cf
1043,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Product liability-related charge,LossContingencyLossInPeriod,usd,296000000,cf
1044,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-411000000,cf
1045,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-91000000,cf
1046,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,3696000000,cf
1047,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Share-based compensation,ShareBasedCompensation,usd,189000000,cf
1048,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,137000000,cf
1049,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,18000000,cf
1050,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net increase in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,365000000,cf
1051,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1681000000,cf
1052,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,1999000000,cf
1053,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Proceeds from long-term debt and term loans,bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans,usd,1715000000,cf
1054,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net income,NetIncomeLoss,usd,1827000000,cf
1055,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net income,NetIncomeLoss,usd,1827000000,cf
1056,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net income,NetIncomeLoss,usd,1827000000,cf
1057,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,283000000,cf
1058,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,52000000,cf
1059,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,766000000,cf
1060,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,-158000000,cf
1061,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,N/A,cf
1062,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Dividends paid,PaymentsOfDividends,usd,789000000,cf
1063,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Repurchases of common stock,PaymentsForRepurchaseOfCommonStock,usd,1000000000,cf
1064,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Net Cash (Used for) Provided by Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-2164000000,cf
1065,Becton Dickson,0000010795,BDX,Medical Products,Q3,2021,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,N/A,cf
1066,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Commitments and Contingencies (See Note 5),CommitmentsAndContingencies,usd,N/A,bs
1067,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1228000000,bs
1068,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Common stock, shares issued (shares)",CommonStockSharesIssued,shares,364639901,bs
1069,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6393000000,bs
1070,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6393000000,bs
1071,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,23000000,bs
1072,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Common stock, par value (USD per share)",CommonStockParOrStatedValuePerShare,usd/shares,1,bs
1073,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2088000000,bs
1074,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2088000000,bs
1075,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,548000000,bs
1076,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Goodwill,Goodwill,usd,23901000000,bs
1077,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Goodwill,Goodwill,usd,23901000000,bs
1078,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Total Current Assets,AssetsCurrent,usd,8838000000,bs
1079,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19272000000,bs
1080,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,109000000,bs
1081,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,109000000,bs
1082,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9417000000,bs
1083,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Common stock, shares authorized (shares)",CommonStockSharesAuthorized,shares,640000000,bs
1084,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Long-Term Debt,LongTermDebtNoncurrent,usd,17110000000,bs
1085,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Long-Term Debt,LongTermDebtNoncurrent,usd,17110000000,bs
1086,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Short-term debt,DebtCurrent,usd,500000000,bs
1087,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Short-term debt,DebtCurrent,usd,500000000,bs
1088,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Common stock — $1 par value: authorized — 640,000,000 shares; issued — 364,639,901 shares in 2021 and 2020.",CommonStockValue,usd,365000000,bs
1089,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Accrued expenses,AccruedLiabilitiesCurrent,usd,2943000000,bs
1090,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2497000000,bs
1091,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Salaries, wages and related items",EmployeeRelatedLiabilitiesCurrent,usd,1214000000,bs
1092,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Common stock in treasury — at cost — 80,163,949 shares in 2021 and 74,622,657 shares in 2020.",TreasuryStockValue,usd,7723000000,bs
1093,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Short-term investments,OtherShortTermInvestments,usd,12000000,bs
1094,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Other Assets,OtherAssetsNoncurrent,usd,1952000000,bs
1095,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Income taxes,AccruedIncomeTaxesCurrent,usd,176000000,bs
1096,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Prepaid expenses and other,OtherAssetsCurrent,usd,1072000000,bs
1097,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2283000000,bs
1098,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2283000000,bs
1099,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5225000000,bs
1100,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Preferred stock,PreferredStockValue,usd,2000000,bs
1101,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Total Current Liabilities,LiabilitiesCurrent,usd,6626000000,bs
1102,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Accounts payable,AccountsPayableCurrent,usd,1793000000,bs
1103,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Inventories,InventoryNet,usd,2866000000,bs
1104,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Inventories,InventoryNet,usd,2866000000,bs
1105,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13826000000,bs
1106,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53866000000,bs
1107,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2818000000,bs
1108,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Total Assets,Assets,usd,53866000000,bs
1109,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Total Shareholders’ Equity,StockholdersEquity,usd,23677000000,bs
1110,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Share-based compensation,ShareBasedCompensation,usd,237000000,cf
1111,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net (Decrease) Increase in Cash and Equivalents and Restricted Cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-525000000,cf
1112,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Change in credit facility borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,0,cf
1113,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,4647000000,cf
1114,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Accounts payable, income taxes and other liabilities",IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,usd,687000000,cf
1115,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Proceeds from issuance of equity securities,ProceedsFromIssuanceOrSaleOfEquity,usd,0,cf
1116,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Other, net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,400000000,cf
1117,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Payments of debt and term loans,RepaymentsOfLongTermDebt,usd,5112000000,cf
1118,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-265000000,cf
1119,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,508000000,cf
1120,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,1231000000,cf
1121,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,1231000000,cf
1122,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Cash Used for Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-1880000000,cf
1123,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Repurchase of common stock,PaymentsForRepurchaseOfCommonStock,usd,1750000000,cf
1124,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Trade receivables, net",IncreaseDecreaseInAccountsAndOtherReceivables,usd,95000000,cf
1125,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-304000000,cf
1126,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Gain on sale of business,GainLossOnSaleOfBusiness,usd,0,cf
1127,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,71000000,cf
1128,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,15000000,cf
1129,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Excess tax benefits from payments under share-based compensation plans,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,-15000000,cf
1130,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Dividends paid,PaymentsOfDividendsCommonStock,usd,1048000000,cf
1131,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Prepaid expenses and other,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,usd,186000000,cf
1132,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Product liability-related charges,LossContingencyLossInPeriod,usd,361000000,cf
1133,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Cash (Used for) Provided by Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-3306000000,cf
1134,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,142000000,cf
1135,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Proceeds from long-term debt and term loans,ProceedsFromIssuanceOfLongTermDebt,usd,4869000000,cf
1136,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,"Proceeds from divestitures, net",ProceedsFromDivestitureOfBusinesses,usd,0,cf
1137,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Inventories,IncreaseDecreaseInInventories,usd,104000000,cf
1138,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,2273000000,cf
1139,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,2273000000,cf
1140,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Income,NetIncomeLoss,usd,2092000000,cf
1141,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Income,NetIncomeLoss,usd,2092000000,cf
1142,Becton Dickson,0000010795,BDX,Medical Products,FY,2021,Net Income,NetIncomeLoss,usd,2092000000,cf
1143,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,6648000000,bs
1144,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1903000000,bs
1145,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1903000000,bs
1146,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Common stock in treasury - at cost,TreasuryStockValue,usd,7855000000,bs
1147,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6384000000,bs
1148,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19435000000,bs
1149,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,144000000,bs
1150,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,144000000,bs
1151,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1078000000,bs
1152,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Other Assets,OtherAssetsNoncurrent,usd,1945000000,bs
1153,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Current debt obligations,DebtCurrent,usd,1064000000,bs
1154,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Finished products,InventoryFinishedGoodsNetOfReserves,usd,1943000000,bs
1155,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Inventories,InventoryNet,usd,3035000000,bs
1156,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
1157,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,53363000000,bs
1158,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Long-Term Debt,LongTermDebtNoncurrent,usd,16360000000,bs
1159,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Preferred stock,PreferredStockValue,usd,2000000,bs
1160,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Materials,InventoryRawMaterialsNetOfReserves,usd,699000000,bs
1161,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Total Shareholders’ Equity,StockholdersEquity,usd,24160000000,bs
1162,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Total Current Assets,AssetsCurrent,usd,8307000000,bs
1163,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9302000000,bs
1164,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,5671000000,bs
1165,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2765000000,bs
1166,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,5030000000,bs
1167,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2177000000,bs
1168,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Work in process,InventoryWorkInProcessNetOfReserves,usd,393000000,bs
1169,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Total Current Liabilities,LiabilitiesCurrent,usd,6735000000,bs
1170,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Total Assets,Assets,usd,53363000000,bs
1171,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Goodwill,Goodwill,usd,24116000000,bs
1172,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Goodwill,Goodwill,usd,24116000000,bs
1173,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Prepaid expenses and other,OtherAssetsCurrent,usd,1040000000,bs
1174,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Common stock,CommonStockValue,usd,365000000,bs
1175,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Short-term investments,OtherShortTermInvestments,usd,8000000,bs
1176,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,544000000,bs
1177,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,14233000000,bs
1178,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,24000000,bs
1179,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2043000000,bs
1180,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2043000000,bs
1181,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,13031000000,bs
1182,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Share-based compensation,ShareBasedCompensation,usd,83000000,cf
1183,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-6000000,cf
1184,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,415000000,cf
1185,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,188000000,cf
1186,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Payments of debt,RepaymentsOfLongTermDebt,usd,N/A,cf
1187,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,278000000,cf
1188,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,674000000,cf
1189,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,-144000000,cf
1190,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,84000000,cf
1191,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net (decrease) increase in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-345000000,cf
1192,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net income,NetIncomeLoss,usd,677000000,cf
1193,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net income,NetIncomeLoss,usd,677000000,cf
1194,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net income,NetIncomeLoss,usd,677000000,cf
1195,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net Cash Used for Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-686000000,cf
1196,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,557000000,cf
1197,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Dividends paid,PaymentsOfDividends,usd,271000000,cf
1198,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-69000000,cf
1199,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-154000000,cf
1200,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,Net Cash Used for Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-327000000,cf
1201,Becton Dickson,0000010795,BDX,Medical Products,Q1,2022,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-56000000,cf
1202,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,6406000000,bs
1203,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Materials,InventoryRawMaterialsNetOfReserves,usd,708000000,bs
1204,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Treasury stock,TreasuryStockValue,usd,7866000000,bs
1205,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Deferred Income Taxes and Other Liabilities,OtherLiabilitiesNoncurrent,usd,4973000000,bs
1206,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Long-Term Employee Benefit Obligations,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,1048000000,bs
1207,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Capital in excess of par value,AdditionalPaidInCapitalCommonStock,usd,19495000000,bs
1208,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Common stock,CommonStockValue,usd,365000000,bs
1209,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3147000000,bs
1210,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Cash and equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3147000000,bs
1211,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Total Assets,Assets,usd,54786000000,bs
1212,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Total Shareholders’ Equity,StockholdersEquity,usd,24525000000,bs
1213,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Total Current Assets,AssetsCurrent,usd,10152000000,bs
1214,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Deferred compensation,bdx:CommonStockSharesHeldInEmployeeTrust1,usd,24000000,bs
1215,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,173000000,bs
1216,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Restricted cash,RestrictedCashAndInvestmentsCurrent,usd,173000000,bs
1217,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Current debt obligations,DebtCurrent,usd,1051000000,bs
1218,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,54786000000,bs
1219,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Inventories,InventoryNet,usd,3258000000,bs
1220,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Developed Technology, Net",bdx:CoreAndDevelopedTechnologyNet,usd,9044000000,bs
1221,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Customer Relationships, Net",bdx:FiniteLivedCustomerRelationshipsNet,usd,2681000000,bs
1222,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,14416000000,bs
1223,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1910000000,bs
1224,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-1910000000,bs
1225,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Prepaid expenses and other,OtherAssetsCurrent,usd,1256000000,bs
1226,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Commitments and Contingencies,CommitmentsAndContingencies,usd,N/A,bs
1227,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Total Current Liabilities,LiabilitiesCurrent,usd,6657000000,bs
1228,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Property, Plant and Equipment",PropertyPlantAndEquipmentGross,usd,13193000000,bs
1229,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Other Intangibles, Net",OtherIntangibleAssetsNet,usd,542000000,bs
1230,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Goodwill,Goodwill,usd,24096000000,bs
1231,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Goodwill,Goodwill,usd,24096000000,bs
1232,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Work in process,InventoryWorkInProcessNetOfReserves,usd,413000000,bs
1233,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Long-Term Debt,LongTermDebtNoncurrent,usd,17584000000,bs
1234,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Trade receivables, net",AccountsReceivableNetCurrent,usd,2303000000,bs
1235,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Less allowances for depreciation and amortization,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,6788000000,bs
1236,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Finished products,InventoryFinishedGoodsNetOfReserves,usd,2137000000,bs
1237,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Other Assets,OtherAssetsNoncurrent,usd,1866000000,bs
1238,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Payables, accrued expenses and other current liabilities",AccountsPayableAndAccruedLiabilitiesCurrent,usd,5605000000,bs
1239,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Preferred stock,PreferredStockValue,usd,2000000,bs
1240,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Short-term investments,OtherShortTermInvestments,usd,15000000,bs
1241,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Dividends paid,PaymentsOfDividends,usd,541000000,cf
1242,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-76000000,cf
1243,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net increase in cash and equivalents and restricted cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,928000000,cf
1244,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Payments of debt,RepaymentsOfLongTermDebt,usd,2000000,cf
1245,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,415000000,cf
1246,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Effect of exchange rate changes on cash and equivalents and restricted cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-4000000,cf
1247,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-80000000,cf
1248,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net income,NetIncomeLoss,usd,1131000000,cf
1249,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net income,NetIncomeLoss,usd,1131000000,cf
1250,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net income,NetIncomeLoss,usd,1131000000,cf
1251,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net Cash Provided by (Used for) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,804000000,cf
1252,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,450000000,cf
1253,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net Cash Provided by Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1118000000,cf
1254,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Proceeds from long-term debt,bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans,usd,N/A,cf
1255,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,124000000,cf
1256,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Proceeds from debt issued in connection with the spin-off (see Note 12),ProceedsFromIssuanceOfOtherLongTermDebt,usd,1424000000,cf
1257,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Change in operating assets and liabilities,IncreaseDecreaseInOperatingCapital,usd,950000000,cf
1258,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-101000000,cf
1259,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Depreciation and amortization,DepreciationDepletionAndAmortization,usd,1114000000,cf
1260,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Net Cash Used for Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-990000000,cf
1261,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Product liability-related charge,LossContingencyLossInPeriod,usd,N/A,cf
1262,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Share-based compensation,ShareBasedCompensation,usd,140000000,cf
1263,Becton Dickson,0000010795,BDX,Medical Products,Q2,2022,Pension obligation,bdx:IncreaseDecreaseinPensionBenefitObligation,usd,-136000000,cf
1264,American Express,0000004962,AXP,Banking,Q2,2017,CashAndDueFromBanks,CashAndDueFromBanks,usd,2709000000,bs
1265,American Express,0000004962,AXP,Banking,Q2,2017,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,26363000000,bs
1266,American Express,0000004962,AXP,Banking,Q2,2017,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,1370000000,bs
1267,American Express,0000004962,AXP,Banking,Q2,2017,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,30442000000,bs
1268,American Express,0000004962,AXP,Banking,Q2,2017,AccountsReceivableNet,AccountsReceivableNet,usd,48930000000,bs
1269,American Express,0000004962,AXP,Banking,Q2,2017,OtherReceivables,OtherReceivables,usd,2832000000,bs
1270,American Express,0000004962,AXP,Banking,Q2,2017,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,64651000000,bs
1271,American Express,0000004962,AXP,Banking,Q2,2017,LoansReceivableNet,LoansReceivableNet,usd,1855000000,bs
1272,American Express,0000004962,AXP,Banking,Q2,2017,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,3360000000,bs
1273,American Express,0000004962,AXP,Banking,Q2,2017,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4445000000,bs
1274,American Express,0000004962,AXP,Banking,Q2,2017,OtherAssets,OtherAssets,usd,10482000000,bs
1275,American Express,0000004962,AXP,Banking,Q2,2017,Assets,Assets,usd,166997000000,bs
1276,American Express,0000004962,AXP,Banking,Q2,2017,Deposits,Deposits,usd,57726000000,bs
1277,American Express,0000004962,AXP,Banking,Q2,2017,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2503000000,bs
1278,American Express,0000004962,AXP,Banking,Q2,2017,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,12106000000,bs
1279,American Express,0000004962,AXP,Banking,Q2,2017,ShortTermBorrowings,ShortTermBorrowings,usd,3426000000,bs
1280,American Express,0000004962,AXP,Banking,Q2,2017,LongTermDebt,LongTermDebt,usd,51945000000,bs
1281,American Express,0000004962,AXP,Banking,Q2,2017,OtherLiabilities,OtherLiabilities,usd,18116000000,bs
1282,American Express,0000004962,AXP,Banking,Q2,2017,Liabilities,Liabilities,usd,145822000000,bs
1283,American Express,0000004962,AXP,Banking,Q2,2017,PreferredStockValue,PreferredStockValue,usd,0,bs
1284,American Express,0000004962,AXP,Banking,Q2,2017,CommonStockValue,CommonStockValue,usd,177000000,bs
1285,American Express,0000004962,AXP,Banking,Q2,2017,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12456000000,bs
1286,American Express,0000004962,AXP,Banking,Q2,2017,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,10970000000,bs
1287,American Express,0000004962,AXP,Banking,Q2,2017,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,13000000,bs
1288,American Express,0000004962,AXP,Banking,Q2,2017,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1913000000,bs
1289,American Express,0000004962,AXP,Banking,Q2,2017,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,528000000,bs
1290,American Express,0000004962,AXP,Banking,Q2,2017,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2428000000,bs
1291,American Express,0000004962,AXP,Banking,Q2,2017,StockholdersEquity,StockholdersEquity,usd,21175000000,bs
1292,American Express,0000004962,AXP,Banking,Q2,2017,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,166997000000,bs
1293,American Express,0000004962,AXP,Banking,Q2,2017,NetIncomeLoss,NetIncomeLoss,usd,2577000000,cf
1294,American Express,0000004962,AXP,Banking,Q2,2017,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,1157000000,cf
1295,American Express,0000004962,AXP,Banking,Q2,2017,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,615000000,cf
1296,American Express,0000004962,AXP,Banking,Q2,2017,axp:DeferredTaxesAndOther,axp:DeferredTaxesAndOther,usd,2000000,cf
1297,American Express,0000004962,AXP,Banking,Q2,2017,ShareBasedCompensation,ShareBasedCompensation,usd,152000000,cf
1298,American Express,0000004962,AXP,Banking,Q2,2017,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,-832000000,cf
1299,American Express,0000004962,AXP,Banking,Q2,2017,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,-181000000,cf
1300,American Express,0000004962,AXP,Banking,Q2,2017,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-902000000,cf
1301,American Express,0000004962,AXP,Banking,Q2,2017,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-330000000,cf
1302,American Express,0000004962,AXP,Banking,Q2,2017,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,4284000000,cf
1303,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,1000000,cf
1304,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,1502000000,cf
1305,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,1768000000,cf
1306,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,3169000000,cf
1307,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,538000000,cf
1308,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,174000000,cf
1309,American Express,0000004962,AXP,Banking,Q2,2017,IncreaseDecreaseInRestrictedCash,IncreaseDecreaseInRestrictedCash,usd,12000000,cf
1310,American Express,0000004962,AXP,Banking,Q2,2017,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-4158000000,cf
1311,American Express,0000004962,AXP,Banking,Q2,2017,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,4666000000,cf
1312,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-2124000000,cf
1313,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,17124000000,cf
1314,American Express,0000004962,AXP,Banking,Q2,2017,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,12349000000,cf
1315,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,usd,0,cf
1316,American Express,0000004962,AXP,Banking,Q2,2017,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,44000000,cf
1317,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,1767000000,cf
1318,American Express,0000004962,AXP,Banking,Q2,2017,PaymentsOfDividends,PaymentsOfDividends,usd,620000000,cf
1319,American Express,0000004962,AXP,Banking,Q2,2017,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,4974000000,cf
1320,American Express,0000004962,AXP,Banking,Q2,2017,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,134000000,cf
1321,American Express,0000004962,AXP,Banking,Q2,2017,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,5234000000,cf
1322,American Express,0000004962,AXP,Banking,Q3,2017,CashAndDueFromBanks,CashAndDueFromBanks,usd,2820000000,bs
1323,American Express,0000004962,AXP,Banking,Q3,2017,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,22059000000,bs
1324,American Express,0000004962,AXP,Banking,Q3,2017,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,1289000000,bs
1325,American Express,0000004962,AXP,Banking,Q3,2017,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,26168000000,bs
1326,American Express,0000004962,AXP,Banking,Q3,2017,AccountsReceivableNet,AccountsReceivableNet,usd,51002000000,bs
1327,American Express,0000004962,AXP,Banking,Q3,2017,OtherReceivables,OtherReceivables,usd,2701000000,bs
1328,American Express,0000004962,AXP,Banking,Q3,2017,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,66376000000,bs
1329,American Express,0000004962,AXP,Banking,Q3,2017,LoansReceivableNet,LoansReceivableNet,usd,2268000000,bs
1330,American Express,0000004962,AXP,Banking,Q3,2017,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,3250000000,bs
1331,American Express,0000004962,AXP,Banking,Q3,2017,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4367000000,bs
1332,American Express,0000004962,AXP,Banking,Q3,2017,OtherAssets,OtherAssets,usd,12445000000,bs
1333,American Express,0000004962,AXP,Banking,Q3,2017,Assets,Assets,usd,168577000000,bs
1334,American Express,0000004962,AXP,Banking,Q3,2017,Deposits,Deposits,usd,61290000000,bs
1335,American Express,0000004962,AXP,Banking,Q3,2017,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2366000000,bs
1336,American Express,0000004962,AXP,Banking,Q3,2017,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,12240000000,bs
1337,American Express,0000004962,AXP,Banking,Q3,2017,ShortTermBorrowings,ShortTermBorrowings,usd,2352000000,bs
1338,American Express,0000004962,AXP,Banking,Q3,2017,LongTermDebt,LongTermDebt,usd,48762000000,bs
1339,American Express,0000004962,AXP,Banking,Q3,2017,OtherLiabilities,OtherLiabilities,usd,20482000000,bs
1340,American Express,0000004962,AXP,Banking,Q3,2017,Liabilities,Liabilities,usd,147492000000,bs
1341,American Express,0000004962,AXP,Banking,Q3,2017,PreferredStockValue,PreferredStockValue,usd,0,bs
1342,American Express,0000004962,AXP,Banking,Q3,2017,CommonStockValue,CommonStockValue,usd,175000000,bs
1343,American Express,0000004962,AXP,Banking,Q3,2017,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12318000000,bs
1344,American Express,0000004962,AXP,Banking,Q3,2017,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,10908000000,bs
1345,American Express,0000004962,AXP,Banking,Q3,2017,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,11000000,bs
1346,American Express,0000004962,AXP,Banking,Q3,2017,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1806000000,bs
1347,American Express,0000004962,AXP,Banking,Q3,2017,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,521000000,bs
1348,American Express,0000004962,AXP,Banking,Q3,2017,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2316000000,bs
1349,American Express,0000004962,AXP,Banking,Q3,2017,StockholdersEquity,StockholdersEquity,usd,21085000000,bs
1350,American Express,0000004962,AXP,Banking,Q3,2017,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,168577000000,bs
1351,American Express,0000004962,AXP,Banking,Q3,2017,NetIncomeLoss,NetIncomeLoss,usd,3933000000,cf
1352,American Express,0000004962,AXP,Banking,Q3,2017,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,1926000000,cf
1353,American Express,0000004962,AXP,Banking,Q3,2017,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,953000000,cf
1354,American Express,0000004962,AXP,Banking,Q3,2017,axp:DeferredTaxesAndOther,axp:DeferredTaxesAndOther,usd,-61000000,cf
1355,American Express,0000004962,AXP,Banking,Q3,2017,ShareBasedCompensation,ShareBasedCompensation,usd,212000000,cf
1356,American Express,0000004962,AXP,Banking,Q3,2017,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,-1043000000,cf
1357,American Express,0000004962,AXP,Banking,Q3,2017,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,137000000,cf
1358,American Express,0000004962,AXP,Banking,Q3,2017,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,1197000000,cf
1359,American Express,0000004962,AXP,Banking,Q3,2017,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-485000000,cf
1360,American Express,0000004962,AXP,Banking,Q3,2017,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,8581000000,cf
1361,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,1000000,cf
1362,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,2198000000,cf
1363,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,2339000000,cf
1364,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,7535000000,cf
1365,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,812000000,cf
1366,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,210000000,cf
1367,American Express,0000004962,AXP,Banking,Q3,2017,IncreaseDecreaseInRestrictedCash,IncreaseDecreaseInRestrictedCash,usd,1773000000,cf
1368,American Express,0000004962,AXP,Banking,Q3,2017,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-10470000000,cf
1369,American Express,0000004962,AXP,Banking,Q3,2017,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,8219000000,cf
1370,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-3232000000,cf
1371,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,19875000000,cf
1372,American Express,0000004962,AXP,Banking,Q3,2017,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,18349000000,cf
1373,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,usd,0,cf
1374,American Express,0000004962,AXP,Banking,Q3,2017,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,82000000,cf
1375,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,3087000000,cf
1376,American Express,0000004962,AXP,Banking,Q3,2017,PaymentsOfDividends,PaymentsOfDividends,usd,925000000,cf
1377,American Express,0000004962,AXP,Banking,Q3,2017,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,2583000000,cf
1378,American Express,0000004962,AXP,Banking,Q3,2017,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,266000000,cf
1379,American Express,0000004962,AXP,Banking,Q3,2017,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,960000000,cf
1380,American Express,0000004962,AXP,Banking,FY,2017,CashAndDueFromBanks,CashAndDueFromBanks,usd,5148000000,bs
1381,American Express,0000004962,AXP,Banking,FY,2017,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,27709000000,bs
1382,American Express,0000004962,AXP,Banking,FY,2017,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,70000000,bs
1383,American Express,0000004962,AXP,Banking,FY,2017,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,32927000000,bs
1384,American Express,0000004962,AXP,Banking,FY,2017,AccountsReceivableNet,AccountsReceivableNet,usd,53526000000,bs
1385,American Express,0000004962,AXP,Banking,FY,2017,OtherReceivables,OtherReceivables,usd,3163000000,bs
1386,American Express,0000004962,AXP,Banking,FY,2017,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,71693000000,bs
1387,American Express,0000004962,AXP,Banking,FY,2017,LoansReceivableNet,LoansReceivableNet,usd,2607000000,bs
1388,American Express,0000004962,AXP,Banking,FY,2017,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,3159000000,bs
1389,American Express,0000004962,AXP,Banking,FY,2017,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4329000000,bs
1390,American Express,0000004962,AXP,Banking,FY,2017,OtherAssets,OtherAssets,usd,9755000000,bs
1391,American Express,0000004962,AXP,Banking,FY,2017,Assets,Assets,usd,181159000000,bs
1392,American Express,0000004962,AXP,Banking,FY,2017,Deposits,Deposits,usd,64452000000,bs
1393,American Express,0000004962,AXP,Banking,FY,2017,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2593000000,bs
1394,American Express,0000004962,AXP,Banking,FY,2017,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,14657000000,bs
1395,American Express,0000004962,AXP,Banking,FY,2017,ShortTermBorrowings,ShortTermBorrowings,usd,3278000000,bs
1396,American Express,0000004962,AXP,Banking,FY,2017,LongTermDebt,LongTermDebt,usd,55804000000,bs
1397,American Express,0000004962,AXP,Banking,FY,2017,OtherLiabilities,OtherLiabilities,usd,22148000000,bs
1398,American Express,0000004962,AXP,Banking,FY,2017,Liabilities,Liabilities,usd,162932000000,bs
1399,American Express,0000004962,AXP,Banking,FY,2017,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,0,bs
1400,American Express,0000004962,AXP,Banking,FY,2017,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1961000000,bs
1401,American Express,0000004962,AXP,Banking,FY,2017,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,467000000,bs
1402,American Express,0000004962,AXP,Banking,FY,2017,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2428000000,bs
1403,American Express,0000004962,AXP,Banking,FY,2017,PreferredStockValue,PreferredStockValue,usd,0,bs
1404,American Express,0000004962,AXP,Banking,FY,2017,CommonStockValue,CommonStockValue,usd,172000000,bs
1405,American Express,0000004962,AXP,Banking,FY,2017,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12210000000,bs
1406,American Express,0000004962,AXP,Banking,FY,2017,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,8273000000,bs
1407,American Express,0000004962,AXP,Banking,FY,2017,StockholdersEquity,StockholdersEquity,usd,18227000000,bs
1408,American Express,0000004962,AXP,Banking,FY,2017,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,181159000000,bs
1409,American Express,0000004962,AXP,Banking,FY,2017,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,2759000000,cf
1410,American Express,0000004962,AXP,Banking,FY,2017,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,1321000000,cf
1411,American Express,0000004962,AXP,Banking,FY,2017,OtherNoncashIncomeExpense,OtherNoncashIncomeExpense,usd,783000000,cf
1412,American Express,0000004962,AXP,Banking,FY,2017,ShareBasedCompensation,ShareBasedCompensation,usd,282000000,cf
1413,American Express,0000004962,AXP,Banking,FY,2017,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,-473000000,cf
1414,American Express,0000004962,AXP,Banking,FY,2017,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,62000000,cf
1415,American Express,0000004962,AXP,Banking,FY,2017,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,5505000000,cf
1416,American Express,0000004962,AXP,Banking,FY,2017,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-257000000,cf
1417,American Express,0000004962,AXP,Banking,FY,2017,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,13540000000,cf
1418,American Express,0000004962,AXP,Banking,FY,2017,NetIncomeLoss,NetIncomeLoss,usd,2736000000,cf
1419,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,2000000,cf
1420,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,2494000000,cf
1421,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromSaleOfEquityMethodInvestments,ProceedsFromSaleOfEquityMethodInvestments,usd,0,cf
1422,American Express,0000004962,AXP,Banking,FY,2017,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,16853000000,cf
1423,American Express,0000004962,AXP,Banking,FY,2017,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,211000000,cf
1424,American Express,0000004962,AXP,Banking,FY,2017,IncreaseDecreaseInRestrictedCash,IncreaseDecreaseInRestrictedCash,usd,31000000,cf
1425,American Express,0000004962,AXP,Banking,FY,2017,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,2612000000,cf
1426,American Express,0000004962,AXP,Banking,FY,2017,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,1062000000,cf
1427,American Express,0000004962,AXP,Banking,FY,2017,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-18273000000,cf
1428,American Express,0000004962,AXP,Banking,FY,2017,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,11385000000,cf
1429,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-2300000000,cf
1430,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,32764000000,cf
1431,American Express,0000004962,AXP,Banking,FY,2017,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,24082000000,cf
1432,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,usd,0,cf
1433,American Express,0000004962,AXP,Banking,FY,2017,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,129000000,cf
1434,American Express,0000004962,AXP,Banking,FY,2017,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,4300000000,cf
1435,American Express,0000004962,AXP,Banking,FY,2017,PaymentsOfDividends,PaymentsOfDividends,usd,1251000000,cf
1436,American Express,0000004962,AXP,Banking,FY,2017,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,12245000000,cf
1437,American Express,0000004962,AXP,Banking,FY,2017,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,207000000,cf
1438,American Express,0000004962,AXP,Banking,FY,2017,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,7719000000,cf
1439,American Express,0000004962,AXP,Banking,Q1,2018,CashAndDueFromBanks,CashAndDueFromBanks,usd,3627000000,bs
1440,American Express,0000004962,AXP,Banking,Q1,2018,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,27315000000,bs
1441,American Express,0000004962,AXP,Banking,Q1,2018,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,150000000,bs
1442,American Express,0000004962,AXP,Banking,Q1,2018,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,31092000000,bs
1443,American Express,0000004962,AXP,Banking,Q1,2018,AccountsReceivableNet,AccountsReceivableNet,usd,53676000000,bs
1444,American Express,0000004962,AXP,Banking,Q1,2018,OtherReceivables,OtherReceivables,usd,3194000000,bs
1445,American Express,0000004962,AXP,Banking,Q1,2018,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,71034000000,bs
1446,American Express,0000004962,AXP,Banking,Q1,2018,LoansReceivableNet,LoansReceivableNet,usd,2872000000,bs
1447,American Express,0000004962,AXP,Banking,Q1,2018,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,3388000000,bs
1448,American Express,0000004962,AXP,Banking,Q1,2018,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4271000000,bs
1449,American Express,0000004962,AXP,Banking,Q1,2018,OtherAssets,OtherAssets,usd,10429000000,bs
1450,American Express,0000004962,AXP,Banking,Q1,2018,Assets,Assets,usd,179956000000,bs
1451,American Express,0000004962,AXP,Banking,Q1,2018,Deposits,Deposits,usd,66665000000,bs
1452,American Express,0000004962,AXP,Banking,Q1,2018,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2435000000,bs
1453,American Express,0000004962,AXP,Banking,Q1,2018,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,14038000000,bs
1454,American Express,0000004962,AXP,Banking,Q1,2018,ShortTermBorrowings,ShortTermBorrowings,usd,1852000000,bs
1455,American Express,0000004962,AXP,Banking,Q1,2018,LongTermDebt,LongTermDebt,usd,52461000000,bs
1456,American Express,0000004962,AXP,Banking,Q1,2018,OtherLiabilities,OtherLiabilities,usd,22892000000,bs
1457,American Express,0000004962,AXP,Banking,Q1,2018,Liabilities,Liabilities,usd,160343000000,bs
1458,American Express,0000004962,AXP,Banking,Q1,2018,PreferredStockValue,PreferredStockValue,usd,0,bs
1459,American Express,0000004962,AXP,Banking,Q1,2018,CommonStockValue,CommonStockValue,usd,172000000,bs
1460,American Express,0000004962,AXP,Banking,Q1,2018,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12225000000,bs
1461,American Express,0000004962,AXP,Banking,Q1,2018,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,9597000000,bs
1462,American Express,0000004962,AXP,Banking,Q1,2018,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,-11000000,bs
1463,American Express,0000004962,AXP,Banking,Q1,2018,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1931000000,bs
1464,American Express,0000004962,AXP,Banking,Q1,2018,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,439000000,bs
1465,American Express,0000004962,AXP,Banking,Q1,2018,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2381000000,bs
1466,American Express,0000004962,AXP,Banking,Q1,2018,StockholdersEquity,StockholdersEquity,usd,19613000000,bs
1467,American Express,0000004962,AXP,Banking,Q1,2018,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,179956000000,bs
1468,American Express,0000004962,AXP,Banking,Q1,2018,NetIncomeLoss,NetIncomeLoss,usd,1634000000,cf
1469,American Express,0000004962,AXP,Banking,Q1,2018,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,775000000,cf
1470,American Express,0000004962,AXP,Banking,Q1,2018,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,348000000,cf
1471,American Express,0000004962,AXP,Banking,Q1,2018,axp:DeferredTaxesAndOther,axp:DeferredTaxesAndOther,usd,-254000000,cf
1472,American Express,0000004962,AXP,Banking,Q1,2018,ShareBasedCompensation,ShareBasedCompensation,usd,84000000,cf
1473,American Express,0000004962,AXP,Banking,Q1,2018,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,-122000000,cf
1474,American Express,0000004962,AXP,Banking,Q1,2018,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,85000000,cf
1475,American Express,0000004962,AXP,Banking,Q1,2018,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-431000000,cf
1476,American Express,0000004962,AXP,Banking,Q1,2018,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-130000000,cf
1477,American Express,0000004962,AXP,Banking,Q1,2018,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,2063000000,cf
1478,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,0,cf
1479,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,886000000,cf
1480,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,1215000000,cf
1481,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,-348000000,cf
1482,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,237000000,cf
1483,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,475000000,cf
1484,American Express,0000004962,AXP,Banking,Q1,2018,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-693000000,cf
1485,American Express,0000004962,AXP,Banking,Q1,2018,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,2206000000,cf
1486,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-1489000000,cf
1487,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,3984000000,cf
1488,American Express,0000004962,AXP,Banking,Q1,2018,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,7203000000,cf
1489,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,usd,0,cf
1490,American Express,0000004962,AXP,Banking,Q1,2018,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,11000000,cf
1491,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,134000000,cf
1492,American Express,0000004962,AXP,Banking,Q1,2018,PaymentsOfDividends,PaymentsOfDividends,usd,324000000,cf
1493,American Express,0000004962,AXP,Banking,Q1,2018,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-2949000000,cf
1494,American Express,0000004962,AXP,Banking,Q1,2018,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-178000000,cf
1495,American Express,0000004962,AXP,Banking,Q1,2018,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-1757000000,cf
1496,American Express,0000004962,AXP,Banking,Q2,2018,CashAndDueFromBanks,CashAndDueFromBanks,usd,3423000000,bs
1497,American Express,0000004962,AXP,Banking,Q2,2018,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,26207000000,bs
1498,American Express,0000004962,AXP,Banking,Q2,2018,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,113000000,bs
1499,American Express,0000004962,AXP,Banking,Q2,2018,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,29743000000,bs
1500,American Express,0000004962,AXP,Banking,Q2,2018,AccountsReceivableNet,AccountsReceivableNet,usd,54424000000,bs
1501,American Express,0000004962,AXP,Banking,Q2,2018,OtherReceivables,OtherReceivables,usd,3241000000,bs
1502,American Express,0000004962,AXP,Banking,Q2,2018,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,73579000000,bs
1503,American Express,0000004962,AXP,Banking,Q2,2018,LoansReceivableNet,LoansReceivableNet,usd,3108000000,bs
1504,American Express,0000004962,AXP,Banking,Q2,2018,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,4753000000,bs
1505,American Express,0000004962,AXP,Banking,Q2,2018,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4251000000,bs
1506,American Express,0000004962,AXP,Banking,Q2,2018,OtherAssets,OtherAssets,usd,11762000000,bs
1507,American Express,0000004962,AXP,Banking,Q2,2018,Assets,Assets,usd,184861000000,bs
1508,American Express,0000004962,AXP,Banking,Q2,2018,Deposits,Deposits,usd,67391000000,bs
1509,American Express,0000004962,AXP,Banking,Q2,2018,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2222000000,bs
1510,American Express,0000004962,AXP,Banking,Q2,2018,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,13800000000,bs
1511,American Express,0000004962,AXP,Banking,Q2,2018,ShortTermBorrowings,ShortTermBorrowings,usd,1972000000,bs
1512,American Express,0000004962,AXP,Banking,Q2,2018,LongTermDebt,LongTermDebt,usd,55883000000,bs
1513,American Express,0000004962,AXP,Banking,Q2,2018,OtherLiabilities,OtherLiabilities,usd,22701000000,bs
1514,American Express,0000004962,AXP,Banking,Q2,2018,Liabilities,Liabilities,usd,163969000000,bs
1515,American Express,0000004962,AXP,Banking,Q2,2018,PreferredStockValue,PreferredStockValue,usd,0,bs
1516,American Express,0000004962,AXP,Banking,Q2,2018,CommonStockValue,CommonStockValue,usd,173000000,bs
1517,American Express,0000004962,AXP,Banking,Q2,2018,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12306000000,bs
1518,American Express,0000004962,AXP,Banking,Q2,2018,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,10896000000,bs
1519,American Express,0000004962,AXP,Banking,Q2,2018,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,-18000000,bs
1520,American Express,0000004962,AXP,Banking,Q2,2018,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2027000000,bs
1521,American Express,0000004962,AXP,Banking,Q2,2018,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,438000000,bs
1522,American Express,0000004962,AXP,Banking,Q2,2018,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2483000000,bs
1523,American Express,0000004962,AXP,Banking,Q2,2018,StockholdersEquity,StockholdersEquity,usd,20892000000,bs
1524,American Express,0000004962,AXP,Banking,Q2,2018,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,184861000000,bs
1525,American Express,0000004962,AXP,Banking,Q2,2018,NetIncomeLoss,NetIncomeLoss,usd,3257000000,cf
1526,American Express,0000004962,AXP,Banking,Q2,2018,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,1581000000,cf
1527,American Express,0000004962,AXP,Banking,Q2,2018,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,685000000,cf
1528,American Express,0000004962,AXP,Banking,Q2,2018,OtherNoncashIncomeExpense,OtherNoncashIncomeExpense,usd,166000000,cf
1529,American Express,0000004962,AXP,Banking,Q2,2018,ShareBasedCompensation,ShareBasedCompensation,usd,154000000,cf
1530,American Express,0000004962,AXP,Banking,Q2,2018,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,164000000,cf
1531,American Express,0000004962,AXP,Banking,Q2,2018,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,-257000000,cf
1532,American Express,0000004962,AXP,Banking,Q2,2018,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-182000000,cf
1533,American Express,0000004962,AXP,Banking,Q2,2018,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-326000000,cf
1534,American Express,0000004962,AXP,Banking,Q2,2018,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,5096000000,cf
1535,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,0,cf
1536,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,1203000000,cf
1537,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,3029000000,cf
1538,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,5538000000,cf
1539,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,536000000,cf
1540,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,481000000,cf
1541,American Express,0000004962,AXP,Banking,Q2,2018,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-8381000000,cf
1542,American Express,0000004962,AXP,Banking,Q2,2018,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,2957000000,cf
1543,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-1307000000,cf
1544,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,10561000000,cf
1545,American Express,0000004962,AXP,Banking,Q2,2018,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,10242000000,cf
1546,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,usd,0,cf
1547,American Express,0000004962,AXP,Banking,Q2,2018,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,49000000,cf
1548,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,138000000,cf
1549,American Express,0000004962,AXP,Banking,Q2,2018,PaymentsOfDividends,PaymentsOfDividends,usd,645000000,cf
1550,American Express,0000004962,AXP,Banking,Q2,2018,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,1235000000,cf
1551,American Express,0000004962,AXP,Banking,Q2,2018,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,49000000,cf
1552,American Express,0000004962,AXP,Banking,Q2,2018,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-2001000000,cf
1553,American Express,0000004962,AXP,Banking,Q3,2018,CashAndDueFromBanks,CashAndDueFromBanks,usd,4323000000,bs
1554,American Express,0000004962,AXP,Banking,Q3,2018,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,25856000000,bs
1555,American Express,0000004962,AXP,Banking,Q3,2018,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,52000000,bs
1556,American Express,0000004962,AXP,Banking,Q3,2018,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,30231000000,bs
1557,American Express,0000004962,AXP,Banking,Q3,2018,AccountsReceivableNet,AccountsReceivableNet,usd,54972000000,bs
1558,American Express,0000004962,AXP,Banking,Q3,2018,OtherReceivables,OtherReceivables,usd,3160000000,bs
1559,American Express,0000004962,AXP,Banking,Q3,2018,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,75666000000,bs
1560,American Express,0000004962,AXP,Banking,Q3,2018,LoansReceivableNet,LoansReceivableNet,usd,3431000000,bs
1561,American Express,0000004962,AXP,Banking,Q3,2018,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,6071000000,bs
1562,American Express,0000004962,AXP,Banking,Q3,2018,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4295000000,bs
1563,American Express,0000004962,AXP,Banking,Q3,2018,OtherAssets,OtherAssets,usd,11266000000,bs
1564,American Express,0000004962,AXP,Banking,Q3,2018,Assets,Assets,usd,189092000000,bs
1565,American Express,0000004962,AXP,Banking,Q3,2018,Deposits,Deposits,usd,69301000000,bs
1566,American Express,0000004962,AXP,Banking,Q3,2018,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2070000000,bs
1567,American Express,0000004962,AXP,Banking,Q3,2018,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,15605000000,bs
1568,American Express,0000004962,AXP,Banking,Q3,2018,ShortTermBorrowings,ShortTermBorrowings,usd,2292000000,bs
1569,American Express,0000004962,AXP,Banking,Q3,2018,LongTermDebt,LongTermDebt,usd,55300000000,bs
1570,American Express,0000004962,AXP,Banking,Q3,2018,OtherLiabilities,OtherLiabilities,usd,23064000000,bs
1571,American Express,0000004962,AXP,Banking,Q3,2018,Liabilities,Liabilities,usd,167632000000,bs
1572,American Express,0000004962,AXP,Banking,Q3,2018,PreferredStockValue,PreferredStockValue,usd,0,bs
1573,American Express,0000004962,AXP,Banking,Q3,2018,CommonStockValue,CommonStockValue,usd,171000000,bs
1574,American Express,0000004962,AXP,Banking,Q3,2018,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12272000000,bs
1575,American Express,0000004962,AXP,Banking,Q3,2018,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,11521000000,bs
1576,American Express,0000004962,AXP,Banking,Q3,2018,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,-29000000,bs
1577,American Express,0000004962,AXP,Banking,Q3,2018,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2046000000,bs
1578,American Express,0000004962,AXP,Banking,Q3,2018,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,429000000,bs
1579,American Express,0000004962,AXP,Banking,Q3,2018,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2504000000,bs
1580,American Express,0000004962,AXP,Banking,Q3,2018,StockholdersEquity,StockholdersEquity,usd,21460000000,bs
1581,American Express,0000004962,AXP,Banking,Q3,2018,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,189092000000,bs
1582,American Express,0000004962,AXP,Banking,Q3,2018,NetIncomeLoss,NetIncomeLoss,usd,4911000000,cf
1583,American Express,0000004962,AXP,Banking,Q3,2018,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,2398000000,cf
1584,American Express,0000004962,AXP,Banking,Q3,2018,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,1007000000,cf
1585,American Express,0000004962,AXP,Banking,Q3,2018,OtherNoncashIncomeExpense,OtherNoncashIncomeExpense,usd,347000000,cf
1586,American Express,0000004962,AXP,Banking,Q3,2018,ShareBasedCompensation,ShareBasedCompensation,usd,230000000,cf
1587,American Express,0000004962,AXP,Banking,Q3,2018,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,88000000,cf
1588,American Express,0000004962,AXP,Banking,Q3,2018,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,-418000000,cf
1589,American Express,0000004962,AXP,Banking,Q3,2018,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,2133000000,cf
1590,American Express,0000004962,AXP,Banking,Q3,2018,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-480000000,cf
1591,American Express,0000004962,AXP,Banking,Q3,2018,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,10182000000,cf
1592,American Express,0000004962,AXP,Banking,Q3,2018,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,0,cf
1593,American Express,0000004962,AXP,Banking,Q3,2018,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,1871000000,cf
1594,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,5198000000,cf
1595,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,9461000000,cf
1596,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,871000000,cf
1597,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,512000000,cf
1598,American Express,0000004962,AXP,Banking,Q3,2018,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-14171000000,cf
1599,American Express,0000004962,AXP,Banking,Q3,2018,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,4876000000,cf
1600,American Express,0000004962,AXP,Banking,Q3,2018,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-969000000,cf
1601,American Express,0000004962,AXP,Banking,Q3,2018,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,17035000000,cf
1602,American Express,0000004962,AXP,Banking,Q3,2018,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,17262000000,cf
1603,American Express,0000004962,AXP,Banking,Q3,2018,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,68000000,cf
1604,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfCommonStock,usd,917000000,cf
1605,American Express,0000004962,AXP,Banking,Q3,2018,PaymentsOfDividends,PaymentsOfDividends,usd,970000000,cf
1606,American Express,0000004962,AXP,Banking,Q3,2018,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,1861000000,cf
1607,American Express,0000004962,AXP,Banking,Q3,2018,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,127000000,cf
1608,American Express,0000004962,AXP,Banking,Q3,2018,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-2001000000,cf
1609,American Express,0000004962,AXP,Banking,FY,2018,CashAndDueFromBanks,CashAndDueFromBanks,usd,3253000000,bs
1610,American Express,0000004962,AXP,Banking,FY,2018,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,24026000000,bs
1611,American Express,0000004962,AXP,Banking,FY,2018,ShortTermInvestments,ShortTermInvestments,usd,166000000,bs
1612,American Express,0000004962,AXP,Banking,FY,2018,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,27445000000,bs
1613,American Express,0000004962,AXP,Banking,FY,2018,AccountsReceivableNet,AccountsReceivableNet,usd,55320000000,bs
1614,American Express,0000004962,AXP,Banking,FY,2018,OtherReceivables,OtherReceivables,usd,2907000000,bs
1615,American Express,0000004962,AXP,Banking,FY,2018,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,79720000000,bs
1616,American Express,0000004962,AXP,Banking,FY,2018,LoansReceivableNet,LoansReceivableNet,usd,3676000000,bs
1617,American Express,0000004962,AXP,Banking,FY,2018,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,4647000000,bs
1618,American Express,0000004962,AXP,Banking,FY,2018,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4416000000,bs
1619,American Express,0000004962,AXP,Banking,FY,2018,OtherAssets,OtherAssets,usd,10471000000,bs
1620,American Express,0000004962,AXP,Banking,FY,2018,Assets,Assets,usd,188602000000,bs
1621,American Express,0000004962,AXP,Banking,FY,2018,Deposits,Deposits,usd,69960000000,bs
1622,American Express,0000004962,AXP,Banking,FY,2018,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2295000000,bs
1623,American Express,0000004962,AXP,Banking,FY,2018,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,12255000000,bs
1624,American Express,0000004962,AXP,Banking,FY,2018,ShortTermBorrowings,ShortTermBorrowings,usd,3100000000,bs
1625,American Express,0000004962,AXP,Banking,FY,2018,LongTermDebt,LongTermDebt,usd,58423000000,bs
1626,American Express,0000004962,AXP,Banking,FY,2018,OtherLiabilities,OtherLiabilities,usd,20279000000,bs
1627,American Express,0000004962,AXP,Banking,FY,2018,Liabilities,Liabilities,usd,166312000000,bs
1628,American Express,0000004962,AXP,Banking,FY,2018,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,-8000000,bs
1629,American Express,0000004962,AXP,Banking,FY,2018,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2133000000,bs
1630,American Express,0000004962,AXP,Banking,FY,2018,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,456000000,bs
1631,American Express,0000004962,AXP,Banking,FY,2018,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2597000000,bs
1632,American Express,0000004962,AXP,Banking,FY,2018,PreferredStockValue,PreferredStockValue,usd,0,bs
1633,American Express,0000004962,AXP,Banking,FY,2018,CommonStockValue,CommonStockValue,usd,170000000,bs
1634,American Express,0000004962,AXP,Banking,FY,2018,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,12218000000,bs
1635,American Express,0000004962,AXP,Banking,FY,2018,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,12499000000,bs
1636,American Express,0000004962,AXP,Banking,FY,2018,StockholdersEquity,StockholdersEquity,usd,22290000000,bs
1637,American Express,0000004962,AXP,Banking,FY,2018,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,188602000000,bs
1638,American Express,0000004962,AXP,Banking,FY,2018,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,3352000000,cf
1639,American Express,0000004962,AXP,Banking,FY,2018,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,1293000000,cf
1640,American Express,0000004962,AXP,Banking,FY,2018,OtherNoncashIncomeExpense,OtherNoncashIncomeExpense,usd,-455000000,cf
1641,American Express,0000004962,AXP,Banking,FY,2018,ShareBasedCompensation,ShareBasedCompensation,usd,283000000,cf
1642,American Express,0000004962,AXP,Banking,FY,2018,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,-248000000,cf
1643,American Express,0000004962,AXP,Banking,FY,2018,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,-743000000,cf
1644,American Express,0000004962,AXP,Banking,FY,2018,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-4121000000,cf
1645,American Express,0000004962,AXP,Banking,FY,2018,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-244000000,cf
1646,American Express,0000004962,AXP,Banking,FY,2018,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,8930000000,cf
1647,American Express,0000004962,AXP,Banking,FY,2018,NetIncomeLoss,NetIncomeLoss,usd,6921000000,cf
1648,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,usd,4000000,cf
1649,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,3499000000,cf
1650,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromSaleOfEquityMethodInvestments,ProceedsFromSaleOfEquityMethodInvestments,usd,0,cf
1651,American Express,0000004962,AXP,Banking,FY,2018,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,15854000000,cf
1652,American Express,0000004962,AXP,Banking,FY,2018,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,520000000,cf
1653,American Express,0000004962,AXP,Banking,FY,2018,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,5434000000,cf
1654,American Express,0000004962,AXP,Banking,FY,2018,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,1310000000,cf
1655,American Express,0000004962,AXP,Banking,FY,2018,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-19615000000,cf
1656,American Express,0000004962,AXP,Banking,FY,2018,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,5542000000,cf
1657,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-148000000,cf
1658,American Express,0000004962,AXP,Banking,FY,2018,axp:PaymentsForRepurchasesOfCommonSharesAndOther,axp:PaymentsForRepurchasesOfCommonSharesAndOther,usd,1685000000,cf
1659,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,21524000000,cf
1660,American Express,0000004962,AXP,Banking,FY,2018,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,18895000000,cf
1661,American Express,0000004962,AXP,Banking,FY,2018,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,87000000,cf
1662,American Express,0000004962,AXP,Banking,FY,2018,PaymentsOfDividends,PaymentsOfDividends,usd,1324000000,cf
1663,American Express,0000004962,AXP,Banking,FY,2018,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,5101000000,cf
1664,American Express,0000004962,AXP,Banking,FY,2018,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,129000000,cf
1665,American Express,0000004962,AXP,Banking,FY,2018,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-5455000000,cf
1666,American Express,0000004962,AXP,Banking,Q1,2019,CashAndDueFromBanks,CashAndDueFromBanks,usd,4026000000,bs
1667,American Express,0000004962,AXP,Banking,Q1,2019,InterestBearingDepositsInBanks,InterestBearingDepositsInBanks,usd,29110000000,bs
1668,American Express,0000004962,AXP,Banking,Q1,2019,CashEquivalentsAtCarryingValue,CashEquivalentsAtCarryingValue,usd,41000000,bs
1669,American Express,0000004962,AXP,Banking,Q1,2019,CashCashEquivalentsAndFederalFundsSold,CashCashEquivalentsAndFederalFundsSold,usd,33177000000,bs
1670,American Express,0000004962,AXP,Banking,Q1,2019,AccountsReceivableNet,AccountsReceivableNet,usd,56227000000,bs
1671,American Express,0000004962,AXP,Banking,Q1,2019,OtherReceivables,OtherReceivables,usd,3128000000,bs
1672,American Express,0000004962,AXP,Banking,Q1,2019,LoansAndLeasesReceivableNetReportedAmount,LoansAndLeasesReceivableNetReportedAmount,usd,78874000000,bs
1673,American Express,0000004962,AXP,Banking,Q1,2019,LoansReceivableNet,LoansReceivableNet,usd,3965000000,bs
1674,American Express,0000004962,AXP,Banking,Q1,2019,AvailableForSaleSecurities,AvailableForSaleSecurities,usd,6457000000,bs
1675,American Express,0000004962,AXP,Banking,Q1,2019,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentNet,usd,4479000000,bs
1676,American Express,0000004962,AXP,Banking,Q1,2019,OtherAssets,OtherAssets,usd,10886000000,bs
1677,American Express,0000004962,AXP,Banking,Q1,2019,Assets,Assets,usd,197193000000,bs
1678,American Express,0000004962,AXP,Banking,Q1,2019,Deposits,Deposits,usd,72857000000,bs
1679,American Express,0000004962,AXP,Banking,Q1,2019,axp:TravelersChequesOutstanding,axp:TravelersChequesOutstanding,usd,2223000000,bs
1680,American Express,0000004962,AXP,Banking,Q1,2019,AccountsPayableCurrentAndNoncurrent,AccountsPayableCurrentAndNoncurrent,usd,16162000000,bs
1681,American Express,0000004962,AXP,Banking,Q1,2019,ShortTermBorrowings,ShortTermBorrowings,usd,2028000000,bs
1682,American Express,0000004962,AXP,Banking,Q1,2019,LongTermDebt,LongTermDebt,usd,58418000000,bs
1683,American Express,0000004962,AXP,Banking,Q1,2019,OtherLiabilities,OtherLiabilities,usd,23287000000,bs
1684,American Express,0000004962,AXP,Banking,Q1,2019,Liabilities,Liabilities,usd,174975000000,bs
1685,American Express,0000004962,AXP,Banking,Q1,2019,PreferredStockValue,PreferredStockValue,usd,0,bs
1686,American Express,0000004962,AXP,Banking,Q1,2019,CommonStockValue,CommonStockValue,usd,168000000,bs
1687,American Express,0000004962,AXP,Banking,Q1,2019,AdditionalPaidInCapital,AdditionalPaidInCapital,usd,11963000000,bs
1688,American Express,0000004962,AXP,Banking,Q1,2019,RetainedEarningsAccumulatedDeficit,RetainedEarningsAccumulatedDeficit,usd,12686000000,bs
1689,American Express,0000004962,AXP,Banking,Q1,2019,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,9000000,bs
1690,American Express,0000004962,AXP,Banking,Q1,2019,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2125000000,bs
1691,American Express,0000004962,AXP,Banking,Q1,2019,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,483000000,bs
1692,American Express,0000004962,AXP,Banking,Q1,2019,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2599000000,bs
1693,American Express,0000004962,AXP,Banking,Q1,2019,StockholdersEquity,StockholdersEquity,usd,22218000000,bs
1694,American Express,0000004962,AXP,Banking,Q1,2019,LiabilitiesAndStockholdersEquity,LiabilitiesAndStockholdersEquity,usd,197193000000,bs
1695,American Express,0000004962,AXP,Banking,Q1,2019,NetIncomeLoss,NetIncomeLoss,usd,1550000000,cf
1696,American Express,0000004962,AXP,Banking,Q1,2019,ProvisionForLoanLeaseAndOtherLosses,ProvisionForLoanLeaseAndOtherLosses,usd,809000000,cf
1697,American Express,0000004962,AXP,Banking,Q1,2019,DepreciationAmortizationAndAccretionNet,DepreciationAmortizationAndAccretionNet,usd,297000000,cf
1698,American Express,0000004962,AXP,Banking,Q1,2019,OtherNoncashIncomeExpense,OtherNoncashIncomeExpense,usd,-137000000,cf
1699,American Express,0000004962,AXP,Banking,Q1,2019,ShareBasedCompensation,ShareBasedCompensation,usd,85000000,cf
1700,American Express,0000004962,AXP,Banking,Q1,2019,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInOtherReceivables,usd,196000000,cf
1701,American Express,0000004962,AXP,Banking,Q1,2019,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingAssets,usd,161000000,cf
1702,American Express,0000004962,AXP,Banking,Q1,2019,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,6100000000,cf
1703,American Express,0000004962,AXP,Banking,Q1,2019,axp:IncreaseDecreaseInTravelersChequesOutstanding,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-74000000,cf
1704,American Express,0000004962,AXP,Banking,Q1,2019,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,8547000000,cf
1705,American Express,0000004962,AXP,Banking,Q1,2019,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,2227000000,cf
1706,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsToAcquireInvestments,PaymentsToAcquireInvestments,usd,4060000000,cf
1707,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsForProceedsFromLoansAndLeases,PaymentsForProceedsFromLoansAndLeases,usd,656000000,cf
1708,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,348000000,cf
1709,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,20000000,cf
1710,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsForProceedsFromOtherInvestingActivities,PaymentsForProceedsFromOtherInvestingActivities,usd,-148000000,cf
1711,American Express,0000004962,AXP,Banking,Q1,2019,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-2709000000,cf
1712,American Express,0000004962,AXP,Banking,Q1,2019,IncreaseDecreaseInDeposits,IncreaseDecreaseInDeposits,usd,2892000000,cf
1713,American Express,0000004962,AXP,Banking,Q1,2019,ProceedsFromRepaymentsOfShortTermDebt,ProceedsFromRepaymentsOfShortTermDebt,usd,-1099000000,cf
1714,American Express,0000004962,AXP,Banking,Q1,2019,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfLongTermDebt,usd,3633000000,cf
1715,American Express,0000004962,AXP,Banking,Q1,2019,RepaymentsOfLongTermDebt,RepaymentsOfLongTermDebt,usd,3821000000,cf
1716,American Express,0000004962,AXP,Banking,Q1,2019,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfCommonStock,usd,19000000,cf
1717,American Express,0000004962,AXP,Banking,Q1,2019,axp:Paymentsforrepurchasesofcommonsharesandother,axp:Paymentsforrepurchasesofcommonsharesandother,usd,1352000000,cf
1718,American Express,0000004962,AXP,Banking,Q1,2019,PaymentsOfDividends,PaymentsOfDividends,usd,355000000,cf
1719,American Express,0000004962,AXP,Banking,Q1,2019,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-83000000,cf
1720,American Express,0000004962,AXP,Banking,Q1,2019,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,68000000,cf
1721,American Express,0000004962,AXP,Banking,Q1,2019,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,5823000000,cf
1722,American Express,0000004962,AXP,Banking,Q2,2019,Cash and due from banks,CashAndDueFromBanks,usd,4700000000,bs
1723,American Express,0000004962,AXP,Banking,Q2,2019,Interest-bearing deposits in other banks (includes securities purchased under resale agreements),InterestBearingDepositsInBanks,usd,22100000000,bs
1724,American Express,0000004962,AXP,Banking,Q2,2019,Short-term investment securities,CashEquivalentsAtCarryingValue,usd,69000000,bs
1725,American Express,0000004962,AXP,Banking,Q2,2019,Cash and cash equivalents per Consolidated Balance Sheets,CashCashEquivalentsAndFederalFundsSold,usd,26869000000,bs
1726,American Express,0000004962,AXP,Banking,Q2,2019,Accounts receivable,AccountsReceivableNet,usd,58092000000,bs
1727,American Express,0000004962,AXP,Banking,Q2,2019,"Other receivables, net",OtherReceivables,usd,3173000000,bs
1728,American Express,0000004962,AXP,Banking,Q2,2019,Loans,LoansAndLeasesReceivableNetReportedAmount,usd,81062000000,bs
1729,American Express,0000004962,AXP,Banking,Q2,2019,"Other loans, less reserves",NotesReceivableNet,usd,4059000000,bs
1730,American Express,0000004962,AXP,Banking,Q2,2019,Total Cost,axp:DebtandEquitySecuritiesAvailableforsale,usd,8542000000,bs
1731,American Express,0000004962,AXP,Banking,Q2,2019,"Premises and equipment, less accumulated depreciation and amortization",PropertyPlantAndEquipmentNet,usd,4658000000,bs
1732,American Express,0000004962,AXP,Banking,Q2,2019,Other financial assets,OtherAssets,usd,11148000000,bs
1733,American Express,0000004962,AXP,Banking,Q2,2019,Assets,Assets,usd,197603000000,bs
1734,American Express,0000004962,AXP,Banking,Q2,2019,Customer deposits,Deposits,usd,72590000000,bs
1735,American Express,0000004962,AXP,Banking,Q2,2019,Travelers Cheques and other prepaid products,axp:TravelersChequesOutstanding,usd,2014000000,bs
1736,American Express,0000004962,AXP,Banking,Q2,2019,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,16518000000,bs
1737,American Express,0000004962,AXP,Banking,Q2,2019,Short-term borrowings,ShortTermBorrowings,usd,2827000000,bs
1738,American Express,0000004962,AXP,Banking,Q2,2019,Long-term Debt,LongTermDebt,usd,57736000000,bs
1739,American Express,0000004962,AXP,Banking,Q2,2019,Other liabilities,OtherLiabilities,usd,22826000000,bs
1740,American Express,0000004962,AXP,Banking,Q2,2019,Liabilities [Abstract],Liabilities,usd,174511000000,bs
1741,American Express,0000004962,AXP,Banking,Q2,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
1742,American Express,0000004962,AXP,Banking,Q2,2019,Preferred shares,PreferredStockValue,usd,N/A,bs
1743,American Express,0000004962,AXP,Banking,Q2,2019,Common shares,CommonStockValue,usd,167000000,bs
1744,American Express,0000004962,AXP,Banking,Q2,2019,Additional Paid-in Capital [Member],AdditionalPaidInCapital,usd,11980000000,bs
1745,American Express,0000004962,AXP,Banking,Q2,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13551000000,bs
1746,American Express,0000004962,AXP,Banking,Q2,2019,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,35000000,bs
1747,American Express,0000004962,AXP,Banking,Q2,2019,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2161000000,bs
1748,American Express,0000004962,AXP,Banking,Q2,2019,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,480000000,bs
1749,American Express,0000004962,AXP,Banking,Q2,2019,Accumulated other comprehensive (loss) income,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2606000000,bs
1750,American Express,0000004962,AXP,Banking,Q2,2019,Shareholders' Equity,StockholdersEquity,usd,23092000000,bs
1751,American Express,0000004962,AXP,Banking,Q2,2019,Liabilities and Shareholders' Equity,LiabilitiesAndStockholdersEquity,usd,197603000000,bs
1752,American Express,0000004962,AXP,Banking,Q2,2019,Net income,NetIncomeLoss,usd,3311000000,cf
1753,American Express,0000004962,AXP,Banking,Q2,2019,Provisions for losses,ProvisionForLoanLeaseAndOtherLosses,usd,1670000000,cf
1754,American Express,0000004962,AXP,Banking,Q2,2019,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,583000000,cf
1755,American Express,0000004962,AXP,Banking,Q2,2019,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-485000000,cf
1756,American Express,0000004962,AXP,Banking,Q2,2019,Stock-based compensation,ShareBasedCompensation,usd,156000000,cf
1757,American Express,0000004962,AXP,Banking,Q2,2019,Other receivables,IncreaseDecreaseInOtherReceivables,usd,268000000,cf
1758,American Express,0000004962,AXP,Banking,Q2,2019,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,204000000,cf
1759,American Express,0000004962,AXP,Banking,Q2,2019,Accounts payable and other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,6028000000,cf
1760,American Express,0000004962,AXP,Banking,Q2,2019,Travelers Cheques and other prepaid products,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-284000000,cf
1761,American Express,0000004962,AXP,Banking,Q2,2019,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,11477000000,cf
1762,American Express,0000004962,AXP,Banking,Q2,2019,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,2426000000,cf
1763,American Express,0000004962,AXP,Banking,Q2,2019,Purchase of investments,PaymentsToAcquireInvestments,usd,6310000000,cf
1764,American Express,0000004962,AXP,Banking,Q2,2019,"Net increase in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,5832000000,cf
1765,American Express,0000004962,AXP,Banking,Q2,2019,"Purchase of premises and equipment, net of sales",PaymentsToAcquirePropertyPlantAndEquipment,usd,840000000,cf
1766,American Express,0000004962,AXP,Banking,Q2,2019,"Acquisitions/Dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,91000000,cf
1767,American Express,0000004962,AXP,Banking,Q2,2019,"Other investing activities, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-148000000,cf
1768,American Express,0000004962,AXP,Banking,Q2,2019,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-10499000000,cf
1769,American Express,0000004962,AXP,Banking,Q2,2019,Net increase (decrease) in customer deposits,IncreaseDecreaseInDeposits,usd,2625000000,cf
1770,American Express,0000004962,AXP,Banking,Q2,2019,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-322000000,cf
1771,American Express,0000004962,AXP,Banking,Q2,2019,Proceeds from long-term borrowings,ProceedsFromIssuanceOfLongTermDebt,usd,9180000000,cf
1772,American Express,0000004962,AXP,Banking,Q2,2019,Payments of long-term borrowings,RepaymentsOfLongTermDebt,usd,10379000000,cf
1773,American Express,0000004962,AXP,Banking,Q2,2019,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,66000000,cf
1774,American Express,0000004962,AXP,Banking,Q2,2019,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,2012000000,cf
1775,American Express,0000004962,AXP,Banking,Q2,2019,Dividends paid,PaymentsOfDividends,usd,702000000,cf
1776,American Express,0000004962,AXP,Banking,Q2,2019,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-1544000000,cf
1777,American Express,0000004962,AXP,Banking,Q2,2019,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,90000000,cf
1778,American Express,0000004962,AXP,Banking,Q2,2019,"Net decrease in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-476000000,cf
1779,American Express,0000004962,AXP,Banking,Q3,2019,Cash and due from banks,CashAndDueFromBanks,usd,3169000000,bs
1780,American Express,0000004962,AXP,Banking,Q3,2019,Interest-bearing deposits in other banks (includes securities purchased under resale agreements),InterestBearingDepositsInBanks,usd,21081000000,bs
1781,American Express,0000004962,AXP,Banking,Q3,2019,Short-term investment securities,CashEquivalentsAtCarryingValue,usd,16000000,bs
1782,American Express,0000004962,AXP,Banking,Q3,2019,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,24266000000,bs
1783,American Express,0000004962,AXP,Banking,Q3,2019,"Card Member receivables (includes gross receivables available to settle obligations of consolidated variable interest entity), less reserves",AccountsReceivableNet,usd,56010000000,bs
1784,American Express,0000004962,AXP,Banking,Q3,2019,"Other receivables, less reserves",OtherReceivables,usd,2846000000,bs
1785,American Express,0000004962,AXP,Banking,Q3,2019,Loans,LoansAndLeasesReceivableNetReportedAmount,usd,81423000000,bs
1786,American Express,0000004962,AXP,Banking,Q3,2019,"Other loans, less reserves",NotesReceivableNet,usd,4340000000,bs
1787,American Express,0000004962,AXP,Banking,Q3,2019,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,8445000000,bs
1788,American Express,0000004962,AXP,Banking,Q3,2019,"Premises and equipment, less accumulated depreciation and amortization",PropertyPlantAndEquipmentNet,usd,4715000000,bs
1789,American Express,0000004962,AXP,Banking,Q3,2019,Other Assets [Member],OtherAssets,usd,12139000000,bs
1790,American Express,0000004962,AXP,Banking,Q3,2019,Assets,Assets,usd,194184000000,bs
1791,American Express,0000004962,AXP,Banking,Q3,2019,Other deposits:,Deposits,usd,73298000000,bs
1792,American Express,0000004962,AXP,Banking,Q3,2019,Travelers Cheques and other prepaid products,axp:TravelersChequesOutstanding,usd,1864000000,bs
1793,American Express,0000004962,AXP,Banking,Q3,2019,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,12866000000,bs
1794,American Express,0000004962,AXP,Banking,Q3,2019,Short-term borrowings,ShortTermBorrowings,usd,2818000000,bs
1795,American Express,0000004962,AXP,Banking,Q3,2019,Long-term debt (includes debt issued by consolidated variable interest entities),LongTermDebt,usd,58474000000,bs
1796,American Express,0000004962,AXP,Banking,Q3,2019,Other liabilities,OtherLiabilities,usd,21839000000,bs
1797,American Express,0000004962,AXP,Banking,Q3,2019,Total Liabilities,Liabilities,usd,171159000000,bs
1798,American Express,0000004962,AXP,Banking,Q3,2019,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
1799,American Express,0000004962,AXP,Banking,Q3,2019,Preferred shares,PreferredStockValue,usd,N/A,bs
1800,American Express,0000004962,AXP,Banking,Q3,2019,Common shares,CommonStockValue,usd,165000000,bs
1801,American Express,0000004962,AXP,Banking,Q3,2019,Additional Paid-in Capital [Member],AdditionalPaidInCapital,usd,11869000000,bs
1802,American Express,0000004962,AXP,Banking,Q3,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13652000000,bs
1803,American Express,0000004962,AXP,Banking,Q3,2019,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,38000000,bs
1804,American Express,0000004962,AXP,Banking,Q3,2019,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2220000000,bs
1805,American Express,0000004962,AXP,Banking,Q3,2019,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,479000000,bs
1806,American Express,0000004962,AXP,Banking,Q3,2019,Total accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2661000000,bs
1807,American Express,0000004962,AXP,Banking,Q3,2019,Shareholders' Equity,StockholdersEquity,usd,23025000000,bs
1808,American Express,0000004962,AXP,Banking,Q3,2019,Total liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,194184000000,bs
1809,American Express,0000004962,AXP,Banking,Q3,2019,Net income available to common shareholders,NetIncomeLoss,usd,5066000000,cf
1810,American Express,0000004962,AXP,Banking,Q3,2019,Total provisions for losses,ProvisionForLoanLeaseAndOtherLosses,usd,2549000000,cf
1811,American Express,0000004962,AXP,Banking,Q3,2019,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,883000000,cf
1812,American Express,0000004962,AXP,Banking,Q3,2019,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-619000000,cf
1813,American Express,0000004962,AXP,Banking,Q3,2019,Stock-based compensation,ShareBasedCompensation,usd,217000000,cf
1814,American Express,0000004962,AXP,Banking,Q3,2019,Other receivables,IncreaseDecreaseInOtherReceivables,usd,-21000000,cf
1815,American Express,0000004962,AXP,Banking,Q3,2019,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,64000000,cf
1816,American Express,0000004962,AXP,Banking,Q3,2019,Accounts payable and other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,1578000000,cf
1817,American Express,0000004962,AXP,Banking,Q3,2019,Travelers Cheques and other prepaid products,axp:IncreaseDecreaseInTravelersChequesOutstanding,usd,-433000000,cf
1818,American Express,0000004962,AXP,Banking,Q3,2019,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,10436000000,cf
1819,American Express,0000004962,AXP,Banking,Q3,2019,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,5072000000,cf
1820,American Express,0000004962,AXP,Banking,Q3,2019,Purchase of investments,PaymentsToAcquireInvestments,usd,8917000000,cf
1821,American Express,0000004962,AXP,Banking,Q3,2019,"Net increase in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,6071000000,cf
1822,American Express,0000004962,AXP,Banking,Q3,2019,"Purchase of premises and equipment, net of sales",PaymentsToAcquirePropertyPlantAndEquipment,usd,1214000000,cf
1823,American Express,0000004962,AXP,Banking,Q3,2019,"Acquisitions/Dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,270000000,cf
1824,American Express,0000004962,AXP,Banking,Q3,2019,"Other investing activities, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-148000000,cf
1825,American Express,0000004962,AXP,Banking,Q3,2019,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-11252000000,cf
1826,American Express,0000004962,AXP,Banking,Q3,2019,Net increase (decrease) in customer deposits,IncreaseDecreaseInDeposits,usd,3346000000,cf
1827,American Express,0000004962,AXP,Banking,Q3,2019,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-285000000,cf
1828,American Express,0000004962,AXP,Banking,Q3,2019,Proceeds from long-term borrowings,ProceedsFromIssuanceOfLongTermDebt,usd,12710000000,cf
1829,American Express,0000004962,AXP,Banking,Q3,2019,Payments of long-term borrowings,RepaymentsOfLongTermDebt,usd,13279000000,cf
1830,American Express,0000004962,AXP,Banking,Q3,2019,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,77000000,cf
1831,American Express,0000004962,AXP,Banking,Q3,2019,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,3463000000,cf
1832,American Express,0000004962,AXP,Banking,Q3,2019,Dividends paid,PaymentsOfDividends,usd,1048000000,cf
1833,American Express,0000004962,AXP,Banking,Q3,2019,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-1942000000,cf
1834,American Express,0000004962,AXP,Banking,Q3,2019,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,304000000,cf
1835,American Express,0000004962,AXP,Banking,Q3,2019,"Net decrease in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-2454000000,cf
1836,American Express,0000004962,AXP,Banking,FY,2019,Cash and cash due from banks,CashAndDueFromBanks,usd,3402000000,bs
1837,American Express,0000004962,AXP,Banking,FY,2019,Interest-bearing deposits in other banks,InterestBearingDepositsInBanks,usd,20392000000,bs
1838,American Express,0000004962,AXP,Banking,FY,2019,Short-term investment securities,ShortTermInvestments,usd,138000000,bs
1839,American Express,0000004962,AXP,Banking,FY,2019,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,23932000000,bs
1840,American Express,0000004962,AXP,Banking,FY,2019,Card Member receivables,AccountsReceivableNet,usd,56794000000,bs
1841,American Express,0000004962,AXP,Banking,FY,2019,Card Member loans,LoansAndLeasesReceivableNetReportedAmount,usd,84998000000,bs
1842,American Express,0000004962,AXP,Banking,FY,2019,"Other loans, less reserves",axp:OtherLoansReceivableNetAmount,usd,4626000000,bs
1843,American Express,0000004962,AXP,Banking,FY,2019,Total Cost,axp:DebtandEquitySecuritiesAvailableforsale,usd,8406000000,bs
1844,American Express,0000004962,AXP,Banking,FY,2019,Premises and equipment,PropertyPlantAndEquipmentNet,usd,4834000000,bs
1845,American Express,0000004962,AXP,Banking,FY,2019,Other Assets [Member],OtherAssets,usd,14731000000,bs
1846,American Express,0000004962,AXP,Banking,FY,2019,Assets,Assets,usd,198321000000,bs
1847,American Express,0000004962,AXP,Banking,FY,2019,Certificates of deposit,Deposits,usd,73287000000,bs
1848,American Express,0000004962,AXP,Banking,FY,2019,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,12738000000,bs
1849,American Express,0000004962,AXP,Banking,FY,2019,Short-term borrowings,ShortTermBorrowings,usd,6442000000,bs
1850,American Express,0000004962,AXP,Banking,FY,2019,Long-term debt,LongTermDebt,usd,57835000000,bs
1851,American Express,0000004962,AXP,Banking,FY,2019,Other liabilities,OtherLiabilities,usd,24948000000,bs
1852,American Express,0000004962,AXP,Banking,FY,2019,Total liabilities,Liabilities,usd,175250000000,bs
1853,American Express,0000004962,AXP,Banking,FY,2019,Contingencies and Commitments,CommitmentsAndContingencies,usd,N/A,bs
1854,American Express,0000004962,AXP,Banking,FY,2019,Preferred shares issued,PreferredStockValue,usd,N/A,bs
1855,American Express,0000004962,AXP,Banking,FY,2019,Common shares,CommonStockValue,usd,163000000,bs
1856,American Express,0000004962,AXP,Banking,FY,2019,Additional Paid-in Capital [Member],AdditionalPaidInCapital,usd,11774000000,bs
1857,American Express,0000004962,AXP,Banking,FY,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13871000000,bs
1858,American Express,0000004962,AXP,Banking,FY,2019,"Net unrealized securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,33000000,bs
1859,American Express,0000004962,AXP,Banking,FY,2019,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2189000000,bs
1860,American Express,0000004962,AXP,Banking,FY,2019,"Net unrealized pension and other postretirement benefit losses, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,581000000,bs
1861,American Express,0000004962,AXP,Banking,FY,2019,Total accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2737000000,bs
1862,American Express,0000004962,AXP,Banking,FY,2019,Shareholders' Equity,StockholdersEquity,usd,23071000000,bs
1863,American Express,0000004962,AXP,Banking,FY,2019,Total liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,198321000000,bs
1864,American Express,0000004962,AXP,Banking,FY,2019,Net income attributable to common shareholders,NetIncomeLoss,usd,6759000000,cf
1865,American Express,0000004962,AXP,Banking,FY,2019,Total provisions for losses,ProvisionForLoanLeaseAndOtherLosses,usd,3573000000,cf
1866,American Express,0000004962,AXP,Banking,FY,2019,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,1188000000,cf
1867,American Express,0000004962,AXP,Banking,FY,2019,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-426000000,cf
1868,American Express,0000004962,AXP,Banking,FY,2019,"Stock Options Granted, shares",ShareBasedCompensation,usd,283000000,cf
1869,American Express,0000004962,AXP,Banking,FY,2019,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,368000000,cf
1870,American Express,0000004962,AXP,Banking,FY,2019,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,1771000000,cf
1871,American Express,0000004962,AXP,Banking,FY,2019,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,13632000000,cf
1872,American Express,0000004962,AXP,Banking,FY,2019,Sale of available-for-sale investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,22000000,cf
1873,American Express,0000004962,AXP,Banking,FY,2019,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,7329000000,cf
1874,American Express,0000004962,AXP,Banking,FY,2019,Purchase of investments,PaymentsToAcquireInvestments,usd,11166000000,cf
1875,American Express,0000004962,AXP,Banking,FY,2019,"Net increase in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,11047000000,cf
1876,American Express,0000004962,AXP,Banking,FY,2019,Purchase of premises and equipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,1645000000,cf
1877,American Express,0000004962,AXP,Banking,FY,2019,"Acquisitions/dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,352000000,cf
1878,American Express,0000004962,AXP,Banking,FY,2019,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-152000000,cf
1879,American Express,0000004962,AXP,Banking,FY,2019,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivities,usd,-16707000000,cf
1880,American Express,0000004962,AXP,Banking,FY,2019,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,3330000000,cf
1881,American Express,0000004962,AXP,Banking,FY,2019,Net increase (decrease) in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,3316000000,cf
1882,American Express,0000004962,AXP,Banking,FY,2019,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,12706000000,cf
1883,American Express,0000004962,AXP,Banking,FY,2019,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,13850000000,cf
1884,American Express,0000004962,AXP,Banking,FY,2019,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,86000000,cf
1885,American Express,0000004962,AXP,Banking,FY,2019,Repurchase of American Express common shares and other,axp:PaymentsForRepurchasesOfCommonSharesAndOther,usd,4685000000,cf
1886,American Express,0000004962,AXP,Banking,FY,2019,Dividends paid,PaymentsOfDividends,usd,1422000000,cf
1887,American Express,0000004962,AXP,Banking,FY,2019,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-519000000,cf
1888,American Express,0000004962,AXP,Banking,FY,2019,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,232000000,cf
1889,American Express,0000004962,AXP,Banking,FY,2019,"Net (decrease) increase in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-3362000000,cf
1890,American Express,0000004962,AXP,Banking,Q1,2020,Cash and due from banks,CashAndDueFromBanks,usd,2286000000,bs
1891,American Express,0000004962,AXP,Banking,Q1,2020,Interest-bearing deposits in other banks (includes securities purchased under resale agreements),InterestBearingDepositsInBanks,usd,33662000000,bs
1892,American Express,0000004962,AXP,Banking,Q1,2020,Short-term investment securities,CashEquivalentsAtCarryingValue,usd,147000000,bs
1893,American Express,0000004962,AXP,Banking,Q1,2020,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,36095000000,bs
1894,American Express,0000004962,AXP,Banking,Q1,2020,"Card Member receivables (includes gross receivables available to settle obligations of consolidated variable interest entity), less reserves",AccountsReceivableNet,usd,44269000000,bs
1895,American Express,0000004962,AXP,Banking,Q1,2020,Loans,LoansAndLeasesReceivableNetReportedAmount,usd,72464000000,bs
1896,American Express,0000004962,AXP,Banking,Q1,2020,"Other loans, less reserves for credit losses",axp:OtherLoansReceivableNetAmount,usd,4954000000,bs
1897,American Express,0000004962,AXP,Banking,Q1,2020,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,5032000000,bs
1898,American Express,0000004962,AXP,Banking,Q1,2020,"Premises and equipment, less accumulated depreciation and amortization",PropertyPlantAndEquipmentNet,usd,4798000000,bs
1899,American Express,0000004962,AXP,Banking,Q1,2020,Other Assets [Member],OtherAssets,usd,18448000000,bs
1900,American Express,0000004962,AXP,Banking,Q1,2020,Total assets,Assets,usd,186060000000,bs
1901,American Express,0000004962,AXP,Banking,Q1,2020,Other deposits:,Deposits,usd,77962000000,bs
1902,American Express,0000004962,AXP,Banking,Q1,2020,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,7977000000,bs
1903,American Express,0000004962,AXP,Banking,Q1,2020,Short-term borrowings,ShortTermBorrowings,usd,3497000000,bs
1904,American Express,0000004962,AXP,Banking,Q1,2020,Long-term debt (includes debt issued by consolidated variable interest entities),LongTermDebt,usd,52588000000,bs
1905,American Express,0000004962,AXP,Banking,Q1,2020,Other Liabilities [Member],OtherLiabilities,usd,23030000000,bs
1906,American Express,0000004962,AXP,Banking,Q1,2020,Total liabilities and shareholders’ equity,Liabilities,usd,165054000000,bs
1907,American Express,0000004962,AXP,Banking,Q1,2020,Contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
1908,American Express,0000004962,AXP,Banking,Q1,2020,Preferred shares,PreferredStockValue,usd,N/A,bs
1909,American Express,0000004962,AXP,Banking,Q1,2020,Common shares,CommonStockValue,usd,161000000,bs
1910,American Express,0000004962,AXP,Banking,Q1,2020,Additional paid-in capital,AdditionalPaidInCapital,usd,11680000000,bs
1911,American Express,0000004962,AXP,Banking,Q1,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12161000000,bs
1912,American Express,0000004962,AXP,Banking,Q1,2020,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,90000000,bs
1913,American Express,0000004962,AXP,Banking,Q1,2020,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2511000000,bs
1914,American Express,0000004962,AXP,Banking,Q1,2020,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,575000000,bs
1915,American Express,0000004962,AXP,Banking,Q1,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2996000000,bs
1916,American Express,0000004962,AXP,Banking,Q1,2020,Shareholders' Equity,StockholdersEquity,usd,21006000000,bs
1917,American Express,0000004962,AXP,Banking,Q1,2020,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,186060000000,bs
1918,American Express,0000004962,AXP,Banking,Q1,2020,Basic and diluted:,NetIncomeLoss,usd,367000000,cf
1919,American Express,0000004962,AXP,Banking,Q1,2020,Provisions for credit losses,ProvisionForLoanLeaseAndOtherLosses,usd,2621000000,cf
1920,American Express,0000004962,AXP,Banking,Q1,2020,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,337000000,cf
1921,American Express,0000004962,AXP,Banking,Q1,2020,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-333000000,cf
1922,American Express,0000004962,AXP,Banking,Q1,2020,Stock-based compensation,ShareBasedCompensation,usd,43000000,cf
1923,American Express,0000004962,AXP,Banking,Q1,2020,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,-309000000,cf
1924,American Express,0000004962,AXP,Banking,Q1,2020,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-6229000000,cf
1925,American Express,0000004962,AXP,Banking,Q1,2020,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,-2219000000,cf
1926,American Express,0000004962,AXP,Banking,Q1,2020,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,4376000000,cf
1927,American Express,0000004962,AXP,Banking,Q1,2020,Purchase of investments,PaymentsToAcquireInvestments,usd,997000000,cf
1928,American Express,0000004962,AXP,Banking,Q1,2020,"Net decrease (increase) in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,-18883000000,cf
1929,American Express,0000004962,AXP,Banking,Q1,2020,"Purchase of premises and equipment, net of sales",PaymentsToAcquirePropertyPlantAndEquipment,usd,335000000,cf
1930,American Express,0000004962,AXP,Banking,Q1,2020,"Acquisitions/dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,N/A,cf
1931,American Express,0000004962,AXP,Banking,Q1,2020,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,N/A,cf
1932,American Express,0000004962,AXP,Banking,Q1,2020,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,21927000000,cf
1933,American Express,0000004962,AXP,Banking,Q1,2020,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,4701000000,cf
1934,American Express,0000004962,AXP,Banking,Q1,2020,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-2880000000,cf
1935,American Express,0000004962,AXP,Banking,Q1,2020,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,N/A,cf
1936,American Express,0000004962,AXP,Banking,Q1,2020,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,5849000000,cf
1937,American Express,0000004962,AXP,Banking,Q1,2020,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,16000000,cf
1938,American Express,0000004962,AXP,Banking,Q1,2020,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,1023000000,cf
1939,American Express,0000004962,AXP,Banking,Q1,2020,Dividends paid,PaymentsOfDividends,usd,383000000,cf
1940,American Express,0000004962,AXP,Banking,Q1,2020,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-5418000000,cf
1941,American Express,0000004962,AXP,Banking,Q1,2020,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-128000000,cf
1942,American Express,0000004962,AXP,Banking,Q1,2020,"Net increase in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,14162000000,cf
1943,American Express,0000004962,AXP,Banking,Q2,2020,Cash and due from banks,CashAndDueFromBanks,usd,2043000000,bs
1944,American Express,0000004962,AXP,Banking,Q2,2020,Interest-bearing deposits in other banks (includes securities purchased under resale agreements),InterestBearingDepositsInBanks,usd,39325000000,bs
1945,American Express,0000004962,AXP,Banking,Q2,2020,Short-term investment securities,CashEquivalentsAtCarryingValue,usd,129000000,bs
1946,American Express,0000004962,AXP,Banking,Q2,2020,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,41497000000,bs
1947,American Express,0000004962,AXP,Banking,Q2,2020,"Card Member receivables (includes gross receivables available to settle obligations of consolidated variable interest entity), less reserves for credit losses",AccountsReceivableNet,usd,37034000000,bs
1948,American Express,0000004962,AXP,Banking,Q2,2020,Loans,LoansAndLeasesReceivableNetReportedAmount,usd,64431000000,bs
1949,American Express,0000004962,AXP,Banking,Q2,2020,"Other loans, less reserves for credit losses",axp:OtherLoansReceivableNetAmount,usd,4129000000,bs
1950,American Express,0000004962,AXP,Banking,Q2,2020,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,19942000000,bs
1951,American Express,0000004962,AXP,Banking,Q2,2020,"Premises and equipment, less accumulated depreciation and amortization",PropertyPlantAndEquipmentNet,usd,4829000000,bs
1952,American Express,0000004962,AXP,Banking,Q2,2020,Other financial assets,OtherAssets,usd,16746000000,bs
1953,American Express,0000004962,AXP,Banking,Q2,2020,Assets,Assets,usd,188608000000,bs
1954,American Express,0000004962,AXP,Banking,Q2,2020,Deposits By Type,Deposits,usd,84805000000,bs
1955,American Express,0000004962,AXP,Banking,Q2,2020,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,7731000000,bs
1956,American Express,0000004962,AXP,Banking,Q2,2020,Short-term borrowings,ShortTermBorrowings,usd,1567000000,bs
1957,American Express,0000004962,AXP,Banking,Q2,2020,Long-term debt (includes debt issued by consolidated variable interest entities),LongTermDebt,usd,48797000000,bs
1958,American Express,0000004962,AXP,Banking,Q2,2020,Other liabilities,OtherLiabilities,usd,24646000000,bs
1959,American Express,0000004962,AXP,Banking,Q2,2020,Liabilities and Shareholders’ Equity,Liabilities,usd,167546000000,bs
1960,American Express,0000004962,AXP,Banking,Q2,2020,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
1961,American Express,0000004962,AXP,Banking,Q2,2020,Preferred shares,PreferredStockValue,usd,N/A,bs
1962,American Express,0000004962,AXP,Banking,Q2,2020,Common shares,CommonStockValue,usd,161000000,bs
1963,American Express,0000004962,AXP,Banking,Q2,2020,Additional Paid-in Capital [Member],AdditionalPaidInCapital,usd,11760000000,bs
1964,American Express,0000004962,AXP,Banking,Q2,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12052000000,bs
1965,American Express,0000004962,AXP,Banking,Q2,2020,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,85000000,bs
1966,American Express,0000004962,AXP,Banking,Q2,2020,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2388000000,bs
1967,American Express,0000004962,AXP,Banking,Q2,2020,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,608000000,bs
1968,American Express,0000004962,AXP,Banking,Q2,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2911000000,bs
1969,American Express,0000004962,AXP,Banking,Q2,2020,"Other changes, primarily employee plans",StockholdersEquity,usd,21062000000,bs
1970,American Express,0000004962,AXP,Banking,Q2,2020,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,188608000000,bs
1971,American Express,0000004962,AXP,Banking,Q2,2020,Net income available to common shareholders,NetIncomeLoss,usd,624000000,cf
1972,American Express,0000004962,AXP,Banking,Q2,2020,Provisions for credit losses,ProvisionForLoanLeaseAndOtherLosses,usd,4176000000,cf
1973,American Express,0000004962,AXP,Banking,Q2,2020,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,711000000,cf
1974,American Express,0000004962,AXP,Banking,Q2,2020,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-335000000,cf
1975,American Express,0000004962,AXP,Banking,Q2,2020,Stock-based compensation,ShareBasedCompensation,usd,109000000,cf
1976,American Express,0000004962,AXP,Banking,Q2,2020,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,792000000,cf
1977,American Express,0000004962,AXP,Banking,Q2,2020,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-5252000000,cf
1978,American Express,0000004962,AXP,Banking,Q2,2020,Net cash (used in) provided by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,-89000000,cf
1979,American Express,0000004962,AXP,Banking,Q2,2020,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,36000000,cf
1980,American Express,0000004962,AXP,Banking,Q2,2020,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,4573000000,cf
1981,American Express,0000004962,AXP,Banking,Q2,2020,Purchase of investments,PaymentsToAcquireInvestments,usd,16132000000,cf
1982,American Express,0000004962,AXP,Banking,Q2,2020,"Net decrease (increase) in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,-34356000000,cf
1983,American Express,0000004962,AXP,Banking,Q2,2020,"Purchase of premises and equipment, net of sales",PaymentsToAcquirePropertyPlantAndEquipment,usd,689000000,cf
1984,American Express,0000004962,AXP,Banking,Q2,2020,"Acquisitions/dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,N/A,cf
1985,American Express,0000004962,AXP,Banking,Q2,2020,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-2000000,cf
1986,American Express,0000004962,AXP,Banking,Q2,2020,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,22146000000,cf
1987,American Express,0000004962,AXP,Banking,Q2,2020,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,11519000000,cf
1988,American Express,0000004962,AXP,Banking,Q2,2020,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-4859000000,cf
1989,American Express,0000004962,AXP,Banking,Q2,2020,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,N/A,cf
1990,American Express,0000004962,AXP,Banking,Q2,2020,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,9699000000,cf
1991,American Express,0000004962,AXP,Banking,Q2,2020,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,33000000,cf
1992,American Express,0000004962,AXP,Banking,Q2,2020,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,1025000000,cf
1993,American Express,0000004962,AXP,Banking,Q2,2020,Dividends paid,PaymentsOfDividends,usd,749000000,cf
1994,American Express,0000004962,AXP,Banking,Q2,2020,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-4780000000,cf
1995,American Express,0000004962,AXP,Banking,Q2,2020,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,380000000,cf
1996,American Express,0000004962,AXP,Banking,Q2,2020,"Net increase (decrease) in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,17657000000,cf
1997,American Express,0000004962,AXP,Banking,Q3,2020,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,33030000000,bs
1998,American Express,0000004962,AXP,Banking,Q3,2020,Total cash and cash equivalents,CashCashEquivalentsAndFederalFundsSold,usd,33030000000,bs
1999,American Express,0000004962,AXP,Banking,Q3,2020,Short-term investment securities,CashEquivalentsAtCarryingValue,usd,108000000,bs
2000,American Express,0000004962,AXP,Banking,Q3,2020,Short-term borrowings,ShortTermBorrowings,usd,1716000000,bs
2001,American Express,0000004962,AXP,Banking,Q3,2020,"Card Member receivables (includes gross receivables available to settle obligations of consolidated variable interest entity), less reserves for credit losses",AccountsReceivableNet,usd,40389000000,bs
2002,American Express,0000004962,AXP,Banking,Q3,2020,"Card Member receivables (includes gross receivables available to settle obligations of consolidated variable interest entity), less reserves for credit losses",AccountsReceivableNet,usd,40389000000,bs
2003,American Express,0000004962,AXP,Banking,Q3,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,12762000000,bs
2004,American Express,0000004962,AXP,Banking,Q3,2020,"Card Member loans (includes gross loans available to settle obligations of consolidated variable interest entity), less reserves for credit losses",LoansAndLeasesReceivableNetReportedAmount,usd,63918000000,bs
2005,American Express,0000004962,AXP,Banking,Q3,2020,"Card Member loans (includes gross loans available to settle obligations of consolidated variable interest entity), less reserves for credit losses",LoansAndLeasesReceivableNetReportedAmount,usd,63918000000,bs
2006,American Express,0000004962,AXP,Banking,Q3,2020,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2348000000,bs
2007,American Express,0000004962,AXP,Banking,Q3,2020,"Other assets (includes restricted cash of consolidated variable interest entities), less reserves for credit losses",OtherAssets,usd,19500000000,bs
2008,American Express,0000004962,AXP,Banking,Q3,2020,Long-term debt (includes debt issued by consolidated variable interest entities),LongTermDebt,usd,44777000000,bs
2009,American Express,0000004962,AXP,Banking,Q3,2020,Interest-bearing deposits in other banks (includes securities purchased under resale agreements),InterestBearingDepositsInBanks,usd,30817000000,bs
2010,American Express,0000004962,AXP,Banking,Q3,2020,Total liabilities,Liabilities,usd,165390000000,bs
2011,American Express,0000004962,AXP,Banking,Q3,2020,Total shareholders’ equity,StockholdersEquity,usd,21869000000,bs
2012,American Express,0000004962,AXP,Banking,Q3,2020,Total shareholders’ equity,StockholdersEquity,usd,21869000000,bs
2013,American Express,0000004962,AXP,Banking,Q3,2020,Total shareholders’ equity,StockholdersEquity,usd,21869000000,bs
2014,American Express,0000004962,AXP,Banking,Q3,2020,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,8232000000,bs
2015,American Express,0000004962,AXP,Banking,Q3,2020,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,187259000000,bs
2016,American Express,0000004962,AXP,Banking,Q3,2020,Contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
2017,American Express,0000004962,AXP,Banking,Q3,2020,Cash and due from banks,CashAndDueFromBanks,usd,2105000000,bs
2018,American Express,0000004962,AXP,Banking,Q3,2020,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,22443000000,bs
2019,American Express,0000004962,AXP,Banking,Q3,2020,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,22443000000,bs
2020,American Express,0000004962,AXP,Banking,Q3,2020,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,600000000,bs
2021,American Express,0000004962,AXP,Banking,Q3,2020,Total assets,Assets,usd,187259000000,bs
2022,American Express,0000004962,AXP,Banking,Q3,2020,Total assets,Assets,usd,187000000000,bs
2023,American Express,0000004962,AXP,Banking,Q3,2020,Total assets,Assets,usd,187000000000,bs
2024,American Express,0000004962,AXP,Banking,Q3,2020,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,76000000,bs
2025,American Express,0000004962,AXP,Banking,Q3,2020,Preferred shares,PreferredStockValue,usd,N/A,bs
2026,American Express,0000004962,AXP,Banking,Q3,2020,Total accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2872000000,bs
2027,American Express,0000004962,AXP,Banking,Q3,2020,Customer deposits,Deposits,usd,85461000000,bs
2028,American Express,0000004962,AXP,Banking,Q3,2020,Customer deposits,Deposits,usd,85461000000,bs
2029,American Express,0000004962,AXP,Banking,Q3,2020,Customer deposits,Deposits,usd,85461000000,bs
2030,American Express,0000004962,AXP,Banking,Q3,2020,Common shares,CommonStockValue,usd,161000000,bs
2031,American Express,0000004962,AXP,Banking,Q3,2020,Additional paid-in capital,AdditionalPaidInCapital,usd,11818000000,bs
2032,American Express,0000004962,AXP,Banking,Q3,2020,"Premises and equipment, less accumulated depreciation and amortization",PropertyPlantAndEquipmentNet,usd,4835000000,bs
2033,American Express,0000004962,AXP,Banking,Q3,2020,Other liabilities,OtherLiabilities,usd,25204000000,bs
2034,American Express,0000004962,AXP,Banking,Q3,2020,"Other loans, less reserves for credit losses",axp:OtherLoansReceivableNetAmount,usd,3144000000,bs
2035,American Express,0000004962,AXP,Banking,Q3,2020,"Other loans, less reserves for credit losses",axp:OtherLoansReceivableNetAmount,usd,3144000000,bs
2036,American Express,0000004962,AXP,Banking,Q3,2020,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,34000000,cf
2037,American Express,0000004962,AXP,Banking,Q3,2020,"Net increase (decrease) in cash, cash equivalents and restricted cash",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,11181000000,cf
2038,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2039,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2040,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2041,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2042,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2043,American Express,0000004962,AXP,Banking,Q3,2020,Net income,NetIncomeLoss,usd,1697000000,cf
2044,American Express,0000004962,AXP,Banking,Q3,2020,"Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash",EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,283000000,cf
2045,American Express,0000004962,AXP,Banking,Q3,2020,Provisions for credit losses,ProvisionForLoanLeaseAndOtherLosses,usd,4841000000,cf
2046,American Express,0000004962,AXP,Banking,Q3,2020,Provisions for credit losses,ProvisionForLoanLeaseAndOtherLosses,usd,4841000000,cf
2047,American Express,0000004962,AXP,Banking,Q3,2020,Deferred taxes and other,OtherNoncashIncomeExpense,usd,-79000000,cf
2048,American Express,0000004962,AXP,Banking,Q3,2020,Purchase of investments,PaymentsToAcquireInvestments,usd,18977000000,cf
2049,American Express,0000004962,AXP,Banking,Q3,2020,"Purchase of premises and equipment, net of sales",PaymentsToAcquirePropertyPlantAndEquipment,usd,1042000000,cf
2050,American Express,0000004962,AXP,Banking,Q3,2020,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,4881000000,cf
2051,American Express,0000004962,AXP,Banking,Q3,2020,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,1432000000,cf
2052,American Express,0000004962,AXP,Banking,Q3,2020,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-4737000000,cf
2053,American Express,0000004962,AXP,Banking,Q3,2020,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,13699000000,cf
2054,American Express,0000004962,AXP,Banking,Q3,2020,Dividends paid,PaymentsOfDividends,usd,1112000000,cf
2055,American Express,0000004962,AXP,Banking,Q3,2020,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-8382000000,cf
2056,American Express,0000004962,AXP,Banking,Q3,2020,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,12158000000,cf
2057,American Express,0000004962,AXP,Banking,Q3,2020,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,58000000,cf
2058,American Express,0000004962,AXP,Banking,Q3,2020,"Net decrease (increase) in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,-32262000000,cf
2059,American Express,0000004962,AXP,Banking,Q3,2020,"Acquisitions/dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,N/A,cf
2060,American Express,0000004962,AXP,Banking,Q3,2020,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,2091000000,cf
2061,American Express,0000004962,AXP,Banking,Q3,2020,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,1026000000,cf
2062,American Express,0000004962,AXP,Banking,Q3,2020,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-4384000000,cf
2063,American Express,0000004962,AXP,Banking,Q3,2020,Net cash provided by (used in) investing activities,NetCashProvidedByUsedInInvestingActivities,usd,17189000000,cf
2064,American Express,0000004962,AXP,Banking,Q3,2020,Stock-based compensation,ShareBasedCompensation,usd,175000000,cf
2065,American Express,0000004962,AXP,Banking,Q3,2020,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,1115000000,cf
2066,American Express,0000004962,AXP,Banking,Q3,2020,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-7000000,cf
2067,American Express,0000004962,AXP,Banking,Q3,2020,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,N/A,cf
2068,American Express,0000004962,AXP,Banking,FY,2020,Cash and due from banks,CashAndDueFromBanks,usd,2984000000,bs
2069,American Express,0000004962,AXP,Banking,FY,2020,Interest-bearing deposits in other banks,InterestBearingDepositsInBanks,usd,29824000000,bs
2070,American Express,0000004962,AXP,Banking,FY,2020,"Short-term investment securities (includes restricted cash of consolidated variable interest entities: 2020 $47; 2019, $85)",ShortTermInvestments,usd,157000000,bs
2071,American Express,0000004962,AXP,Banking,FY,2020,Net increase (decrease) in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,32965000000,bs
2072,American Express,0000004962,AXP,Banking,FY,2020,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,21631000000,bs
2073,American Express,0000004962,AXP,Banking,FY,2020,Premises and equipment,PropertyPlantAndEquipmentNet,usd,5015000000,bs
2074,American Express,0000004962,AXP,Banking,FY,2020,Other Assets [Abstract],OtherAssets,usd,17679000000,bs
2075,American Express,0000004962,AXP,Banking,FY,2020,Assets,Assets,usd,191367000000,bs
2076,American Express,0000004962,AXP,Banking,FY,2020,U.S.:,Deposits,usd,86875000000,bs
2077,American Express,0000004962,AXP,Banking,FY,2020,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,9444000000,bs
2078,American Express,0000004962,AXP,Banking,FY,2020,Short-term borrowings,ShortTermBorrowings,usd,1878000000,bs
2079,American Express,0000004962,AXP,Banking,FY,2020,2023,LongTermDebt,usd,42952000000,bs
2080,American Express,0000004962,AXP,Banking,FY,2020,Summary of other liabilities,OtherLiabilities,usd,27234000000,bs
2081,American Express,0000004962,AXP,Banking,FY,2020,Liabilities and Shareholders’ Equity,Liabilities,usd,168383000000,bs
2082,American Express,0000004962,AXP,Banking,FY,2020,Contingencies and Commitments,CommitmentsAndContingencies,usd,N/A,bs
2083,American Express,0000004962,AXP,Banking,FY,2020,Preferred shares issued,PreferredStockValueOutstanding,usd,N/A,bs
2084,American Express,0000004962,AXP,Banking,FY,2020,Common shares,CommonStockValue,usd,161000000,bs
2085,American Express,0000004962,AXP,Banking,FY,2020,Additional Paid-in Capital [Member],AdditionalPaidInCapital,usd,11881000000,bs
2086,American Express,0000004962,AXP,Banking,FY,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13837000000,bs
2087,American Express,0000004962,AXP,Banking,FY,2020,"Net unrealized securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,65000000,bs
2088,American Express,0000004962,AXP,Banking,FY,2020,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2229000000,bs
2089,American Express,0000004962,AXP,Banking,FY,2020,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,731000000,bs
2090,American Express,0000004962,AXP,Banking,FY,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2895000000,bs
2091,American Express,0000004962,AXP,Banking,FY,2020,Total shareholders’ equity,StockholdersEquity,usd,22984000000,bs
2092,American Express,0000004962,AXP,Banking,FY,2020,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,191367000000,bs
2093,American Express,0000004962,AXP,Banking,FY,2020,Net income attributable to common shareholders  ,NetIncomeLoss,usd,3135000000,cf
2094,American Express,0000004962,AXP,Banking,FY,2020,Provisions for credit losses,ProvisionForLoanLossesExpensed,usd,4730000000,cf
2095,American Express,0000004962,AXP,Banking,FY,2020,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,1543000000,cf
2096,American Express,0000004962,AXP,Banking,FY,2020,Deferred taxes and other,OtherNoncashIncomeExpense,usd,256000000,cf
2097,American Express,0000004962,AXP,Banking,FY,2020,"RSAs/RSUs Granted, shares",ShareBasedCompensation,usd,249000000,cf
2098,American Express,0000004962,AXP,Banking,FY,2020,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,1785000000,cf
2099,American Express,0000004962,AXP,Banking,FY,2020,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-2025000000,cf
2100,American Express,0000004962,AXP,Banking,FY,2020,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,5591000000,cf
2101,American Express,0000004962,AXP,Banking,FY,2020,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,69000000,cf
2102,American Express,0000004962,AXP,Banking,FY,2020,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,7159000000,cf
2103,American Express,0000004962,AXP,Banking,FY,2020,Purchase of investments,PaymentsToAcquireInvestments,usd,20562000000,cf
2104,American Express,0000004962,AXP,Banking,FY,2020,"Net decrease (increase) in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,-26906000000,cf
2105,American Express,0000004962,AXP,Banking,FY,2020,Purchase of premises and equipment,PaymentsToAcquirePropertyPlantAndEquipment,usd,1478000000,cf
2106,American Express,0000004962,AXP,Banking,FY,2020,"Acquisitions/dispositions, net of cash acquired",PaymentsForProceedsFromBusinessesAndInterestInAffiliates,usd,597000000,cf
2107,American Express,0000004962,AXP,Banking,FY,2020,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-135000000,cf
2108,American Express,0000004962,AXP,Banking,FY,2020,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,11632000000,cf
2109,American Express,0000004962,AXP,Banking,FY,2020,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,13542000000,cf
2110,American Express,0000004962,AXP,Banking,FY,2020,Net (decrease) increase in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-4627000000,cf
2111,American Express,0000004962,AXP,Banking,FY,2020,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,69000000,cf
2112,American Express,0000004962,AXP,Banking,FY,2020,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,15593000000,cf
2113,American Express,0000004962,AXP,Banking,FY,2020,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,44000000,cf
2114,American Express,0000004962,AXP,Banking,FY,2020,Repurchase of American Express common shares and other,axp:PaymentsForRepurchasesOfCommonSharesAndOther,usd,1029000000,cf
2115,American Express,0000004962,AXP,Banking,FY,2020,Dividends paid,PaymentsOfDividends,usd,1474000000,cf
2116,American Express,0000004962,AXP,Banking,FY,2020,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-9068000000,cf
2117,American Express,0000004962,AXP,Banking,FY,2020,Effect of foreign currency exchange rates on cash and cash equivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,364000000,cf
2118,American Express,0000004962,AXP,Banking,FY,2020,Net increase (decrease) in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,8519000000,cf
2119,American Express,0000004962,AXP,Banking,Q1,2021,Cash and due from banks,CashAndDueFromBanks,usd,2662000000,bs
2120,American Express,0000004962,AXP,Banking,Q1,2021,"Interest-bearing deposits in other banks (includes securities purchased under resale agreements: 2021, $119; 2020, $92)",InterestBearingDepositsInBanks,usd,37405000000,bs
2121,American Express,0000004962,AXP,Banking,Q1,2021,"Short-term investment securities (includes restricted cash of consolidated variable interest entities: 2021, $46; 2020, $47)",ShortTermInvestments,usd,213000000,bs
2122,American Express,0000004962,AXP,Banking,Q1,2021,"Cash, cash equivalents and restricted cash reconciliation",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,40280000000,bs
2123,American Express,0000004962,AXP,Banking,Q1,2021,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,21270000000,bs
2124,American Express,0000004962,AXP,Banking,Q1,2021,"Premises and equipment, less accumulated depreciation and amortization: 2021, $7,800; 2020, $7,540",PropertyPlantAndEquipmentNet,usd,4943000000,bs
2125,American Express,0000004962,AXP,Banking,Q1,2021,Other financial assets,OtherAssets,usd,17008000000,bs
2126,American Express,0000004962,AXP,Banking,Q1,2021,Assets,Assets,usd,193067000000,bs
2127,American Express,0000004962,AXP,Banking,Q1,2021,Deposits By Type,Deposits,usd,89193000000,bs
2128,American Express,0000004962,AXP,Banking,Q1,2021,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,8585000000,bs
2129,American Express,0000004962,AXP,Banking,Q1,2021,Short-term borrowings,ShortTermBorrowings,usd,1578000000,bs
2130,American Express,0000004962,AXP,Banking,Q1,2021,"Long-term debt (includes debt issued by consolidated variable interest entities: 2021, $12,763; 2020, $12,760)",LongTermDebt,usd,42019000000,bs
2131,American Express,0000004962,AXP,Banking,Q1,2021,Other liabilities,OtherLiabilities,usd,27243000000,bs
2132,American Express,0000004962,AXP,Banking,Q1,2021,Liabilities and Shareholders’ Equity,Liabilities,usd,168618000000,bs
2133,American Express,0000004962,AXP,Banking,Q1,2021,Contingencies,CommitmentsAndContingencies,usd,N/A,bs
2134,American Express,0000004962,AXP,Banking,Q1,2021,"Preferred shares, $1.662/3 par value, authorized 20 million shares; issued and outstanding 1,600 shares as of March 31, 2021 and December 31, 2020",PreferredStockValue,usd,N/A,bs
2135,American Express,0000004962,AXP,Banking,Q1,2021,"Common shares, $0.20 par value, authorized 3.6 billion shares; issued and outstanding 803 million shares as of March 31, 2021 and 805 million shares as of December 31, 2020",CommonStockValue,usd,161000000,bs
2136,American Express,0000004962,AXP,Banking,Q1,2021,Additional Paid-in Capital,AdditionalPaidInCapital,usd,11878000000,bs
2137,American Express,0000004962,AXP,Banking,Q1,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,15308000000,bs
2138,American Express,0000004962,AXP,Banking,Q1,2021,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,53000000,bs
2139,American Express,0000004962,AXP,Banking,Q1,2021,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2246000000,bs
2140,American Express,0000004962,AXP,Banking,Q1,2021,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,705000000,bs
2141,American Express,0000004962,AXP,Banking,Q1,2021,Accumulated other comprehensive income (loss),AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2898000000,bs
2142,American Express,0000004962,AXP,Banking,Q1,2021,"Other changes, primarily employee plans",StockholdersEquity,usd,24449000000,bs
2143,American Express,0000004962,AXP,Banking,Q1,2021,Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,193067000000,bs
2144,American Express,0000004962,AXP,Banking,Q1,2021,Net income available to common shareholders,NetIncomeLoss,usd,2235000000,cf
2145,American Express,0000004962,AXP,Banking,Q1,2021,Provisions,ProvisionForLoanLossesExpensed,usd,-675000000,cf
2146,American Express,0000004962,AXP,Banking,Q1,2021,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,422000000,cf
2147,American Express,0000004962,AXP,Banking,Q1,2021,Deferred taxes and other,OtherNoncashIncomeExpense,usd,81000000,cf
2148,American Express,0000004962,AXP,Banking,Q1,2021,Stock-based compensation,ShareBasedCompensation,usd,98000000,cf
2149,American Express,0000004962,AXP,Banking,Q1,2021,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,-477000000,cf
2150,American Express,0000004962,AXP,Banking,Q1,2021,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,-196000000,cf
2151,American Express,0000004962,AXP,Banking,Q1,2021,Net cash provided by (used in) operating activities,NetCashProvidedByUsedInOperatingActivities,usd,2280000000,cf
2152,American Express,0000004962,AXP,Banking,Q1,2021,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,37000000,cf
2153,American Express,0000004962,AXP,Banking,Q1,2021,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,553000000,cf
2154,American Express,0000004962,AXP,Banking,Q1,2021,Purchase of investments,PaymentsToAcquireInvestments,usd,366000000,cf
2155,American Express,0000004962,AXP,Banking,Q1,2021,"Net decrease in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,-4869000000,cf
2156,American Express,0000004962,AXP,Banking,Q1,2021,"Purchase of premises and equipment, net of sales: 2021, $3; 2020, nil",PaymentsToAcquirePropertyPlantAndEquipment,usd,319000000,cf
2157,American Express,0000004962,AXP,Banking,Q1,2021,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,4774000000,cf
2158,American Express,0000004962,AXP,Banking,Q1,2021,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,2327000000,cf
2159,American Express,0000004962,AXP,Banking,Q1,2021,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-271000000,cf
2160,American Express,0000004962,AXP,Banking,Q1,2021,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,750000000,cf
2161,American Express,0000004962,AXP,Banking,Q1,2021,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,31000000,cf
2162,American Express,0000004962,AXP,Banking,Q1,2021,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,513000000,cf
2163,American Express,0000004962,AXP,Banking,Q1,2021,Dividends paid,PaymentsOfDividends,usd,363000000,cf
2164,American Express,0000004962,AXP,Banking,Q1,2021,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,461000000,cf
2165,American Express,0000004962,AXP,Banking,Q1,2021,Effect of foreign currency exchange rates on cash and cash equivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-200000000,cf
2166,American Express,0000004962,AXP,Banking,Q1,2021,Net increase in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,7315000000,cf
2167,American Express,0000004962,AXP,Banking,Q2,2021,"Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2021, $1,379; 2020, $47)",ShortTermInvestments,usd,1423000000,bs
2168,American Express,0000004962,AXP,Banking,Q2,2021,Total accumulated other comprehensive income (loss),AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2881000000,bs
2169,American Express,0000004962,AXP,Banking,Q2,2021,"Cash and due from banks (includes restricted cash of consolidated variable interest entities: 2021, $14; 2020, nil)",CashAndDueFromBanks,usd,2671000000,bs
2170,American Express,0000004962,AXP,Banking,Q2,2021,Total shareholders’ equity,StockholdersEquity,usd,25539000000,bs
2171,American Express,0000004962,AXP,Banking,Q2,2021,Total shareholders’ equity,StockholdersEquity,usd,25539000000,bs
2172,American Express,0000004962,AXP,Banking,Q2,2021,Total shareholders’ equity,StockholdersEquity,usd,25539000000,bs
2173,American Express,0000004962,AXP,Banking,Q2,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,16402000000,bs
2174,American Express,0000004962,AXP,Banking,Q2,2021,"Long-term debt (includes debt issued by consolidated variable interest entities: 2021, $11,866; 2020, $12,760)",LongTermDebt,usd,37363000000,bs
2175,American Express,0000004962,AXP,Banking,Q2,2021,"Other assets, less reserves for credit losses: 2021, $39; 2020, $85",OtherAssets,usd,17402000000,bs
2176,American Express,0000004962,AXP,Banking,Q2,2021,"Preferred shares, $1.662/3 par value, authorized 20 million shares; issued and outstanding 1,600 shares as of June 30, 2021 and December 31, 2020",PreferredStockValue,usd,N/A,bs
2177,American Express,0000004962,AXP,Banking,Q2,2021,"Interest-bearing deposits in other banks (includes securities purchased under resale agreements: 2021, $46; 2020, $92)",InterestBearingDepositsInBanks,usd,26702000000,bs
2178,American Express,0000004962,AXP,Banking,Q2,2021,"Common shares, $0.20 par value, authorized 3.6 billion shares; issued and outstanding 798 million shares as of June 30, 2021 and 805 million shares as of December 31, 2020",CommonStockValue,usd,160000000,bs
2179,American Express,0000004962,AXP,Banking,Q2,2021,"Premises and equipment, less accumulated depreciation and amortization: 2021, $8,084; 2020, $7,540",PropertyPlantAndEquipmentNet,usd,4891000000,bs
2180,American Express,0000004962,AXP,Banking,Q2,2021,"Net unrealized pension and other postretirement benefits, net of tax",AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,696000000,bs
2181,American Express,0000004962,AXP,Banking,Q2,2021,Short-term borrowings,ShortTermBorrowings,usd,1864000000,bs
2182,American Express,0000004962,AXP,Banking,Q2,2021,"Foreign currency translation adjustments, net of tax",AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2227000000,bs
2183,American Express,0000004962,AXP,Banking,Q2,2021,Other liabilities,OtherLiabilities,usd,27594000000,bs
2184,American Express,0000004962,AXP,Banking,Q2,2021,Restricted cash and cash equivalents,RestrictedCashAndCashEquivalents,usd,1841000000,bs
2185,American Express,0000004962,AXP,Banking,Q2,2021,Customer deposits,Deposits,usd,84905000000,bs
2186,American Express,0000004962,AXP,Banking,Q2,2021,Customer deposits,Deposits,usd,84905000000,bs
2187,American Express,0000004962,AXP,Banking,Q2,2021,Customer deposits,Deposits,usd,84905000000,bs
2188,American Express,0000004962,AXP,Banking,Q2,2021,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,30796000000,bs
2189,American Express,0000004962,AXP,Banking,Q2,2021,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,30796000000,bs
2190,American Express,0000004962,AXP,Banking,Q2,2021,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,30796000000,bs
2191,American Express,0000004962,AXP,Banking,Q2,2021,"Net unrealized debt securities gains (losses), net of tax",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,42000000,bs
2192,American Express,0000004962,AXP,Banking,Q2,2021,Contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
2193,American Express,0000004962,AXP,Banking,Q2,2021,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,186973000000,bs
2194,American Express,0000004962,AXP,Banking,Q2,2021,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,9708000000,bs
2195,American Express,0000004962,AXP,Banking,Q2,2021,Total liabilities,Liabilities,usd,161434000000,bs
2196,American Express,0000004962,AXP,Banking,Q2,2021,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,12443000000,bs
2197,American Express,0000004962,AXP,Banking,Q2,2021,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,12443000000,bs
2198,American Express,0000004962,AXP,Banking,Q2,2021,Total assets,Assets,usd,186973000000,bs
2199,American Express,0000004962,AXP,Banking,Q2,2021,Total assets,Assets,usd,187000000000,bs
2200,American Express,0000004962,AXP,Banking,Q2,2021,Total assets,Assets,usd,187000000000,bs
2201,American Express,0000004962,AXP,Banking,Q2,2021,Additional paid-in capital,AdditionalPaidInCapital,usd,11858000000,bs
2202,American Express,0000004962,AXP,Banking,Q2,2021,Net (decrease) increase in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-2169000000,cf
2203,American Express,0000004962,AXP,Banking,Q2,2021,Dividends paid,PaymentsOfDividends,usd,724000000,cf
2204,American Express,0000004962,AXP,Banking,Q2,2021,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,834000000,cf
2205,American Express,0000004962,AXP,Banking,Q2,2021,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,9684000000,cf
2206,American Express,0000004962,AXP,Banking,Q2,2021,Net cash provided by (used in) operating activities,NetCashProvidedByUsedInOperatingActivities,usd,5465000000,cf
2207,American Express,0000004962,AXP,Banking,Q2,2021,"Purchase of premises and equipment, net of sales: 2021, $40; 2020, nil",PaymentsToAcquirePropertyPlantAndEquipment,usd,609000000,cf
2208,American Express,0000004962,AXP,Banking,Q2,2021,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,45000000,cf
2209,American Express,0000004962,AXP,Banking,Q2,2021,Provisions for credit losses,ProvisionForLoanLossesExpensed,usd,-1281000000,cf
2210,American Express,0000004962,AXP,Banking,Q2,2021,Provisions for credit losses,ProvisionForLoanLossesExpensed,usd,-1281000000,cf
2211,American Express,0000004962,AXP,Banking,Q2,2021,Repurchase of American Express common shares and other,axp:Paymentsforrepurchasesofcommonsharesandother,usd,1397000000,cf
2212,American Express,0000004962,AXP,Banking,Q2,2021,Effect of foreign currency exchange rates on cash and cash equivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-227000000,cf
2213,American Express,0000004962,AXP,Banking,Q2,2021,"Net (increase) decrease in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,6280000000,cf
2214,American Express,0000004962,AXP,Banking,Q2,2021,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-9416000000,cf
2215,American Express,0000004962,AXP,Banking,Q2,2021,Net income,NetIncomeLoss,usd,4515000000,cf
2216,American Express,0000004962,AXP,Banking,Q2,2021,Net income,NetIncomeLoss,usd,4515000000,cf
2217,American Express,0000004962,AXP,Banking,Q2,2021,Net income,NetIncomeLoss,usd,4515000000,cf
2218,American Express,0000004962,AXP,Banking,Q2,2021,Net income,NetIncomeLoss,usd,4515000000,cf
2219,American Express,0000004962,AXP,Banking,Q2,2021,Net income,NetIncomeLoss,usd,4515000000,cf
2220,American Express,0000004962,AXP,Banking,Q2,2021,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,1226000000,cf
2221,American Express,0000004962,AXP,Banking,Q2,2021,Stock-based compensation,ShareBasedCompensation,usd,183000000,cf
2222,American Express,0000004962,AXP,Banking,Q2,2021,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,5409000000,cf
2223,American Express,0000004962,AXP,Banking,Q2,2021,Deferred taxes and other,OtherNoncashIncomeExpense,usd,294000000,cf
2224,American Express,0000004962,AXP,Banking,Q2,2021,Other investing activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-1000000,cf
2225,American Express,0000004962,AXP,Banking,Q2,2021,Net cash provided by investing activities,NetCashProvidedByUsedInInvestingActivities,usd,2009000000,cf
2226,American Express,0000004962,AXP,Banking,Q2,2021,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,18000000,cf
2227,American Express,0000004962,AXP,Banking,Q2,2021,Purchase of investments,PaymentsToAcquireInvestments,usd,824000000,cf
2228,American Express,0000004962,AXP,Banking,Q2,2021,Net (decrease) increase in customer deposits,IncreaseDecreaseInDeposits,usd,-1966000000,cf
2229,American Express,0000004962,AXP,Banking,Q2,2021,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,-282000000,cf
2230,American Express,0000004962,AXP,Banking,Q2,2021,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,37000000,cf
2231,American Express,0000004962,AXP,Banking,Q2,2021,Net increase (decrease) in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,17000000,cf
2232,American Express,0000004962,AXP,Banking,Q1,2022,Accumulated other comprehensive income (loss),AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-2973000000,bs
2233,American Express,0000004962,AXP,Banking,Q1,2022,Accounts payable,AccountsPayableCurrentAndNoncurrent,usd,11196000000,bs
2234,American Express,0000004962,AXP,Banking,Q1,2022,Total liabilities,Liabilities,usd,173479000000,bs
2235,American Express,0000004962,AXP,Banking,Q1,2022,"Common shares, $0.20 par value, authorized 3.6 billion shares; issued and outstanding 755 million shares as of March 31, 2022 and 761 million shares as of December 31, 2021",CommonStockValue,usd,151000000,bs
2236,American Express,0000004962,AXP,Banking,Q1,2022,Contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
2237,American Express,0000004962,AXP,Banking,Q1,2022,Customer deposits,Deposits,usd,90917000000,bs
2238,American Express,0000004962,AXP,Banking,Q1,2022,Customer deposits,Deposits,usd,90917000000,bs
2239,American Express,0000004962,AXP,Banking,Q1,2022,Customer deposits,Deposits,usd,90917000000,bs
2240,American Express,0000004962,AXP,Banking,Q1,2022,Total assets,Assets,usd,195862000000,bs
2241,American Express,0000004962,AXP,Banking,Q1,2022,Total assets,Assets,usd,196000000000,bs
2242,American Express,0000004962,AXP,Banking,Q1,2022,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,195862000000,bs
2243,American Express,0000004962,AXP,Banking,Q1,2022,"Interest-bearing deposits in other banks (includes securities purchased under resale agreements: 2022, $476; 2021, $463)",InterestBearingDepositsInBanks,usd,22896000000,bs
2244,American Express,0000004962,AXP,Banking,Q1,2022,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,13754000000,bs
2245,American Express,0000004962,AXP,Banking,Q1,2022,"Long-term debt (includes debt issued by consolidated variable interest entities: 2022, $11,788; 2021, $13,803)",LongTermDebt,usd,38337000000,bs
2246,American Express,0000004962,AXP,Banking,Q1,2022,Additional paid-in capital,AdditionalPaidInCapital,usd,11451000000,bs
2247,American Express,0000004962,AXP,Banking,Q1,2022,"Cash and due from banks (includes restricted cash of consolidated variable interest entities: 2022, $8; 2021, $11)",CashAndDueFromBanks,usd,3011000000,bs
2248,American Express,0000004962,AXP,Banking,Q1,2022,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,4058000000,bs
2249,American Express,0000004962,AXP,Banking,Q1,2022,Investment securities,axp:DebtandEquitySecuritiesAvailableforsale,usd,4058000000,bs
2250,American Express,0000004962,AXP,Banking,Q1,2022,Total shareholders’ equity,StockholdersEquity,usd,22383000000,bs
2251,American Express,0000004962,AXP,Banking,Q1,2022,Total shareholders’ equity,StockholdersEquity,usd,22383000000,bs
2252,American Express,0000004962,AXP,Banking,Q1,2022,"Other assets, less reserves for credit losses: 2022, $22; 2021, $25",OtherAssets,usd,16877000000,bs
2253,American Express,0000004962,AXP,Banking,Q1,2022,"Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2022, $1,745; 2021, $32)",ShortTermInvestments,usd,1771000000,bs
2254,American Express,0000004962,AXP,Banking,Q1,2022,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,27678000000,bs
2255,American Express,0000004962,AXP,Banking,Q1,2022,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,27678000000,bs
2256,American Express,0000004962,AXP,Banking,Q1,2022,Total cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,27678000000,bs
2257,American Express,0000004962,AXP,Banking,Q1,2022,"Premises and equipment, less accumulated depreciation and amortization: 2022, $8,907; 2021, $8,602",PropertyPlantAndEquipmentNet,usd,5046000000,bs
2258,American Express,0000004962,AXP,Banking,Q1,2022,"Preferred shares, $1.662/3 par value, authorized 20 million shares; issued and outstanding 1,600 shares as of March 31, 2022 and December 31, 2021",PreferredStockValue,usd,N/A,bs
2259,American Express,0000004962,AXP,Banking,Q1,2022,Other liabilities,OtherLiabilities,usd,30907000000,bs
2260,American Express,0000004962,AXP,Banking,Q1,2022,Short-term borrowings,ShortTermBorrowings,usd,2122000000,bs
2261,American Express,0000004962,AXP,Banking,Q1,2022,Payments of long-term debt,RepaymentsOfLongTermDebt,usd,6314000000,cf
2262,American Express,0000004962,AXP,Banking,Q1,2022,Effect of foreign currency exchange rates on cash and cash equivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,14000000,cf
2263,American Express,0000004962,AXP,Banking,Q1,2022,Net cash provided by financing activities,NetCashProvidedByUsedInFinancingActivities,usd,4533000000,cf
2264,American Express,0000004962,AXP,Banking,Q1,2022,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,3880000000,cf
2265,American Express,0000004962,AXP,Banking,Q1,2022,Proceeds from long-term debt,ProceedsFromIssuanceOfLongTermDebt,usd,6231000000,cf
2266,American Express,0000004962,AXP,Banking,Q1,2022,Net cash (used in) provided by investing activities,NetCashProvidedByUsedInInvestingActivities,usd,-2777000000,cf
2267,American Express,0000004962,AXP,Banking,Q1,2022,Other non-cash items,OtherNoncashIncomeExpense,usd,47000000,cf
2268,American Express,0000004962,AXP,Banking,Q1,2022,Dividends paid,PaymentsOfDividends,usd,345000000,cf
2269,American Express,0000004962,AXP,Banking,Q1,2022,Maturities and redemptions of investment securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,767000000,cf
2270,American Express,0000004962,AXP,Banking,Q1,2022,Provisions for credit losses,ProvisionForLoanLossesExpensed,usd,-33000000,cf
2271,American Express,0000004962,AXP,Banking,Q1,2022,Provisions for credit losses,ProvisionForLoanLossesExpensed,usd,-33000000,cf
2272,American Express,0000004962,AXP,Banking,Q1,2022,Other assets,IncreaseDecreaseInOtherOperatingAssets,usd,-323000000,cf
2273,American Express,0000004962,AXP,Banking,Q1,2022,Net increase in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,5650000000,cf
2274,American Express,0000004962,AXP,Banking,Q1,2022,Purchase of investments,PaymentsToAcquireInvestments,usd,2328000000,cf
2275,American Express,0000004962,AXP,Banking,Q1,2022,Accounts payable & other liabilities,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,usd,1087000000,cf
2276,American Express,0000004962,AXP,Banking,Q1,2022,Net decrease in short-term borrowings,ProceedsFromRepaymentsOfShortTermDebt,usd,-59000000,cf
2277,American Express,0000004962,AXP,Banking,Q1,2022,"Purchase of premises and equipment, net of sales: 2022, nil; 2021, $3",PaymentsToAcquirePropertyPlantAndEquipment,usd,447000000,cf
2278,American Express,0000004962,AXP,Banking,Q1,2022,Stock-based compensation,ShareBasedCompensation,usd,122000000,cf
2279,American Express,0000004962,AXP,Banking,Q1,2022,Repurchase of American Express common shares and other,PaymentsForRepurchaseOfCommonStock,usd,1570000000,cf
2280,American Express,0000004962,AXP,Banking,Q1,2022,Sale of investment securities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,16000000,cf
2281,American Express,0000004962,AXP,Banking,Q1,2022,Net increase in customer deposits,IncreaseDecreaseInDeposits,usd,6541000000,cf
2282,American Express,0000004962,AXP,Banking,Q1,2022,Depreciation and amortization,DepreciationAmortizationAndAccretionNet,usd,398000000,cf
2283,American Express,0000004962,AXP,Banking,Q1,2022,Net income,NetIncomeLoss,usd,2099000000,cf
2284,American Express,0000004962,AXP,Banking,Q1,2022,Net income,NetIncomeLoss,usd,2099000000,cf
2285,American Express,0000004962,AXP,Banking,Q1,2022,Net income,NetIncomeLoss,usd,2099000000,cf
2286,American Express,0000004962,AXP,Banking,Q1,2022,Net income,NetIncomeLoss,usd,2099000000,cf
2287,American Express,0000004962,AXP,Banking,Q1,2022,Net income,NetIncomeLoss,usd,2099000000,cf
2288,American Express,0000004962,AXP,Banking,Q1,2022,Issuance of American Express common shares,ProceedsFromIssuanceOfCommonStock,usd,49000000,cf
2289,American Express,0000004962,AXP,Banking,Q1,2022,Deferred taxes,IncreaseDecreaseInDeferredIncomeTaxes,usd,69000000,cf
2290,American Express,0000004962,AXP,Banking,Q1,2022,"Net (increase) decrease in Card Member loans and receivables, and other loans",PaymentsForProceedsFromLoansAndLeases,usd,785000000,cf
2291,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1444000000,bs
2292,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Receivables, net of allowance for doubtful accounts of $0.4 and $0.5, respectively",ReceivablesNetCurrent,usd,397400000,bs
2293,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Inventory,InventoryNet,usd,482500000,bs
2294,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other current assets,OtherAssetsCurrent,usd,88100000,bs
2295,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Current assets:,AssetsCurrent,usd,2412000000,bs
2296,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,857700000,bs
2297,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Goodwill,Goodwill,usd,881800000,bs
2298,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,60800000,bs
2299,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,51400000,bs
2300,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other assets,OtherAssetsNoncurrent,usd,46500000,bs
2301,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Current assets:,Assets,usd,4310200000,bs
2302,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Accounts payable,AccountsPayableCurrent,usd,178700000,bs
2303,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,67700000,bs
2304,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other current liabilities,OtherLiabilitiesCurrent,usd,54400000,bs
2305,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Current liabilities:,LiabilitiesCurrent,usd,300800000,bs
2306,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,82800000,bs
2307,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,28800000,bs
2308,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,412400000,bs
2309,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Commitments and contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
2310,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2311,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Common stock, $0.25 par value; 525.0 shares authorized; 225.6 shares issued and 183.7 shares outstanding as of June 30, 2017, and 222.5 shares issued and 184.9 shares outstanding as of September 30, 2016",CommonStockValue,usd,45900000,bs
2312,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2846100000,bs
2313,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Treasury stock, at cost",TreasuryStockValue,usd,1822200000,bs
2314,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,2837200000,bs
2315,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-9200000,bs
2316,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Stockholders' Equity Attributable to Parent [Abstract],StockholdersEquity,usd,3897800000,bs
2317,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4310200000,bs
2318,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net income,NetIncomeLoss,usd,728900000,cf
2319,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Share-based compensation,ShareBasedCompensation,usd,64300000,cf
2320,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Depreciation,Depreciation,usd,166800000,cf
2321,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,22600000,cf
2322,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Contribution of common shares to savings and retirement plans,swks:ContributionOfCommonSharesToSavingsAndRetirementPlansRelatedExpense,usd,7200000,cf
2323,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,2800000,cf
2324,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,35400000,cf
2325,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Receivables, net",IncreaseDecreaseInReceivables,usd,-20200000,cf
2326,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Inventory,IncreaseDecreaseInInventories,usd,58700000,cf
2327,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,9300000,cf
2328,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,68100000,cf
2329,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,68400000,cf
2330,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,1045900000,cf
2331,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,218000000,cf
2332,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,13700000,cf
2333,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,3200000,cf
2334,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-228500000,cf
2335,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,35400000,cf
2336,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,48000000,cf
2337,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,330500000,cf
2338,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Dividends paid,PaymentsOfOrdinaryDividends,usd,155700000,cf
2339,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,45800000,cf
2340,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Payments of contingent consideration,swks:PaymentOfContingentConsiderationObligations,usd,4200000,cf
2341,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-457200000,cf
2342,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Net increase (decrease) in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,360200000,cf
2343,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2017,Income taxes paid,IncomeTaxesPaid,usd,131900000,cf
2344,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,1616800000,bs
2345,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Receivables, net of allowance for doubtful accounts of $0.5 and $0.5, respectively",ReceivablesNetCurrent,usd,454700000,bs
2346,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Inventory, Net [Abstract]",InventoryNet,usd,493500000,bs
2347,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other current assets,OtherAssetsCurrent,usd,68700000,bs
2348,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Current assets:,AssetsCurrent,usd,2633700000,bs
2349,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,882300000,bs
2350,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,883000000,bs
2351,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net carrying amount,IntangibleAssetsNetExcludingGoodwill,usd,67800000,bs
2352,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,66500000,bs
2353,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other assets,OtherAssetsNoncurrent,usd,40300000,bs
2354,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,ASSETS,Assets,usd,4573600000,bs
2355,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Accounts payable,AccountsPayableCurrent,usd,258400000,bs
2356,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,68100000,bs
2357,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other current liabilities,OtherLiabilitiesCurrent,usd,61400000,bs
2358,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Current liabilities:,LiabilitiesCurrent,usd,387900000,bs
2359,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,92900000,bs
2360,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,27100000,bs
2361,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,LIABILITIES AND STOCKHOLDERS' EQUITY,Liabilities,usd,507900000,bs
2362,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2363,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2364,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Common stock, $0.25 par value: 525.0 shares authorized; 226.0 shares issued and 183.1 shares outstanding as of September 29, 2017, and 222.5 shares issued and 184.9 shares outstanding as of September 30, 2016",CommonStockValue,usd,45800000,bs
2365,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2893800000,bs
2366,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Treasury stock, at cost",TreasuryStockValue,usd,1925000000,bs
2367,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3059600000,bs
2368,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8500000,bs
2369,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4065700000,bs
2370,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,LIABILITIES AND STOCKHOLDERS' EQUITY,LiabilitiesAndStockholdersEquity,usd,4573600000,bs
2371,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net income,NetIncomeLoss,usd,1010200000,cf
2372,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Share-based compensation,ShareBasedCompensation,usd,88500000,cf
2373,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Depreciation,Depreciation,usd,227200000,cf
2374,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,27600000,cf
2375,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Contribution of common shares to savings and retirement plans,swks:ContributionOfCommonSharesToSavingsAndRetirementPlansRelatedExpense,usd,15000000,cf
2376,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,2200000,cf
2377,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,40800000,cf
2378,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other,OtherNoncashIncomeExpense,usd,-300000,cf
2379,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Receivables, net",IncreaseDecreaseInReceivables,usd,37100000,cf
2380,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Inventory,IncreaseDecreaseInInventories,usd,69200000,cf
2381,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,-3300000,cf
2382,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,147800000,cf
2383,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,96300000,cf
2384,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,1471300000,cf
2385,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,303300000,cf
2386,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,13700000,cf
2387,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Purchased intangibles,PaymentsToAcquireIntangibleAssets,usd,12100000,cf
2388,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,3200000,cf
2389,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-325900000,cf
2390,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Payments for obligations recorded for business combinations,swks:PaymentofObligationsRelatedtoBusinessCombinations,usd,0,cf
2391,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,40800000,cf
2392,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,49200000,cf
2393,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,432300000,cf
2394,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Dividends paid,PaymentsOfOrdinaryDividends,usd,214600000,cf
2395,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,53800000,cf
2396,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Deferred payments for intangible assets,RepaymentsOfOtherDebt,usd,5500000,cf
2397,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Payment for obligations recorded for business combinations,swks:PaymentOfContingentConsiderationObligations,usd,5400000,cf
2398,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-612400000,cf
2399,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,533000000,cf
2400,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2017,Income taxes paid,IncomeTaxesPaid,usd,163200000,cf
2401,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1681500000,bs
2402,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Receivables, net of allowance for doubtful accounts of $0.5 and $0.5, respectively",ReceivablesNetCurrent,usd,458800000,bs
2403,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Inventory,InventoryNet,usd,458600000,bs
2404,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other current assets,OtherAssetsCurrent,usd,87700000,bs
2405,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Current assets:,AssetsCurrent,usd,2686600000,bs
2406,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,869100000,bs
2407,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Goodwill,Goodwill,usd,883000000,bs
2408,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,68200000,bs
2409,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,45300000,bs
2410,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other assets,OtherAssetsNoncurrent,usd,42100000,bs
2411,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,ASSETS,Assets,usd,4594300000,bs
2412,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Accounts payable,AccountsPayableCurrent,usd,161600000,bs
2413,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,63900000,bs
2414,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other current liabilities,OtherLiabilitiesCurrent,usd,96000000,bs
2415,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Current liabilities:,LiabilitiesCurrent,usd,321500000,bs
2416,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,331700000,bs
2417,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,40600000,bs
2418,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,693800000,bs
2419,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Commitments and contingencies (Note 7),CommitmentsAndContingencies,usd,N/A,bs
2420,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2421,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Common stock, $0.25 par value; 525.0 shares authorized; 227.3 shares issued and 182.4 shares outstanding at December 29, 2017, and 226.0 shares issued and 183.1 shares outstanding at September 29, 2017",CommonStockValue,usd,45600000,bs
2422,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2936300000,bs
2423,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Treasury stock, at cost",TreasuryStockValue,usd,2142200000,bs
2424,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3069300000,bs
2425,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8500000,bs
2426,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,3900500000,bs
2427,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4594300000,bs
2428,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net income,NetIncomeLoss,usd,70400000,cf
2429,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Share-based compensation,ShareBasedCompensation,usd,25800000,cf
2430,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Depreciation,Depreciation,usd,63600000,cf
2431,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,5500000,cf
2432,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,21400000,cf
2433,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,0,cf
2434,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Receivables, net",IncreaseDecreaseInReceivables,usd,4100000,cf
2435,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Inventory,IncreaseDecreaseInInventories,usd,-34500000,cf
2436,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,20600000,cf
2437,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-105400000,cf
2438,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,269700000,cf
2439,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,360800000,cf
2440,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,28200000,cf
2441,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
2442,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Purchased intangibles,PaymentsForSoftware,usd,6000000,cf
2443,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,0,cf
2444,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-34200000,cf
2445,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
2446,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,44700000,cf
2447,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,172500000,cf
2448,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Dividends paid,PaymentsOfOrdinaryDividends,usd,59100000,cf
2449,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,14400000,cf
2450,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Payments of contingent consideration,swks:PaymentOfContingentConsiderationObligations,usd,0,cf
2451,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-261900000,cf
2452,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,64700000,cf
2453,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2018,Income taxes paid,IncomeTaxesPaid,usd,7200000,cf
2454,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,1881300000,bs
2455,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Receivables, net of allowance for doubtful accounts of $0.5 and $0.5, respectively",ReceivablesNetCurrent,usd,367200000,bs
2456,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Inventory, Net [Abstract]",InventoryNet,usd,466400000,bs
2457,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other current assets,OtherAssetsCurrent,usd,96000000,bs
2458,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Current assets:,AssetsCurrent,usd,2810900000,bs
2459,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,907100000,bs
2460,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,883000000,bs
2461,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Total intangible assets, Net Carrying Amount",IntangibleAssetsNetExcludingGoodwill,usd,62700000,bs
2462,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,41200000,bs
2463,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other assets,OtherAssetsNoncurrent,usd,40200000,bs
2464,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Current assets:,Assets,usd,4745100000,bs
2465,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Accounts payable,AccountsPayableCurrent,usd,198400000,bs
2466,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,66500000,bs
2467,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other current liabilities,OtherLiabilitiesCurrent,usd,53600000,bs
2468,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Current liabilities:,LiabilitiesCurrent,usd,318500000,bs
2469,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,321200000,bs
2470,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,35200000,bs
2471,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,674900000,bs
2472,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2473,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2474,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Common stock, $0.25 par value; 525.0 shares authorized; 228.0 shares issued and 182.1 shares outstanding at March 30, 2018, and 226.0 shares issued and 183.1 shares outstanding at September 29, 2017",CommonStockValue,usd,45500000,bs
2475,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3002400000,bs
2476,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Stock repurchased,TreasuryStockValue,usd,2255700000,bs
2477,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3286800000,bs
2478,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8800000,bs
2479,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4070200000,bs
2480,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4745100000,bs
2481,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net income,NetIncomeLoss,usd,346400000,cf
2482,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Share-based compensation,ShareBasedCompensation,usd,66800000,cf
2483,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Depreciation,Depreciation,usd,129600000,cf
2484,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,11100000,cf
2485,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,25600000,cf
2486,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,0,cf
2487,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Receivables, net",IncreaseDecreaseInReceivables,usd,-87500000,cf
2488,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Inventory,IncreaseDecreaseInInventories,usd,-26300000,cf
2489,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,27100000,cf
2490,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-82200000,cf
2491,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,211000000,cf
2492,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,795000000,cf
2493,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,118500000,cf
2494,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
2495,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Payments for Software,PaymentsForSoftware,usd,6000000,cf
2496,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,0,cf
2497,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-124500000,cf
2498,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
2499,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,46500000,cf
2500,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,284200000,cf
2501,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Dividends paid,PaymentsOfOrdinaryDividends,usd,117500000,cf
2502,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,32300000,cf
2503,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Contribution of common stock to savings and retirement plans,swks:ContributionOfCommonSharesToSavingsAndRetirementPlansRelatedExpense,usd,9900000,cf
2504,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Payments of contingent consideration,swks:PaymentOfContingentConsiderationObligations,usd,0,cf
2505,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-406000000,cf
2506,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,264500000,cf
2507,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2018,Income taxes paid,IncomeTaxesPaid,usd,76200000,cf
2508,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,1158100000,bs
2509,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,384400000,bs
2510,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Receivables, net of allowance for doubtful accounts of $0.6 and $0.5, respectively",ReceivablesNetCurrent,usd,468400000,bs
2511,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Inventory, Net [Abstract]",InventoryNet,usd,502800000,bs
2512,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other current assets,OtherAssetsCurrent,usd,117700000,bs
2513,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Current assets:,AssetsCurrent,usd,2631400000,bs
2514,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1034600000,bs
2515,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,883000000,bs
2516,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,59900000,bs
2517,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,30900000,bs
2518,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,106300000,bs
2519,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other assets,OtherAssetsNoncurrent,usd,37200000,bs
2520,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,ASSETS,Assets,usd,4783300000,bs
2521,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Accounts payable,AccountsPayableCurrent,usd,230200000,bs
2522,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,79100000,bs
2523,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other current liabilities,OtherLiabilitiesCurrent,usd,49000000,bs
2524,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Current liabilities:,LiabilitiesCurrent,usd,358300000,bs
2525,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,309900000,bs
2526,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,32200000,bs
2527,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,700400000,bs
2528,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2529,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2530,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Common stock, $0.25 par value; 525.0 shares authorized; 228.1 shares issued and 179.7 shares outstanding at June 29, 2018, and 226.0 shares issued and 183.1 shares outstanding at September 29, 2017",CommonStockValue,usd,44900000,bs
2531,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3028300000,bs
2532,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Treasury stock, at cost",TreasuryStockValue,usd,2496900000,bs
2533,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3515400000,bs
2534,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8800000,bs
2535,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4082900000,bs
2536,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4783300000,bs
2537,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net income,NetIncomeLoss,usd,632900000,cf
2538,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Percentage of outstanding stock, maximum",ShareBasedCompensation,usd,86300000,cf
2539,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Depreciation,Depreciation,usd,198900000,cf
2540,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,16500000,cf
2541,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,35600000,cf
2542,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,0,cf
2543,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Changes in fair value of contingent consideration,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-7800000,cf
2544,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other,OtherOperatingActivitiesCashFlowStatement,usd,300000,cf
2545,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Receivables, net",IncreaseDecreaseInReceivables,usd,13700000,cf
2546,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Inventory,IncreaseDecreaseInInventories,usd,10200000,cf
2547,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,45800000,cf
2548,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-56300000,cf
2549,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,216300000,cf
2550,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,1053000000,cf
2551,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,310000000,cf
2552,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
2553,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Payments for Software,PaymentsForSoftware,usd,8600000,cf
2554,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,523200000,cf
2555,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,32600000,cf
2556,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-809200000,cf
2557,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
2558,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,47500000,cf
2559,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,524500000,cf
2560,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Dividends paid,PaymentsOfOrdinaryDividends,usd,175200000,cf
2561,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,34800000,cf
2562,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Proceeds from employee stock purchase plan,swks:ContributionOfCommonSharesToSavingsAndRetirementPlansRelatedExpense,usd,9900000,cf
2563,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Payments of contingent consideration,swks:PaymentOfContingentConsiderationObligations,usd,0,cf
2564,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-702500000,cf
2565,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Net increase (decrease) in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-458700000,cf
2566,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2018,Income taxes paid,IncomeTaxesPaid,usd,117100000,cf
2567,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,733300000,bs
2568,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,294100000,bs
2569,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Receivables, net of allowance for doubtful accounts of $0.6 and $0.5, respectively",ReceivablesNetCurrent,usd,655800000,bs
2570,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Inventory, Net [Abstract]",InventoryNet,usd,490200000,bs
2571,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other current assets,OtherAssetsCurrent,usd,88800000,bs
2572,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Current assets:,AssetsCurrent,usd,2262200000,bs
2573,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1140900000,bs
2574,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2575,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,143700000,bs
2576,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,36500000,bs
2577,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,22800000,bs
2578,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other assets,OtherAssetsNoncurrent,usd,33000000,bs
2579,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Total,Assets,usd,4828900000,bs
2580,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Accounts payable,AccountsPayableCurrent,usd,229900000,bs
2581,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,85200000,bs
2582,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other current liabilities,OtherLiabilitiesCurrent,usd,74600000,bs
2583,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Current liabilities:,LiabilitiesCurrent,usd,389700000,bs
2584,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,310500000,bs
2585,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,31700000,bs
2586,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Total,Liabilities,usd,731900000,bs
2587,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2588,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2589,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Common stock, $0.25 par value: 525.0 shares authorized; 228.4 shares issued and 177.4 shares outstanding at September 28, 2018, and 226.0 shares issued and 183.1 shares outstanding at September 29, 2017",CommonStockValue,usd,44400000,bs
2590,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3061000000,bs
2591,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Share repurchase program,TreasuryStockValue,usd,2732500000,bs
2592,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3732900000,bs
2593,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8800000,bs
2594,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4097000000,bs
2595,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,LIABILITIES AND STOCKHOLDERS' EQUITY,LiabilitiesAndStockholdersEquity,usd,4828900000,bs
2596,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net income,NetIncomeLoss,usd,918400000,cf
2597,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Share-based compensation,ShareBasedCompensation,usd,107800000,cf
2598,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Depreciation,Depreciation,usd,272500000,cf
2599,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,26700000,cf
2600,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,27300000,cf
2601,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,0,cf
2602,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-11900000,cf
2603,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other,OtherNoncashIncomeExpense,usd,700000,cf
2604,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Receivables, net",IncreaseDecreaseInReceivables,usd,193800000,cf
2605,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Inventory,IncreaseDecreaseInInventories,usd,-11900000,cf
2606,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,12200000,cf
2607,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-126000000,cf
2608,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,240600000,cf
2609,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,1260600000,cf
2610,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,422300000,cf
2611,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,404000000,cf
2612,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Purchased intangibles,PaymentsToAcquireIntangibleAssets,usd,8600000,cf
2613,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,683700000,cf
2614,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,368200000,cf
2615,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-1150400000,cf
2616,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Payments for obligations recorded for business combinations,swks:PaymentofObligationsRelatedtoBusinessCombinations,usd,0,cf
2617,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
2618,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,48000000,cf
2619,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,759500000,cf
2620,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Dividends paid,PaymentsOfOrdinaryDividends,usd,243200000,cf
2621,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,38800000,cf
2622,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,"Proceeds from exercise of stock options, employee stock purchase plan",swks:Proceedsfromexerciseofstockoptionsemployeestockpurchaseplan,usd,18200000,cf
2623,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Deferred payments for intangible assets,RepaymentsOfOtherDebt,usd,0,cf
2624,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Payment for obligations recorded for business combinations,swks:PaymentOfContingentConsiderationObligations,usd,0,cf
2625,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-993700000,cf
2626,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-883500000,cf
2627,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2018,Income taxes paid,IncomeTaxesPaid,usd,135900000,cf
2628,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,1085700000,bs
2629,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,13400000,bs
2630,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Receivables, net of allowance for doubtful accounts of $0.7 and $0.6, respectively",ReceivablesNetCurrent,usd,524400000,bs
2631,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Inventory, Net [Abstract]",InventoryNet,usd,493100000,bs
2632,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other current assets,OtherAssetsCurrent,usd,91900000,bs
2633,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Current assets:,AssetsCurrent,usd,2208500000,bs
2634,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1140600000,bs
2635,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2636,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,130100000,bs
2637,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,34700000,bs
2638,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,2700000,bs
2639,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other assets,OtherAssetsNoncurrent,usd,32500000,bs
2640,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Assets, Fair Value Disclosure, Recurring",Assets,usd,4738900000,bs
2641,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Accounts payable,AccountsPayableCurrent,usd,156500000,bs
2642,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,70800000,bs
2643,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other current liabilities,OtherLiabilitiesCurrent,usd,130000000,bs
2644,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Current liabilities:,LiabilitiesCurrent,usd,357300000,bs
2645,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,313500000,bs
2646,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,29800000,bs
2647,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Total,Liabilities,usd,700600000,bs
2648,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2649,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2650,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Common stock, $0.25 par value: 525.0 shares authorized; 229.3 shares issued and 174.1 shares outstanding at December 28, 2018, and 228.4 shares issued and 177.4 shares outstanding at September 28, 2018",CommonStockValue,usd,43500000,bs
2651,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3088400000,bs
2652,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Stock repurchased,TreasuryStockValue,usd,3036100000,bs
2653,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,3950700000,bs
2654,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8200000,bs
2655,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4038300000,bs
2656,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4738900000,bs
2657,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net income,NetIncomeLoss,usd,284900000,cf
2658,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Share-based compensation,ShareBasedCompensation,usd,20800000,cf
2659,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Depreciation,Depreciation,usd,77500000,cf
2660,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Amortization of intangible assets, including inventory step-up",OtherDepreciationAndAmortization,usd,15500000,cf
2661,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,1800000,cf
2662,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,1000000,cf
2663,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,"Receivables, net",IncreaseDecreaseInReceivables,usd,-131400000,cf
2664,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Inventory,IncreaseDecreaseInInventories,usd,5000000,cf
2665,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,2600000,cf
2666,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-22200000,cf
2667,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,45900000,cf
2668,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,549000000,cf
2669,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,129500000,cf
2670,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Payments for Software,PaymentsForSoftware,usd,0,cf
2671,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,2200000,cf
2672,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,303200000,cf
2673,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net cash provided by (used in) investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,171500000,cf
2674,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,19400000,cf
2675,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,284000000,cf
2676,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Dividends paid,PaymentsOfOrdinaryDividends,usd,67100000,cf
2677,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,2400000,cf
2678,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-368100000,cf
2679,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,352400000,cf
2680,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2019,Income taxes paid,IncomeTaxesPaid,usd,1600000,cf
2681,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,816300000,bs
2682,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,141100000,bs
2683,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Receivables, net of allowance for doubtful accounts of $0.6 and $0.5, respectively",ReceivablesNetCurrent,usd,543800000,bs
2684,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Inventory, Net [Abstract]",InventoryNet,usd,555000000,bs
2685,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other current assets,OtherAssetsCurrent,usd,103900000,bs
2686,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Current assets:,AssetsCurrent,usd,2160100000,bs
2687,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1169800000,bs
2688,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2689,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Total intangible assets, Net Carrying Amount",IntangibleAssetsNetExcludingGoodwill,usd,129900000,bs
2690,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,49200000,bs
2691,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,33900000,bs
2692,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other assets,OtherAssetsNoncurrent,usd,32800000,bs
2693,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Current assets:,Assets,usd,4765500000,bs
2694,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Accounts payable,AccountsPayableCurrent,usd,167900000,bs
2695,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,70300000,bs
2696,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other current liabilities,OtherLiabilitiesCurrent,usd,100100000,bs
2697,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Current liabilities:,LiabilitiesCurrent,usd,338300000,bs
2698,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,315700000,bs
2699,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,30600000,bs
2700,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,684600000,bs
2701,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Commitments and contingencies (Note 8),CommitmentsAndContingencies,usd,N/A,bs
2702,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,0,bs
2703,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Common stock, $0.25 par value; 525.0 shares authorized; 228.1 shares issued and 179.7 shares outstanding at June 29, 2018, and 226.0 shares issued and 183.1 shares outstanding at September 29, 2017",CommonStockValue,usd,43200000,bs
2704,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3126200000,bs
2705,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Treasury stock, at cost",TreasuryStockValue,usd,3179100000,bs
2706,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4098700000,bs
2707,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8100000,bs
2708,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4080900000,bs
2709,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4765500000,bs
2710,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net income,NetIncomeLoss,usd,498800000,cf
2711,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Share-based compensation,ShareBasedCompensation,usd,42600000,cf
2712,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Depreciation,Depreciation,usd,156400000,cf
2713,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,28600000,cf
2714,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-27600000,cf
2715,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other,OtherOperatingActivitiesCashFlowStatement,usd,800000,cf
2716,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,"Receivables, net",IncreaseDecreaseInReceivables,usd,-112000000,cf
2717,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Inventory,IncreaseDecreaseInInventories,usd,66900000,cf
2718,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,14900000,cf
2719,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-23900000,cf
2720,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,35200000,cf
2721,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,741100000,cf
2722,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,226200000,cf
2723,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Payments for Software,PaymentsForSoftware,usd,12900000,cf
2724,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,166700000,cf
2725,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,309200000,cf
2726,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-96600000,cf
2727,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,21000000,cf
2728,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,425500000,cf
2729,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Dividends paid,PaymentsOfOrdinaryDividends,usd,133100000,cf
2730,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,6800000,cf
2731,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Proceeds from employee stock purchase plan,swks:ContributionOfCommonSharesToSavingsAndRetirementPlansRelatedExpense,usd,11300000,cf
2732,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-561500000,cf
2733,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Net increase (decrease) in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,83000000,cf
2734,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2019,Income taxes paid,IncomeTaxesPaid,usd,87500000,cf
2735,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,742800000,bs
2736,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,192200000,bs
2737,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Receivables, net of allowance for doubtful accounts of $0.7 and $0.6, respectively",ReceivablesNetCurrent,usd,557800000,bs
2738,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Inventory, Net [Abstract]",InventoryNet,usd,580800000,bs
2739,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other current assets,OtherAssetsCurrent,usd,132700000,bs
2740,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Current assets:,AssetsCurrent,usd,2206300000,bs
2741,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1230100000,bs
2742,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2743,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Total intangible assets, Net Carrying Amount",IntangibleAssetsNetExcludingGoodwill,usd,114100000,bs
2744,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,33700000,bs
2745,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,35100000,bs
2746,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other long-term assets,OtherAssetsNoncurrent,usd,33200000.000000004,bs
2747,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Current assets:,Assets,usd,4842300000,bs
2748,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Accounts payable,AccountsPayableCurrent,usd,218900000,bs
2749,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,85200000,bs
2750,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other current liabilities,OtherLiabilitiesCurrent,usd,92400000,bs
2751,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Current liabilities:,LiabilitiesCurrent,usd,396500000,bs
2752,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,315500000,bs
2753,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,30400000,bs
2754,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Total,Liabilities,usd,742400000,bs
2755,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
2756,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
2757,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Common stock, $0.25 par value: 525.0 shares authorized; 229.6 shares issued and 172.7 shares outstanding at March 29, 2019, and 228.4 shares issued and 177.4 shares outstanding at September 28, 2018",CommonStockValue,usd,42900000,bs
2758,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3153300000,bs
2759,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Stock repurchased,TreasuryStockValue,usd,3265600000,bs
2760,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4177100000.000001,bs
2761,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7800000,bs
2762,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4099899999.999999,bs
2763,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4842300000,bs
2764,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net income,NetIncomeLoss,usd,643000000,cf
2765,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Share-based compensation,ShareBasedCompensation,usd,58600000,cf
2766,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Depreciation,Depreciation,usd,235400000,cf
2767,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Amortization of intangible assets, including inventory step-up",OtherDepreciationAndAmortization,usd,43300000,cf
2768,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-12100000,cf
2769,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Changes in fair value of contingent consideration,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-3100000,cf
2770,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,100000,cf
2771,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,"Receivables, net",IncreaseDecreaseInReceivables,usd,-98000000,cf
2772,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Inventory,IncreaseDecreaseInInventories,usd,89700000,cf
2773,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,44100000,cf
2774,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-24500000,cf
2775,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,45500000,cf
2776,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net cash provided by operating activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,950400000,cf
2777,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,314000000,cf
2778,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Payments for Software,PaymentsForSoftware,usd,11800000,cf
2779,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,243700000,cf
2780,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,334400000,cf
2781,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net cash used in investing activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-235100000,cf
2782,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,21600000,cf
2783,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,511300000,cf
2784,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Dividends paid,PaymentsOfOrdinaryDividends,usd,198800000,cf
2785,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,14600000,cf
2786,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,11300000,cf
2787,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net cash used in financing activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-705800000,cf
2788,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,9500000,cf
2789,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2019,Income taxes paid,IncomeTaxesPaid,usd,116500000,cf
2790,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,851300000,bs
2791,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,203300000,bs
2792,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Receivables, net of allowance for doubtful accounts of $0.8 and $0.6, respectively",ReceivablesNetCurrent,usd,465300000,bs
2793,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Inventory, Net [Abstract]",InventoryNet,usd,609700000,bs
2794,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other current assets,OtherAssetsCurrent,usd,105000000,bs
2795,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Current assets:,AssetsCurrent,usd,2234600000,bs
2796,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1205600000,bs
2797,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2798,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,107900000,bs
2799,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,40800000,bs
2800,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,27600000,bs
2801,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other assets,OtherAssetsNoncurrent,usd,33299999.999999996,bs
2802,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,ASSETS,Assets,usd,4839600000,bs
2803,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Accounts payable,AccountsPayableCurrent,usd,190500000,bs
2804,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,76000000,bs
2805,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other current liabilities,OtherLiabilitiesCurrent,usd,107500000,bs
2806,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Current liabilities:,LiabilitiesCurrent,usd,374000000,bs
2807,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,312400000,bs
2808,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,30900000,bs
2809,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,LIABILITIES AND STOCKHOLDERS' EQUITY,Liabilities,usd,717300000,bs
2810,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
2811,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Common stock, $0.25 par value: 525.0 shares authorized; 230.2 shares issued and 170.1 shares outstanding at September 27, 2019, and 228.4 shares issued and 177.4 shares outstanding at September 28, 2018",CommonStockValue,usd,42500000,bs
2812,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3188000000,bs
2813,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Share repurchase program,TreasuryStockValue,usd,3412900000,bs
2814,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4312600000,bs
2815,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7900000,bs
2816,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4122300000,bs
2817,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,LIABILITIES AND STOCKHOLDERS' EQUITY,LiabilitiesAndStockholdersEquity,usd,4839600000,bs
2818,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Net income,NetIncomeLoss,usd,853600000,cf
2819,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Award Type [Domain],ShareBasedCompensation,usd,80100000,cf
2820,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Depreciation,Depreciation,usd,314900000,cf
2821,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,56700000,cf
2822,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-6100000,cf
2823,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,usd,N/A,cf
2824,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-3100000,cf
2825,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other,OtherNoncashIncomeExpense,usd,-16800000,cf
2826,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Receivables, net",IncreaseDecreaseInReceivables,usd,-190500000,cf
2827,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Inventory,IncreaseDecreaseInInventories,usd,119600000,cf
2828,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other current and long-term assets,IncreaseDecreaseInOtherOperatingAssets,usd,16700000,cf
2829,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-33000000,cf
2830,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Other current and long-term liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,33299999.999999996,cf
2831,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,1367400000,cf
2832,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,398400000,cf
2833,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
2834,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Purchased intangibles,PaymentsToAcquireIntangibleAssets,usd,25000000,cf
2835,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,360500000,cf
2836,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,447000000,cf
2837,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-336900000,cf
2838,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Excess tax benefit from share-based compensation,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,N/A,cf
2839,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,22800000,cf
2840,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,657600000,cf
2841,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Dividends paid,PaymentsOfOrdinaryDividends,usd,273900000,cf
2842,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,19700000,cf
2843,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,22100000,cf
2844,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Deferred payments for intangible assets,RepaymentsOfOtherDebt,usd,N/A,cf
2845,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Payment for obligations recorded for business combinations,swks:PaymentOfContingentConsiderationObligations,usd,N/A,cf
2846,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-912500000,cf
2847,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,118000000,cf
2848,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2019,Income taxes paid,IncomeTaxesPaid,usd,124400000,cf
2849,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,928200000,bs
2850,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,262200000,bs
2851,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Receivables, net of allowance of $0.8 and $0.8, respectively",ReceivablesNetCurrent,usd,426800000,bs
2852,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Inventory, Net [Abstract]",InventoryNet,usd,604400000,bs
2853,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current assets,OtherAssetsCurrent,usd,124900000,bs
2854,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Current assets:,AssetsCurrent,usd,2346500000,bs
2855,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Total property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1190800000,bs
2856,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,159100000,bs
2857,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2858,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Total intangible assets, Net Carrying Amount",IntangibleAssetsNetExcludingGoodwill,usd,96500000,bs
2859,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Deferred tax assets, net",DeferredTaxAssetsLiabilitiesNetNoncurrent,usd,39900000,bs
2860,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,38200000,bs
2861,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other long-term assets,OtherAssetsNoncurrent,usd,31000000,bs
2862,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,ASSETS,Assets,usd,5091800000,bs
2863,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accounts payable,AccountsPayableCurrent,usd,138500000,bs
2864,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,79900000,bs
2865,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current liabilities,OtherLiabilitiesCurrent,usd,114800000,bs
2866,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Current liabilities:,LiabilitiesCurrent,usd,333200000,bs
2867,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,309500000,bs
2868,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,150900000,bs
2869,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,30900000,bs
2870,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,824500000,bs
2871,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
2872,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Common stock, $0.25 par value: 525.0 shares authorized; 231.5 shares issued and 170.5 shares outstanding at December 27, 2019, and 230.2 shares issued and 170.1 shares outstanding at September 27, 2019",CommonStockValue,usd,42600000,bs
2873,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3251900000,bs
2874,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Treasury stock, at cost",TreasuryStockValue,usd,3513800000,bs
2875,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4494600000,bs
2876,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8000000,bs
2877,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4267300000,bs
2878,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,5091800000,bs
2879,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net income,NetIncomeLoss,usd,257100000.00000003,cf
2880,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Share-based compensation,ShareBasedCompensation,usd,33600000,cf
2881,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Depreciation,Depreciation,usd,79800000,cf
2882,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Amortization of intangible assets, including inventory step-up",OtherDepreciationAndAmortization,usd,11400000,cf
2883,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,900000,cf
2884,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,N/A,cf
2885,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Receivables, net",IncreaseDecreaseInReceivables,usd,-38500000,cf
2886,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Inventory,IncreaseDecreaseInInventories,usd,-7900000,cf
2887,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-6700000,cf
2888,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,-24100000,cf
2889,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,398400000,cf
2890,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Capital expenditures,PaymentsToAcquireProductiveAssets,usd,111200000,cf
2891,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,131500000,cf
2892,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,62200000,cf
2893,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-180500000,cf
2894,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,26600000,cf
2895,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,74200000,cf
2896,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Dividends paid,PaymentsOfOrdinaryDividends,usd,75100000,cf
2897,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,34900000,cf
2898,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-141000000,cf
2899,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net increase in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,76900000,cf
2900,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Income taxes paid,IncomeTaxesPaid,usd,26100000,cf
2901,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,70100000,cf
2902,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash and cash equivalents at beginning of period,CashAndCashEquivalentsAtCarryingValue,usd,912400000,bs
2903,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,161500000,bs
2904,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Receivables, net of allowance of $0.8 and $0.8, respectively",ReceivablesNetCurrent,usd,367600000,bs
2905,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Inventory, Net [Abstract]",InventoryNet,usd,648900000,bs
2906,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current assets,OtherAssetsCurrent,usd,130400000,bs
2907,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Current assets:,AssetsCurrent,usd,2220800000,bs
2908,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1207900000,bs
2909,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,171300000,bs
2910,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,1189800000,bs
2911,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,85400000,bs
2912,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Deferred Income Tax Assets, Net",DeferredIncomeTaxAssetsNet,usd,39600000,bs
2913,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,34100000,bs
2914,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other long-term assets,OtherAssetsNoncurrent,usd,33000000,bs
2915,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)",Assets,usd,4981900000,bs
2916,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accounts payable,AccountsPayableCurrent,usd,169500000,bs
2917,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,78400000,bs
2918,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current liabilities,OtherLiabilitiesCurrent,usd,114300000,bs
2919,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Current liabilities:,LiabilitiesCurrent,usd,362200000,bs
2920,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,293000000,bs
2921,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,151900000,bs
2922,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,32000000,bs
2923,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Total,Liabilities,usd,839100000,bs
2924,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
2925,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Common stock, $0.25 par value: 525.0 shares authorized; 231.9 shares issued and 167.5 shares outstanding at March 27, 2020, and 230.2 shares issued and 170.1 shares outstanding at September 27, 2019",CommonStockValue,usd,41900000,bs
2926,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3307200000,bs
2927,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Stock repurchased,TreasuryStockValue,usd,3799600000,bs
2928,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4600800000,bs
2929,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7500000,bs
2930,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Stockholders' Equity Attributable to Parent [Abstract],StockholdersEquity,usd,4142800000,bs
2931,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,4981900000,bs
2932,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net income,NetIncomeLoss,usd,438100000,cf
2933,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Share-based compensation,ShareBasedCompensation,usd,73800000,cf
2934,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Depreciation,Depreciation,usd,160300000,cf
2935,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Amortization of intangible assets, including inventory step-up",OtherDepreciationAndAmortization,usd,22700000,cf
2936,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,1100000,cf
2937,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,2100000,cf
2938,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Receivables, net",IncreaseDecreaseInReceivables,usd,-97700000,cf
2939,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Inventory,IncreaseDecreaseInInventories,usd,37000000,cf
2940,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,-13200000,cf
2941,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,-66800000,cf
2942,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,678800000,cf
2943,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,171900000,cf
2944,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,178800000,cf
2945,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Payments to Acquire Intangible Assets,PaymentsToAcquireIntangibleAssets,usd,200000,cf
2946,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,214400000,cf
2947,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-136500000,cf
2948,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,28700000,cf
2949,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,358000000,cf
2950,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Dividends paid,PaymentsOfOrdinaryDividends,usd,150000000,cf
2951,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,43300000,cf
2952,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,12200000,cf
2953,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-481200000,cf
2954,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,61100000,cf
2955,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Income taxes paid,IncomeTaxesPaid,usd,81100000,cf
2956,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2020,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,95400000,cf
2957,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,791300000,bs
2958,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,347000000,bs
2959,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Receivables, net of allowance of $0.9 and $0.8, respectively",ReceivablesNetCurrent,usd,346100000,bs
2960,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Inventory, Net [Abstract]",InventoryNet,usd,698200000,bs
2961,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Other current assets,OtherAssetsCurrent,usd,154800000,bs
2962,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Total current assets,AssetsCurrent,usd,2337400000,bs
2963,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1206900000,bs
2964,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,172700000,bs
2965,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Goodwill,Goodwill,usd,1189800000,bs
2966,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,62900000,bs
2967,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Deferred Income Tax Assets, Net",DeferredIncomeTaxAssetsNet,usd,42600000,bs
2968,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,24100000,bs
2969,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Other long-term assets,OtherAssetsNoncurrent,usd,36000000,bs
2970,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Total assets,Assets,usd,5072400000,bs
2971,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Accounts payable,AccountsPayableCurrent,usd,200900000,bs
2972,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,94600000,bs
2973,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Other current liabilities,OtherLiabilitiesCurrent,usd,105600000,bs
2974,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Total current liabilities,LiabilitiesCurrent,usd,401100000,bs
2975,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,300600000,bs
2976,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,155800000,bs
2977,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,32500000,bs
2978,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Total current liabilities,Liabilities,usd,890000000,bs
2979,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
2980,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Common stock, $0.25 par value: 525.0 shares authorized; 232.1 shares issued and 167.1 shares outstanding at June 26, 2020, and 230.2 shares issued and 170.1 shares outstanding at September 27, 2019",CommonStockValue,usd,41800000,bs
2981,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3351500000,bs
2982,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Treasury stock, at cost",TreasuryStockValue,usd,3860300000,bs
2983,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4657000000,bs
2984,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7600000,bs
2985,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4182399999.999999,bs
2986,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Total liabilities and stockholders’ equity,LiabilitiesAndStockholdersEquity,usd,5072400000,bs
2987,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Net income,NetIncomeLoss,usd,567900000,cf
2988,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Share-based compensation,ShareBasedCompensation,usd,111600000,cf
2989,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Depreciation,Depreciation,usd,238200000,cf
2990,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Amortization of intangible assets, including inventory step-up",OtherDepreciationAndAmortization,usd,35400000,cf
2991,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-1800000,cf
2992,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,2800000,cf
2993,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Receivables, net",IncreaseDecreaseInReceivables,usd,-119200000,cf
2994,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Inventory,IncreaseDecreaseInInventories,usd,83500000,cf
2995,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,12700000,cf
2996,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,-76800000,cf
2997,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,937500000,cf
2998,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,243500000,cf
2999,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,439900000,cf
3000,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Payments to Acquire Intangible Assets,PaymentsToAcquireIntangibleAssets,usd,7600000,cf
3001,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,300000000,cf
3002,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-391000000,cf
3003,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,30900000,cf
3004,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,416500000,cf
3005,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Dividends paid,PaymentsOfOrdinaryDividends,usd,223500000,cf
3006,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,52200000,cf
3007,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,12200000,cf
3008,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Net Cash Provided by (Used in) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-606500000,cf
3009,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-60000000,cf
3010,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Income taxes paid,IncomeTaxesPaid,usd,103400000,cf
3011,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,105800000,cf
3012,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2020,Asset Impairment Charges,AssetImpairmentCharges,usd,11800000,cf
3013,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total assets,Assets,usd,5106700000,bs
3014,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Other current liabilities,OtherLiabilitiesCurrent,usd,108000000,bs
3015,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total current assets,AssetsCurrent,usd,2317600000,bs
3016,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,113500000,bs
3017,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,53500000,bs
3018,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,53500000,bs
3019,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,5200000,bs
3020,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total liabilities,Liabilities,usd,942500000,bs
3021,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,167900000,bs
3022,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1249500000,bs
3023,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1249500000,bs
3024,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1249500000,bs
3025,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,566700000,bs
3026,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,566700000,bs
3027,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
3028,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total liabilities and stockholders' equity,LiabilitiesAndStockholdersEquity,usd,5106700000,bs
3029,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,311300000,bs
3030,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Other current assets,OtherAssetsCurrent,usd,143200000,bs
3031,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Treasury stock, at cost",TreasuryStockValue,usd,4093500000,bs
3032,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total current liabilities,LiabilitiesCurrent,usd,448400000,bs
3033,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7800000,bs
3034,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3403700000,bs
3035,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Accounts payable,AccountsPayableCurrent,usd,226900000,bs
3036,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Inventory,InventoryNet,usd,806000000,bs
3037,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Inventory,InventoryNet,usd,806000000,bs
3038,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,32100000,bs
3039,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4820400000,bs
3040,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Other assets,OtherAssetsNoncurrent,usd,67900000,bs
3041,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Receivables, net of allowance for doubtful accounts of $0.8 and $0.6, respectively",ReceivablesNetCurrent,usd,393600000,bs
3042,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Goodwill,Goodwill,usd,1189800000,bs
3043,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Goodwill,Goodwill,usd,1189800000,bs
3044,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Common stock, $0.25 par value: 525.0 shares authorized; 230.2 shares issued and 170.1 shares outstanding at September 27, 2019, and 228.4 shares issued and 177.4 shares outstanding at September 28, 2018",CommonStockValue,usd,41400000,bs
3045,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,408100000,bs
3046,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,150700000,bs
3047,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,150700000,bs
3048,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total stockholders' equity,StockholdersEquity,usd,4164200000,bs
3049,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Total stockholders' equity,StockholdersEquity,usd,4164200000,bs
3050,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Deferred tax assets, net",DeferredIncomeTaxAssetsNet,usd,55300000,bs
3051,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net increase in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-284600000,cf
3052,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,46000000,cf
3053,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Asset Impairment Charges,AssetImpairmentCharges,usd,11800000,cf
3054,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Purchased intangibles,PaymentsToAcquireIntangibleAssets,usd,9100000,cf
3055,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Cash Provided by (Used in) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-907700000,cf
3056,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Inventory,IncreaseDecreaseInInventories,usd,190400000,cf
3057,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,N/A,cf
3058,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-13400000,cf
3059,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,790500000,cf
3060,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Cash Provided by (Used in) Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-581400000,cf
3061,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Increase (Decrease) in Other Operating Assets and Liabilities, Net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,75800000,cf
3062,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,57100000,cf
3063,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
3064,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,33100000,cf
3065,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,607600000,cf
3066,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Share-based compensation,ShareBasedCompensation,usd,156600000,cf
3067,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Share-based compensation,ShareBasedCompensation,usd,156600000,cf
3068,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,22800000,cf
3069,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,"Receivables, net",IncreaseDecreaseInReceivables,usd,-71700000,cf
3070,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,61100000,cf
3071,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1204500000,cf
3072,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Dividends paid,PaymentsOfOrdinaryDividends,usd,307000000,cf
3073,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Depreciation,Depreciation,usd,318300000,cf
3074,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,647500000,cf
3075,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Other,OtherNoncashIncomeExpense,usd,-3800000,cf
3076,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,389400000,cf
3077,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,78700000,cf
3078,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3079,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3080,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3081,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3082,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3083,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3084,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Net Income,NetIncomeLoss,usd,814800000,cf
3085,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2020,Income taxes paid,IncomeTaxesPaid,usd,110800000,cf
3086,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,617200000,bs
3087,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,401400000,bs
3088,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Receivables, net of allowance of $0.6 and $0.6, respectively",ReceivablesNetCurrent,usd,689900000,bs
3089,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Inventory, Net [Abstract]",InventoryNet,usd,718500000,bs
3090,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Other current assets,OtherAssetsCurrent,usd,148200000,bs
3091,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Total current assets,AssetsCurrent,usd,2575200000,bs
3092,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Property, plant, and equipment, net",PropertyPlantAndEquipmentNet,usd,1305400000,bs
3093,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,172400000,bs
3094,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Goodwill,Goodwill,usd,1189800000,bs
3095,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,46400000,bs
3096,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Deferred Income Tax Assets, Net",DeferredIncomeTaxAssetsNet,usd,56400000,bs
3097,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,700000,bs
3098,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Other long-term assets,OtherAssetsNoncurrent,usd,73500000,bs
3099,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)",Assets,usd,5419800000,bs
3100,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Accounts payable,AccountsPayableCurrent,usd,264600000.00000003,bs
3101,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,85000000,bs
3102,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,158000000,bs
3103,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Total current liabilities,LiabilitiesCurrent,usd,507600000,bs
3104,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,310600000,bs
3105,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,154900000,bs
3106,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,31800000,bs
3107,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Total current liabilities,Liabilities,usd,1004900000,bs
3108,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
3109,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Common stock, $0.25 par value: 525.0 shares authorized; 233.4 shares issued and 164.9 shares outstanding at January 1, 2021, and 232.3 shares issued and 165.6 shares outstanding at October 2, 2020",CommonStockValue,usd,41200000,bs
3110,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3471600000,bs
3111,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Treasury stock, at cost",TreasuryStockValue,usd,4336900000,bs
3112,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,5246700000,bs
3113,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7700000,bs
3114,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,4414900000,bs
3115,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,5419800000,bs
3116,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Net income,NetIncomeLoss,usd,509300000,cf
3117,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Share-based compensation,ShareBasedCompensation,usd,44500000,cf
3118,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Depreciation,Depreciation,usd,78400000,cf
3119,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,8000000,cf
3120,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Other, net",OtherOperatingActivitiesCashFlowStatement,usd,-700000,cf
3121,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Receivables, net",IncreaseDecreaseInReceivables,usd,296300000,cf
3122,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Inventory,IncreaseDecreaseInInventories,usd,-88900000,cf
3123,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,22400000,cf
3124,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,30600000,cf
3125,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,485100000,cf
3126,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,118900000,cf
3127,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,99400000,cf
3128,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Payments to Acquire Intangible Assets,PaymentsToAcquireIntangibleAssets,usd,4300000,cf
3129,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,111600000,cf
3130,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Net Cash Provided by (Used in) Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-111000000,cf
3131,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,47700000,cf
3132,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3133,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Dividends paid,PaymentsOfOrdinaryDividends,usd,83000000,cf
3134,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,2700000,cf
3135,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-323600000,cf
3136,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,50500000,cf
3137,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Income taxes paid,IncomeTaxesPaid,usd,8100000,cf
3138,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Stock Issued,StockIssued1,usd,27500000,cf
3139,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,94300000,cf
3140,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q1,2021,Right-of-Use Asset Obtained in Exchange for Operating Lease Liability,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,usd,12500000,cf
3141,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,1059900000,bs
3142,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,359700000,bs
3143,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Receivables, net of allowance of $0.6 and $0.6, respectively",ReceivablesNetCurrent,usd,499000000,bs
3144,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Inventory,InventoryNet,usd,739800000,bs
3145,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Other current assets,OtherAssetsCurrent,usd,146300000,bs
3146,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Total current assets,AssetsCurrent,usd,2804700000,bs
3147,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Property, plant, and equipment, net",PropertyPlantAndEquipmentNet,usd,1396600000,bs
3148,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,168000000,bs
3149,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Goodwill,Goodwill,usd,1189800000,bs
3150,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,39100000,bs
3151,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Deferred Income Tax Assets, Net",DeferredIncomeTaxAssetsNet,usd,59000000,bs
3152,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,4000000,bs
3153,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Other long-term assets,OtherAssetsNoncurrent,usd,73200000,bs
3154,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,ASSETS,Assets,usd,5734400000,bs
3155,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Accounts payable,AccountsPayableCurrent,usd,276200000,bs
3156,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,102900000,bs
3157,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,159300000,bs
3158,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Total current liabilities,LiabilitiesCurrent,usd,538400000,bs
3159,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,304200000,bs
3160,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,148300000,bs
3161,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,31200000,bs
3162,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,LIABILITIES AND STOCKHOLDERS’ EQUITY,Liabilities,usd,1022100000,bs
3163,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
3164,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Common stock, $0.25 par value: 525.0 shares authorized; 233.6 shares issued and 165.1 shares outstanding at April 2, 2021, and 232.3 shares issued and 165.6 shares outstanding at October 2, 2020",CommonStockValue,usd,41300000,bs
3165,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,3530200000,bs
3166,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Treasury Stock, Value, Acquired, Par Value Method",TreasuryStockValue,usd,4340500000,bs
3167,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,5489100000,bs
3168,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7800000,bs
3169,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,STOCKHOLDERS' EQUITY,StockholdersEquity,usd,4712300000,bs
3170,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,LIABILITIES AND STOCKHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,5734400000,bs
3171,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Net income,NetIncomeLoss,usd,834300000,cf
3172,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Share-based compensation,ShareBasedCompensation,usd,100800000,cf
3173,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Depreciation,Depreciation,usd,158200000,cf
3174,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Amortization,AdjustmentForAmortization,usd,17500000,cf
3175,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-3600000,cf
3176,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Other, net",OtherNoncashIncomeExpense,usd,N/A,cf
3177,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Receivables, net",IncreaseDecreaseInReceivables,usd,105400000,cf
3178,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Inventory,IncreaseDecreaseInInventories,usd,-61800000,cf
3179,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,3700000,cf
3180,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,33500000,cf
3181,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1100800000,cf
3182,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,259800000,cf
3183,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,308100000,cf
3184,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Payments to Acquire Intangible Assets,PaymentsToAcquireIntangibleAssets,usd,5900000,cf
3185,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,358900000,cf
3186,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-214900000,cf
3187,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,51300000,cf
3188,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3189,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Dividends paid,PaymentsOfOrdinaryDividends,usd,165600000,cf
3190,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,7100000,cf
3191,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,12700000,cf
3192,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Net Cash Provided by (Used in) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-392700000,cf
3193,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,493200000,cf
3194,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Income taxes paid,IncomeTaxesPaid,usd,73700000,cf
3195,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Stock Issued,StockIssued1,usd,27500000,cf
3196,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,124300000,cf
3197,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q2,2021,Right-of-Use Asset Obtained in Exchange for Operating Lease Liability,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,usd,13300000,cf
3198,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,4952100000,bs
3199,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,142700000,bs
3200,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Property, plant, and equipment, net",PropertyPlantAndEquipmentNet,usd,1452200000,bs
3201,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Property, plant, and equipment, net",PropertyPlantAndEquipmentNet,usd,1452200000,bs
3202,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,31500000,bs
3203,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,17500000,bs
3204,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total stockholders’ equity,StockholdersEquity,usd,5002800000,bs
3205,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total stockholders’ equity,StockholdersEquity,usd,5002800000,bs
3206,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Receivables, net of allowances of $0.7 and $0.6, respectively",ReceivablesNetCurrent,usd,570500000,bs
3207,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,243800000,bs
3208,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
3209,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Deferred Income Tax Assets, Net",DeferredIncomeTaxAssetsNet,usd,58000000,bs
3210,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Treasury stock, at cost",TreasuryStockValue,usd,100000,bs
3211,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,108500000,bs
3212,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total liabilities,Liabilities,usd,2483400000,bs
3213,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Goodwill,Goodwill,usd,1189800000,bs
3214,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,3900000,bs
3215,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Long-term Debt,LongTermDebt,usd,1487100000,bs
3216,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Long-term Debt,LongTermDebt,usd,1487100000,bs
3217,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other long-term assets,OtherAssetsNoncurrent,usd,63100000,bs
3218,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total current liabilities,LiabilitiesCurrent,usd,578300000,bs
3219,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other current assets,OtherAssetsCurrent,usd,168500000,bs
3220,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total assets,Assets,usd,7486200000,bs
3221,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,129200000,bs
3222,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-8000000,bs
3223,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,34700000,bs
3224,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,34700000,bs
3225,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Inventory,InventoryNet,usd,808700000,bs
3226,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Inventory,InventoryNet,usd,808700000,bs
3227,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,162600000,bs
3228,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Accounts payable,AccountsPayableCurrent,usd,319500000,bs
3229,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Common stock, $0.25 par value: 525.0 shares authorized; 165.1 shares issued and 165.1 shares outstanding at July 2, 2021, and 232.3 shares issued and 165.6 shares outstanding at October 2, 2020",CommonStockValue,usd,41300000,bs
3230,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total liabilities and stockholders’ equity,LiabilitiesAndStockholdersEquity,usd,7486200000,bs
3231,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,150300000,bs
3232,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,150300000,bs
3233,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Total current assets,AssetsCurrent,usd,4521900000,bs
3234,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2845000000,bs
3235,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,2845000000,bs
3236,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,7800000,cf
3237,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-2600000,cf
3238,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,2278300000,cf
3239,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Stock Issued,StockIssued1,usd,27500000,cf
3240,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Dividends paid,PaymentsOfOrdinaryDividends,usd,248100000,cf
3241,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Dividends paid,PaymentsOfOrdinaryDividends,usd,248100000,cf
3242,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,689600000,cf
3243,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3244,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3245,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Repurchase of common stock - stock repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3246,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,53600000,cf
3247,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net income,NetIncomeLoss,usd,1172000000,cf
3248,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net income,NetIncomeLoss,usd,1172000000,cf
3249,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net income,NetIncomeLoss,usd,1172000000,cf
3250,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net income,NetIncomeLoss,usd,1172000000,cf
3251,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,374800000,cf
3252,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Payments to Acquire Property, Plant, and Equipment",PaymentsToAcquirePropertyPlantAndEquipment,usd,374800000,cf
3253,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,12700000,cf
3254,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,149900000,cf
3255,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Other, net",OtherNoncashIncomeExpense,usd,-200000,cf
3256,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Amortization,AdjustmentForAmortization,usd,23800000,cf
3257,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Depreciation,Depreciation,usd,242900000,cf
3258,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Proceeds from Debt, Net of Issuance Costs",ProceedsFromDebtNetOfIssuanceCosts,usd,1489700000,cf
3259,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1373700000,cf
3260,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net Cash Provided by (Used in) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1005600000,cf
3261,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,21800000,cf
3262,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Payments to Acquire Intangible Assets,PaymentsToAcquireIntangibleAssets,usd,7400000,cf
3263,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Right-of-Use Asset Obtained in Exchange for Operating Lease Liability,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,usd,15900000,cf
3264,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Inventory,IncreaseDecreaseInInventories,usd,5900000,cf
3265,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Income taxes paid,IncomeTaxesPaid,usd,136500000,cf
3266,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Net Cash Provided by (Used in) Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-101000000,cf
3267,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Asset Impairment Charges,AssetImpairmentCharges,usd,N/A,cf
3268,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,408400000,cf
3269,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Payments of Debt Issuance Costs,PaymentsOfDebtIssuanceCosts,usd,7300000,cf
3270,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Other current and long-term assets and liabilities,IncreaseDecreaseInOtherOperatingLiabilities,usd,-45900000,cf
3271,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,"Receivables, net",IncreaseDecreaseInReceivables,usd,176900000,cf
3272,Sky Works Solutions,0000004127,SWKS,Semiconductor,Q3,2021,Share-based compensation,ShareBasedCompensation,usd,144300000,cf
3273,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Marketable Securities, Current",MarketableSecuritiesCurrent,usd,137200000,bs
3274,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,287200000,bs
3275,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other current liabilities,OtherLiabilitiesCurrent,usd,287200000,bs
3276,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total liabilities,Liabilities,usd,3293600000,bs
3277,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Treasury stock, at cost",TreasuryStockValue,usd,1700000,bs
3278,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,5185800000,bs
3279,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Inventory,InventoryNet,usd,885000000,bs
3280,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Inventory,InventoryNet,usd,885000000,bs
3281,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total stockholders' equity,StockholdersEquity,usd,5297100000,bs
3282,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total stockholders' equity,StockholdersEquity,usd,5297100000,bs
3283,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Common stock, $0.25 par value: 525.0 shares authorized; 230.2 shares issued and 170.1 shares outstanding at September 27, 2019, and 228.4 shares issued and 177.4 shares outstanding at September 28, 2018",CommonStockValue,usd,41300000,bs
3284,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total liabilities and stockholders' equity,LiabilitiesAndStockholdersEquity,usd,8590700000,bs
3285,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other current assets,OtherAssetsCurrent,usd,204100000,bs
3286,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total assets,Assets,usd,8590700000,bs
3287,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total current assets,AssetsCurrent,usd,2865400000,bs
3288,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Receivables, net of allowance for doubtful accounts of $0.8 and $0.6, respectively",ReceivablesNetCurrent,usd,756200000,bs
3289,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other assets,OtherAssetsNoncurrent,usd,55700000,bs
3290,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Long-term tax liabilities,LiabilityForUncertainTaxPositionsNoncurrent,usd,222800000,bs
3291,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Marketable Securities, Noncurrent",MarketableSecuritiesNoncurrent,usd,7100000,bs
3292,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,79600000,bs
3293,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Total current liabilities,LiabilitiesCurrent,usd,658500000,bs
3294,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,144500000,bs
3295,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Operating Lease, Liability, Noncurrent",OperatingLeaseLiabilityNoncurrent,usd,144500000,bs
3296,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Operating Lease, Right-of-Use Asset",OperatingLeaseRightOfUseAsset,usd,166100000,bs
3297,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Preferred stock, no par value: 25.0 shares authorized, no shares issued",PreferredStockValue,usd,N/A,bs
3298,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,1698600000,bs
3299,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Intangible assets, net",IntangibleAssetsNetExcludingGoodwill,usd,1698600000,bs
3300,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Accounts payable,AccountsPayableCurrent,usd,236000000,bs
3301,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Accumulated other comprehensive loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-7900000,bs
3302,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Deferred tax assets, net",DeferredIncomeTaxAssetsNet,usd,119500000,bs
3303,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Deferred tax assets, net",DeferredIncomeTaxAssetsNet,usd,119500000,bs
3304,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Long-term Debt,LongTermDebt,usd,2235600000,bs
3305,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Long-term Debt,LongTermDebt,usd,2235600000,bs
3306,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Accrued compensation and benefits,EmployeeRelatedLiabilitiesCurrent,usd,135300000,bs
3307,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,882900000,bs
3308,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,882900000,bs
3309,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other long-term liabilities,OtherLiabilitiesNoncurrent,usd,32200000.000000004,bs
3310,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1501600000,bs
3311,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1501600000,bs
3312,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,1501600000,bs
3313,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Goodwill,Goodwill,usd,2176700000,bs
3314,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Goodwill,Goodwill,usd,2176700000,bs
3315,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Dividends paid,PaymentsOfOrdinaryDividends,usd,340600000,cf
3316,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Cash Provided by (Used in) Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-3133200000,cf
3317,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Repurchase of common stock - share repurchase program,PaymentsForRepurchaseOfCommonStock,usd,195600000,cf
3318,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Interest Paid, Excluding Capitalized Interest, Operating Activities",InterestPaidNet,usd,2200000,cf
3319,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Capital Expenditures Incurred but Not yet Paid,CapitalExpendituresIncurredButNotYetPaid,usd,29300000,cf
3320,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Purchased intangibles,PaymentsToAcquireIntangibleAssets,usd,14300000,cf
3321,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Payments of Financing Costs,PaymentsOfFinancingCosts,usd,5800000,cf
3322,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Maturity of investments,ProceedsFromSaleAndMaturityOfOtherInvestments,usd,770700000,cf
3323,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Inventory,IncreaseDecreaseInInventories,usd,41200000,cf
3324,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Asset Impairment Charges,AssetImpairmentCharges,usd,7100000,cf
3325,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Repurchase of common stock - payroll tax withholdings on equity awards,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,usd,55200000,cf
3326,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Proceeds from Issuance of Common Stock,ProceedsFromIssuanceOfCommonStock,usd,24800000,cf
3327,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Payments to Acquire Marketable Securities,PaymentsToAcquireMarketableSecurities,usd,500800000,cf
3328,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Excess tax benefit from share-based compensation,AmortizationOfFinancingCostsAndDiscounts,usd,1100000,cf
3329,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Stock Issued,StockIssued1,usd,27500000,cf
3330,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3331,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3332,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3333,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3334,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3335,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Income,NetIncomeLoss,usd,1498300000,cf
3336,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Proceeds from Issuance of Debt,ProceedsFromIssuanceOfDebt,usd,2488200000,cf
3337,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net increase in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,316200000,cf
3338,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Amortization of intangible assets,OtherDepreciationAndAmortization,usd,104500000,cf
3339,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Share-based compensation,ShareBasedCompensation,usd,191900000,cf
3340,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Share-based compensation,ShareBasedCompensation,usd,191900000,cf
3341,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Treasury Stock, Retired, Cost Method, Amount",TreasuryStockRetiredCostMethodAmount,usd,4342600000,cf
3342,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Treasury Stock, Retired, Cost Method, Amount",TreasuryStockRetiredCostMethodAmount,usd,4342600000,cf
3343,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,N/A,cf
3344,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Repayments of Long-term Debt,RepaymentsOfLongTermDebt,usd,250000000,cf
3345,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Repayments of Long-term Debt,RepaymentsOfLongTermDebt,usd,250000000,cf
3346,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Other,OtherNoncashIncomeExpense,usd,-200000,cf
3347,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Accounts payable,IncreaseDecreaseInAccountsPayable,usd,59600000,cf
3348,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Receivables, net",IncreaseDecreaseInReceivables,usd,397700000,cf
3349,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Cash Provided by (Used in) Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,1772000000,cf
3350,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Payments for acquisitions, net of cash acquired",PaymentsToAcquireBusinessesGross,usd,2751000000,cf
3351,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net Cash Provided by (Used in) Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,1677400000,cf
3352,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Capital expenditures,PaymentsToAcquirePropertyPlantAndEquipment,usd,637800000,cf
3353,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Deferred income taxes,DeferredIncomeTaxesAndTaxCredits,usd,-59500000,cf
3354,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,"Increase (Decrease) in Other Operating Assets and Liabilities, Net",IncreaseDecreaseInOtherOperatingCapitalNet,usd,-75500000,cf
3355,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Depreciation,Depreciation,usd,332200000,cf
3356,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Income taxes paid,IncomeTaxesPaid,usd,184000000,cf
3357,Sky Works Solutions,0000004127,SWKS,Semiconductor,FY,2021,Net proceeds from exercise of stock options,ProceedsFromStockOptionsExercised,usd,11600000,cf
3358,Aflac,0000004977,AFL,Insurance,Q2,2017,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,32613000000,bs
3359,Aflac,0000004977,AFL,Insurance,Q2,2017,Other Investments,OtherInvestments,usd,2016000000,bs
3360,Aflac,0000004977,AFL,Insurance,Q2,2017,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,4264000000,bs
3361,Aflac,0000004977,AFL,Insurance,Q2,2017,Investments and Cash,InvestmentsAndCash,usd,121896000000,bs
3362,Aflac,0000004977,AFL,Insurance,Q2,2017,Receivables,PremiumsAndOtherReceivablesNet,usd,871000000,bs
3363,Aflac,0000004977,AFL,Insurance,Q2,2017,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,760000000,bs
3364,Aflac,0000004977,AFL,Insurance,Q2,2017,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9340000000,bs
3365,Aflac,0000004977,AFL,Insurance,Q2,2017,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,442000000,bs
3366,Aflac,0000004977,AFL,Insurance,Q2,2017,Other assets,OtherAssets,usd,2085000000,bs
3367,Aflac,0000004977,AFL,Insurance,Q2,2017,"Assets, fair value",Assets,usd,135394000000,bs
3368,Aflac,0000004977,AFL,Insurance,Q2,2017,POLICY LIABILITIES,LiabilityForFuturePolicyBenefits,usd,80652000000,bs
3369,Aflac,0000004977,AFL,Insurance,Q2,2017,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4281000000,bs
3370,Aflac,0000004977,AFL,Insurance,Q2,2017,Unearned premiums,UnearnedPremiums,usd,6547000000,bs
3371,Aflac,0000004977,AFL,Insurance,Q2,2017,Other policyholder funds,OtherPolicyholderFunds,usd,6978000000,bs
3372,Aflac,0000004977,AFL,Insurance,Q2,2017,Total policy liabilities,afl:TotalPolicyLiabilities,usd,98458000000,bs
3373,Aflac,0000004977,AFL,Insurance,Q2,2017,Income Taxes,TaxesPayableCurrentAndNoncurrent,usd,6057000000,bs
3374,Aflac,0000004977,AFL,Insurance,Q2,2017,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,663000000,bs
3375,Aflac,0000004977,AFL,Insurance,Q2,2017,Notes payable,DebtAndCapitalLeaseObligations,usd,5252000000,bs
3376,Aflac,0000004977,AFL,Insurance,Q2,2017,Other liabilities,OtherLiabilities,usd,3461000000,bs
3377,Aflac,0000004977,AFL,Insurance,Q2,2017,Liabilities:,Liabilities,usd,113891000000,bs
3378,Aflac,0000004977,AFL,Insurance,Q2,2017,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2017 and 2016; issued 672,037 shares in 2017 and 671,249 shares in 2016",CommonStockValue,usd,67000000,bs
3379,Aflac,0000004977,AFL,Insurance,Q2,2017,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2048000000,bs
3380,Aflac,0000004977,AFL,Insurance,Q2,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,26942000000,bs
3381,Aflac,0000004977,AFL,Insurance,Q2,2017,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1580000000,bs
3382,Aflac,0000004977,AFL,Insurance,Q2,2017,"Shareholders' equity, unrealized gains (losses) on investment securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5173000000,bs
3383,Aflac,0000004977,AFL,Insurance,Q2,2017,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-23000000,bs
3384,Aflac,0000004977,AFL,Insurance,Q2,2017,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,169000000,bs
3385,Aflac,0000004977,AFL,Insurance,Q2,2017,Purchases of treasury stock,TreasuryStockValue,usd,10955000000,bs
3386,Aflac,0000004977,AFL,Insurance,Q2,2017,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,21503000000,bs
3387,Aflac,0000004977,AFL,Insurance,Q2,2017,Liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,135394000000,bs
3388,Aflac,0000004977,AFL,Insurance,Q2,2017,Net earnings,NetIncomeLoss,usd,1305000000,cf
3389,Aflac,0000004977,AFL,Insurance,Q2,2017,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,-8000000,cf
3390,Aflac,0000004977,AFL,Insurance,Q2,2017,Increase in deferred policy acquisition costs,IncreaseDecreaseInDeferredPolicyAcquisitionCosts,usd,116000000,cf
3391,Aflac,0000004977,AFL,Insurance,Q2,2017,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1326000000,cf
3392,Aflac,0000004977,AFL,Insurance,Q2,2017,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,368000000,cf
3393,Aflac,0000004977,AFL,Insurance,Q2,2017,Gain (Loss) on Investments,GainLossOnInvestments,usd,-196000000,cf
3394,Aflac,0000004977,AFL,Insurance,Q2,2017,"Other, net",OtherNoncashIncomeExpense,usd,-78000000,cf
3395,Aflac,0000004977,AFL,Insurance,Q2,2017,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,3165000000,cf
3396,Aflac,0000004977,AFL,Insurance,Q2,2017,Fixed maturities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,2114000000,cf
3397,Aflac,0000004977,AFL,Insurance,Q2,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,451000000,cf
3398,Aflac,0000004977,AFL,Insurance,Q2,2017,Perpetual securities matured or called,afl:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSalePerpetualSecurities,usd,9000000,cf
3399,Aflac,0000004977,AFL,Insurance,Q2,2017,Equity securities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesEquity,usd,157000000,cf
3400,Aflac,0000004977,AFL,Insurance,Q2,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,1311000000,cf
3401,Aflac,0000004977,AFL,Insurance,Q2,2017,Available for sale fixed maturities acquired,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,5662000000,cf
3402,Aflac,0000004977,AFL,Insurance,Q2,2017,Available for sale equity securities acquired,PaymentsToAcquireAvailableForSaleSecuritiesEquity,usd,178000000,cf
3403,Aflac,0000004977,AFL,Insurance,Q2,2017,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestments,usd,514000000,cf
3404,Aflac,0000004977,AFL,Insurance,Q2,2017,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,34000000,cf
3405,Aflac,0000004977,AFL,Insurance,Q2,2017,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,129000000,cf
3406,Aflac,0000004977,AFL,Insurance,Q2,2017,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,42000000,cf
3407,Aflac,0000004977,AFL,Insurance,Q2,2017,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2517000000,cf
3408,Aflac,0000004977,AFL,Insurance,Q2,2017,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,813000000,cf
3409,Aflac,0000004977,AFL,Insurance,Q2,2017,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,524000000,cf
3410,Aflac,0000004977,AFL,Insurance,Q2,2017,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,656000000,cf
3411,Aflac,0000004977,AFL,Insurance,Q2,2017,Dividends paid to shareholders,PaymentsOfDividends,usd,328000000,cf
3412,Aflac,0000004977,AFL,Insurance,Q2,2017,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,23000000,cf
3413,Aflac,0000004977,AFL,Insurance,Q2,2017,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,17000000,cf
3414,Aflac,0000004977,AFL,Insurance,Q2,2017,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,2000000,cf
3415,Aflac,0000004977,AFL,Insurance,Q2,2017,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1231000000,cf
3416,Aflac,0000004977,AFL,Insurance,Q2,2017,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-12000000,cf
3417,Aflac,0000004977,AFL,Insurance,Q2,2017,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-595000000,cf
3418,Aflac,0000004977,AFL,Insurance,Q2,2017,Income taxes paid,IncomeTaxesPaidNet,usd,293000000,cf
3419,Aflac,0000004977,AFL,Insurance,Q2,2017,Interest paid,InterestPaid,usd,103000000,cf
3420,Aflac,0000004977,AFL,Insurance,Q2,2017,Noncash interest,OtherNoncashExpense,usd,19000000,cf
3421,Aflac,0000004977,AFL,Insurance,Q2,2017,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet,usd,19000000,cf
3422,Aflac,0000004977,AFL,Insurance,Q2,2017,Capital lease obligations incurred,CapitalLeaseObligationsIncurred,usd,3000000,cf
3423,Aflac,0000004977,AFL,Insurance,Q3,2017,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,31998000000,bs
3424,Aflac,0000004977,AFL,Insurance,Q3,2017,Other Investments,OtherInvestments,usd,2358000000,bs
3425,Aflac,0000004977,AFL,Insurance,Q3,2017,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4927000000,bs
3426,Aflac,0000004977,AFL,Insurance,Q3,2017,Investments and Cash,InvestmentsAndCash,usd,122489000000,bs
3427,Aflac,0000004977,AFL,Insurance,Q3,2017,Receivables,PremiumsAndOtherReceivablesNet,usd,937000000,bs
3428,Aflac,0000004977,AFL,Insurance,Q3,2017,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,730000000,bs
3429,Aflac,0000004977,AFL,Insurance,Q3,2017,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9413000000,bs
3430,Aflac,0000004977,AFL,Insurance,Q3,2017,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,439000000,bs
3431,Aflac,0000004977,AFL,Insurance,Q3,2017,Other,OtherAssets,usd,2075000000,bs
3432,Aflac,0000004977,AFL,Insurance,Q3,2017,Assets:,Assets,usd,136083000000,bs
3433,Aflac,0000004977,AFL,Insurance,Q3,2017,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,81116000000,bs
3434,Aflac,0000004977,AFL,Insurance,Q3,2017,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4368000000,bs
3435,Aflac,0000004977,AFL,Insurance,Q3,2017,Unearned premiums,UnearnedPremiums,usd,6262000000,bs
3436,Aflac,0000004977,AFL,Insurance,Q3,2017,Other policyholders’ funds,OtherPolicyholderFunds,usd,6967000000,bs
3437,Aflac,0000004977,AFL,Insurance,Q3,2017,Total policy liabilities,afl:TotalPolicyLiabilities,usd,98713000000,bs
3438,Aflac,0000004977,AFL,Insurance,Q3,2017,Income Taxes,TaxesPayableCurrentAndNoncurrent,usd,6195000000,bs
3439,Aflac,0000004977,AFL,Insurance,Q3,2017,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,522000000,bs
3440,Aflac,0000004977,AFL,Insurance,Q3,2017,Notes payable,DebtAndCapitalLeaseObligations,usd,5248000000,bs
3441,Aflac,0000004977,AFL,Insurance,Q3,2017,Other,OtherLiabilities,usd,3428000000,bs
3442,Aflac,0000004977,AFL,Insurance,Q3,2017,Liabilities and shareholders' equity,Liabilities,usd,114106000000,bs
3443,Aflac,0000004977,AFL,Insurance,Q3,2017,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2017 and 2016; issued 672,669 shares in 2017 and 671,249 shares in 2016",CommonStockValue,usd,67000000,bs
3444,Aflac,0000004977,AFL,Insurance,Q3,2017,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2077000000,bs
3445,Aflac,0000004977,AFL,Insurance,Q3,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,27489000000,bs
3446,Aflac,0000004977,AFL,Insurance,Q3,2017,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1715000000,bs
3447,Aflac,0000004977,AFL,Insurance,Q3,2017,Unrealized gain (losses) on investment securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5437000000,bs
3448,Aflac,0000004977,AFL,Insurance,Q3,2017,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-23000000,bs
3449,Aflac,0000004977,AFL,Insurance,Q3,2017,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,168000000,bs
3450,Aflac,0000004977,AFL,Insurance,Q3,2017,"Treasury stock, at average cost",TreasuryStockValue,usd,11187000000,bs
3451,Aflac,0000004977,AFL,Insurance,Q3,2017,Shareholders’ equity:,StockholdersEquity,usd,21977000000,bs
3452,Aflac,0000004977,AFL,Insurance,Q3,2017,Liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,136083000000,bs
3453,Aflac,0000004977,AFL,Insurance,Q3,2017,Net earnings,NetIncomeLoss,usd,2021000000,cf
3454,Aflac,0000004977,AFL,Insurance,Q3,2017,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,32000000,cf
3455,Aflac,0000004977,AFL,Insurance,Q3,2017,Increase in deferred policy acquisition costs,IncreaseDecreaseInDeferredPolicyAcquisitionCosts,usd,229000000,cf
3456,Aflac,0000004977,AFL,Insurance,Q3,2017,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,2137000000,cf
3457,Aflac,0000004977,AFL,Insurance,Q3,2017,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,323000000,cf
3458,Aflac,0000004977,AFL,Insurance,Q3,2017,Debt Security Category [Axis],GainLossOnInvestments,usd,-166000000,cf
3459,Aflac,0000004977,AFL,Insurance,Q3,2017,"Other, net",OtherNoncashIncomeExpense,usd,-210000000,cf
3460,Aflac,0000004977,AFL,Insurance,Q3,2017,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,4596000000,cf
3461,Aflac,0000004977,AFL,Insurance,Q3,2017,Fixed maturities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,2633000000,cf
3462,Aflac,0000004977,AFL,Insurance,Q3,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,740000000,cf
3463,Aflac,0000004977,AFL,Insurance,Q3,2017,Perpetual securities matured or called,afl:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSalePerpetualSecurities,usd,9000000,cf
3464,Aflac,0000004977,AFL,Insurance,Q3,2017,Equity securities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesEquity,usd,755000000,cf
3465,Aflac,0000004977,AFL,Insurance,Q3,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,1714000000,cf
3466,Aflac,0000004977,AFL,Insurance,Q3,2017,Available for sale fixed maturities acquired,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,6827000000,cf
3467,Aflac,0000004977,AFL,Insurance,Q3,2017,Available for sale equity securities acquired,PaymentsToAcquireAvailableForSaleSecuritiesEquity,usd,391000000,cf
3468,Aflac,0000004977,AFL,Insurance,Q3,2017,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestments,usd,949000000,cf
3469,Aflac,0000004977,AFL,Insurance,Q3,2017,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,240000000,cf
3470,Aflac,0000004977,AFL,Insurance,Q3,2017,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,273000000,cf
3471,Aflac,0000004977,AFL,Insurance,Q3,2017,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,58000000,cf
3472,Aflac,0000004977,AFL,Insurance,Q3,2017,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2887000000,cf
3473,Aflac,0000004977,AFL,Insurance,Q3,2017,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1053000000,cf
3474,Aflac,0000004977,AFL,Insurance,Q3,2017,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,524000000,cf
3475,Aflac,0000004977,AFL,Insurance,Q3,2017,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,660000000,cf
3476,Aflac,0000004977,AFL,Insurance,Q3,2017,Dividends paid to shareholders,PaymentsOfDividends,usd,491000000,cf
3477,Aflac,0000004977,AFL,Insurance,Q3,2017,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,39000000,cf
3478,Aflac,0000004977,AFL,Insurance,Q3,2017,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,23000000,cf
3479,Aflac,0000004977,AFL,Insurance,Q3,2017,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,5000000,cf
3480,Aflac,0000004977,AFL,Insurance,Q3,2017,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1613000000,cf
3481,Aflac,0000004977,AFL,Insurance,Q3,2017,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-28000000,cf
3482,Aflac,0000004977,AFL,Insurance,Q3,2017,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,68000000,cf
3483,Aflac,0000004977,AFL,Insurance,Q3,2017,Income taxes paid,IncomeTaxesPaidNet,usd,693000000,cf
3484,Aflac,0000004977,AFL,Insurance,Q3,2017,Interest paid,InterestPaid,usd,144000000,cf
3485,Aflac,0000004977,AFL,Insurance,Q3,2017,Noncash interest,OtherNoncashExpense,usd,38000000,cf
3486,Aflac,0000004977,AFL,Insurance,Q3,2017,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet,usd,27000000,cf
3487,Aflac,0000004977,AFL,Insurance,Q3,2017,Capital lease obligations incurred,CapitalLeaseObligationsIncurred,usd,7000000,cf
3488,Aflac,0000004977,AFL,Insurance,FY,2017,"Securities held to maturity, fixed maturities, fair value",HeldToMaturitySecurities,usd,31430000000,bs
3489,Aflac,0000004977,AFL,Insurance,FY,2017,"Other investments, amortized cost",OtherInvestments,usd,3402000000,bs
3490,Aflac,0000004977,AFL,Insurance,FY,2017,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,3491000000,bs
3491,Aflac,0000004977,AFL,Insurance,FY,2017,Investments and cash:,InvestmentsAndCash,usd,123659000000,bs
3492,Aflac,0000004977,AFL,Insurance,FY,2017,Receivables,PremiumsAndOtherReceivablesNet,usd,827000000,bs
3493,Aflac,0000004977,AFL,Insurance,FY,2017,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,769000000,bs
3494,Aflac,0000004977,AFL,Insurance,FY,2017,Deferred Policy Acquisition Costs Disclosures [Abstract],DeferredPolicyAcquisitionCosts,usd,9505000000,bs
3495,Aflac,0000004977,AFL,Insurance,FY,2017,Property and equipment:,PropertyPlantAndEquipmentNet,usd,434000000,bs
3496,Aflac,0000004977,AFL,Insurance,FY,2017,Other assets,OtherAssets,usd,2023000000,bs
3497,Aflac,0000004977,AFL,Insurance,FY,2017,Exchange effect on total assets,Assets,usd,137217000000,bs
3498,Aflac,0000004977,AFL,Insurance,FY,2017,Liability amounts,LiabilityForFuturePolicyBenefits,usd,81857000000,bs
3499,Aflac,0000004977,AFL,Insurance,FY,2017,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4392000000,bs
3500,Aflac,0000004977,AFL,Insurance,FY,2017,Unearned premiums,UnearnedPremiums,usd,5959000000,bs
3501,Aflac,0000004977,AFL,Insurance,FY,2017,Other policyholders' funds,OtherPolicyholderFunds,usd,6939000000,bs
3502,Aflac,0000004977,AFL,Insurance,FY,2017,Total policy liabilities,afl:TotalPolicyLiabilities,usd,99147000000,bs
3503,Aflac,0000004977,AFL,Insurance,FY,2017,Total income tax liability,TaxesPayableCurrentAndNoncurrent,usd,4745000000,bs
3504,Aflac,0000004977,AFL,Insurance,FY,2017,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,606000000,bs
3505,Aflac,0000004977,AFL,Insurance,FY,2017,Notes payable,DebtAndCapitalLeaseObligations,usd,5289000000,bs
3506,Aflac,0000004977,AFL,Insurance,FY,2017,Other Liabilities,OtherLiabilities,usd,2832000000,bs
3507,Aflac,0000004977,AFL,Insurance,FY,2017,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
3508,Aflac,0000004977,AFL,Insurance,FY,2017,Exchange effect on total liabilities,Liabilities,usd,112619000000,bs
3509,Aflac,0000004977,AFL,Insurance,FY,2017,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2017 and 2016; issued 672,881 shares in 2017 and 671,249 shares in 2016",CommonStockValue,usd,67000000,bs
3510,Aflac,0000004977,AFL,Insurance,FY,2017,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2120000000,bs
3511,Aflac,0000004977,AFL,Insurance,FY,2017,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,29895000000,bs
3512,Aflac,0000004977,AFL,Insurance,FY,2017,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1750000000,bs
3513,Aflac,0000004977,AFL,Insurance,FY,2017,Unrealized gains (losses) on investment securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5964000000,bs
3514,Aflac,0000004977,AFL,Insurance,FY,2017,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-23000000,bs
3515,Aflac,0000004977,AFL,Insurance,FY,2017,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,163000000,bs
3516,Aflac,0000004977,AFL,Insurance,FY,2017,Purchases of treasury stock,TreasuryStockValue,usd,11512000000,bs
3517,Aflac,0000004977,AFL,Insurance,FY,2017,Treasury Stock,StockholdersEquity,usd,24598000000,bs
3518,Aflac,0000004977,AFL,Insurance,FY,2017,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,137217000000,bs
3519,Aflac,0000004977,AFL,Insurance,FY,2017,Net earnings,NetIncomeLoss,usd,4604000000,cf
3520,Aflac,0000004977,AFL,Insurance,FY,2017,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,91000000,cf
3521,Aflac,0000004977,AFL,Insurance,FY,2017,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,1468000000,cf
3522,Aflac,0000004977,AFL,Insurance,FY,2017,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,1132000000,cf
3523,Aflac,0000004977,AFL,Insurance,FY,2017,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,2890000000,cf
3524,Aflac,0000004977,AFL,Insurance,FY,2017,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-1240000000,cf
3525,Aflac,0000004977,AFL,Insurance,FY,2017,Investments by Category [Axis],GainLossOnInvestments,usd,-151000000,cf
3526,Aflac,0000004977,AFL,Insurance,FY,2017,"Other, net",OtherNoncashIncomeExpense,usd,-150000000,cf
3527,Aflac,0000004977,AFL,Insurance,FY,2017,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,6128000000,cf
3528,Aflac,0000004977,AFL,Insurance,FY,2017,Fixed maturities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,3819000000,cf
3529,Aflac,0000004977,AFL,Insurance,FY,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,768000000,cf
3530,Aflac,0000004977,AFL,Insurance,FY,2017,Perpetual securities matured or called,afl:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSalePerpetualSecurities,usd,93000000,cf
3531,Aflac,0000004977,AFL,Insurance,FY,2017,Equity securities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesEquity,usd,902000000,cf
3532,Aflac,0000004977,AFL,Insurance,FY,2017,Fixed maturities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,2212000000,cf
3533,Aflac,0000004977,AFL,Insurance,FY,2017,Available for sale fixed maturities acquired,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,9867000000,cf
3534,Aflac,0000004977,AFL,Insurance,FY,2017,Available-for-sale equity securities acquired,PaymentsToAcquireAvailableForSaleSecuritiesEquity,usd,446000000,cf
3535,Aflac,0000004977,AFL,Insurance,FY,2017,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestments,usd,2018000000,cf
3536,Aflac,0000004977,AFL,Insurance,FY,2017,Purchase of subsidiary,PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
3537,Aflac,0000004977,AFL,Insurance,FY,2017,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,621000000,cf
3538,Aflac,0000004977,AFL,Insurance,FY,2017,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,205000000,cf
3539,Aflac,0000004977,AFL,Insurance,FY,2017,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,68000000,cf
3540,Aflac,0000004977,AFL,Insurance,FY,2017,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-5431000000,cf
3541,Aflac,0000004977,AFL,Insurance,FY,2017,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1351000000,cf
3542,Aflac,0000004977,AFL,Insurance,FY,2017,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,1040000000,cf
3543,Aflac,0000004977,AFL,Insurance,FY,2017,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,1161000000,cf
3544,Aflac,0000004977,AFL,Insurance,FY,2017,Dividends paid to shareholders,PaymentsOfDividends,usd,661000000,cf
3545,Aflac,0000004977,AFL,Insurance,FY,2017,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,35000000,cf
3546,Aflac,0000004977,AFL,Insurance,FY,2017,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,33000000,cf
3547,Aflac,0000004977,AFL,Insurance,FY,2017,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,0,cf
3548,Aflac,0000004977,AFL,Insurance,FY,2017,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-2065000000,cf
3549,Aflac,0000004977,AFL,Insurance,FY,2017,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,0,cf
3550,Aflac,0000004977,AFL,Insurance,FY,2017,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-1368000000,cf
3551,Aflac,0000004977,AFL,Insurance,FY,2017,Income taxes paid,IncomeTaxesPaidNet,usd,780000000,cf
3552,Aflac,0000004977,AFL,Insurance,FY,2017,Interest paid,InterestPaid,usd,196000000,cf
3553,Aflac,0000004977,AFL,Insurance,FY,2017,Noncash interest,OtherNoncashExpense,usd,44000000,cf
3554,Aflac,0000004977,AFL,Insurance,FY,2017,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet,usd,37000000,cf
3555,Aflac,0000004977,AFL,Insurance,FY,2017,Capitalized lease obligations,CapitalLeaseObligationsIncurred,usd,12000000,cf
3556,Aflac,0000004977,AFL,Insurance,Q1,2018,"Securities available for sale, fixed maturities, fair value",AvailableForSaleSecuritiesDebtSecurities,usd,89033000000,bs
3557,Aflac,0000004977,AFL,Insurance,Q1,2018,"Securities held to maturity, fixed maturities, fair value",HeldToMaturitySecurities,usd,33377000000,bs
3558,Aflac,0000004977,AFL,Insurance,Q1,2018,Fair Value,afl:EquitySecuritiesFVNI,usd,1108000000,bs
3559,Aflac,0000004977,AFL,Insurance,Q1,2018,Other Investments [Abstract],OtherInvestments,usd,5073000000,bs
3560,Aflac,0000004977,AFL,Insurance,Q1,2018,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,4080000000,bs
3561,Aflac,0000004977,AFL,Insurance,Q1,2018,Investments and Cash,InvestmentsAndCash,usd,132671000000,bs
3562,Aflac,0000004977,AFL,Insurance,Q1,2018,Receivables,PremiumsAndOtherReceivablesNet,usd,906000000,bs
3563,Aflac,0000004977,AFL,Insurance,Q1,2018,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,745000000,bs
3564,Aflac,0000004977,AFL,Insurance,Q1,2018,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9933000000,bs
3565,Aflac,0000004977,AFL,Insurance,Q1,2018,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,448000000,bs
3566,Aflac,0000004977,AFL,Insurance,Q1,2018,Other,OtherAssets,usd,2653000000,bs
3567,Aflac,0000004977,AFL,Insurance,Q1,2018,"Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]",Assets,usd,147356000000,bs
3568,Aflac,0000004977,AFL,Insurance,Q1,2018,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,87268000000,bs
3569,Aflac,0000004977,AFL,Insurance,Q1,2018,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4630000000,bs
3570,Aflac,0000004977,AFL,Insurance,Q1,2018,Unearned premiums,UnearnedPremiums,usd,6084000000,bs
3571,Aflac,0000004977,AFL,Insurance,Q1,2018,Other policyholders’ funds,OtherPolicyholderFunds,usd,7417000000,bs
3572,Aflac,0000004977,AFL,Insurance,Q1,2018,Total policy liabilities,afl:TotalPolicyLiabilities,usd,105399000000,bs
3573,Aflac,0000004977,AFL,Insurance,Q1,2018,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4407000000,bs
3574,Aflac,0000004977,AFL,Insurance,Q1,2018,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,5368000000,bs
3575,Aflac,0000004977,AFL,Insurance,Q1,2018,Notes payable,DebtAndCapitalLeaseObligations,usd,5372000000,bs
3576,Aflac,0000004977,AFL,Insurance,Q1,2018,Other,OtherLiabilities,usd,2523000000,bs
3577,Aflac,0000004977,AFL,Insurance,Q1,2018,Liabilities and shareholders' equity,Liabilities,usd,123069000000,bs
3578,Aflac,0000004977,AFL,Insurance,Q1,2018,"Common stock of $.10 par value. In thousands: authorized 3,800,000 shares in 2018 and 2017; issued 1,346,776 shares in 2018 and 1,345,762 shares in 2017",CommonStockValue,usd,135000000,bs
3579,Aflac,0000004977,AFL,Insurance,Q1,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2089000000,bs
3580,Aflac,0000004977,AFL,Insurance,Q1,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,30183000000,bs
3581,Aflac,0000004977,AFL,Insurance,Q1,2018,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1303000000,bs
3582,Aflac,0000004977,AFL,Insurance,Q1,2018,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5206000000,bs
3583,Aflac,0000004977,AFL,Insurance,Q1,2018,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-21000000,bs
3584,Aflac,0000004977,AFL,Insurance,Q1,2018,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,197000000,bs
3585,Aflac,0000004977,AFL,Insurance,Q1,2018,"Treasury stock, at average cost",TreasuryStockValue,usd,11805000000,bs
3586,Aflac,0000004977,AFL,Insurance,Q1,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,24287000000,bs
3587,Aflac,0000004977,AFL,Insurance,Q1,2018,Liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,147356000000,bs
3588,Aflac,0000004977,AFL,Insurance,Q1,2018,Net of tax,NetIncomeLoss,usd,717000000,cf
3589,Aflac,0000004977,AFL,Insurance,Q1,2018,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,-14000000,cf
3590,Aflac,0000004977,AFL,Insurance,Q1,2018,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,349000000,cf
3591,Aflac,0000004977,AFL,Insurance,Q1,2018,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,314000000,cf
3592,Aflac,0000004977,AFL,Insurance,Q1,2018,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,572000000,cf
3593,Aflac,0000004977,AFL,Insurance,Q1,2018,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-131000000,cf
3594,Aflac,0000004977,AFL,Insurance,Q1,2018,Other gains (losses),GainLossOnInvestments,usd,-134000000,cf
3595,Aflac,0000004977,AFL,Insurance,Q1,2018,"Other, net",OtherNoncashIncomeExpense,usd,33000000,cf
3596,Aflac,0000004977,AFL,Insurance,Q1,2018,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,1238000000,cf
3597,Aflac,0000004977,AFL,Insurance,Q1,2018,Fixed maturity securities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,usd,433000000,cf
3598,Aflac,0000004977,AFL,Insurance,Q1,2018,Fixed maturity securities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,usd,510000000,cf
3599,Aflac,0000004977,AFL,Insurance,Q1,2018,Equity securities sold,ProceedsFromSaleOfAvailableForSaleSecuritiesEquity,usd,157000000,cf
3600,Aflac,0000004977,AFL,Insurance,Q1,2018,Fixed maturity securities matured or called,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,50000000,cf
3601,Aflac,0000004977,AFL,Insurance,Q1,2018,Other investments - loan receivables proceeds,afl:ProceedsfromSaleofOtherInvestmentsLoanReceivables,usd,146000000,cf
3602,Aflac,0000004977,AFL,Insurance,Q1,2018,Available for sale fixed maturity securities acquired,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,3975000000,cf
3603,Aflac,0000004977,AFL,Insurance,Q1,2018,Equity securities acquired,afl:PaymentstoAcquireEquitySecurities,usd,166000000,cf
3604,Aflac,0000004977,AFL,Insurance,Q1,2018,"Other investments, loan receivables acquired",afl:PaymentstoAcquireOtherInvestmentsLoanReceivables,usd,1772000000,cf
3605,Aflac,0000004977,AFL,Insurance,Q1,2018,"Other investments, excluding loan receivables. net",afl:PaymentsForProceedsFromOtherInvestmentsExcludingLoanReceivablesNet,usd,125000000,cf
3606,Aflac,0000004977,AFL,Insurance,Q1,2018,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,1000000,cf
3607,Aflac,0000004977,AFL,Insurance,Q1,2018,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-4578000000,cf
3608,Aflac,0000004977,AFL,Insurance,Q1,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,34000000,cf
3609,Aflac,0000004977,AFL,Insurance,Q1,2018,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-199000000,cf
3610,Aflac,0000004977,AFL,Insurance,Q1,2018,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,296000000,cf
3611,Aflac,0000004977,AFL,Insurance,Q1,2018,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,2000000,cf
3612,Aflac,0000004977,AFL,Insurance,Q1,2018,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,0,cf
3613,Aflac,0000004977,AFL,Insurance,Q1,2018,Dividends paid to shareholders,PaymentsOfDividends,usd,195000000,cf
3614,Aflac,0000004977,AFL,Insurance,Q1,2018,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,7000000,cf
3615,Aflac,0000004977,AFL,Insurance,Q1,2018,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,14000000,cf
3616,Aflac,0000004977,AFL,Insurance,Q1,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-5000000,cf
3617,Aflac,0000004977,AFL,Insurance,Q1,2018,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-473000000,cf
3618,Aflac,0000004977,AFL,Insurance,Q1,2018,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,23000000,cf
3619,Aflac,0000004977,AFL,Insurance,Q1,2018,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,589000000,cf
3620,Aflac,0000004977,AFL,Insurance,Q1,2018,Income taxes paid,IncomeTaxesPaidNet,usd,396000000,cf
3621,Aflac,0000004977,AFL,Insurance,Q1,2018,Interest paid,InterestPaid,usd,36000000,cf
3622,Aflac,0000004977,AFL,Insurance,Q1,2018,Noncash interest,OtherNoncashExpense,usd,21000000,cf
3623,Aflac,0000004977,AFL,Insurance,Q1,2018,Other than temporary impairment losses realized,OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet,usd,7000000,cf
3624,Aflac,0000004977,AFL,Insurance,Q1,2018,Capital lease obligations,CapitalLeaseObligationsIncurred,usd,1000000,cf
3625,Aflac,0000004977,AFL,Insurance,Q2,2018,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,85881000000,bs
3626,Aflac,0000004977,AFL,Insurance,Q2,2018,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,31259000000,bs
3627,Aflac,0000004977,AFL,Insurance,Q2,2018,Equity securities,EquitySecuritiesFvNi,usd,1103000000,bs
3628,Aflac,0000004977,AFL,Insurance,Q2,2018,Other investments,OtherInvestments,usd,5831000000,bs
3629,Aflac,0000004977,AFL,Insurance,Q2,2018,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,3847000000,bs
3630,Aflac,0000004977,AFL,Insurance,Q2,2018,Investments and Cash,InvestmentsAndCash,usd,127921000000,bs
3631,Aflac,0000004977,AFL,Insurance,Q2,2018,Receivables,PremiumsAndOtherReceivablesNet,usd,892000000,bs
3632,Aflac,0000004977,AFL,Insurance,Q2,2018,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,769000000,bs
3633,Aflac,0000004977,AFL,Insurance,Q2,2018,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9740000000,bs
3634,Aflac,0000004977,AFL,Insurance,Q2,2018,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,448000000,bs
3635,Aflac,0000004977,AFL,Insurance,Q2,2018,Other,OtherAssets,usd,2216000000,bs
3636,Aflac,0000004977,AFL,Insurance,Q2,2018,"Assets, fair value disclosure",Assets,usd,141986000000,bs
3637,Aflac,0000004977,AFL,Insurance,Q2,2018,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,85046000000,bs
3638,Aflac,0000004977,AFL,Insurance,Q2,2018,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4524000000,bs
3639,Aflac,0000004977,AFL,Insurance,Q2,2018,Unearned premiums,UnearnedPremiums,usd,5600000000,bs
3640,Aflac,0000004977,AFL,Insurance,Q2,2018,Other policyholders’ funds,OtherPolicyholderFunds,usd,7140000000,bs
3641,Aflac,0000004977,AFL,Insurance,Q2,2018,Total policy liabilities,afl:TotalPolicyLiabilities,usd,102310000000,bs
3642,Aflac,0000004977,AFL,Insurance,Q2,2018,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4069000000,bs
3643,Aflac,0000004977,AFL,Insurance,Q2,2018,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,3712000000,bs
3644,Aflac,0000004977,AFL,Insurance,Q2,2018,Notes payable,DebtAndCapitalLeaseObligations,usd,5315000000,bs
3645,Aflac,0000004977,AFL,Insurance,Q2,2018,Other,OtherLiabilities,usd,2780000000,bs
3646,Aflac,0000004977,AFL,Insurance,Q2,2018,"Liabilities, fair value disclosure",Liabilities,usd,118186000000,bs
3647,Aflac,0000004977,AFL,Insurance,Q2,2018,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2018 and 2017; issued 1,347,061 shares in 2018 and 1,345,762 shares in 2017",CommonStockValue,usd,135000000,bs
3648,Aflac,0000004977,AFL,Insurance,Q2,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2117000000,bs
3649,Aflac,0000004977,AFL,Insurance,Q2,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,30809000000,bs
3650,Aflac,0000004977,AFL,Insurance,Q2,2018,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1766000000,bs
3651,Aflac,0000004977,AFL,Insurance,Q2,2018,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,4836000000,bs
3652,Aflac,0000004977,AFL,Insurance,Q2,2018,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-23000000,bs
3653,Aflac,0000004977,AFL,Insurance,Q2,2018,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,195000000,bs
3654,Aflac,0000004977,AFL,Insurance,Q2,2018,"Treasury stock, at average cost",TreasuryStockValue,usd,12113000000,bs
3655,Aflac,0000004977,AFL,Insurance,Q2,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,23800000000,bs
3656,Aflac,0000004977,AFL,Insurance,Q2,2018,Liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,141986000000,bs
3657,Aflac,0000004977,AFL,Insurance,Q2,2018,Net of tax,NetIncomeLoss,usd,1550000000,cf
3658,Aflac,0000004977,AFL,Insurance,Q2,2018,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,1000000,cf
3659,Aflac,0000004977,AFL,Insurance,Q2,2018,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,716000000,cf
3660,Aflac,0000004977,AFL,Insurance,Q2,2018,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,617000000,cf
3661,Aflac,0000004977,AFL,Insurance,Q2,2018,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1346000000,cf
3662,Aflac,0000004977,AFL,Insurance,Q2,2018,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-180000000,cf
3663,Aflac,0000004977,AFL,Insurance,Q2,2018,Gain (Loss) on Investments,GainLossOnInvestments,usd,-131000000,cf
3664,Aflac,0000004977,AFL,Insurance,Q2,2018,"Other, net",OtherNoncashIncomeExpense,usd,-60000000,cf
3665,Aflac,0000004977,AFL,Insurance,Q2,2018,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,2807000000,cf
3666,Aflac,0000004977,AFL,Insurance,Q2,2018,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,3869000000,cf
3667,Aflac,0000004977,AFL,Insurance,Q2,2018,"Equity securities, FV-NI",afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,216000000,cf
3668,Aflac,0000004977,AFL,Insurance,Q2,2018,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,878000000,cf
3669,Aflac,0000004977,AFL,Insurance,Q2,2018,Other investments - loan receivables,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,358000000,cf
3670,Aflac,0000004977,AFL,Insurance,Q2,2018,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,6798000000,cf
3671,Aflac,0000004977,AFL,Insurance,Q2,2018,"Equity securities, FV-NI",afl:PaymentstoAcquireEquitySecurities,usd,233000000,cf
3672,Aflac,0000004977,AFL,Insurance,Q2,2018,Other investments - loan receivables,PaymentsToAcquireLoansReceivable,usd,2705000000,cf
3673,Aflac,0000004977,AFL,Insurance,Q2,2018,"Other investments, excluding loan receivables, net",afl:PaymentsForProceedsFromOtherInvestmentsExcludingLoanReceivablesNet,usd,175000000,cf
3674,Aflac,0000004977,AFL,Insurance,Q2,2018,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,36000000,cf
3675,Aflac,0000004977,AFL,Insurance,Q2,2018,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-3110000000,cf
3676,Aflac,0000004977,AFL,Insurance,Q2,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-73000000,cf
3677,Aflac,0000004977,AFL,Insurance,Q2,2018,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-1443000000,cf
3678,Aflac,0000004977,AFL,Insurance,Q2,2018,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,601000000,cf
3679,Aflac,0000004977,AFL,Insurance,Q2,2018,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,0,cf
3680,Aflac,0000004977,AFL,Insurance,Q2,2018,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,0,cf
3681,Aflac,0000004977,AFL,Insurance,Q2,2018,Dividends paid to shareholders,PaymentsOfDividends,usd,396000000,cf
3682,Aflac,0000004977,AFL,Insurance,Q2,2018,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,9000000,cf
3683,Aflac,0000004977,AFL,Insurance,Q2,2018,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,12000000,cf
3684,Aflac,0000004977,AFL,Insurance,Q2,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-12000000,cf
3685,Aflac,0000004977,AFL,Insurance,Q2,2018,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-988000000,cf
3686,Aflac,0000004977,AFL,Insurance,Q2,2018,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-20000000,cf
3687,Aflac,0000004977,AFL,Insurance,Q2,2018,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,356000000,cf
3688,Aflac,0000004977,AFL,Insurance,Q2,2018,Income taxes paid,IncomeTaxesPaidNet,usd,744000000,cf
3689,Aflac,0000004977,AFL,Insurance,Q2,2018,Interest paid,InterestPaid,usd,90000000,cf
3690,Aflac,0000004977,AFL,Insurance,Q2,2018,Noncash interest,OtherNoncashExpense,usd,21000000,cf
3691,Aflac,0000004977,AFL,Insurance,Q2,2018,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings,usd,12000000,cf
3692,Aflac,0000004977,AFL,Insurance,Q2,2018,Capital lease obligations,CapitalLeaseObligationsIncurred,usd,10000000,cf
3693,Aflac,0000004977,AFL,Insurance,Q3,2018,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,82296000000,bs
3694,Aflac,0000004977,AFL,Insurance,Q3,2018,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,30421000000,bs
3695,Aflac,0000004977,AFL,Insurance,Q3,2018,"Equity securities, FV-NI, cost",EquitySecuritiesFvNi,usd,1059000000,bs
3696,Aflac,0000004977,AFL,Insurance,Q3,2018,Other investments,OtherInvestments,usd,7009000000,bs
3697,Aflac,0000004977,AFL,Insurance,Q3,2018,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,3429000000,bs
3698,Aflac,0000004977,AFL,Insurance,Q3,2018,Investments and Cash,InvestmentsAndCash,usd,124214000000,bs
3699,Aflac,0000004977,AFL,Insurance,Q3,2018,Receivables,PremiumsAndOtherReceivablesNet,usd,784000000,bs
3700,Aflac,0000004977,AFL,Insurance,Q3,2018,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,735000000,bs
3701,Aflac,0000004977,AFL,Insurance,Q3,2018,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9622000000,bs
3702,Aflac,0000004977,AFL,Insurance,Q3,2018,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,435000000,bs
3703,Aflac,0000004977,AFL,Insurance,Q3,2018,Other,OtherAssets,usd,2151000000,bs
3704,Aflac,0000004977,AFL,Insurance,Q3,2018,"Assets, fair value disclosure",Assets,usd,137941000000,bs
3705,Aflac,0000004977,AFL,Insurance,Q3,2018,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,83856000000,bs
3706,Aflac,0000004977,AFL,Insurance,Q3,2018,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4530000000,bs
3707,Aflac,0000004977,AFL,Insurance,Q3,2018,Unearned premiums,UnearnedPremiums,usd,5224000000,bs
3708,Aflac,0000004977,AFL,Insurance,Q3,2018,Other policyholders’ funds,OtherPolicyholderFunds,usd,6974000000,bs
3709,Aflac,0000004977,AFL,Insurance,Q3,2018,Total policy liabilities,afl:TotalPolicyLiabilities,usd,100584000000,bs
3710,Aflac,0000004977,AFL,Insurance,Q3,2018,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,3887000000,bs
3711,Aflac,0000004977,AFL,Insurance,Q3,2018,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1970000000,bs
3712,Aflac,0000004977,AFL,Insurance,Q3,2018,Notes payable,DebtAndCapitalLeaseObligations,usd,5279000000,bs
3713,Aflac,0000004977,AFL,Insurance,Q3,2018,Other,OtherLiabilities,usd,2987000000,bs
3714,Aflac,0000004977,AFL,Insurance,Q3,2018,Liabilities,Liabilities,usd,114707000000,bs
3715,Aflac,0000004977,AFL,Insurance,Q3,2018,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2018 and 2017; issued 1,347,061 shares in 2018 and 1,345,762 shares in 2017",CommonStockValue,usd,135000000,bs
3716,Aflac,0000004977,AFL,Insurance,Q3,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2151000000,bs
3717,Aflac,0000004977,AFL,Insurance,Q3,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,31461000000,bs
3718,Aflac,0000004977,AFL,Insurance,Q3,2018,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2113000000,bs
3719,Aflac,0000004977,AFL,Insurance,Q3,2018,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,4240000000,bs
3720,Aflac,0000004977,AFL,Insurance,Q3,2018,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-24000000,bs
3721,Aflac,0000004977,AFL,Insurance,Q3,2018,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,194000000,bs
3722,Aflac,0000004977,AFL,Insurance,Q3,2018,"Treasury stock, at average cost",TreasuryStockValue,usd,12422000000,bs
3723,Aflac,0000004977,AFL,Insurance,Q3,2018,Shareholders’ equity:,StockholdersEquity,usd,23234000000,bs
3724,Aflac,0000004977,AFL,Insurance,Q3,2018,Liabilities and shareholders' equity,LiabilitiesAndStockholdersEquity,usd,137941000000,bs
3725,Aflac,0000004977,AFL,Insurance,Q3,2018,Net earnings,NetIncomeLoss,usd,2395000000,cf
3726,Aflac,0000004977,AFL,Insurance,Q3,2018,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,27000000,cf
3727,Aflac,0000004977,AFL,Insurance,Q3,2018,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,1082000000,cf
3728,Aflac,0000004977,AFL,Insurance,Q3,2018,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,932000000,cf
3729,Aflac,0000004977,AFL,Insurance,Q3,2018,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1821000000,cf
3730,Aflac,0000004977,AFL,Insurance,Q3,2018,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,38000000,cf
3731,Aflac,0000004977,AFL,Insurance,Q3,2018,Total realized investment gains (losses),GainLossOnInvestments,usd,-76000000,cf
3732,Aflac,0000004977,AFL,Insurance,Q3,2018,"Other, net",OtherNoncashIncomeExpense,usd,-506000000,cf
3733,Aflac,0000004977,AFL,Insurance,Q3,2018,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,4659000000,cf
3734,Aflac,0000004977,AFL,Insurance,Q3,2018,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,5991000000,cf
3735,Aflac,0000004977,AFL,Insurance,Q3,2018,"Equity securities, FV-NI",afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,369000000,cf
3736,Aflac,0000004977,AFL,Insurance,Q3,2018,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,880000000,cf
3737,Aflac,0000004977,AFL,Insurance,Q3,2018,Other investments - loan receivables,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,597000000,cf
3738,Aflac,0000004977,AFL,Insurance,Q3,2018,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,7845000000,cf
3739,Aflac,0000004977,AFL,Insurance,Q3,2018,"Equity securities, FV-NI",afl:PaymentstoAcquireEquitySecurities,usd,338000000,cf
3740,Aflac,0000004977,AFL,Insurance,Q3,2018,Other investments - loan receivables,PaymentsToAcquireLoansReceivable,usd,4150000000,cf
3741,Aflac,0000004977,AFL,Insurance,Q3,2018,"Other investments, excluding loan receivables, net",afl:PaymentsForProceedsFromOtherInvestmentsExcludingLoanReceivablesNet,usd,136000000,cf
3742,Aflac,0000004977,AFL,Insurance,Q3,2018,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,141000000,cf
3743,Aflac,0000004977,AFL,Insurance,Q3,2018,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-1413000000,cf
3744,Aflac,0000004977,AFL,Insurance,Q3,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-188000000,cf
3745,Aflac,0000004977,AFL,Insurance,Q3,2018,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-3172000000,cf
3746,Aflac,0000004977,AFL,Insurance,Q3,2018,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,923000000,cf
3747,Aflac,0000004977,AFL,Insurance,Q3,2018,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,0,cf
3748,Aflac,0000004977,AFL,Insurance,Q3,2018,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,0,cf
3749,Aflac,0000004977,AFL,Insurance,Q3,2018,Dividends paid to shareholders,PaymentsOfDividends,usd,595000000,cf
3750,Aflac,0000004977,AFL,Insurance,Q3,2018,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-17000000,cf
3751,Aflac,0000004977,AFL,Insurance,Q3,2018,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,36000000,cf
3752,Aflac,0000004977,AFL,Insurance,Q3,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-14000000,cf
3753,Aflac,0000004977,AFL,Insurance,Q3,2018,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1513000000,cf
3754,Aflac,0000004977,AFL,Insurance,Q3,2018,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-36000000,cf
3755,Aflac,0000004977,AFL,Insurance,Q3,2018,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-62000000,cf
3756,Aflac,0000004977,AFL,Insurance,Q3,2018,Income taxes paid,IncomeTaxesPaidNet,usd,827000000,cf
3757,Aflac,0000004977,AFL,Insurance,Q3,2018,Interest paid,InterestPaid,usd,124000000,cf
3758,Aflac,0000004977,AFL,Insurance,Q3,2018,Noncash interest,OtherNoncashExpense,usd,41000000,cf
3759,Aflac,0000004977,AFL,Insurance,Q3,2018,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings,usd,17000000,cf
3760,Aflac,0000004977,AFL,Insurance,Q3,2018,Capital lease obligations,CapitalLeaseObligationsIncurred,usd,10000000,cf
3761,Aflac,0000004977,AFL,Insurance,FY,2018,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,82895000000,bs
3762,Aflac,0000004977,AFL,Insurance,FY,2018,"Held to maturity, fixed maturity securities, fair value",HeldToMaturitySecurities,usd,30318000000,bs
3763,Aflac,0000004977,AFL,Insurance,FY,2018,"Equity securities, FV-NI, cost",EquitySecuritiesFvNi,usd,987000000,bs
3764,Aflac,0000004977,AFL,Insurance,FY,2018,Other Investments [Abstract],OtherInvestments,usd,7706000000,bs
3765,Aflac,0000004977,AFL,Insurance,FY,2018,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,4337000000,bs
3766,Aflac,0000004977,AFL,Insurance,FY,2018,Investments and cash:,InvestmentsAndCash,usd,126243000000,bs
3767,Aflac,0000004977,AFL,Insurance,FY,2018,Receivables,PremiumsAndOtherReceivablesNet,usd,851000000,bs
3768,Aflac,0000004977,AFL,Insurance,FY,2018,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,773000000,bs
3769,Aflac,0000004977,AFL,Insurance,FY,2018,Deferred Policy Acquisition Costs Disclosures [Abstract],DeferredPolicyAcquisitionCosts,usd,9875000000,bs
3770,Aflac,0000004977,AFL,Insurance,FY,2018,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,443000000,bs
3771,Aflac,0000004977,AFL,Insurance,FY,2018,Other assets,OtherAssets,usd,2221000000,bs
3772,Aflac,0000004977,AFL,Insurance,FY,2018,"Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]",Assets,usd,140406000000,bs
3773,Aflac,0000004977,AFL,Insurance,FY,2018,Liability amounts,LiabilityForFuturePolicyBenefits,usd,86368000000,bs
3774,Aflac,0000004977,AFL,Insurance,FY,2018,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4584000000,bs
3775,Aflac,0000004977,AFL,Insurance,FY,2018,Unearned premiums,UnearnedPremiums,usd,5090000000,bs
3776,Aflac,0000004977,AFL,Insurance,FY,2018,Other policyholders' funds,OtherPolicyholderFunds,usd,7146000000,bs
3777,Aflac,0000004977,AFL,Insurance,FY,2018,Total policy liabilities,afl:TotalPolicyLiabilities,usd,103188000000,bs
3778,Aflac,0000004977,AFL,Insurance,FY,2018,Total income tax liability,TaxesPayableCurrentAndNoncurrent,usd,4020000000,bs
3779,Aflac,0000004977,AFL,Insurance,FY,2018,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1052000000,bs
3780,Aflac,0000004977,AFL,Insurance,FY,2018,Notes payable,DebtAndCapitalLeaseObligations,usd,5778000000,bs
3781,Aflac,0000004977,AFL,Insurance,FY,2018,Other liabilities,OtherLiabilities,usd,2906000000,bs
3782,Aflac,0000004977,AFL,Insurance,FY,2018,Commitments and contingent liabilities (Note 15),CommitmentsAndContingencies,usd,N/A,bs
3783,Aflac,0000004977,AFL,Insurance,FY,2018,Liabilities,Liabilities,usd,116944000000,bs
3784,Aflac,0000004977,AFL,Insurance,FY,2018,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2018 and 2017; issued 1,347,540 shares in 2018 and 1,345,762 shares in 2017",CommonStockValue,usd,135000000,bs
3785,Aflac,0000004977,AFL,Insurance,FY,2018,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2177000000,bs
3786,Aflac,0000004977,AFL,Insurance,FY,2018,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,31788000000,bs
3787,Aflac,0000004977,AFL,Insurance,FY,2018,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1847000000,bs
3788,Aflac,0000004977,AFL,Insurance,FY,2018,"Shareholders' equity, unrealized gains (losses) on investment securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,4234000000,bs
3789,Aflac,0000004977,AFL,Insurance,FY,2018,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-24000000,bs
3790,Aflac,0000004977,AFL,Insurance,FY,2018,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,212000000,bs
3791,Aflac,0000004977,AFL,Insurance,FY,2018,"Treasury stock, at average cost",TreasuryStockValue,usd,12789000000,bs
3792,Aflac,0000004977,AFL,Insurance,FY,2018,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,23462000000,bs
3793,Aflac,0000004977,AFL,Insurance,FY,2018,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,140406000000,bs
3794,Aflac,0000004977,AFL,Insurance,FY,2018,Net earnings,NetIncomeLoss,usd,2920000000,cf
3795,Aflac,0000004977,AFL,Insurance,FY,2018,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,55000000,cf
3796,Aflac,0000004977,AFL,Insurance,FY,2018,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,1504000000,cf
3797,Aflac,0000004977,AFL,Insurance,FY,2018,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,1245000000,cf
3798,Aflac,0000004977,AFL,Insurance,FY,2018,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,2343000000,cf
3799,Aflac,0000004977,AFL,Insurance,FY,2018,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,64000000,cf
3800,Aflac,0000004977,AFL,Insurance,FY,2018,Realized investment (gains) losses,GainLossOnInvestments,usd,-430000000,cf
3801,Aflac,0000004977,AFL,Insurance,FY,2018,"Other, net",OtherNoncashIncomeExpense,usd,-571000000,cf
3802,Aflac,0000004977,AFL,Insurance,FY,2018,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,6014000000,cf
3803,Aflac,0000004977,AFL,Insurance,FY,2018,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,7888000000,cf
3804,Aflac,0000004977,AFL,Insurance,FY,2018,"Equity securities, FV-NI",afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,429000000,cf
3805,Aflac,0000004977,AFL,Insurance,FY,2018,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,1670000000,cf
3806,Aflac,0000004977,AFL,Insurance,FY,2018,Other investments - loan receivables,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,936000000,cf
3807,Aflac,0000004977,AFL,Insurance,FY,2018,Fixed maturity securities purchased,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,9086000000,cf
3808,Aflac,0000004977,AFL,Insurance,FY,2018,"Equity securities, FV-NI",afl:PaymentstoAcquireEquitySecurities,usd,440000000,cf
3809,Aflac,0000004977,AFL,Insurance,FY,2018,Other investments - loan receivables,PaymentsToAcquireLoansReceivable,usd,4848000000,cf
3810,Aflac,0000004977,AFL,Insurance,FY,2018,Other investments sold (purchased),afl:PaymentsForProceedsFromOtherInvestmentsExcludingLoanReceivablesNet,usd,414000000,cf
3811,Aflac,0000004977,AFL,Insurance,FY,2018,Settlement of derivatives,PaymentsForProceedsFromHedgeInvestingActivities,usd,241000000,cf
3812,Aflac,0000004977,AFL,Insurance,FY,2018,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-348000000,cf
3813,Aflac,0000004977,AFL,Insurance,FY,2018,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-176000000,cf
3814,Aflac,0000004977,AFL,Insurance,FY,2018,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-3582000000,cf
3815,Aflac,0000004977,AFL,Insurance,FY,2018,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1301000000,cf
3816,Aflac,0000004977,AFL,Insurance,FY,2018,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,1020000000,cf
3817,Aflac,0000004977,AFL,Insurance,FY,2018,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,550000000,cf
3818,Aflac,0000004977,AFL,Insurance,FY,2018,Dividends paid to shareholders,PaymentsOfDividends,usd,793000000,cf
3819,Aflac,0000004977,AFL,Insurance,FY,2018,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-31000000,cf
3820,Aflac,0000004977,AFL,Insurance,FY,2018,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,58000000,cf
3821,Aflac,0000004977,AFL,Insurance,FY,2018,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-19000000,cf
3822,Aflac,0000004977,AFL,Insurance,FY,2018,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1616000000,cf
3823,Aflac,0000004977,AFL,Insurance,FY,2018,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,30000000,cf
3824,Aflac,0000004977,AFL,Insurance,FY,2018,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,846000000,cf
3825,Aflac,0000004977,AFL,Insurance,FY,2018,Income taxes paid,IncomeTaxesPaidNet,usd,998000000,cf
3826,Aflac,0000004977,AFL,Insurance,FY,2018,Interest paid,InterestPaid,usd,181000000,cf
3827,Aflac,0000004977,AFL,Insurance,FY,2018,Noncash interest,OtherNoncashExpense,usd,41000000,cf
3828,Aflac,0000004977,AFL,Insurance,FY,2018,Impairment losses included in realized investment losses,OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings,usd,81000000,cf
3829,Aflac,0000004977,AFL,Insurance,FY,2018,Capitalized lease obligations,CapitalLeaseObligationsIncurred,usd,11000000,cf
3830,Aflac,0000004977,AFL,Insurance,Q1,2019,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,87924000000,bs
3831,Aflac,0000004977,AFL,Insurance,Q1,2019,"Held to maturity, fixed maturity securities, fair value",HeldToMaturitySecurities,usd,30163000000,bs
3832,Aflac,0000004977,AFL,Insurance,Q1,2019,Equity securities,EquitySecuritiesFvNi,usd,1041000000,bs
3833,Aflac,0000004977,AFL,Insurance,Q1,2019,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,7180000000,bs
3834,Aflac,0000004977,AFL,Insurance,Q1,2019,Other Investments [Abstract],OtherInvestments,usd,1238000000,bs
3835,Aflac,0000004977,AFL,Insurance,Q1,2019,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,3892000000,bs
3836,Aflac,0000004977,AFL,Insurance,Q1,2019,Investments and Cash:,InvestmentsAndCash,usd,131438000000,bs
3837,Aflac,0000004977,AFL,Insurance,Q1,2019,Receivables,PremiumsAndOtherReceivablesNet,usd,858000000,bs
3838,Aflac,0000004977,AFL,Insurance,Q1,2019,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,728000000,bs
3839,Aflac,0000004977,AFL,Insurance,Q1,2019,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9892000000,bs
3840,Aflac,0000004977,AFL,Insurance,Q1,2019,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,559000000,bs
3841,Aflac,0000004977,AFL,Insurance,Q1,2019,Other,OtherAssets,usd,2204000000,bs
3842,Aflac,0000004977,AFL,Insurance,Q1,2019,"Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]",Assets,usd,145679000000,bs
3843,Aflac,0000004977,AFL,Insurance,Q1,2019,POLICY LIABILITIES,LiabilityForFuturePolicyBenefits,usd,87011000000,bs
3844,Aflac,0000004977,AFL,Insurance,Q1,2019,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4625000000,bs
3845,Aflac,0000004977,AFL,Insurance,Q1,2019,Unearned premiums,UnearnedPremiums,usd,4859000000,bs
3846,Aflac,0000004977,AFL,Insurance,Q1,2019,Other policyholders’ funds,OtherPolicyholderFunds,usd,7185000000,bs
3847,Aflac,0000004977,AFL,Insurance,Q1,2019,Total policy liabilities,afl:TotalPolicyLiabilities,usd,103680000000,bs
3848,Aflac,0000004977,AFL,Insurance,Q1,2019,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,5182000000,bs
3849,Aflac,0000004977,AFL,Insurance,Q1,2019,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1969000000,bs
3850,Aflac,0000004977,AFL,Insurance,Q1,2019,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,5900000000,bs
3851,Aflac,0000004977,AFL,Insurance,Q1,2019,Other,OtherLiabilities,usd,2899000000,bs
3852,Aflac,0000004977,AFL,Insurance,Q1,2019,"Liabilities, fair value",Liabilities,usd,119630000000,bs
3853,Aflac,0000004977,AFL,Insurance,Q1,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
3854,Aflac,0000004977,AFL,Insurance,Q1,2019,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2019 and 2018; issued 1,348,600 shares in 2019 and 1,347,540 shares in 2018",CommonStockValue,usd,135000000,bs
3855,Aflac,0000004977,AFL,Insurance,Q1,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2208000000,bs
3856,Aflac,0000004977,AFL,Insurance,Q1,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,32513000000,bs
3857,Aflac,0000004977,AFL,Insurance,Q1,2019,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1848000000,bs
3858,Aflac,0000004977,AFL,Insurance,Q1,2019,"Shareholders' equity, unrealized gains (losses) on fixed maturity securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,6561000000,bs
3859,Aflac,0000004977,AFL,Insurance,Q1,2019,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-26000000,bs
3860,Aflac,0000004977,AFL,Insurance,Q1,2019,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,206000000,bs
3861,Aflac,0000004977,AFL,Insurance,Q1,2019,Purchases of treasury stock,TreasuryStockValue,usd,13288000000,bs
3862,Aflac,0000004977,AFL,Insurance,Q1,2019,"Balance, beginning of period",StockholdersEquity,usd,26049000000,bs
3863,Aflac,0000004977,AFL,Insurance,Q1,2019,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,145679000000,bs
3864,Aflac,0000004977,AFL,Insurance,Q1,2019,Net earnings,NetIncomeLoss,usd,928000000,cf
3865,Aflac,0000004977,AFL,Insurance,Q1,2019,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,-35000000,cf
3866,Aflac,0000004977,AFL,Insurance,Q1,2019,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,357000000,cf
3867,Aflac,0000004977,AFL,Insurance,Q1,2019,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,340000000,cf
3868,Aflac,0000004977,AFL,Insurance,Q1,2019,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,468000000,cf
3869,Aflac,0000004977,AFL,Insurance,Q1,2019,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,316000000,cf
3870,Aflac,0000004977,AFL,Insurance,Q1,2019,Total realized investment gains (losses),GainLossOnInvestments,usd,71000000,cf
3871,Aflac,0000004977,AFL,Insurance,Q1,2019,"Other, net",OtherNoncashIncomeExpense,usd,115000000,cf
3872,Aflac,0000004977,AFL,Insurance,Q1,2019,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,1544000000,cf
3873,Aflac,0000004977,AFL,Insurance,Q1,2019,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,760000000,cf
3874,Aflac,0000004977,AFL,Insurance,Q1,2019,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,153000000,cf
3875,Aflac,0000004977,AFL,Insurance,Q1,2019,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,155000000,cf
3876,Aflac,0000004977,AFL,Insurance,Q1,2019,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,493000000,cf
3877,Aflac,0000004977,AFL,Insurance,Q1,2019,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,2548000000,cf
3878,Aflac,0000004977,AFL,Insurance,Q1,2019,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,151000000,cf
3879,Aflac,0000004977,AFL,Insurance,Q1,2019,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,669000000,cf
3880,Aflac,0000004977,AFL,Insurance,Q1,2019,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,442000000,cf
3881,Aflac,0000004977,AFL,Insurance,Q1,2019,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,3000000,cf
3882,Aflac,0000004977,AFL,Insurance,Q1,2019,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-976000000,cf
3883,Aflac,0000004977,AFL,Insurance,Q1,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,15000000,cf
3884,Aflac,0000004977,AFL,Insurance,Q1,2019,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-1291000000,cf
3885,Aflac,0000004977,AFL,Insurance,Q1,2019,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,490000000,cf
3886,Aflac,0000004977,AFL,Insurance,Q1,2019,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,0,cf
3887,Aflac,0000004977,AFL,Insurance,Q1,2019,Dividends paid to shareholders,PaymentsOfDividends,usd,195000000,cf
3888,Aflac,0000004977,AFL,Insurance,Q1,2019,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-13000000,cf
3889,Aflac,0000004977,AFL,Insurance,Q1,2019,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,12000000,cf
3890,Aflac,0000004977,AFL,Insurance,Q1,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,0,cf
3891,Aflac,0000004977,AFL,Insurance,Q1,2019,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-686000000,cf
3892,Aflac,0000004977,AFL,Insurance,Q1,2019,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-12000000,cf
3893,Aflac,0000004977,AFL,Insurance,Q1,2019,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-445000000,cf
3894,Aflac,0000004977,AFL,Insurance,Q1,2019,Income taxes paid,IncomeTaxesPaidNet,usd,-2000000,cf
3895,Aflac,0000004977,AFL,Insurance,Q1,2019,Interest paid,InterestPaid,usd,36000000,cf
3896,Aflac,0000004977,AFL,Insurance,Q1,2019,Noncash interest,OtherNoncashExpense,usd,22000000,cf
3897,Aflac,0000004977,AFL,Insurance,Q1,2019,Other-than-temporary impairment losses realized,OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings,usd,2000000,cf
3898,Aflac,0000004977,AFL,Insurance,Q1,2019,Lease obligations,CapitalLeaseObligationsIncurred,usd,1000000,cf
3899,Aflac,0000004977,AFL,Insurance,Q2,2019,"Total fixed maturity securities, available for sale, fair value",AvailableForSaleSecuritiesDebtSecurities,usd,92435000000,bs
3900,Aflac,0000004977,AFL,Insurance,Q2,2019,Held to maturity:,HeldToMaturitySecurities,usd,31007000000,bs
3901,Aflac,0000004977,AFL,Insurance,Q2,2019,Equity securities,EquitySecuritiesFvNi,usd,1087000000,bs
3902,Aflac,0000004977,AFL,Insurance,Q2,2019,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,7622000000,bs
3903,Aflac,0000004977,AFL,Insurance,Q2,2019,Other Investments [Abstract],OtherInvestments,usd,1427000000,bs
3904,Aflac,0000004977,AFL,Insurance,Q2,2019,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,3019000000,bs
3905,Aflac,0000004977,AFL,Insurance,Q2,2019,Investments and Cash:,InvestmentsAndCash,usd,136597000000,bs
3906,Aflac,0000004977,AFL,Insurance,Q2,2019,Receivables,PremiumsAndOtherReceivablesNet,usd,883000000,bs
3907,Aflac,0000004977,AFL,Insurance,Q2,2019,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,785000000,bs
3908,Aflac,0000004977,AFL,Insurance,Q2,2019,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,10128000000,bs
3909,Aflac,0000004977,AFL,Insurance,Q2,2019,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,562000000,bs
3910,Aflac,0000004977,AFL,Insurance,Q2,2019,Other,OtherAssets,usd,2445000000,bs
3911,Aflac,0000004977,AFL,Insurance,Q2,2019,Assets,Assets,usd,151400000000,bs
3912,Aflac,0000004977,AFL,Insurance,Q2,2019,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,90117000000,bs
3913,Aflac,0000004977,AFL,Insurance,Q2,2019,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4706000000,bs
3914,Aflac,0000004977,AFL,Insurance,Q2,2019,Unearned premiums,UnearnedPremiums,usd,4763000000,bs
3915,Aflac,0000004977,AFL,Insurance,Q2,2019,Other policyholders’ funds,OtherPolicyholderFunds,usd,7403000000,bs
3916,Aflac,0000004977,AFL,Insurance,Q2,2019,Total policy liabilities,afl:TotalPolicyLiabilities,usd,106989000000,bs
3917,Aflac,0000004977,AFL,Insurance,Q2,2019,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,5243000000,bs
3918,Aflac,0000004977,AFL,Insurance,Q2,2019,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1557000000,bs
3919,Aflac,0000004977,AFL,Insurance,Q2,2019,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,6231000000,bs
3920,Aflac,0000004977,AFL,Insurance,Q2,2019,Other,OtherLiabilities,usd,3139000000,bs
3921,Aflac,0000004977,AFL,Insurance,Q2,2019,Liabilities:,Liabilities,usd,123159000000,bs
3922,Aflac,0000004977,AFL,Insurance,Q2,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
3923,Aflac,0000004977,AFL,Insurance,Q2,2019,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2019 and 2018; issued 1,349,044 shares in 2019 and 1,347,540 shares in 2018",CommonStockValue,usd,135000000,bs
3924,Aflac,0000004977,AFL,Insurance,Q2,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2247000000,bs
3925,Aflac,0000004977,AFL,Insurance,Q2,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,33130000000,bs
3926,Aflac,0000004977,AFL,Insurance,Q2,2019,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1455000000,bs
3927,Aflac,0000004977,AFL,Insurance,Q2,2019,"Shareholders' equity, unrealized gains (losses) on fixed maturity securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,8055000000,bs
3928,Aflac,0000004977,AFL,Insurance,Q2,2019,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-27000000,bs
3929,Aflac,0000004977,AFL,Insurance,Q2,2019,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,209000000,bs
3930,Aflac,0000004977,AFL,Insurance,Q2,2019,Purchases of treasury stock,TreasuryStockValue,usd,13635000000,bs
3931,Aflac,0000004977,AFL,Insurance,Q2,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,28241000000,bs
3932,Aflac,0000004977,AFL,Insurance,Q2,2019,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,151400000000,bs
3933,Aflac,0000004977,AFL,Insurance,Q2,2019,Net of tax,NetIncomeLoss,usd,1745000000,cf
3934,Aflac,0000004977,AFL,Insurance,Q2,2019,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,17000000,cf
3935,Aflac,0000004977,AFL,Insurance,Q2,2019,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,712000000,cf
3936,Aflac,0000004977,AFL,Insurance,Q2,2019,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,649000000,cf
3937,Aflac,0000004977,AFL,Insurance,Q2,2019,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1019000000,cf
3938,Aflac,0000004977,AFL,Insurance,Q2,2019,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-268000000,cf
3939,Aflac,0000004977,AFL,Insurance,Q2,2019,Total realized investment gains (losses),GainLossOnInvestments,usd,5000000,cf
3940,Aflac,0000004977,AFL,Insurance,Q2,2019,"Other, net",OtherNoncashIncomeExpense,usd,54000000,cf
3941,Aflac,0000004977,AFL,Insurance,Q2,2019,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,2357000000,cf
3942,Aflac,0000004977,AFL,Insurance,Q2,2019,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,2105000000,cf
3943,Aflac,0000004977,AFL,Insurance,Q2,2019,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,154000000,cf
3944,Aflac,0000004977,AFL,Insurance,Q2,2019,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,203000000,cf
3945,Aflac,0000004977,AFL,Insurance,Q2,2019,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,888000000,cf
3946,Aflac,0000004977,AFL,Insurance,Q2,2019,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,4352000000,cf
3947,Aflac,0000004977,AFL,Insurance,Q2,2019,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,181000000,cf
3948,Aflac,0000004977,AFL,Insurance,Q2,2019,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,1534000000,cf
3949,Aflac,0000004977,AFL,Insurance,Q2,2019,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,616000000,cf
3950,Aflac,0000004977,AFL,Insurance,Q2,2019,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,14000000,cf
3951,Aflac,0000004977,AFL,Insurance,Q2,2019,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-495000000,cf
3952,Aflac,0000004977,AFL,Insurance,Q2,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-125000000,cf
3953,Aflac,0000004977,AFL,Insurance,Q2,2019,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2727000000,cf
3954,Aflac,0000004977,AFL,Insurance,Q2,2019,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,847000000,cf
3955,Aflac,0000004977,AFL,Insurance,Q2,2019,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,268000000,cf
3956,Aflac,0000004977,AFL,Insurance,Q2,2019,Dividends paid to shareholders,PaymentsOfDividends,usd,389000000,cf
3957,Aflac,0000004977,AFL,Insurance,Q2,2019,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-34000000,cf
3958,Aflac,0000004977,AFL,Insurance,Q2,2019,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,26000000,cf
3959,Aflac,0000004977,AFL,Insurance,Q2,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-2000000,cf
3960,Aflac,0000004977,AFL,Insurance,Q2,2019,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-978000000,cf
3961,Aflac,0000004977,AFL,Insurance,Q2,2019,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,30000000,cf
3962,Aflac,0000004977,AFL,Insurance,Q2,2019,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-1318000000,cf
3963,Aflac,0000004977,AFL,Insurance,Q2,2019,Income taxes paid,IncomeTaxesPaidNet,usd,874000000,cf
3964,Aflac,0000004977,AFL,Insurance,Q2,2019,Interest paid,InterestPaid,usd,93000000,cf
3965,Aflac,0000004977,AFL,Insurance,Q2,2019,Noncash interest,OtherNoncashExpense,usd,22000000,cf
3966,Aflac,0000004977,AFL,Insurance,Q2,2019,Impairment losses and loan loss reserves included in realized investment losses,afl:Impairmentlossesandloanlossreservesincludedinrealizedinvestmentlosses,usd,4000000,cf
3967,Aflac,0000004977,AFL,Insurance,Q2,2019,Lease obligations,CapitalLeaseObligationsIncurred,usd,1000000,cf
3968,Aflac,0000004977,AFL,Insurance,Q3,2019,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,93940000000,bs
3969,Aflac,0000004977,AFL,Insurance,Q3,2019,"Held to maturity, fixed maturity securities, fair value",HeldToMaturitySecurities,usd,30733000000,bs
3970,Aflac,0000004977,AFL,Insurance,Q3,2019,Fair Value,EquitySecuritiesFvNi,usd,830000000,bs
3971,Aflac,0000004977,AFL,Insurance,Q3,2019,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,8284000000,bs
3972,Aflac,0000004977,AFL,Insurance,Q3,2019,Other Investments [Abstract],OtherInvestments,usd,1507000000,bs
3973,Aflac,0000004977,AFL,Insurance,Q3,2019,"Cash and cash equivalents, beginning of period",CashAndCashEquivalentsAtCarryingValue,usd,4216000000,bs
3974,Aflac,0000004977,AFL,Insurance,Q3,2019,Investments and Cash:,InvestmentsAndCash,usd,139510000000,bs
3975,Aflac,0000004977,AFL,Insurance,Q3,2019,Receivables,PremiumsAndOtherReceivablesNet,usd,908000000,bs
3976,Aflac,0000004977,AFL,Insurance,Q3,2019,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,734000000,bs
3977,Aflac,0000004977,AFL,Insurance,Q3,2019,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,10148000000,bs
3978,Aflac,0000004977,AFL,Insurance,Q3,2019,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,562000000,bs
3979,Aflac,0000004977,AFL,Insurance,Q3,2019,Other,OtherAssets,usd,2275000000,bs
3980,Aflac,0000004977,AFL,Insurance,Q3,2019,"Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]",Assets,usd,154137000000,bs
3981,Aflac,0000004977,AFL,Insurance,Q3,2019,POLICY LIABILITIES,LiabilityForFuturePolicyBenefits,usd,90824000000,bs
3982,Aflac,0000004977,AFL,Insurance,Q3,2019,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4741000000,bs
3983,Aflac,0000004977,AFL,Insurance,Q3,2019,Unearned premiums,UnearnedPremiums,usd,4544000000,bs
3984,Aflac,0000004977,AFL,Insurance,Q3,2019,Other policyholders’ funds,OtherPolicyholderFunds,usd,7421000000,bs
3985,Aflac,0000004977,AFL,Insurance,Q3,2019,Total policy liabilities,afl:TotalPolicyLiabilities,usd,107530000000,bs
3986,Aflac,0000004977,AFL,Insurance,Q3,2019,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,5737000000,bs
3987,Aflac,0000004977,AFL,Insurance,Q3,2019,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,2189000000,bs
3988,Aflac,0000004977,AFL,Insurance,Q3,2019,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,6233000000,bs
3989,Aflac,0000004977,AFL,Insurance,Q3,2019,Other,OtherLiabilities,usd,3010000000,bs
3990,Aflac,0000004977,AFL,Insurance,Q3,2019,"Liabilities, fair value",Liabilities,usd,124699000000,bs
3991,Aflac,0000004977,AFL,Insurance,Q3,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
3992,Aflac,0000004977,AFL,Insurance,Q3,2019,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2019 and 2018; issued 1,349,190 shares in 2019 and 1,347,540 shares in 2018",CommonStockValue,usd,135000000,bs
3993,Aflac,0000004977,AFL,Insurance,Q3,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2277000000,bs
3994,Aflac,0000004977,AFL,Insurance,Q3,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,33710000000,bs
3995,Aflac,0000004977,AFL,Insurance,Q3,2019,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1479000000,bs
3996,Aflac,0000004977,AFL,Insurance,Q3,2019,"Shareholders' equity, unrealized gains (losses) on fixed maturity securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,8970000000,bs
3997,Aflac,0000004977,AFL,Insurance,Q3,2019,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-33000000,bs
3998,Aflac,0000004977,AFL,Insurance,Q3,2019,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,207000000,bs
3999,Aflac,0000004977,AFL,Insurance,Q3,2019,Purchases of treasury stock,TreasuryStockValue,usd,13935000000,bs
4000,Aflac,0000004977,AFL,Insurance,Q3,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,29438000000,bs
4001,Aflac,0000004977,AFL,Insurance,Q3,2019,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,154137000000,bs
4002,Aflac,0000004977,AFL,Insurance,Q3,2019,Net earnings,NetIncomeLoss,usd,2523000000,cf
4003,Aflac,0000004977,AFL,Insurance,Q3,2019,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,36000000,cf
4004,Aflac,0000004977,AFL,Insurance,Q3,2019,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,1057000000,cf
4005,Aflac,0000004977,AFL,Insurance,Q3,2019,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,967000000,cf
4006,Aflac,0000004977,AFL,Insurance,Q3,2019,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1659000000,cf
4007,Aflac,0000004977,AFL,Insurance,Q3,2019,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-85000000,cf
4008,Aflac,0000004977,AFL,Insurance,Q3,2019,Total realized investment gains (losses),GainLossOnInvestments,usd,-147000000,cf
4009,Aflac,0000004977,AFL,Insurance,Q3,2019,"Other, net",OtherNoncashIncomeExpense,usd,-145000000,cf
4010,Aflac,0000004977,AFL,Insurance,Q3,2019,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,4263000000,cf
4011,Aflac,0000004977,AFL,Insurance,Q3,2019,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,3127000000,cf
4012,Aflac,0000004977,AFL,Insurance,Q3,2019,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,570000000,cf
4013,Aflac,0000004977,AFL,Insurance,Q3,2019,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,437000000,cf
4014,Aflac,0000004977,AFL,Insurance,Q3,2019,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,1293000000,cf
4015,Aflac,0000004977,AFL,Insurance,Q3,2019,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,5908000000,cf
4016,Aflac,0000004977,AFL,Insurance,Q3,2019,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,321000000,cf
4017,Aflac,0000004977,AFL,Insurance,Q3,2019,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,2634000000,cf
4018,Aflac,0000004977,AFL,Insurance,Q3,2019,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,682000000,cf
4019,Aflac,0000004977,AFL,Insurance,Q3,2019,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-13000000,cf
4020,Aflac,0000004977,AFL,Insurance,Q3,2019,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-1144000000,cf
4021,Aflac,0000004977,AFL,Insurance,Q3,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-15000000,cf
4022,Aflac,0000004977,AFL,Insurance,Q3,2019,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2946000000,cf
4023,Aflac,0000004977,AFL,Insurance,Q3,2019,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1157000000,cf
4024,Aflac,0000004977,AFL,Insurance,Q3,2019,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,268000000,cf
4025,Aflac,0000004977,AFL,Insurance,Q3,2019,Dividends paid to shareholders,PaymentsOfDividends,usd,579000000,cf
4026,Aflac,0000004977,AFL,Insurance,Q3,2019,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,0,cf
4027,Aflac,0000004977,AFL,Insurance,Q3,2019,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,38000000,cf
4028,Aflac,0000004977,AFL,Insurance,Q3,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,1000000,cf
4029,Aflac,0000004977,AFL,Insurance,Q3,2019,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1429000000,cf
4030,Aflac,0000004977,AFL,Insurance,Q3,2019,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-9000000,cf
4031,Aflac,0000004977,AFL,Insurance,Q3,2019,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-121000000,cf
4032,Aflac,0000004977,AFL,Insurance,Q3,2019,Income taxes paid,IncomeTaxesPaidNet,usd,950000000,cf
4033,Aflac,0000004977,AFL,Insurance,Q3,2019,Interest paid,InterestPaidNet,usd,132000000,cf
4034,Aflac,0000004977,AFL,Insurance,Q3,2019,Noncash interest,OtherNoncashExpense,usd,38000000,cf
4035,Aflac,0000004977,AFL,Insurance,Q3,2019,Impairment losses and loan loss reserves included in realized investment losses,afl:Impairmentlossesandloanlossreservesincludedinrealizedinvestmentlosses,usd,21000000,cf
4036,Aflac,0000004977,AFL,Insurance,Q3,2019,Lease obligations,CapitalLeaseObligationsIncurred,usd,82000000,cf
4037,Aflac,0000004977,AFL,Insurance,FY,2019,Fair Value,AvailableForSaleSecuritiesDebtSecurities,usd,91262000000,bs
4038,Aflac,0000004977,AFL,Insurance,FY,2019,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,30085000000,bs
4039,Aflac,0000004977,AFL,Insurance,FY,2019,Equity securities,EquitySecuritiesFvNi,usd,802000000,bs
4040,Aflac,0000004977,AFL,Insurance,FY,2019,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,9569000000,bs
4041,Aflac,0000004977,AFL,Insurance,FY,2019,Other investments,OtherInvestments,usd,1477000000,bs
4042,Aflac,0000004977,AFL,Insurance,FY,2019,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4896000000,bs
4043,Aflac,0000004977,AFL,Insurance,FY,2019,Investments and cash:,InvestmentsAndCash,usd,138091000000,bs
4044,Aflac,0000004977,AFL,Insurance,FY,2019,Receivables,PremiumsAndOtherReceivablesNet,usd,828000000,bs
4045,Aflac,0000004977,AFL,Insurance,FY,2019,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,772000000,bs
4046,Aflac,0000004977,AFL,Insurance,FY,2019,Deferred Policy Acquisition Costs Disclosures [Abstract],DeferredPolicyAcquisitionCosts,usd,10128000000,bs
4047,Aflac,0000004977,AFL,Insurance,FY,2019,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,581000000,bs
4048,Aflac,0000004977,AFL,Insurance,FY,2019,Other,OtherAssets,usd,2368000000,bs
4049,Aflac,0000004977,AFL,Insurance,FY,2019,Exchange effect on total assets,Assets,usd,152768000000,bs
4050,Aflac,0000004977,AFL,Insurance,FY,2019,"Liability for future policy benefits, interest rate",LiabilityForFuturePolicyBenefits,usd,90335000000,bs
4051,Aflac,0000004977,AFL,Insurance,FY,2019,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4659000000,bs
4052,Aflac,0000004977,AFL,Insurance,FY,2019,Unearned premiums,UnearnedPremiums,usd,4243000000,bs
4053,Aflac,0000004977,AFL,Insurance,FY,2019,Other policyholders' funds,OtherPolicyholderFunds,usd,7317000000,bs
4054,Aflac,0000004977,AFL,Insurance,FY,2019,Total policy liabilities,afl:TotalPolicyLiabilities,usd,106554000000,bs
4055,Aflac,0000004977,AFL,Insurance,FY,2019,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,5370000000,bs
4056,Aflac,0000004977,AFL,Insurance,FY,2019,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1876000000,bs
4057,Aflac,0000004977,AFL,Insurance,FY,2019,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,6569000000,bs
4058,Aflac,0000004977,AFL,Insurance,FY,2019,Other,OtherLiabilities,usd,3440000000,bs
4059,Aflac,0000004977,AFL,Insurance,FY,2019,Exchange effect on total liabilities,Liabilities,usd,123809000000,bs
4060,Aflac,0000004977,AFL,Insurance,FY,2019,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
4061,Aflac,0000004977,AFL,Insurance,FY,2019,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2019 and 2018; issued 1,349,309 shares in 2019 and 1,347,540 shares in 2018",CommonStockValue,usd,135000000,bs
4062,Aflac,0000004977,AFL,Insurance,FY,2019,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2313000000,bs
4063,Aflac,0000004977,AFL,Insurance,FY,2019,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,34291000000,bs
4064,Aflac,0000004977,AFL,Insurance,FY,2019,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1623000000,bs
4065,Aflac,0000004977,AFL,Insurance,FY,2019,"Shareholders' equity, unrealized gains (losses) on investment securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,8548000000,bs
4066,Aflac,0000004977,AFL,Insurance,FY,2019,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-33000000,bs
4067,Aflac,0000004977,AFL,Insurance,FY,2019,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,277000000,bs
4068,Aflac,0000004977,AFL,Insurance,FY,2019,"Treasury stock, at average cost",TreasuryStockValue,usd,14395000000,bs
4069,Aflac,0000004977,AFL,Insurance,FY,2019,Stockholders' Equity Note [Abstract],StockholdersEquity,usd,28959000000,bs
4070,Aflac,0000004977,AFL,Insurance,FY,2019,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,152768000000,bs
4071,Aflac,0000004977,AFL,Insurance,FY,2019,Net earnings,NetIncomeLoss,usd,3304000000,cf
4072,Aflac,0000004977,AFL,Insurance,FY,2019,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,32000000,cf
4073,Aflac,0000004977,AFL,Insurance,FY,2019,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,1452000000,cf
4074,Aflac,0000004977,AFL,Insurance,FY,2019,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,1282000000,cf
4075,Aflac,0000004977,AFL,Insurance,FY,2019,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,2104000000,cf
4076,Aflac,0000004977,AFL,Insurance,FY,2019,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-244000000,cf
4077,Aflac,0000004977,AFL,Insurance,FY,2019,Total realized investment gains (losses),GainLossOnInvestments,usd,-135000000,cf
4078,Aflac,0000004977,AFL,Insurance,FY,2019,"Other, net",OtherNoncashIncomeExpense,usd,-358000000,cf
4079,Aflac,0000004977,AFL,Insurance,FY,2019,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,5455000000,cf
4080,Aflac,0000004977,AFL,Insurance,FY,2019,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,5284000000,cf
4081,Aflac,0000004977,AFL,Insurance,FY,2019,"Equity securities, FV-NI",afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,650000000,cf
4082,Aflac,0000004977,AFL,Insurance,FY,2019,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,622000000,cf
4083,Aflac,0000004977,AFL,Insurance,FY,2019,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,1814000000,cf
4084,Aflac,0000004977,AFL,Insurance,FY,2019,Fixed maturity securities purchased,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,6934000000,cf
4085,Aflac,0000004977,AFL,Insurance,FY,2019,"Equity securities, FV-NI",afl:PaymentstoAcquireEquitySecurities,usd,347000000,cf
4086,Aflac,0000004977,AFL,Insurance,FY,2019,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,4401000000,cf
4087,Aflac,0000004977,AFL,Insurance,FY,2019,Other investments sold (purchased),afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,653000000,cf
4088,Aflac,0000004977,AFL,Insurance,FY,2019,Settlement of derivatives,PaymentsForProceedsFromHedgeInvestingActivities,usd,9000000,cf
4089,Aflac,0000004977,AFL,Insurance,FY,2019,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-926000000,cf
4090,Aflac,0000004977,AFL,Insurance,FY,2019,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,123000000,cf
4091,Aflac,0000004977,AFL,Insurance,FY,2019,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-3171000000,cf
4092,Aflac,0000004977,AFL,Insurance,FY,2019,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1627000000,cf
4093,Aflac,0000004977,AFL,Insurance,FY,2019,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,615000000,cf
4094,Aflac,0000004977,AFL,Insurance,FY,2019,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,0,cf
4095,Aflac,0000004977,AFL,Insurance,FY,2019,Dividends paid to shareholders,PaymentsOfDividends,usd,771000000,cf
4096,Aflac,0000004977,AFL,Insurance,FY,2019,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-1000000,cf
4097,Aflac,0000004977,AFL,Insurance,FY,2019,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,49000000,cf
4098,Aflac,0000004977,AFL,Insurance,FY,2019,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,22000000,cf
4099,Aflac,0000004977,AFL,Insurance,FY,2019,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-1713000000,cf
4100,Aflac,0000004977,AFL,Insurance,FY,2019,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-12000000,cf
4101,Aflac,0000004977,AFL,Insurance,FY,2019,Net change in cash and cash equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,559000000,cf
4102,Aflac,0000004977,AFL,Insurance,FY,2019,Income taxes paid,IncomeTaxesPaidNet,usd,1384000000,cf
4103,Aflac,0000004977,AFL,Insurance,FY,2019,Interest paid,InterestPaidNet,usd,190000000,cf
4104,Aflac,0000004977,AFL,Insurance,FY,2019,Noncash interest,OtherNoncashExpense,usd,37000000,cf
4105,Aflac,0000004977,AFL,Insurance,FY,2019,Impairment losses and loan loss reserves included in realized investment losses,afl:Impairmentlossesandloanlossreservesincludedinrealizedinvestmentlosses,usd,31000000,cf
4106,Aflac,0000004977,AFL,Insurance,FY,2019,Lease obligations,CapitalLeaseObligationsIncurred,usd,132000000,cf
4107,Aflac,0000004977,AFL,Insurance,Q1,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,96288000000,bs
4108,Aflac,0000004977,AFL,Insurance,Q1,2020,"Total fixed maturity securities, held to maturity, amortized cost",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,23278000000,bs
4109,Aflac,0000004977,AFL,Insurance,Q1,2020,"Held to maturity, fixed maturity securities, fair value",HeldToMaturitySecurities,usd,23287000000,bs
4110,Aflac,0000004977,AFL,Insurance,Q1,2020,Equity securities,EquitySecuritiesFvNi,usd,660000000,bs
4111,Aflac,0000004977,AFL,Insurance,Q1,2020,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10750000000,bs
4112,Aflac,0000004977,AFL,Insurance,Q1,2020,Other investments,OtherInvestments,usd,1843000000,bs
4113,Aflac,0000004977,AFL,Insurance,Q1,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4148000000,bs
4114,Aflac,0000004977,AFL,Insurance,Q1,2020,Investments and Cash:,InvestmentsAndCash,usd,136967000000,bs
4115,Aflac,0000004977,AFL,Insurance,Q1,2020,Receivables,PremiumsAndOtherReceivablesNet,usd,813000000,bs
4116,Aflac,0000004977,AFL,Insurance,Q1,2020,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,734000000,bs
4117,Aflac,0000004977,AFL,Insurance,Q1,2020,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,10164000000,bs
4118,Aflac,0000004977,AFL,Insurance,Q1,2020,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,586000000,bs
4119,Aflac,0000004977,AFL,Insurance,Q1,2020,Other,OtherAssets,usd,2352000000,bs
4120,Aflac,0000004977,AFL,Insurance,Q1,2020,Assets,Assets,usd,151616000000,bs
4121,Aflac,0000004977,AFL,Insurance,Q1,2020,POLICY LIABILITIES,LiabilityForFuturePolicyBenefits,usd,91393000000,bs
4122,Aflac,0000004977,AFL,Insurance,Q1,2020,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4693000000,bs
4123,Aflac,0000004977,AFL,Insurance,Q1,2020,Unearned premiums,UnearnedPremiums,usd,4044000000,bs
4124,Aflac,0000004977,AFL,Insurance,Q1,2020,Other policyholders’ funds,OtherPolicyholderFunds,usd,7422000000,bs
4125,Aflac,0000004977,AFL,Insurance,Q1,2020,Total policy liabilities,afl:TotalPolicyLiabilities,usd,107552000000,bs
4126,Aflac,0000004977,AFL,Insurance,Q1,2020,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4610000000,bs
4127,Aflac,0000004977,AFL,Insurance,Q1,2020,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,2969000000,bs
4128,Aflac,0000004977,AFL,Insurance,Q1,2020,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,6758000000,bs
4129,Aflac,0000004977,AFL,Insurance,Q1,2020,Other,OtherLiabilities,usd,3325000000,bs
4130,Aflac,0000004977,AFL,Insurance,Q1,2020,Liabilities:,Liabilities,usd,125214000000,bs
4131,Aflac,0000004977,AFL,Insurance,Q1,2020,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
4132,Aflac,0000004977,AFL,Insurance,Q1,2020,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2020 and 2019; issued 1,350,650 shares in 2020 and 1,349,309 shares in 2019",CommonStockValue,usd,135000000,bs
4133,Aflac,0000004977,AFL,Insurance,Q1,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2334000000,bs
4134,Aflac,0000004977,AFL,Insurance,Q1,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,34599000000,bs
4135,Aflac,0000004977,AFL,Insurance,Q1,2020,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1543000000,bs
4136,Aflac,0000004977,AFL,Insurance,Q1,2020,"Shareholders' equity, unrealized gains (losses) on fixed maturity securities",AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,6043000000,bs
4137,Aflac,0000004977,AFL,Insurance,Q1,2020,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-35000000,bs
4138,Aflac,0000004977,AFL,Insurance,Q1,2020,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,277000000,bs
4139,Aflac,0000004977,AFL,Insurance,Q1,2020,Purchases of treasury stock,TreasuryStockValue,usd,14854000000,bs
4140,Aflac,0000004977,AFL,Insurance,Q1,2020,"Balance, beginning of period",StockholdersEquity,usd,26402000000,bs
4141,Aflac,0000004977,AFL,Insurance,Q1,2020,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,151616000000,bs
4142,Aflac,0000004977,AFL,Insurance,Q1,2020,Net earnings,NetIncomeLoss,usd,566000000,cf
4143,Aflac,0000004977,AFL,Insurance,Q1,2020,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,-15000000,cf
4144,Aflac,0000004977,AFL,Insurance,Q1,2020,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,325000000,cf
4145,Aflac,0000004977,AFL,Insurance,Q1,2020,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,333000000,cf
4146,Aflac,0000004977,AFL,Insurance,Q1,2020,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,368000000,cf
4147,Aflac,0000004977,AFL,Insurance,Q1,2020,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,153000000,cf
4148,Aflac,0000004977,AFL,Insurance,Q1,2020,Total net investment gains (losses),GainLossOnInvestments,usd,-463000000,cf
4149,Aflac,0000004977,AFL,Insurance,Q1,2020,"Other, net",OtherNoncashIncomeExpense,usd,159000000,cf
4150,Aflac,0000004977,AFL,Insurance,Q1,2020,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,1414000000,cf
4151,Aflac,0000004977,AFL,Insurance,Q1,2020,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,726000000,cf
4152,Aflac,0000004977,AFL,Insurance,Q1,2020,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,3000000,cf
4153,Aflac,0000004977,AFL,Insurance,Q1,2020,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,0,cf
4154,Aflac,0000004977,AFL,Insurance,Q1,2020,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,408000000,cf
4155,Aflac,0000004977,AFL,Insurance,Q1,2020,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,1817000000,cf
4156,Aflac,0000004977,AFL,Insurance,Q1,2020,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,6000000,cf
4157,Aflac,0000004977,AFL,Insurance,Q1,2020,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,1787000000,cf
4158,Aflac,0000004977,AFL,Insurance,Q1,2020,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,361000000,cf
4159,Aflac,0000004977,AFL,Insurance,Q1,2020,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-13000000,cf
4160,Aflac,0000004977,AFL,Insurance,Q1,2020,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-1160000000,cf
4161,Aflac,0000004977,AFL,Insurance,Q1,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,55000000,cf
4162,Aflac,0000004977,AFL,Insurance,Q1,2020,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-1716000000,cf
4163,Aflac,0000004977,AFL,Insurance,Q1,2020,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,449000000,cf
4164,Aflac,0000004977,AFL,Insurance,Q1,2020,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,545000000,cf
4165,Aflac,0000004977,AFL,Insurance,Q1,2020,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,350000000,cf
4166,Aflac,0000004977,AFL,Insurance,Q1,2020,Dividends paid to shareholders,PaymentsOfDividends,usd,195000000,cf
4167,Aflac,0000004977,AFL,Insurance,Q1,2020,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-5000000,cf
4168,Aflac,0000004977,AFL,Insurance,Q1,2020,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,9000000,cf
4169,Aflac,0000004977,AFL,Insurance,Q1,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-1000000,cf
4170,Aflac,0000004977,AFL,Insurance,Q1,2020,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-446000000,cf
4171,Aflac,0000004977,AFL,Insurance,Q1,2020,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,0,cf
4172,Aflac,0000004977,AFL,Insurance,Q1,2020,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-748000000,cf
4173,Aflac,0000004977,AFL,Insurance,Q1,2020,Income taxes paid,IncomeTaxesPaidNet,usd,2000000,cf
4174,Aflac,0000004977,AFL,Insurance,Q1,2020,Interest paid,InterestPaidNet,usd,39000000,cf
4175,Aflac,0000004977,AFL,Insurance,Q1,2020,Noncash interest,OtherNoncashExpense,usd,15000000,cf
4176,Aflac,0000004977,AFL,Insurance,Q1,2020,Lease obligations,CapitalLeaseObligationsIncurred,usd,13000000,cf
4177,Aflac,0000004977,AFL,Insurance,Q2,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,99959000000,bs
4178,Aflac,0000004977,AFL,Insurance,Q2,2020,"Held to maturity, fixed maturity securities, net carrying amount",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,23509000000,bs
4179,Aflac,0000004977,AFL,Insurance,Q2,2020,"Securities held to maturity, fixed maturities, amortized cost",HeldToMaturitySecurities,usd,23518000000,bs
4180,Aflac,0000004977,AFL,Insurance,Q2,2020,Fair Value,EquitySecuritiesFvNi,usd,749000000,bs
4181,Aflac,0000004977,AFL,Insurance,Q2,2020,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10717000000,bs
4182,Aflac,0000004977,AFL,Insurance,Q2,2020,Other investments,OtherInvestments,usd,1771000000,bs
4183,Aflac,0000004977,AFL,Insurance,Q2,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,5528000000,bs
4184,Aflac,0000004977,AFL,Insurance,Q2,2020,Investments and Cash:,InvestmentsAndCash,usd,142233000000,bs
4185,Aflac,0000004977,AFL,Insurance,Q2,2020,Receivables,PremiumsAndOtherReceivablesNet,usd,894000000,bs
4186,Aflac,0000004977,AFL,Insurance,Q2,2020,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,782000000,bs
4187,Aflac,0000004977,AFL,Insurance,Q2,2020,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,10222000000,bs
4188,Aflac,0000004977,AFL,Insurance,Q2,2020,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,584000000,bs
4189,Aflac,0000004977,AFL,Insurance,Q2,2020,Other,OtherAssets,usd,2372000000,bs
4190,Aflac,0000004977,AFL,Insurance,Q2,2020,Assets:,Assets,usd,157087000000,bs
4191,Aflac,0000004977,AFL,Insurance,Q2,2020,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,92992000000,bs
4192,Aflac,0000004977,AFL,Insurance,Q2,2020,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4773000000,bs
4193,Aflac,0000004977,AFL,Insurance,Q2,2020,Unearned premiums,UnearnedPremiums,usd,3854000000,bs
4194,Aflac,0000004977,AFL,Insurance,Q2,2020,Other policyholders’ funds,OtherPolicyholderFunds,usd,7484000000,bs
4195,Aflac,0000004977,AFL,Insurance,Q2,2020,Total policy liabilities,afl:TotalPolicyLiabilities,usd,109103000000,bs
4196,Aflac,0000004977,AFL,Insurance,Q2,2020,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,5228000000,bs
4197,Aflac,0000004977,AFL,Insurance,Q2,2020,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,2275000000,bs
4198,Aflac,0000004977,AFL,Insurance,Q2,2020,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,7771000000,bs
4199,Aflac,0000004977,AFL,Insurance,Q2,2020,Other,OtherLiabilities,usd,3290000000,bs
4200,Aflac,0000004977,AFL,Insurance,Q2,2020,Liabilities:,Liabilities,usd,127667000000,bs
4201,Aflac,0000004977,AFL,Insurance,Q2,2020,Commitments and Contingencies Disclosure [Abstract],CommitmentsAndContingencies,usd,N/A,bs
4202,Aflac,0000004977,AFL,Insurance,Q2,2020,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2020 and 2019; issued 1,350,735 shares in 2020 and 1,349,309 shares in 2019",CommonStockValue,usd,135000000,bs
4203,Aflac,0000004977,AFL,Insurance,Q2,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2358000000,bs
4204,Aflac,0000004977,AFL,Insurance,Q2,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,35204000000,bs
4205,Aflac,0000004977,AFL,Insurance,Q2,2020,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1469000000,bs
4206,Aflac,0000004977,AFL,Insurance,Q2,2020,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,8532000000,bs
4207,Aflac,0000004977,AFL,Insurance,Q2,2020,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-36000000,bs
4208,Aflac,0000004977,AFL,Insurance,Q2,2020,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,277000000,bs
4209,Aflac,0000004977,AFL,Insurance,Q2,2020,Purchases of treasury stock,TreasuryStockValue,usd,15027000000,bs
4210,Aflac,0000004977,AFL,Insurance,Q2,2020,"Balance, beginning of period",StockholdersEquity,usd,29420000000,bs
4211,Aflac,0000004977,AFL,Insurance,Q2,2020,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,157087000000,bs
4212,Aflac,0000004977,AFL,Insurance,Q2,2020,Net earnings,NetIncomeLoss,usd,1370000000,cf
4213,Aflac,0000004977,AFL,Insurance,Q2,2020,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,65000000,cf
4214,Aflac,0000004977,AFL,Insurance,Q2,2020,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,604000000,cf
4215,Aflac,0000004977,AFL,Insurance,Q2,2020,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,622000000,cf
4216,Aflac,0000004977,AFL,Insurance,Q2,2020,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,936000000,cf
4217,Aflac,0000004977,AFL,Insurance,Q2,2020,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-117000000,cf
4218,Aflac,0000004977,AFL,Insurance,Q2,2020,Gain (Loss) on Investments,GainLossOnInvestments,usd,-633000000,cf
4219,Aflac,0000004977,AFL,Insurance,Q2,2020,"Other, net",OtherNoncashIncomeExpense,usd,174000000,cf
4220,Aflac,0000004977,AFL,Insurance,Q2,2020,Cash flows from operating activities:,NetCashProvidedByUsedInOperatingActivities,usd,2601000000,cf
4221,Aflac,0000004977,AFL,Insurance,Q2,2020,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,1981000000,cf
4222,Aflac,0000004977,AFL,Insurance,Q2,2020,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,93000000,cf
4223,Aflac,0000004977,AFL,Insurance,Q2,2020,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,2000000,cf
4224,Aflac,0000004977,AFL,Insurance,Q2,2020,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,685000000,cf
4225,Aflac,0000004977,AFL,Insurance,Q2,2020,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,2691000000,cf
4226,Aflac,0000004977,AFL,Insurance,Q2,2020,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,150000000,cf
4227,Aflac,0000004977,AFL,Insurance,Q2,2020,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,2108000000,cf
4228,Aflac,0000004977,AFL,Insurance,Q2,2020,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,293000000,cf
4229,Aflac,0000004977,AFL,Insurance,Q2,2020,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-21000000,cf
4230,Aflac,0000004977,AFL,Insurance,Q2,2020,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-459000000,cf
4231,Aflac,0000004977,AFL,Insurance,Q2,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,119000000,cf
4232,Aflac,0000004977,AFL,Insurance,Q2,2020,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2120000000,cf
4233,Aflac,0000004977,AFL,Insurance,Q2,2020,"Common stock, share repurchase, dollar amount",PaymentsForRepurchaseOfCommonStock,usd,637000000,cf
4234,Aflac,0000004977,AFL,Insurance,Q2,2020,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,1545000000,cf
4235,Aflac,0000004977,AFL,Insurance,Q2,2020,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,350000000,cf
4236,Aflac,0000004977,AFL,Insurance,Q2,2020,Dividends paid to shareholders,PaymentsOfDividends,usd,388000000,cf
4237,Aflac,0000004977,AFL,Insurance,Q2,2020,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-17000000,cf
4238,Aflac,0000004977,AFL,Insurance,Q2,2020,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,21000000,cf
4239,Aflac,0000004977,AFL,Insurance,Q2,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-22000000,cf
4240,Aflac,0000004977,AFL,Insurance,Q2,2020,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,152000000,cf
4241,Aflac,0000004977,AFL,Insurance,Q2,2020,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-1000000,cf
4242,Aflac,0000004977,AFL,Insurance,Q2,2020,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,632000000,cf
4243,Aflac,0000004977,AFL,Insurance,Q2,2020,Income taxes paid,IncomeTaxesPaidNet,usd,536000000,cf
4244,Aflac,0000004977,AFL,Insurance,Q2,2020,Interest paid,InterestPaidNet,usd,97000000,cf
4245,Aflac,0000004977,AFL,Insurance,Q2,2020,Noncash interest,OtherNoncashExpense,usd,19000000,cf
4246,Aflac,0000004977,AFL,Insurance,Q2,2020,Lease obligations,CapitalLeaseObligationsIncurred,usd,22000000,cf
4247,Aflac,0000004977,AFL,Insurance,Q3,2020,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,160955000000,bs
4248,Aflac,0000004977,AFL,Insurance,Q3,2020,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,9520000000,bs
4249,Aflac,0000004977,AFL,Insurance,Q3,2020,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,9520000000,bs
4250,Aflac,0000004977,AFL,Insurance,Q3,2020,Total policy liabilities,afl:TotalPolicyLiabilities,usd,111587000000,bs
4251,Aflac,0000004977,AFL,Insurance,Q3,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,103128000000,bs
4252,Aflac,0000004977,AFL,Insurance,Q3,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,103128000000,bs
4253,Aflac,0000004977,AFL,Insurance,Q3,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,103128000000,bs
4254,Aflac,0000004977,AFL,Insurance,Q3,2020,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,103128000000,bs
4255,Aflac,0000004977,AFL,Insurance,Q3,2020,Other,OtherLiabilities,usd,3291000000,bs
4256,Aflac,0000004977,AFL,Insurance,Q3,2020,"Held to maturity, fixed maturity securities, amortized cost",HeldToMaturitySecurities,usd,23946000000,bs
4257,Aflac,0000004977,AFL,Insurance,Q3,2020,Total assets,Assets,usd,160955000000,bs
4258,Aflac,0000004977,AFL,Insurance,Q3,2020,Total assets,Assets,usd,160955000000,bs
4259,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,EquitySecuritiesFvNi,usd,775000000,bs
4260,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,EquitySecuritiesFvNi,usd,775000000,bs
4261,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,EquitySecuritiesFvNi,usd,775000000,bs
4262,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,EquitySecuritiesFvNi,usd,775000000,bs
4263,Aflac,0000004977,AFL,Insurance,Q3,2020,Commitments and contingent liabilities (Note 13),CommitmentsAndContingencies,usd,N/A,bs
4264,Aflac,0000004977,AFL,Insurance,Q3,2020,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1290000000,bs
4265,Aflac,0000004977,AFL,Insurance,Q3,2020,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,37460000000,bs
4266,Aflac,0000004977,AFL,Insurance,Q3,2020,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,278000000,bs
4267,Aflac,0000004977,AFL,Insurance,Q3,2020,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,95240000000,bs
4268,Aflac,0000004977,AFL,Insurance,Q3,2020,Total investments and cash,InvestmentsAndCash,usd,146129000000,bs
4269,Aflac,0000004977,AFL,Insurance,Q3,2020,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,10319000000,bs
4270,Aflac,0000004977,AFL,Insurance,Q3,2020,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4278000000,bs
4271,Aflac,0000004977,AFL,Insurance,Q3,2020,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,7825000000,bs
4272,Aflac,0000004977,AFL,Insurance,Q3,2020,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,7825000000,bs
4273,Aflac,0000004977,AFL,Insurance,Q3,2020,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1495000000,bs
4274,Aflac,0000004977,AFL,Insurance,Q3,2020,Total shareholders’ equity,StockholdersEquity,usd,32479000000,bs
4275,Aflac,0000004977,AFL,Insurance,Q3,2020,Total shareholders’ equity,StockholdersEquity,usd,32479000000,bs
4276,Aflac,0000004977,AFL,Insurance,Q3,2020,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,5563000000,bs
4277,Aflac,0000004977,AFL,Insurance,Q3,2020,Other,OtherAssets,usd,2362000000,bs
4278,Aflac,0000004977,AFL,Insurance,Q3,2020,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10822000000,bs
4279,Aflac,0000004977,AFL,Insurance,Q3,2020,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10822000000,bs
4280,Aflac,0000004977,AFL,Insurance,Q3,2020,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10822000000,bs
4281,Aflac,0000004977,AFL,Insurance,Q3,2020,Unearned premiums,UnearnedPremiums,usd,3729000000,bs
4282,Aflac,0000004977,AFL,Insurance,Q3,2020,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,737000000,bs
4283,Aflac,0000004977,AFL,Insurance,Q3,2020,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,584000000,bs
4284,Aflac,0000004977,AFL,Insurance,Q3,2020,Other policyholders’ funds,OtherPolicyholderFunds,usd,7642000000,bs
4285,Aflac,0000004977,AFL,Insurance,Q3,2020,Other policyholders’ funds,OtherPolicyholderFunds,usd,7642000000,bs
4286,Aflac,0000004977,AFL,Insurance,Q3,2020,Receivables,PremiumsAndOtherReceivablesNet,usd,824000000,bs
4287,Aflac,0000004977,AFL,Insurance,Q3,2020,"Treasury stock, at average cost",TreasuryStockValue,usd,15416000000,bs
4288,Aflac,0000004977,AFL,Insurance,Q3,2020,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2020 and 2019; issued 1,350,855 shares in 2020 and 1,349,309 shares in 2019",CommonStockValue,usd,135000000,bs
4289,Aflac,0000004977,AFL,Insurance,Q3,2020,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2383000000,bs
4290,Aflac,0000004977,AFL,Insurance,Q3,2020,"Held to maturity, fixed maturity securities, net carrying amount",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,23937000000,bs
4291,Aflac,0000004977,AFL,Insurance,Q3,2020,"Held to maturity, fixed maturity securities, net carrying amount",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,23937000000,bs
4292,Aflac,0000004977,AFL,Insurance,Q3,2020,"Held to maturity, fixed maturity securities, net carrying amount",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,23937000000,bs
4293,Aflac,0000004977,AFL,Insurance,Q3,2020,Total liabilities,Liabilities,usd,128476000000,bs
4294,Aflac,0000004977,AFL,Insurance,Q3,2020,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-35000000,bs
4295,Aflac,0000004977,AFL,Insurance,Q3,2020,Other investments,OtherInvestments,usd,1904000000,bs
4296,Aflac,0000004977,AFL,Insurance,Q3,2020,Other investments,OtherInvestments,usd,1904000000,bs
4297,Aflac,0000004977,AFL,Insurance,Q3,2020,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4976000000,bs
4298,Aflac,0000004977,AFL,Insurance,Q3,2020,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,3000000,cf
4299,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,275000000,cf
4300,Aflac,0000004977,AFL,Insurance,Q3,2020,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1037000000,cf
4301,Aflac,0000004977,AFL,Insurance,Q3,2020,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,2554000000,cf
4302,Aflac,0000004977,AFL,Insurance,Q3,2020,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,1115000000,cf
4303,Aflac,0000004977,AFL,Insurance,Q3,2020,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,914000000,cf
4304,Aflac,0000004977,AFL,Insurance,Q3,2020,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,914000000,cf
4305,Aflac,0000004977,AFL,Insurance,Q3,2020,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,1601000000,cf
4306,Aflac,0000004977,AFL,Insurance,Q3,2020,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-7000000,cf
4307,Aflac,0000004977,AFL,Insurance,Q3,2020,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,870000000,cf
4308,Aflac,0000004977,AFL,Insurance,Q3,2020,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-15000000,cf
4309,Aflac,0000004977,AFL,Insurance,Q3,2020,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,-12000000,cf
4310,Aflac,0000004977,AFL,Insurance,Q3,2020,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,217000000,cf
4311,Aflac,0000004977,AFL,Insurance,Q3,2020,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,3710000000,cf
4312,Aflac,0000004977,AFL,Insurance,Q3,2020,Net cash provided (used) by investing activities,NetCashProvidedByUsedInInvestingActivities,usd,-3511000000,cf
4313,Aflac,0000004977,AFL,Insurance,Q3,2020,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,27000000,cf
4314,Aflac,0000004977,AFL,Insurance,Q3,2020,Interest paid,InterestPaidNet,usd,131000000,cf
4315,Aflac,0000004977,AFL,Insurance,Q3,2020,Net cash provided (used) by financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-431000000,cf
4316,Aflac,0000004977,AFL,Insurance,Q3,2020,Net cash provided (used) by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,4601000000,cf
4317,Aflac,0000004977,AFL,Insurance,Q3,2020,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,185000000,cf
4318,Aflac,0000004977,AFL,Insurance,Q3,2020,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,420000000,cf
4319,Aflac,0000004977,AFL,Insurance,Q3,2020,Net earnings,NetIncomeLoss,usd,3826000000,cf
4320,Aflac,0000004977,AFL,Insurance,Q3,2020,Net earnings,NetIncomeLoss,usd,3826000000,cf
4321,Aflac,0000004977,AFL,Insurance,Q3,2020,Net earnings,NetIncomeLoss,usd,3826000000,cf
4322,Aflac,0000004977,AFL,Insurance,Q3,2020,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-29000000,cf
4323,Aflac,0000004977,AFL,Insurance,Q3,2020,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,350000000,cf
4324,Aflac,0000004977,AFL,Insurance,Q3,2020,Dividends paid to shareholders,PaymentsOfDividends,usd,580000000,cf
4325,Aflac,0000004977,AFL,Insurance,Q3,2020,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-1509000000,cf
4326,Aflac,0000004977,AFL,Insurance,Q3,2020,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,8000000,cf
4327,Aflac,0000004977,AFL,Insurance,Q3,2020,Income taxes paid,IncomeTaxesPaidNet,usd,626000000,cf
4328,Aflac,0000004977,AFL,Insurance,Q3,2020,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,2688000000,cf
4329,Aflac,0000004977,AFL,Insurance,Q3,2020,"Other, net",OtherNoncashIncomeExpense,usd,-102000000,cf
4330,Aflac,0000004977,AFL,Insurance,Q3,2020,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,1545000000,cf
4331,Aflac,0000004977,AFL,Insurance,Q3,2020,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,667000000,cf
4332,Aflac,0000004977,AFL,Insurance,Q3,2020,Noncash interest,OtherNoncashExpense,usd,47000000,cf
4333,Aflac,0000004977,AFL,Insurance,Q3,2020,Realized investment (gains) losses,GainLossOnInvestments,usd,-525000000,cf
4334,Aflac,0000004977,AFL,Insurance,Q3,2020,Realized investment (gains) losses,GainLossOnInvestments,usd,-525000000,cf
4335,Aflac,0000004977,AFL,Insurance,Q3,2020,Realized investment (gains) losses,GainLossOnInvestments,usd,-525000000,cf
4336,Aflac,0000004977,AFL,Insurance,Q3,2020,Lease obligations,CapitalLeaseObligationsIncurred,usd,31000000,cf
4337,Aflac,0000004977,AFL,Insurance,Q3,2020,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,405000000,cf
4338,Aflac,0000004977,AFL,Insurance,Q1,2021,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,100744000000,bs
4339,Aflac,0000004977,AFL,Insurance,Q1,2021,"Held to maturity, fixed maturity securities, net carrying amount",afl:DebtSecuritiesHeldtoMaturityNetCarryingAmount,usd,22868000000,bs
4340,Aflac,0000004977,AFL,Insurance,Q1,2021,"Equity securities, FV-NI, unrealized gain (loss)",EquitySecuritiesFvNi,usd,1174000000,bs
4341,Aflac,0000004977,AFL,Insurance,Q1,2021,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,10847000000,bs
4342,Aflac,0000004977,AFL,Insurance,Q1,2021,Other Investments [Abstract],OtherInvestments,usd,2666000000,bs
4343,Aflac,0000004977,AFL,Insurance,Q1,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4990000000,bs
4344,Aflac,0000004977,AFL,Insurance,Q1,2021,Total investments and cash,InvestmentsAndCash,usd,143289000000,bs
4345,Aflac,0000004977,AFL,Insurance,Q1,2021,Receivables,PremiumsAndOtherReceivablesNet,usd,777000000,bs
4346,Aflac,0000004977,AFL,Insurance,Q1,2021,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,706000000,bs
4347,Aflac,0000004977,AFL,Insurance,Q1,2021,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9835000000,bs
4348,Aflac,0000004977,AFL,Insurance,Q1,2021,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,578000000,bs
4349,Aflac,0000004977,AFL,Insurance,Q1,2021,Other,OtherAssets,usd,2972000000,bs
4350,Aflac,0000004977,AFL,Insurance,Q1,2021,Assets:,Assets,usd,158157000000,bs
4351,Aflac,0000004977,AFL,Insurance,Q1,2021,POLICY LIABILITIES,LiabilityForFuturePolicyBenefits,usd,92396000000,bs
4352,Aflac,0000004977,AFL,Insurance,Q1,2021,Liability for Unpaid Claims and Claims Expenses,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4948000000,bs
4353,Aflac,0000004977,AFL,Insurance,Q1,2021,Unearned premiums,UnearnedPremiums,usd,3194000000,bs
4354,Aflac,0000004977,AFL,Insurance,Q1,2021,Other policyholders’ funds,OtherPolicyholderFunds,usd,7367000000,bs
4355,Aflac,0000004977,AFL,Insurance,Q1,2021,Total policy liabilities,afl:TotalPolicyLiabilities,usd,107905000000,bs
4356,Aflac,0000004977,AFL,Insurance,Q1,2021,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4350000000,bs
4357,Aflac,0000004977,AFL,Insurance,Q1,2021,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,1896000000,bs
4358,Aflac,0000004977,AFL,Insurance,Q1,2021,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,8088000000,bs
4359,Aflac,0000004977,AFL,Insurance,Q1,2021,Other,OtherLiabilities,usd,3815000000,bs
4360,Aflac,0000004977,AFL,Insurance,Q1,2021,Liabilities and shareholders' equity:,Liabilities,usd,126054000000,bs
4361,Aflac,0000004977,AFL,Insurance,Q1,2021,COMMITMENTS AND CONTINGENT LIABILITIES,CommitmentsAndContingencies,usd,N/A,bs
4362,Aflac,0000004977,AFL,Insurance,Q1,2021,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2021 and 2020; issued 1,352,279 shares in 2021 and 1,351,018 shares in 2020",CommonStockValue,usd,135000000,bs
4363,Aflac,0000004977,AFL,Insurance,Q1,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2438000000,bs
4364,Aflac,0000004977,AFL,Insurance,Q1,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,39277000000,bs
4365,Aflac,0000004977,AFL,Insurance,Q1,2021,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1674000000,bs
4366,Aflac,0000004977,AFL,Insurance,Q1,2021,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,8794000000,bs
4367,Aflac,0000004977,AFL,Insurance,Q1,2021,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-33000000,bs
4368,Aflac,0000004977,AFL,Insurance,Q1,2021,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,280000000,bs
4369,Aflac,0000004977,AFL,Insurance,Q1,2021,Purchases of treasury stock,TreasuryStockValue,usd,16554000000,bs
4370,Aflac,0000004977,AFL,Insurance,Q1,2021,Total shareholders’ equity,StockholdersEquity,usd,32103000000,bs
4371,Aflac,0000004977,AFL,Insurance,Q1,2021,Liabilities and shareholders' equity:,LiabilitiesAndStockholdersEquity,usd,158157000000,bs
4372,Aflac,0000004977,AFL,Insurance,Q1,2021,Net earnings,NetIncomeLoss,usd,1293000000,cf
4373,Aflac,0000004977,AFL,Insurance,Q1,2021,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,19000000,cf
4374,Aflac,0000004977,AFL,Insurance,Q1,2021,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,262000000,cf
4375,Aflac,0000004977,AFL,Insurance,Q1,2021,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,311000000,cf
4376,Aflac,0000004977,AFL,Insurance,Q1,2021,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,204000000,cf
4377,Aflac,0000004977,AFL,Insurance,Q1,2021,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,331000000,cf
4378,Aflac,0000004977,AFL,Insurance,Q1,2021,Gain (Loss) on Investments,GainLossOnInvestments,usd,307000000,cf
4379,Aflac,0000004977,AFL,Insurance,Q1,2021,"Other, net",OtherNoncashIncomeExpense,usd,185000000,cf
4380,Aflac,0000004977,AFL,Insurance,Q1,2021,Net cash provided (used) by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,1366000000,cf
4381,Aflac,0000004977,AFL,Insurance,Q1,2021,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,651000000,cf
4382,Aflac,0000004977,AFL,Insurance,Q1,2021,Equity securities,afl:ProceedsFromSaleOfEquitySecuritiesFVNI,usd,123000000,cf
4383,Aflac,0000004977,AFL,Insurance,Q1,2021,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,725000000,cf
4384,Aflac,0000004977,AFL,Insurance,Q1,2021,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,2475000000,cf
4385,Aflac,0000004977,AFL,Insurance,Q1,2021,Equity securities,afl:PaymentstoAcquireEquitySecurities,usd,126000000,cf
4386,Aflac,0000004977,AFL,Insurance,Q1,2021,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,956000000,cf
4387,Aflac,0000004977,AFL,Insurance,Q1,2021,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,201000000,cf
4388,Aflac,0000004977,AFL,Insurance,Q1,2021,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-116000000,cf
4389,Aflac,0000004977,AFL,Insurance,Q1,2021,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-1206000000,cf
4390,Aflac,0000004977,AFL,Insurance,Q1,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,32000000,cf
4391,Aflac,0000004977,AFL,Insurance,Q1,2021,Cash flows from investing activities:,NetCashProvidedByUsedInInvestingActivities,usd,-969000000,cf
4392,Aflac,0000004977,AFL,Insurance,Q1,2021,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,650000000,cf
4393,Aflac,0000004977,AFL,Insurance,Q1,2021,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,400000000,cf
4394,Aflac,0000004977,AFL,Insurance,Q1,2021,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,0,cf
4395,Aflac,0000004977,AFL,Insurance,Q1,2021,Dividends paid to shareholders,PaymentsOfDividends,usd,219000000,cf
4396,Aflac,0000004977,AFL,Insurance,Q1,2021,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-12000000,cf
4397,Aflac,0000004977,AFL,Insurance,Q1,2021,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,9000000,cf
4398,Aflac,0000004977,AFL,Insurance,Q1,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,2000000,cf
4399,Aflac,0000004977,AFL,Insurance,Q1,2021,Cash flows from financing activities:,NetCashProvidedByUsedInFinancingActivities,usd,-470000000,cf
4400,Aflac,0000004977,AFL,Insurance,Q1,2021,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-78000000,cf
4401,Aflac,0000004977,AFL,Insurance,Q1,2021,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-151000000,cf
4402,Aflac,0000004977,AFL,Insurance,Q1,2021,Income taxes paid,IncomeTaxesPaidNet,usd,-20000000,cf
4403,Aflac,0000004977,AFL,Insurance,Q1,2021,Interest paid,InterestPaidNet,usd,35000000,cf
4404,Aflac,0000004977,AFL,Insurance,Q1,2021,Noncash interest,OtherNoncashExpense,usd,27000000,cf
4405,Aflac,0000004977,AFL,Insurance,Q1,2021,Lease obligations,CapitalLeaseObligationsIncurred,usd,20000000,cf
4406,Aflac,0000004977,AFL,Insurance,Q2,2021,Other,OtherAssets,usd,2861000000,bs
4407,Aflac,0000004977,AFL,Insurance,Q2,2021,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,22891000000,bs
4408,Aflac,0000004977,AFL,Insurance,Q2,2021,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,22891000000,bs
4409,Aflac,0000004977,AFL,Insurance,Q2,2021,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,22891000000,bs
4410,Aflac,0000004977,AFL,Insurance,Q2,2021,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,8121000000,bs
4411,Aflac,0000004977,AFL,Insurance,Q2,2021,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,8121000000,bs
4412,Aflac,0000004977,AFL,Insurance,Q2,2021,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,279000000,bs
4413,Aflac,0000004977,AFL,Insurance,Q2,2021,Total assets,Assets,usd,161492000000,bs
4414,Aflac,0000004977,AFL,Insurance,Q2,2021,Total assets,Assets,usd,161492000000,bs
4415,Aflac,0000004977,AFL,Insurance,Q2,2021,Commitments and contingent liabilities (Note 12),CommitmentsAndContingencies,usd,N/A,bs
4416,Aflac,0000004977,AFL,Insurance,Q2,2021,Unearned premiums,UnearnedPremiums,usd,3005000000,bs
4417,Aflac,0000004977,AFL,Insurance,Q2,2021,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,5469000000,bs
4418,Aflac,0000004977,AFL,Insurance,Q2,2021,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,9992000000,bs
4419,Aflac,0000004977,AFL,Insurance,Q2,2021,Unrealized gain (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,9992000000,bs
4420,Aflac,0000004977,AFL,Insurance,Q2,2021,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,11332000000,bs
4421,Aflac,0000004977,AFL,Insurance,Q2,2021,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,11332000000,bs
4422,Aflac,0000004977,AFL,Insurance,Q2,2021,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,11332000000,bs
4423,Aflac,0000004977,AFL,Insurance,Q2,2021,Payables for return of cash collateral on loaned securities,afl:ObligationToReturnCashOrSecuritiesReceivedAsCollateral,usd,3133000000,bs
4424,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,EquitySecuritiesFvNi,usd,1475000000,bs
4425,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,EquitySecuritiesFvNi,usd,1475000000,bs
4426,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,EquitySecuritiesFvNi,usd,1475000000,bs
4427,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,EquitySecuritiesFvNi,usd,1475000000,bs
4428,Aflac,0000004977,AFL,Insurance,Q2,2021,Other policyholders’ funds,OtherPolicyholderFunds,usd,7368000000,bs
4429,Aflac,0000004977,AFL,Insurance,Q2,2021,Other policyholders’ funds,OtherPolicyholderFunds,usd,7368000000,bs
4430,Aflac,0000004977,AFL,Insurance,Q2,2021,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2465000000,bs
4431,Aflac,0000004977,AFL,Insurance,Q2,2021,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9810000000,bs
4432,Aflac,0000004977,AFL,Insurance,Q2,2021,Total liabilities,Liabilities,usd,127757000000,bs
4433,Aflac,0000004977,AFL,Insurance,Q2,2021,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,92992000000,bs
4434,Aflac,0000004977,AFL,Insurance,Q2,2021,Other,OtherLiabilities,usd,3766000000,bs
4435,Aflac,0000004977,AFL,Insurance,Q2,2021,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,563000000,bs
4436,Aflac,0000004977,AFL,Insurance,Q2,2021,Total policy liabilities,afl:TotalPolicyLiabilities,usd,108286000000,bs
4437,Aflac,0000004977,AFL,Insurance,Q2,2021,Total shareholders’ equity,StockholdersEquity,usd,33735000000,bs
4438,Aflac,0000004977,AFL,Insurance,Q2,2021,Total shareholders’ equity,StockholdersEquity,usd,33735000000,bs
4439,Aflac,0000004977,AFL,Insurance,Q2,2021,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,761000000,bs
4440,Aflac,0000004977,AFL,Insurance,Q2,2021,Unrealized gains (losses) on derivatives,AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax,usd,-33000000,bs
4441,Aflac,0000004977,AFL,Insurance,Q2,2021,"Treasury stock, at average cost",TreasuryStockValue,usd,17046000000,bs
4442,Aflac,0000004977,AFL,Insurance,Q2,2021,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,102284000000,bs
4443,Aflac,0000004977,AFL,Insurance,Q2,2021,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,102284000000,bs
4444,Aflac,0000004977,AFL,Insurance,Q2,2021,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,102284000000,bs
4445,Aflac,0000004977,AFL,Insurance,Q2,2021,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,102284000000,bs
4446,Aflac,0000004977,AFL,Insurance,Q2,2021,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,4451000000,bs
4447,Aflac,0000004977,AFL,Insurance,Q2,2021,Other investments,OtherInvestments,usd,3258000000,bs
4448,Aflac,0000004977,AFL,Insurance,Q2,2021,Other investments,OtherInvestments,usd,3258000000,bs
4449,Aflac,0000004977,AFL,Insurance,Q2,2021,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-1661000000,bs
4450,Aflac,0000004977,AFL,Insurance,Q2,2021,Receivables,PremiumsAndOtherReceivablesNet,usd,788000000,bs
4451,Aflac,0000004977,AFL,Insurance,Q2,2021,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2021 and 2020; issued 1,352,392 shares in 2021 and 1,351,018 shares in 2020",CommonStockValue,usd,135000000,bs
4452,Aflac,0000004977,AFL,Insurance,Q2,2021,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4921000000,bs
4453,Aflac,0000004977,AFL,Insurance,Q2,2021,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,161492000000,bs
4454,Aflac,0000004977,AFL,Insurance,Q2,2021,Total investments and cash,InvestmentsAndCash,usd,146709000000,bs
4455,Aflac,0000004977,AFL,Insurance,Q2,2021,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,40162000000,bs
4456,Aflac,0000004977,AFL,Insurance,Q2,2021,Lease obligations,CapitalLeaseObligationsIncurred,usd,30000000,cf
4457,Aflac,0000004977,AFL,Insurance,Q2,2021,Held-to-maturity fixed maturity securities,ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities,usd,2000000,cf
4458,Aflac,0000004977,AFL,Insurance,Q2,2021,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,328000000,cf
4459,Aflac,0000004977,AFL,Insurance,Q2,2021,Net cash provided (used) by investing activities,NetCashProvidedByUsedInInvestingActivities,usd,-839000000,cf
4460,Aflac,0000004977,AFL,Insurance,Q2,2021,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,-155000000,cf
4461,Aflac,0000004977,AFL,Insurance,Q2,2021,Net cash provided (used) by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,2328000000,cf
4462,Aflac,0000004977,AFL,Insurance,Q2,2021,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-24000000,cf
4463,Aflac,0000004977,AFL,Insurance,Q2,2021,Income taxes paid,IncomeTaxesPaidNet,usd,480000000,cf
4464,Aflac,0000004977,AFL,Insurance,Q2,2021,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,1468000000,cf
4465,Aflac,0000004977,AFL,Insurance,Q2,2021,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,515000000,cf
4466,Aflac,0000004977,AFL,Insurance,Q2,2021,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,1150000000,cf
4467,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,ProceedsFromSaleOfEquitySecuritiesFvNi,usd,124000000,cf
4468,Aflac,0000004977,AFL,Insurance,Q2,2021,Dividends paid to shareholders,PaymentsOfDividends,usd,430000000,cf
4469,Aflac,0000004977,AFL,Insurance,Q2,2021,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,1679000000,cf
4470,Aflac,0000004977,AFL,Insurance,Q2,2021,"Other, net",OtherNoncashIncomeExpense,usd,323000000,cf
4471,Aflac,0000004977,AFL,Insurance,Q2,2021,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,13000000,cf
4472,Aflac,0000004977,AFL,Insurance,Q2,2021,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,478000000,cf
4473,Aflac,0000004977,AFL,Insurance,Q2,2021,Equity securities,PaymentsToAcquireEquitySecuritiesFvNi,usd,258000000,cf
4474,Aflac,0000004977,AFL,Insurance,Q2,2021,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-5000000,cf
4475,Aflac,0000004977,AFL,Insurance,Q2,2021,Principal payments under debt obligations,RepaymentsOfLongTermDebtAndCapitalSecurities,usd,700000000,cf
4476,Aflac,0000004977,AFL,Insurance,Q2,2021,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-20000000,cf
4477,Aflac,0000004977,AFL,Insurance,Q2,2021,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,4000000,cf
4478,Aflac,0000004977,AFL,Insurance,Q2,2021,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-2412000000,cf
4479,Aflac,0000004977,AFL,Insurance,Q2,2021,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,2376000000,cf
4480,Aflac,0000004977,AFL,Insurance,Q2,2021,Net cash provided (used) by financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-1141000000,cf
4481,Aflac,0000004977,AFL,Insurance,Q2,2021,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,-3000000,cf
4482,Aflac,0000004977,AFL,Insurance,Q2,2021,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,1153000000,cf
4483,Aflac,0000004977,AFL,Insurance,Q2,2021,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,685000000,cf
4484,Aflac,0000004977,AFL,Insurance,Q2,2021,Available for sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,3365000000,cf
4485,Aflac,0000004977,AFL,Insurance,Q2,2021,Interest paid,InterestPaidNet,usd,109000000,cf
4486,Aflac,0000004977,AFL,Insurance,Q2,2021,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,592000000,cf
4487,Aflac,0000004977,AFL,Insurance,Q2,2021,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,592000000,cf
4488,Aflac,0000004977,AFL,Insurance,Q2,2021,Noncash interest,OtherNoncashExpense,usd,14000000,cf
4489,Aflac,0000004977,AFL,Insurance,Q2,2021,Net investment (gains) losses,GainLossOnInvestments,usd,396000000,cf
4490,Aflac,0000004977,AFL,Insurance,Q2,2021,Net investment (gains) losses,GainLossOnInvestments,usd,396000000,cf
4491,Aflac,0000004977,AFL,Insurance,Q2,2021,Net investment (gains) losses,GainLossOnInvestments,usd,396000000,cf
4492,Aflac,0000004977,AFL,Insurance,Q2,2021,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,98000000,cf
4493,Aflac,0000004977,AFL,Insurance,Q2,2021,Net earnings,NetIncomeLoss,usd,2398000000,cf
4494,Aflac,0000004977,AFL,Insurance,Q2,2021,Net earnings,NetIncomeLoss,usd,2398000000,cf
4495,Aflac,0000004977,AFL,Insurance,Q2,2021,Net earnings,NetIncomeLoss,usd,2398000000,cf
4496,Aflac,0000004977,AFL,Insurance,Q1,2022,Total policy liabilities,afl:TotalPolicyLiabilities,usd,99643000000,bs
4497,Aflac,0000004977,AFL,Insurance,Q1,2022,Unpaid policy claims,LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet,usd,4754000000,bs
4498,Aflac,0000004977,AFL,Insurance,Q1,2022,Total liabilities and shareholders’ equity,LiabilitiesAndStockholdersEquity,usd,147046000000,bs
4499,Aflac,0000004977,AFL,Insurance,Q1,2022,Other investments,OtherInvestments,usd,3960000000,bs
4500,Aflac,0000004977,AFL,Insurance,Q1,2022,Other investments,OtherInvestments,usd,3960000000,bs
4501,Aflac,0000004977,AFL,Insurance,Q1,2022,"Treasury stock, at average cost",TreasuryStockValue,usd,18694000000,bs
4502,Aflac,0000004977,AFL,Insurance,Q1,2022,Unrealized foreign currency translation gains (losses),AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,usd,-2482000000,bs
4503,Aflac,0000004977,AFL,Insurance,Q1,2022,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,7768000000,bs
4504,Aflac,0000004977,AFL,Insurance,Q1,2022,Notes payable and lease obligations,DebtAndCapitalLeaseObligations,usd,7768000000,bs
4505,Aflac,0000004977,AFL,Insurance,Q1,2022,Retained earnings,RetainedEarningsAccumulatedDeficit,usd,42413000000,bs
4506,Aflac,0000004977,AFL,Insurance,Q1,2022,Total liabilities,Liabilities,usd,117519000000,bs
4507,Aflac,0000004977,AFL,Insurance,Q1,2022,Income taxes,TaxesPayableCurrentAndNoncurrent,usd,3503000000,bs
4508,Aflac,0000004977,AFL,Insurance,Q1,2022,"Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2022 and 2021; issued 1,353,780 shares in 2022 and 1,352,739 shares in 2021",CommonStockValue,usd,135000000,bs
4509,Aflac,0000004977,AFL,Insurance,Q1,2022,Commitments and contingent liabilities (Note 12),CommitmentsAndContingencies,usd,N/A,bs
4510,Aflac,0000004977,AFL,Insurance,Q1,2022,Future policy benefits,LiabilityForFuturePolicyBenefits,usd,85866000000,bs
4511,Aflac,0000004977,AFL,Insurance,Q1,2022,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,12312000000,bs
4512,Aflac,0000004977,AFL,Insurance,Q1,2022,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,12312000000,bs
4513,Aflac,0000004977,AFL,Insurance,Q1,2022,Commercial mortgage and other loans,LoansAndLeasesReceivableNetReportedAmount,usd,12312000000,bs
4514,Aflac,0000004977,AFL,Insurance,Q1,2022,"Property and equipment, at cost less accumulated depreciation",PropertyPlantAndEquipmentNet,usd,538000000,bs
4515,Aflac,0000004977,AFL,Insurance,Q1,2022,Other,OtherLiabilities,usd,4407000000,bs
4516,Aflac,0000004977,AFL,Insurance,Q1,2022,Receivables,PremiumsAndOtherReceivablesNet,usd,730000000,bs
4517,Aflac,0000004977,AFL,Insurance,Q1,2022,Additional paid-in capital,AdditionalPaidInCapitalCommonStock,usd,2560000000,bs
4518,Aflac,0000004977,AFL,Insurance,Q1,2022,Unrealized gains (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5787000000,bs
4519,Aflac,0000004977,AFL,Insurance,Q1,2022,Unrealized gains (losses) on fixed maturity securities,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,usd,5787000000,bs
4520,Aflac,0000004977,AFL,Insurance,Q1,2022,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,20672000000,bs
4521,Aflac,0000004977,AFL,Insurance,Q1,2022,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,20672000000,bs
4522,Aflac,0000004977,AFL,Insurance,Q1,2022,"Held to maturity, fixed maturity securities",DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss,usd,20672000000,bs
4523,Aflac,0000004977,AFL,Insurance,Q1,2022,Other policyholders’ funds,OtherPolicyholderFunds,usd,6705000000,bs
4524,Aflac,0000004977,AFL,Insurance,Q1,2022,Other policyholders’ funds,OtherPolicyholderFunds,usd,6705000000,bs
4525,Aflac,0000004977,AFL,Insurance,Q1,2022,Pension liability adjustment,AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax,usd,163000000,bs
4526,Aflac,0000004977,AFL,Insurance,Q1,2022,Cash and cash equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4275000000,bs
4527,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,EquitySecuritiesFvNi,usd,1415000000,bs
4528,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,EquitySecuritiesFvNi,usd,1415000000,bs
4529,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,EquitySecuritiesFvNi,usd,1415000000,bs
4530,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,EquitySecuritiesFvNi,usd,1415000000,bs
4531,Aflac,0000004977,AFL,Insurance,Q1,2022,Other,OtherAssets,usd,3414000000,bs
4532,Aflac,0000004977,AFL,Insurance,Q1,2022,Payables for return of cash collateral on loaned securities,ObligationToReturnSecuritiesReceivedAsCollateral,usd,2198000000,bs
4533,Aflac,0000004977,AFL,Insurance,Q1,2022,Unrealized gains (losses) on derivatives,AociLossCashFlowHedgeCumulativeGainLossAfterTax,usd,-29000000,bs
4534,Aflac,0000004977,AFL,Insurance,Q1,2022,Total shareholders’ equity,StockholdersEquity,usd,29527000000,bs
4535,Aflac,0000004977,AFL,Insurance,Q1,2022,Total shareholders’ equity,StockholdersEquity,usd,29527000000,bs
4536,Aflac,0000004977,AFL,Insurance,Q1,2022,Deferred policy acquisition costs,DeferredPolicyAcquisitionCosts,usd,9082000000,bs
4537,Aflac,0000004977,AFL,Insurance,Q1,2022,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,89965000000,bs
4538,Aflac,0000004977,AFL,Insurance,Q1,2022,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,89965000000,bs
4539,Aflac,0000004977,AFL,Insurance,Q1,2022,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,89965000000,bs
4540,Aflac,0000004977,AFL,Insurance,Q1,2022,"Available for sale, fixed maturity securities",AvailableForSaleSecuritiesDebtSecurities,usd,89965000000,bs
4541,Aflac,0000004977,AFL,Insurance,Q1,2022,Accrued investment income,AccruedInvestmentIncomeReceivable,usd,683000000,bs
4542,Aflac,0000004977,AFL,Insurance,Q1,2022,Unearned premiums,UnearnedPremiums,usd,2318000000,bs
4543,Aflac,0000004977,AFL,Insurance,Q1,2022,Total assets,Assets,usd,147046000000,bs
4544,Aflac,0000004977,AFL,Insurance,Q1,2022,Total assets,Assets,usd,147046000000,bs
4545,Aflac,0000004977,AFL,Insurance,Q1,2022,Total investments and cash,InvestmentsAndCash,usd,132599000000,bs
4546,Aflac,0000004977,AFL,Insurance,Q1,2022,Effect of exchange rate changes on cash and cash equivalents,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,usd,-89000000,cf
4547,Aflac,0000004977,AFL,Insurance,Q1,2022,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,322000000,cf
4548,Aflac,0000004977,AFL,Insurance,Q1,2022,Amortization of deferred policy acquisition costs,DeferredPolicyAcquisitionCostAmortizationExpense,usd,322000000,cf
4549,Aflac,0000004977,AFL,Insurance,Q1,2022,"Other, net",OtherNoncashIncomeExpense,usd,206000000,cf
4550,Aflac,0000004977,AFL,Insurance,Q1,2022,Change in receivables and advance premiums,IncreaseDecreaseInReceivables,usd,30000000,cf
4551,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,PaymentsToAcquireEquitySecuritiesFvNi,usd,114000000,cf
4552,Aflac,0000004977,AFL,Insurance,Q1,2022,Commercial mortgage and other loans,PaymentsToAcquireLoansReceivable,usd,1161000000,cf
4553,Aflac,0000004977,AFL,Insurance,Q1,2022,Change in income tax liabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,321000000,cf
4554,Aflac,0000004977,AFL,Insurance,Q1,2022,"Other, net",PaymentsForProceedsFromOtherInvestingActivities,usd,-41000000,cf
4555,Aflac,0000004977,AFL,Insurance,Q1,2022,Dividends paid to shareholders,PaymentsOfDividends,usd,250000000,cf
4556,Aflac,0000004977,AFL,Insurance,Q1,2022,Income taxes paid,IncomeTaxesPaidNet,usd,-77000000,cf
4557,Aflac,0000004977,AFL,Insurance,Q1,2022,Equity securities,ProceedsFromSaleOfEquitySecuritiesFvNi,usd,102000000,cf
4558,Aflac,0000004977,AFL,Insurance,Q1,2022,Available-for-sale fixed maturity securities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,usd,707000000,cf
4559,Aflac,0000004977,AFL,Insurance,Q1,2022,Net cash provided (used) by financing activities,NetCashProvidedByUsedInFinancingActivities,usd,-737000000,cf
4560,Aflac,0000004977,AFL,Insurance,Q1,2022,"Other, net",ProceedsFromPaymentsForOtherFinancingActivities,usd,25000000,cf
4561,Aflac,0000004977,AFL,Insurance,Q1,2022,Available-for-sale fixed maturity securities,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,usd,545000000,cf
4562,Aflac,0000004977,AFL,Insurance,Q1,2022,Noncash interest,OtherNoncashExpense,usd,19000000,cf
4563,Aflac,0000004977,AFL,Insurance,Q1,2022,Lease obligations,CapitalLeaseObligationsIncurred,usd,73000000,cf
4564,Aflac,0000004977,AFL,Insurance,Q1,2022,"Other investments, net",afl:PaymentsForProceedsFromOtherInvestmentsNet,usd,138000000,cf
4565,Aflac,0000004977,AFL,Insurance,Q1,2022,Net investment (gains) losses,GainLossOnInvestments,usd,122000000,cf
4566,Aflac,0000004977,AFL,Insurance,Q1,2022,Net investment (gains) losses,GainLossOnInvestments,usd,122000000,cf
4567,Aflac,0000004977,AFL,Insurance,Q1,2022,Net investment (gains) losses,GainLossOnInvestments,usd,122000000,cf
4568,Aflac,0000004977,AFL,Insurance,Q1,2022,Proceeds from borrowings,ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet,usd,0,cf
4569,Aflac,0000004977,AFL,Insurance,Q1,2022,"Change in investment-type contracts, net",NetChangeAnnuitiesAndInvestmentCertificates,usd,-21000000,cf
4570,Aflac,0000004977,AFL,Insurance,Q1,2022,Capitalization of deferred policy acquisition costs,afl:CapitalizationofDeferredPolicyAcquisitionCosts,usd,255000000,cf
4571,Aflac,0000004977,AFL,Insurance,Q1,2022,Net earnings,NetIncomeLoss,usd,1032000000,cf
4572,Aflac,0000004977,AFL,Insurance,Q1,2022,Net earnings,NetIncomeLoss,usd,1032000000,cf
4573,Aflac,0000004977,AFL,Insurance,Q1,2022,Net earnings,NetIncomeLoss,usd,1032000000,cf
4574,Aflac,0000004977,AFL,Insurance,Q1,2022,Net earnings,NetIncomeLoss,usd,1032000000,cf
4575,Aflac,0000004977,AFL,Insurance,Q1,2022,"Cash received (pledged or returned) as collateral, net",afl:IncreaseDecreaseInCollateralHeldForSecuritiesLendingAndDerivatives,usd,-142000000,cf
4576,Aflac,0000004977,AFL,Insurance,Q1,2022,Increase in policy liabilities,IncreaseDecreaseInInsuranceLiabilities,usd,198000000,cf
4577,Aflac,0000004977,AFL,Insurance,Q1,2022,Treasury stock reissued,ProceedsFromSaleOfTreasuryStock,usd,9000000,cf
4578,Aflac,0000004977,AFL,Insurance,Q1,2022,Purchases of treasury stock,PaymentsForRepurchaseOfCommonStock,usd,500000000,cf
4579,Aflac,0000004977,AFL,Insurance,Q1,2022,Interest paid,InterestPaidNet,usd,37000000,cf
4580,Aflac,0000004977,AFL,Insurance,Q1,2022,Net change in cash and cash equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-776000000,cf
4581,Aflac,0000004977,AFL,Insurance,Q1,2022,Net cash provided (used) by operating activities,NetCashProvidedByUsedInOperatingActivities,usd,1260000000,cf
4582,Aflac,0000004977,AFL,Insurance,Q1,2022,Commercial mortgage and other loans,ProceedsFromSaleAndCollectionOfLoansReceivable,usd,638000000,cf
4583,Aflac,0000004977,AFL,Insurance,Q1,2022,Net cash provided (used) by investing activities,NetCashProvidedByUsedInInvestingActivities,usd,-1210000000,cf
4584,Aflac,0000004977,AFL,Insurance,Q1,2022,"Settlement of derivatives, net",PaymentsForProceedsFromHedgeInvestingActivities,usd,558000000,cf
4585,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,8268000,bs
4586,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,120380000,bs
4587,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,"Inventory, net",InventoryNet,usd,134423000,bs
4588,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,14444000,bs
4589,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Current Assets:,AssetsCurrent,usd,277515000,bs
4590,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,122646000,bs
4591,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other Assets,OtherAssetsNoncurrent,usd,15738000,bs
4592,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,94364000,bs
4593,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,117565000,bs
4594,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Total Assets,Assets,usd,627828000,bs
4595,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2651000,bs
4596,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accounts Payable,AccountsPayableCurrent,usd,30840000,bs
4597,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,30504000,bs
4598,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Customer Advance Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,20095000,bs
4599,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Current Liabilities:,LiabilitiesCurrent,usd,84090000,bs
4600,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Long-term Debt,LongTermDebtNoncurrent,usd,160315000,bs
4601,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other Liabilities,OtherLiabilitiesNoncurrent,usd,35700000,bs
4602,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Current Liabilities:,Liabilities,usd,280105000,bs
4603,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Common Stock,CommonStockValue,usd,297000,bs
4604,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-12741000,bs
4605,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,360167000,bs
4606,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Beginning of Period,StockholdersEquity,usd,347723000,bs
4607,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,627828000,bs
4608,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Net Income,NetIncomeLoss,usd,19272000,cf
4609,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,12587000,cf
4610,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,918000,cf
4611,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Stock Compensation Expense,ShareBasedCompensation,usd,1456000,cf
4612,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-536000,cf
4613,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other,OtherNoncashIncomeExpense,usd,804000,cf
4614,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,7076000,cf
4615,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Inventories,IncreaseDecreaseInInventories,usd,10453000,cf
4616,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,3349000,cf
4617,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-7106000,cf
4618,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,2668000,cf
4619,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,-4143000,cf
4620,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-1028000,cf
4621,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,758000,cf
4622,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,4526000,cf
4623,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Business acquisition purchase price paid in cash,PaymentsToAcquireBusinessesNetOfCashAcquired,usd,10223000,cf
4624,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,5750000,cf
4625,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-186000,cf
4626,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-15787000,cf
4627,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,22000000,cf
4628,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,7341000,cf
4629,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,13524000,cf
4630,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,0,cf
4631,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,317000,cf
4632,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Income Tax Benefit from Exercise of Stock Options,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
4633,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,1452000,cf
4634,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,176000,cf
4635,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2017,(Decrease) Increase in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-9633000,cf
4636,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Cash and Cash Equivalents at Beginning of Year,CashAndCashEquivalentsAtCarryingValue,usd,17901000,bs
4637,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accounts Receivable,AccountsReceivableNetCurrent,usd,109415000,bs
4638,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Total Inventory,InventoryNet,usd,116597000,bs
4639,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,11160000,bs
4640,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Current Assets:,AssetsCurrent,usd,255073000,bs
4641,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Land,Land,usd,11112000,bs
4642,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Buildings and Improvements,BuildingsAndImprovementsGross,usd,79191000,bs
4643,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Machinery and Equipment,MachineryAndEquipmentGross,usd,93683000,bs
4644,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Construction in Progress,ConstructionInProgressGross,usd,8182000,bs
4645,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,"Total Property, Plant and Equipment, at Cost",PropertyPlantAndEquipmentGross,usd,192168000,bs
4646,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Less Accumulated Depreciation,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,69356000,bs
4647,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,122812000,bs
4648,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Other Assets,OtherAssetsNoncurrent,usd,13149000,bs
4649,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,98103000,bs
4650,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Goodwill and Intangible Assets,Goodwill,usd,115207000,bs
4651,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Total Assets,Assets,usd,604344000,bs
4652,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2636000,bs
4653,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accounts Payable,AccountsPayableCurrent,usd,25070000,bs
4654,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accrued Payroll and Employee Benefits,EmployeeRelatedLiabilitiesCurrent,usd,24743000,bs
4655,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accrued Income Taxes,AccruedIncomeTaxesCurrent,usd,62000,bs
4656,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Other Accrued Expenses,AccountsPayableAndOtherAccruedLiabilitiesCurrent,usd,10881000,bs
4657,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Customer Advanced Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,23168000,bs
4658,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Current Liabilities:,LiabilitiesCurrent,usd,86560000,bs
4659,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Long-term Debt,LongTermDebtNoncurrent,usd,145484000,bs
4660,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Supplemental Retirement Plan and Other Liabilities for Pension Benefits,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,22140000,bs
4661,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Other Liabilities,OtherLiabilitiesNoncurrent,usd,1414000,bs
4662,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Deferred Tax Liabilities — Long-term,DeferredIncomeTaxLiabilitiesNet,usd,11297000,bs
4663,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,LIABILITIES AND SHAREHOLDERS’ EQUITY,Liabilities,usd,266895000,bs
4664,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Additional Paid-in Capital,AdditionalPaidInCapitalCommonStock,usd,64752000,bs
4665,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15494000,bs
4666,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Retained Earnings,RetainedEarningsAccumulatedDeficit,usd,305512000,bs
4667,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Purchase of Shares,TreasuryStockValue,usd,17618000,bs
4668,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Shareholders' Equity,StockholdersEquity,usd,337449000,bs
4669,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,LIABILITIES AND SHAREHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,604344000,bs
4670,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Net Income,NetIncomeLoss,usd,48424000,cf
4671,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Total Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,25790000,cf
4672,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Provision for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,2404000,cf
4673,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Year 1,ShareBasedCompensation,usd,2281000,cf
4674,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-4756000,cf
4675,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Non-cash Adjustment to Contingent Consideration,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,0,cf
4676,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Other,OtherNoncashIncomeExpense,usd,-165000,cf
4677,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,14622000,cf
4678,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Inventories,IncreaseDecreaseInInventories,usd,2671000,cf
4679,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Prepaid Expenses and Other Current Assets,IncreaseDecreaseInPrepaidExpense,usd,-108000,cf
4680,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-2000000,cf
4681,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-174000,cf
4682,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Income Taxes Payable,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,7926000,cf
4683,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,-15539000,cf
4684,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1518000,cf
4685,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Cash Provided By Operating Activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,48854000,cf
4686,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Business acquisition purchase price paid in cash,PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
4687,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Total Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,13037000,cf
4688,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Other,PaymentsForProceedsFromOtherInvestingActivities,usd,1585000,cf
4689,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Cash Used For Investing Activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-14622000,cf
4690,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Proceeds From Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,20000000,cf
4691,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,41835000,cf
4692,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,17618000,cf
4693,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,0,cf
4694,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,3813000,cf
4695,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Excess Tax Benefit from Exercise of Stock Options,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,834000,cf
4696,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Cash Used For Financing Activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-34806000,cf
4697,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-86000,cf
4698,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Decrease in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-660000,cf
4699,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,Interest Paid,InterestPaid,usd,4536000,cf
4700,Astronics Corp,0000008063,ATRO,Aerospace,FY,2016,"Income Taxes Paid, Net of Refunds",IncomeTaxesPaidNet,usd,15898000,cf
4701,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,15377000,bs
4702,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,114985000,bs
4703,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Inventories,InventoryNet,usd,139265000,bs
4704,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,16044000,bs
4705,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Current Assets:,AssetsCurrent,usd,285671000,bs
4706,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,124281000,bs
4707,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other Assets,OtherAssetsNoncurrent,usd,16503000,bs
4708,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,95055000,bs
4709,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,119118000,bs
4710,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Current Assets:,Assets,usd,640628000,bs
4711,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2695000,bs
4712,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accounts Payable,AccountsPayableCurrent,usd,35876000,bs
4713,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,32533000,bs
4714,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Customer Advance Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,21988000,bs
4715,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Current Liabilities:,LiabilitiesCurrent,usd,93092000,bs
4716,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Long-term Debt,LongTermDebtNoncurrent,usd,174652000,bs
4717,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other Liabilities,OtherLiabilitiesNoncurrent,usd,35554000,bs
4718,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Current Liabilities:,Liabilities,usd,303298000,bs
4719,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Common Stock,CommonStockValue,usd,297000,bs
4720,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-11115000,bs
4721,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,348148000,bs
4722,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Shareholders' Equity,StockholdersEquity,usd,337330000,bs
4723,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,640628000,bs
4724,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Net Income,NetIncomeLoss,usd,25332000,cf
4725,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,19269000,cf
4726,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,943000,cf
4727,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Stock Compensation Expense,ShareBasedCompensation,usd,2203000,cf
4728,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-920000,cf
4729,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other,OtherNoncashIncomeExpense,usd,657000,cf
4730,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,1515000,cf
4731,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Inventories,IncreaseDecreaseInInventories,usd,18480000,cf
4732,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,8267000,cf
4733,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-5483000,cf
4734,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,4556000,cf
4735,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,-2336000,cf
4736,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-883000,cf
4737,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1129000,cf
4738,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,22313000,cf
4739,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Business acquisition purchase price paid in cash,PaymentsToAcquireBusinessesNetOfCashAcquired,usd,10199000,cf
4740,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,9715000,cf
4741,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,2070000,cf
4742,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-21984000,cf
4743,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,42000000,cf
4744,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,13031000,cf
4745,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,32382000,cf
4746,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,0,cf
4747,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,349000,cf
4748,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Income Tax Benefit from Exercise of Stock Options,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
4749,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-3064000,cf
4750,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,211000,cf
4751,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2017,Decrease in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-2524000,cf
4752,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,17914000,bs
4753,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accounts Receivable,AccountsReceivableNetCurrent,usd,132633000,bs
4754,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Inventories,InventoryNet,usd,150196000,bs
4755,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,14586000,bs
4756,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Current Assets:,AssetsCurrent,usd,315329000,bs
4757,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Land,Land,usd,11237000,bs
4758,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Buildings and Improvements,BuildingsAndImprovementsGross,usd,81872000,bs
4759,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Machinery and Equipment,MachineryAndEquipmentGross,usd,105827000,bs
4760,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Construction in Progress,ConstructionInProgressGross,usd,9761000,bs
4761,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,"Total Property, Plant and Equipment, at Cost",PropertyPlantAndEquipmentGross,usd,208697000,bs
4762,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Less Accumulated Depreciation,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,usd,82867000,bs
4763,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,125830000,bs
4764,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Other Assets,OtherAssetsNoncurrent,usd,15659000,bs
4765,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,153493000,bs
4766,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Impairment Loss,Goodwill,usd,125645000,bs
4767,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,ASSETS,Assets,usd,735956000,bs
4768,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2689000,bs
4769,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accounts Payable,AccountsPayableCurrent,usd,41846000,bs
4770,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accrued Payroll and Employee Benefits,EmployeeRelatedLiabilitiesCurrent,usd,24890000,bs
4771,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accrued Income Taxes,AccruedIncomeTaxesCurrent,usd,261000,bs
4772,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Other Accrued Expenses,AccountsPayableAndOtherAccruedLiabilitiesCurrent,usd,13598000,bs
4773,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Customer Advanced Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,19607000,bs
4774,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Current Liabilities:,LiabilitiesCurrent,usd,102891000,bs
4775,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Long-term Debt,LongTermDebtNoncurrent,usd,269078000,bs
4776,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Supplemental Retirement Plan and Other Liabilities for Pension Benefits,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,26030000,bs
4777,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Other Liabilities,OtherLiabilitiesNoncurrent,usd,2909000,bs
4778,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Deferred Tax Liabilities — Long-term,DeferredIncomeTaxLiabilitiesNet,usd,5121000,bs
4779,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,LIABILITIES AND SHAREHOLDERS’ EQUITY,Liabilities,usd,406029000,bs
4780,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Additional Paid-in Capital,AdditionalPaidInCapitalCommonStock,usd,67791000,bs
4781,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-13352000,bs
4782,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Retained Earnings,RetainedEarningsAccumulatedDeficit,usd,325191000,bs
4783,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,"Treasury Stock; 1,674,714 Shares at December 31, 2017, 532,132 Shares at December 31, 2016",TreasuryStockValue,usd,50000000,bs
4784,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Shareholders' Equity,StockholdersEquity,usd,329927000,bs
4785,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,LIABILITIES AND SHAREHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,735956000,bs
4786,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Net Income,NetIncomeLoss,usd,19679000,cf
4787,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Impairment Loss,GoodwillImpairmentLoss,usd,16237000,cf
4788,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Total Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,27063000,cf
4789,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Provision for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,2973000,cf
4790,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Share-based Compensation Arrangement by Share-based Payment Award,ShareBasedCompensation,usd,2598000,cf
4791,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Deferred,DeferredIncomeTaxExpenseBenefit,usd,-5494000,cf
4792,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Non-cash Adjustment to Contingent Consideration,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,0,cf
4793,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Other,OtherNoncashIncomeExpense,usd,937000,cf
4794,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,9844000,cf
4795,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Inventories,IncreaseDecreaseInInventories,usd,18116000,cf
4796,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Prepaid Expenses and Other Current Assets,IncreaseDecreaseInPrepaidExpense,usd,2132000,cf
4797,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,10439000,cf
4798,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-702000,cf
4799,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Income Taxes Payable,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-376000,cf
4800,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,-4918000,cf
4801,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1313000,cf
4802,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Cash Provided By Operating Activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,37783000,cf
4803,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Business acquisition purchase price paid in cash,PaymentsToAcquireBusinessesNetOfCashAcquired,usd,114039000,cf
4804,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Total Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,13478000,cf
4805,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Other,PaymentsForProceedsFromOtherInvestingActivities,usd,2044000,cf
4806,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Cash Used For Investing Activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-129561000,cf
4807,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Proceeds From Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,147086000,cf
4808,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,23720000,cf
4809,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,32382000,cf
4810,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,441000,cf
4811,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Excess Tax Benefit from Exercise of Stock Options,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,0,cf
4812,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Cash Provided by (Used for) Financing Activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,91425000,cf
4813,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,366000,cf
4814,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Increase (Decrease) in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,13000,cf
4815,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,Interest Paid,InterestPaid,usd,4775000,cf
4816,Astronics Corp,0000008063,ATRO,Aerospace,FY,2017,"Income Taxes Paid, Net of Refunds",IncomeTaxesPaidNet,usd,10777000,cf
4817,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Cash and Cash Equivalents at Beginning of Period,CashAndCashEquivalentsAtCarryingValue,usd,16387000,bs
4818,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,157650000,bs
4819,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Inventories,InventoryNet,usd,159961000,bs
4820,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,15895000,bs
4821,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Current Assets:,AssetsCurrent,usd,349893000,bs
4822,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,"Property, plant and equipment, net",PropertyPlantAndEquipmentNet,usd,124762000,bs
4823,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Other Assets,OtherAssetsNoncurrent,usd,19693000,bs
4824,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,147592000,bs
4825,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Goodwill and Intangible Assets Disclosure [Abstract],Goodwill,usd,125630000,bs
4826,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Total Assets,Assets,usd,767570000,bs
4827,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2478000,bs
4828,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accounts Payable,AccountsPayableCurrent,usd,61387000,bs
4829,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,36510000,bs
4830,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Customer Advance Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,22164000,bs
4831,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Current Liabilities:,LiabilitiesCurrent,usd,122539000,bs
4832,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Long-term Debt,LongTermDebtNoncurrent,usd,273627000,bs
4833,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Other Liabilities,OtherLiabilitiesNoncurrent,usd,33376000,bs
4834,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Current Liabilities:,Liabilities,usd,429542000,bs
4835,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Common Stock,CommonStockValue,usd,298000,bs
4836,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-14277000,bs
4837,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,352007000,bs
4838,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Beginning of Period,StockholdersEquity,usd,338028000,bs
4839,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,767570000,bs
4840,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Net Income,NetIncomeLoss,usd,3294000,cf
4841,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,9841000,cf
4842,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,564000,cf
4843,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Stock Compensation Expense,ShareBasedCompensation,usd,931000,cf
4844,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-1128000,cf
4845,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Other,OtherNoncashIncomeExpense,usd,467000,cf
4846,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,20868000,cf
4847,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Inventories,IncreaseDecreaseInInventories,usd,18204000,cf
4848,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,19418000,cf
4849,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-3194000,cf
4850,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,3474000,cf
4851,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,10482000,cf
4852,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,1303000,cf
4853,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,448000,cf
4854,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,-1054000,cf
4855,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,4346000,cf
4856,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-4346000,cf
4857,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,15000000,cf
4858,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,10705000,cf
4859,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,0,cf
4860,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,516000,cf
4861,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,160000,cf
4862,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,3939000,cf
4863,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-66000,cf
4864,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2018,Decrease in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-1527000,cf
4865,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,10608000,bs
4866,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,169496000,bs
4867,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Inventories,InventoryNet,usd,159479000,bs
4868,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,13912000,bs
4869,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Current Assets:,AssetsCurrent,usd,353495000,bs
4870,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,124696000,bs
4871,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other Assets,OtherAssetsNoncurrent,usd,18451000,bs
4872,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,142544000,bs
4873,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Goodwill,Goodwill,usd,125237000,bs
4874,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Current Assets:,Assets,usd,764423000,bs
4875,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,2190000,bs
4876,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accounts Payable,AccountsPayableCurrent,usd,49580000,bs
4877,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,38590000,bs
4878,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiability,usd,25429000,bs
4879,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Current Liabilities:,LiabilitiesCurrent,usd,115789000,bs
4880,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Long-term Debt,LongTermDebtNoncurrent,usd,263155000,bs
4881,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other Liabilities,OtherLiabilitiesNoncurrent,usd,34189000,bs
4882,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Current Liabilities:,Liabilities,usd,413133000,bs
4883,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Common Stock,CommonStockValue,usd,298000,bs
4884,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15867000,bs
4885,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,366859000,bs
4886,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Shareholders’ Equity:,StockholdersEquity,usd,351290000,bs
4887,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,764423000,bs
4888,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Net Income,NetIncomeLoss,usd,17319000,cf
4889,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,18584000,cf
4890,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,1819000,cf
4891,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Stock Compensation Expense,ShareBasedCompensation,usd,1637000,cf
4892,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-516000,cf
4893,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other,OtherNoncashIncomeExpense,usd,431000,cf
4894,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,33347000,cf
4895,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Inventories,IncreaseDecreaseInInventories,usd,19761000,cf
4896,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,7981000,cf
4897,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,53000,cf
4898,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,404000,cf
4899,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Customer Advanced Payments and Deferred Revenue,atro:IncreaseDecreaseInContractWithCustomerLiability,usd,14469000,cf
4900,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-189000,cf
4901,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,896000,cf
4902,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,8110000,cf
4903,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,"Acquisition of Business, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,0,cf
4904,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,8495000,cf
4905,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,0,cf
4906,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-8495000,cf
4907,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,30015000,cf
4908,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,36416000,cf
4909,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,0,cf
4910,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,516000,cf
4911,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,281000,cf
4912,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-6636000,cf
4913,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-285000,cf
4914,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2018,Decrease in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-7306000,cf
4915,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,4893000,bs
4916,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,189110000,bs
4917,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Inventories,InventoryNet,usd,154870000,bs
4918,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,17155000,bs
4919,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Total Current Assets,AssetsCurrent,usd,366028000,bs
4920,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,124652000,bs
4921,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other Assets,OtherAssetsNoncurrent,usd,21893000,bs
4922,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,138347000,bs
4923,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Acquisition/Adjustments,Goodwill,usd,125136000,bs
4924,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Assets,Assets,usd,776056000,bs
4925,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,1965000,bs
4926,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accounts Payable,AccountsPayableCurrent,usd,42184000,bs
4927,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,43338000,bs
4928,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,30186000,bs
4929,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Total Current Liabilities,LiabilitiesCurrent,usd,117673000,bs
4930,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Long-term Debt,LongTermDebtNoncurrent,usd,257680000,bs
4931,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other Liabilities,OtherLiabilitiesNoncurrent,usd,31258000,bs
4932,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Liabilities,Liabilities,usd,406611000,bs
4933,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Common Stock,CommonStockValue,usd,341000,bs
4934,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15425000,bs
4935,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,384529000,bs
4936,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Shareholders' Equity,StockholdersEquity,usd,369445000,bs
4937,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,776056000,bs
4938,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Net Income,NetIncomeLoss,usd,34318000,cf
4939,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,26756000,cf
4940,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,2432000,cf
4941,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Stock Compensation Expense,ShareBasedCompensation,usd,2349000,cf
4942,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-1536000,cf
4943,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other,OtherNoncashIncomeExpense,usd,507000,cf
4944,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,52890000,cf
4945,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Inventories,IncreaseDecreaseInInventories,usd,15768000,cf
4946,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,571000,cf
4947,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,4977000,cf
4948,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,1620000,cf
4949,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,19241000,cf
4950,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-4315000,cf
4951,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1351000,cf
4952,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,15359000,cf
4953,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,"Acquisition of Business, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
4954,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,12416000,cf
4955,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,3376000,cf
4956,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-15792000,cf
4957,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,35015000,cf
4958,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,47116000,cf
4959,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
4960,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,516000,cf
4961,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,283000,cf
4962,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-12334000,cf
4963,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-254000,cf
4964,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2018,Decrease in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-13021000,cf
4965,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Cash and Cash Equivalents,CashAndCashEquivalentsAtCarryingValue,usd,16622000,bs
4966,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,182308000,bs
4967,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Inventories,InventoryNet,usd,138685000,bs
4968,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,17198000,bs
4969,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,19358000,bs
4970,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Total Current Assets,AssetsCurrent,usd,374171000,bs
4971,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,120862000,bs
4972,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Other Assets,OtherAssetsNoncurrent,usd,21272000,bs
4973,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,133383000,bs
4974,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Acquisition,Goodwill,usd,124952000,bs
4975,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,ASSETS,Assets,usd,774640000,bs
4976,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,1870000,bs
4977,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accounts Payable,AccountsPayableCurrent,usd,50664000,bs
4978,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accrued Payroll and Employee Benefits,EmployeeRelatedLiabilitiesCurrent,usd,31732000,bs
4979,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accrued Income Taxes,AccruedIncomeTaxesCurrent,usd,312000,bs
4980,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Other Accrued Expenses,AccountsPayableAndOtherAccruedLiabilitiesCurrent,usd,15728000,bs
4981,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Customer Advanced Payments and Deferred Revenue,DeferredRevenueAndCreditsCurrent,usd,26880000,bs
4982,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Liabilities Held for Sale,atro:LiabilitiesHeldForSaleNotPartOfDisposalGroupCurrent,usd,906000,bs
4983,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Total Current Liabilities,LiabilitiesCurrent,usd,128092000,bs
4984,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Long-term Debt,LongTermDebtNoncurrent,usd,232112000,bs
4985,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Supplemental Retirement Plan and Other Liabilities for Pension Benefits,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,22689000,bs
4986,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Other Liabilities,OtherLiabilitiesNoncurrent,usd,1923000,bs
4987,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Deferred Income Taxes,DeferredIncomeTaxLiabilitiesNet,usd,3199000,bs
4988,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Liabilities,Liabilities,usd,388015000,bs
4989,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Additional Paid-in Capital,AdditionalPaidInCapitalCommonStock,usd,73044000,bs
4990,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-13329000,bs
4991,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Retained Earnings,RetainedEarningsAccumulatedDeficit,usd,376567000,bs
4992,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Treasury Stock; 1,674,714 Shares at December 31, 2018, 1,674,714 Shares at December 31, 2017",TreasuryStockValue,usd,50000000,bs
4993,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Shareholders' Equity,StockholdersEquity,usd,386625000,bs
4994,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,774640000,bs
4995,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Net Income,NetIncomeLoss,usd,46803000,cf
4996,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,35032000,cf
4997,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Provision for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,3271000,cf
4998,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Weighted Average Exercise Price,ShareBasedCompensation,usd,3098000,cf
4999,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Deferred,DeferredIncomeTaxExpenseBenefit,usd,-2680000,cf
5000,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Impairment Loss,GoodwillImpairmentLoss,usd,N/A,cf
5001,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Other,OtherNoncashIncomeExpense,usd,668000,cf
5002,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,47291000,cf
5003,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Inventories,IncreaseDecreaseInInventories,usd,14695000,cf
5004,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Prepaid Expenses and Other Current Assets,IncreaseDecreaseInPrepaidExpense,usd,-464000,cf
5005,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,9171000,cf
5006,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,9177000,cf
5007,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Income Taxes Payable,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-4460000,cf
5008,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits,usd,15735000,cf
5009,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1924000,cf
5010,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Cash Provided By Operating Activities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,usd,54881000,cf
5011,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Acquisitions of Business, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
5012,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,16317000,cf
5013,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Other,PaymentsForProceedsFromOtherInvestingActivities,usd,3350000,cf
5014,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Cash Used For Investing Activities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,usd,-19667000,cf
5015,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Proceeds From Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,35015000,cf
5016,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,72834000,cf
5017,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
5018,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Payments of Debt Issuance Costs,PaymentsOfDebtIssuanceCosts,usd,516000,cf
5019,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,2201000,cf
5020,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Excess Tax Benefit from Exercise of Stock Options,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,usd,N/A,cf
5021,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Cash (Used for) Provided by Financing Activities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,usd,-36134000,cf
5022,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashAndCashEquivalents,usd,-372000,cf
5023,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,(Decrease) Increase in Cash and Cash Equivalents,CashAndCashEquivalentsPeriodIncreaseDecrease,usd,-1292000,cf
5024,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,Interest Paid,InterestPaid,usd,9710000,cf
5025,Astronics Corp,0000008063,ATRO,Aerospace,FY,2018,"Income Taxes Paid, Net of Refunds",IncomeTaxesPaidNet,usd,12218000,cf
5026,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,15966000,bs
5027,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,188564000,bs
5028,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Inventories,InventoryNet,usd,139090000,bs
5029,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,17796000,bs
5030,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
5031,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Total Current Assets,AssetsCurrent,usd,361416000,bs
5032,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,117307000,bs
5033,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other Assets,OtherAssetsNoncurrent,usd,47811000,bs
5034,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,129133000,bs
5035,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Goodwill,Goodwill,usd,124854000,bs
5036,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Assets Held for Sale,Assets,usd,780521000,bs
5037,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,112000,bs
5038,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accounts Payable,AccountsPayableCurrent,usd,48492000,bs
5039,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,68430000,bs
5040,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,30937000,bs
5041,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Liabilities Held for Sale,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent,usd,N/A,bs
5042,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Total Current Liabilities,LiabilitiesCurrent,usd,147971000,bs
5043,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Long-term Debt,LongTermDebtNoncurrent,usd,115194000,bs
5044,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other Liabilities,OtherLiabilitiesNoncurrent,usd,51353000,bs
5045,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Liabilities Held for Sale,Liabilities,usd,314518000,bs
5046,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Common Stock,CommonStockValue,usd,343000,bs
5047,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-13449000,bs
5048,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,479109000,bs
5049,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Shareholders' Equity,StockholdersEquity,usd,466003000,bs
5050,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,780521000,bs
5051,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Net Income,NetIncomeLoss,usd,78146000,cf
5052,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,8076000,cf
5053,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,2498000,cf
5054,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Equity-based Compensation Expense,ShareBasedCompensation,usd,1193000,cf
5055,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-3398000,cf
5056,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Gain on Sale of Business,GainLossOnSaleOfBusiness,usd,80133000,cf
5057,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other,OtherNoncashIncomeExpense,usd,-252000,cf
5058,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,6414000,cf
5059,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Inventories,IncreaseDecreaseInInventories,usd,5943000,cf
5060,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-2032000,cf
5061,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-9283000,cf
5062,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,2860000,cf
5063,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,4055000,cf
5064,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,26824000,cf
5065,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,373000,cf
5066,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,11354000,cf
5067,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Total cash proceeds of divesture,ProceedsFromDivestitureOfBusinesses,usd,103793000,cf
5068,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,3474000,cf
5069,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,100319000,cf
5070,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,10000000,cf
5071,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,122026000,cf
5072,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,N/A,cf
5073,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,159000,cf
5074,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Other Financing Activities,ProceedsFromPaymentsForOtherFinancingActivities,usd,-395000,cf
5075,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-112262000,cf
5076,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-67000,cf
5077,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2019,Decrease in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-656000,cf
5078,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,17106000,bs
5079,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,177102000,bs
5080,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Inventories,InventoryNet,usd,142853000,bs
5081,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,17587000,bs
5082,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
5083,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Total Current Assets,AssetsCurrent,usd,354648000,bs
5084,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,"Property, Plant and Equipment, Net",PropertyPlantAndEquipmentNet,usd,117389000,bs
5085,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other Assets,OtherAssetsNoncurrent,usd,45189000,bs
5086,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,125039000,bs
5087,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Acquisition/Adjustments,Goodwill,usd,124998000,bs
5088,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Assets Held for Sale,Assets,usd,767263000,bs
5089,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,170000,bs
5090,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accounts Payable,AccountsPayableCurrent,usd,42964000,bs
5091,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,51054000,bs
5092,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,25402000,bs
5093,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Liabilities Held for Sale,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent,usd,N/A,bs
5094,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Total Current Liabilities,LiabilitiesCurrent,usd,119590000,bs
5095,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Long-term Debt,LongTermDebtNoncurrent,usd,122113000,bs
5096,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other Liabilities,OtherLiabilitiesNoncurrent,usd,50594000,bs
5097,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Liabilities Held for Sale,Liabilities,usd,292297000,bs
5098,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Common Stock,CommonStockValue,usd,344000,bs
5099,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-12421000,bs
5100,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,487043000,bs
5101,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Shareholders' Equity,StockholdersEquity,usd,474966000,bs
5102,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,767263000,bs
5103,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Net Income,NetIncomeLoss,usd,84872000,cf
5104,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,15980000,cf
5105,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,4429000,cf
5106,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Equity-based Compensation Expense,ShareBasedCompensation,usd,2145000,cf
5107,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-3371000,cf
5108,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Gain on Sale of Business,GainLossOnSaleOfBusiness,usd,80133000,cf
5109,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other,OtherNoncashIncomeExpense,usd,-263000,cf
5110,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-5266000,cf
5111,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Inventories,IncreaseDecreaseInInventories,usd,11276000,cf
5112,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-7685000,cf
5113,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-9141000,cf
5114,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,975000,cf
5115,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-1234000,cf
5116,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,9181000,cf
5117,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,735000,cf
5118,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,9056000,cf
5119,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Total cash proceeds of divesture,ProceedsFromDivestitureOfBusinesses,usd,103793000,cf
5120,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,6917000,cf
5121,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,96876000,cf
5122,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,27000000,cf
5123,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,132053000,cf
5124,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,N/A,cf
5125,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,416000,cf
5126,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Other Financing Activities,ProceedsFromPaymentsForOtherFinancingActivities,usd,-834000,cf
5127,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-105471000,cf
5128,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,23000,cf
5129,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2019,Increase (Decrease) in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,484000,cf
5130,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,22795000,bs
5131,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,159715000,bs
5132,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Inventories,InventoryNet,usd,149621000,bs
5133,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,17576000,bs
5134,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Disposal Group, Including Discontinued Operation, Assets",AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,3186000,bs
5135,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Total Current Assets,AssetsCurrent,usd,352893000,bs
5136,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,113137000,bs
5137,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Assets,OtherAssetsNoncurrent,usd,45911000,bs
5138,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,132433000,bs
5139,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Goodwill,Goodwill,usd,133594000,bs
5140,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Disposal Group, Including Discontinued Operation, Assets",Assets,usd,777968000,bs
5141,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,191000,bs
5142,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accounts Payable,AccountsPayableCurrent,usd,46046000,bs
5143,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,49321000,bs
5144,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,23525000,bs
5145,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Liabilities Held for Sale,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent,usd,N/A,bs
5146,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Total Current Liabilities,LiabilitiesCurrent,usd,119083000,bs
5147,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Long-term Debt,LongTermDebtNoncurrent,usd,180055000,bs
5148,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Liabilities,OtherLiabilitiesNoncurrent,usd,53038000,bs
5149,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Liabilities Held for Sale,Liabilities,usd,352176000,bs
5150,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Common Stock,CommonStockValue,usd,344000,bs
5151,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-13610000,bs
5152,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,439058000,bs
5153,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Shareholders' Equity,StockholdersEquity,usd,425792000,bs
5154,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,777968000,bs
5155,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Net Income,NetIncomeLoss,usd,86082000,cf
5156,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,24183000,cf
5157,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,4613000,cf
5158,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Equity-based Compensation Expense,ShareBasedCompensation,usd,2943000,cf
5159,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-3820000,cf
5160,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Net (Gain) Loss on Sale of Businesses,GainLossOnSaleOfBusiness,usd,78801000,cf
5161,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other,OtherNoncashIncomeExpense,usd,792000,cf
5162,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-23423000,cf
5163,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Inventories,IncreaseDecreaseInInventories,usd,18963000,cf
5164,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-5494000,cf
5165,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-5867000,cf
5166,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,697000,cf
5167,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-3266000,cf
5168,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,5581000,cf
5169,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1116000,cf
5170,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,30241000,cf
5171,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,"Acquisition of Business, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,21785000,cf
5172,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Total cash proceeds of divesture,ProceedsFromDivestitureOfBusinesses,usd,104792000,cf
5173,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,8850000,cf
5174,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,N/A,cf
5175,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Cash Flows From Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,74157000,cf
5176,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,99000000,cf
5177,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,146080000,cf
5178,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,50000000,cf
5179,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,N/A,cf
5180,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Proceeds from Exercise of Stock Options,ProceedsFromStockOptionsExercised,usd,423000,cf
5181,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Other Financing Activities,ProceedsFromPaymentsForOtherFinancingActivities,usd,-1284000,cf
5182,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Cash Flows From Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-97941000,cf
5183,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-284000,cf
5184,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2019,Increase (Decrease) in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,6173000,cf
5185,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,31906000,bs
5186,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,147998000,bs
5187,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Inventories,InventoryNet,usd,145787000,bs
5188,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,15853000,bs
5189,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,1537000,bs
5190,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Total Current Assets,AssetsCurrent,usd,343081000,bs
5191,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,112499000,bs
5192,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,23602000,bs
5193,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Other Assets,OtherAssetsNoncurrent,usd,31271000,bs
5194,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,127293000,bs
5195,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Goodwill,Goodwill,usd,144970000,bs
5196,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Total Current Assets,Assets,usd,782716000,bs
5197,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,224000,bs
5198,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accounts Payable,AccountsPayableCurrent,usd,35842000,bs
5199,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accrued Payroll and Employee Benefits,EmployeeRelatedLiabilitiesCurrent,usd,22485000,bs
5200,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accrued Income Taxes,AccruedIncomeTaxesCurrent,usd,1080000,bs
5201,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4517000,bs
5202,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Other Accrued Expenses,AccountsPayableAndOtherAccruedLiabilitiesCurrent,usd,25132000,bs
5203,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Customer Advanced Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,31360000,bs
5204,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Liabilities Held for Sale,atro:LiabilitiesHeldForSaleNotPartOfDisposalGroupCurrent,usd,N/A,bs
5205,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Current Liabilities:,LiabilitiesCurrent,usd,120640000,bs
5206,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Long-term Debt,LongTermDebtNoncurrent,usd,188000000,bs
5207,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Supplemental Retirement Plan and Other Liabilities for Pension Benefits,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,27247000,bs
5208,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,21039000,bs
5209,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Other Liabilities,OtherLiabilitiesNoncurrent,usd,33011000,bs
5210,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Deferred Income Taxes,DeferredIncomeTaxLiabilitiesNet,usd,3922000,bs
5211,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Current Liabilities:,Liabilities,usd,393859000,bs
5212,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Additional Paid-in Capital,AdditionalPaidInCapitalCommonStock,usd,76340000,bs
5213,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15628000,bs
5214,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Retained Earnings,RetainedEarningsAccumulatedDeficit,usd,428584000,bs
5215,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Treasury Stock; 3,526,018 Shares at December 31, 2019, 1,674,714 Shares at December 31, 2018",TreasuryStockValue,usd,100784000,bs
5216,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Shareholders’ Equity:,StockholdersEquity,usd,388857000,bs
5217,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,LIABILITIES AND SHAREHOLDERS’ EQUITY,LiabilitiesAndStockholdersEquity,usd,782716000,bs
5218,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Net Income,NetIncomeLoss,usd,52017000,cf
5219,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,33049000,cf
5220,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Provision for Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,16947000,cf
5221,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Number of awards vested in period (in shares),ShareBasedCompensation,usd,3843000,cf
5222,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,-14385000,cf
5223,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Operating Lease Expense,atro:NoncashOperatingLeaseExpense,usd,4208000,cf
5224,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Net Gain on Sale of Businesses,GainLossOnSaleOfBusiness,usd,78801000,cf
5225,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Impairment Loss,AssetImpairmentCharges,usd,11083000,cf
5226,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accrued Litigation Claim,GainLossRelatedToLitigationSettlement,usd,-19619000,cf
5227,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Restructuring Activities,RestructuringCosts,usd,6539000,cf
5228,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Equity Investment Other Than Temporary Impairment,EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount,usd,5000000,cf
5229,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Other,OtherNoncashIncomeExpense,usd,-1610000,cf
5230,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-34083000,cf
5231,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Inventories,IncreaseDecreaseInInventories,usd,12711000,cf
5232,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Prepaid Expenses and Other Current Assets,IncreaseDecreaseInPrepaidExpense,usd,1160000,cf
5233,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-16617000,cf
5234,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-10737000,cf
5235,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Income Taxes Payable,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,3371000,cf
5236,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-11919000,cf
5237,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-3840000,cf
5238,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,1490000,cf
5239,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,42689000,cf
5240,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Acquisitions of Businesses, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,28907000,cf
5241,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Proceeds from Sale of Businesses,ProceedsFromDivestitureOfBusinesses,usd,104877000,cf
5242,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,12083000,cf
5243,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,-743000,cf
5244,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,64630000,cf
5245,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Proceeds From Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,117000000,cf
5246,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,156107000,cf
5247,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,50784000,cf
5248,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,N/A,cf
5249,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Stock Options Activity,atro:ProceedsOfStockOptionsExercisedNetOfTaxesRemitted,usd,-545000,cf
5250,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,1746000,cf
5251,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Cash Flows From Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-92182000,cf
5252,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,147000,cf
5253,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Increase (Decrease) in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,15284000,cf
5254,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,Interest Paid,InterestPaidNet,usd,5707000,cf
5255,Astronics Corp,0000008063,ATRO,Aerospace,FY,2019,"Income Taxes Paid, Net of Refunds",IncomeTaxesPaidNet,usd,27343000,cf
5256,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,188364000,bs
5257,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,133729000,bs
5258,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Inventories,InventoryNet,usd,151798000,bs
5259,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,20658000,bs
5260,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
5261,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total Current Assets,AssetsCurrent,usd,494549000,bs
5262,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,111522000,bs
5263,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,22018000,bs
5264,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Other Assets,OtherAssetsNoncurrent,usd,27932000,bs
5265,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,123008000,bs
5266,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Goodwill,Goodwill,usd,70997000,bs
5267,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total Assets,Assets,usd,850026000,bs
5268,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,223000,bs
5269,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accounts Payable,AccountsPayableCurrent,usd,42080000,bs
5270,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4687000,bs
5271,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,42380000,bs
5272,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,30832000,bs
5273,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total Current Liabilities,LiabilitiesCurrent,usd,120202000,bs
5274,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Long-term Debt,LongTermDebtNoncurrent,usd,333000000,bs
5275,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,19992000,bs
5276,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Other Liabilities,OtherLiabilitiesNoncurrent,usd,63023000,bs
5277,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total Current Liabilities,Liabilities,usd,536217000,bs
5278,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Common Stock,CommonStockValue,usd,346000,bs
5279,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-17717000,bs
5280,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,331180000,bs
5281,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Shareholders' Equity,StockholdersEquity,usd,313809000,bs
5282,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,850026000,bs
5283,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Net (Loss) Income,NetIncomeLoss,usd,-66963000,cf
5284,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,7971000,cf
5285,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,872000,cf
5286,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Equity-based Compensation Expense,ShareBasedCompensation,usd,1703000,cf
5287,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Deferred Tax Expense (Benefit),DeferredIncomeTaxExpenseBenefit,usd,2050000,cf
5288,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Operating Lease Amortization Expense,atro:OperatingLeaseAmortization,usd,1210000,cf
5289,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Gain on Sale of Business,GainLossOnSaleOfBusiness,usd,N/A,cf
5290,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Impairment Loss,AssetImpairmentCharges,usd,74408000,cf
5291,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Other,OtherNoncashIncomeExpense,usd,-968000,cf
5292,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-13644000,cf
5293,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Inventories,IncreaseDecreaseInInventories,usd,7224000,cf
5294,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,6295000,cf
5295,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-5730000,cf
5296,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,557000,cf
5297,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-490000,cf
5298,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-3591000,cf
5299,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-1217000,cf
5300,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-99000,cf
5301,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Cash Flows From Operating Activities:,NetCashProvidedByUsedInOperatingActivities,usd,23250000,cf
5302,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Total cash proceeds of divesture,ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
5303,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,2793000,cf
5304,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Cash Flows from Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2793000,cf
5305,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,150000000,cf
5306,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,5000000,cf
5307,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,7732000,cf
5308,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Stock Options Activity,ProceedsFromStockOptionsExercised,usd,33000,cf
5309,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,461000,cf
5310,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,136840000,cf
5311,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-839000,cf
5312,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2020,Increase (Decrease) in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,156458000,cf
5313,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,46639000,bs
5314,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,102659000,bs
5315,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Inventories,InventoryNet,usd,156584000,bs
5316,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,20734000,bs
5317,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
5318,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Current Assets:,AssetsCurrent,usd,326616000,bs
5319,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,109381000,bs
5320,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,21782000,bs
5321,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Other Assets,OtherAssetsNoncurrent,usd,23659000,bs
5322,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,118648000,bs
5323,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,ForeignCurrencyTranslation,Goodwill,usd,58440000,bs
5324,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Total Assets,Assets,usd,658526000,bs
5325,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,224000,bs
5326,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accounts Payable,AccountsPayableCurrent,usd,35371000,bs
5327,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4818000,bs
5328,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,44965000,bs
5329,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,27120000,bs
5330,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Total Current Liabilities,LiabilitiesCurrent,usd,112498000,bs
5331,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Long-term Debt,LongTermDebtNoncurrent,usd,173000000,bs
5332,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,19749000,bs
5333,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Other Liabilities,OtherLiabilitiesNoncurrent,usd,60920000,bs
5334,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Total Current Liabilities,Liabilities,usd,366167000,bs
5335,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Common Stock,CommonStockValue,usd,346000,bs
5336,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-16692000,bs
5337,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,308705000,bs
5338,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Shareholders' Equity,StockholdersEquity,usd,292359000,bs
5339,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,658526000,bs
5340,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Net (Loss) Income,NetIncomeLoss,usd,-90542000,cf
5341,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,16052000,cf
5342,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,3297000,cf
5343,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Equity-based Compensation Expense,ShareBasedCompensation,usd,2806000,cf
5344,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Deferred Tax Expense (Benefit),DeferredIncomeTaxExpenseBenefit,usd,1190000,cf
5345,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Non-cash Severance Expense,SeveranceCosts1,usd,4669000,cf
5346,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Operating Lease Amortization Expense,atro:OperatingLeaseAmortization,usd,2236000,cf
5347,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Non-cash Litigation Provision,GainLossRelatedToLitigationSettlement,usd,-1450000,cf
5348,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Gain on Sale of Business,GainLossOnSaleOfBusiness,usd,N/A,cf
5349,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Equity Investment Other Than Temporary Impairment,EquityMethodInvestmentOtherThanTemporaryImpairment,usd,3493000,cf
5350,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Impairment Loss,OtherAssetImpairmentCharges,usd,87016000,cf
5351,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Other,OtherNoncashIncomeExpense,usd,-4459000,cf
5352,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-43417000,cf
5353,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Inventories,IncreaseDecreaseInInventories,usd,12778000,cf
5354,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-446000,cf
5355,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-12473000,cf
5356,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,1983000,cf
5357,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-4221000,cf
5358,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-3667000,cf
5359,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-2222000,cf
5360,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-204000,cf
5361,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,41549000,cf
5362,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Proceeds on Sale of Business,ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
5363,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,3905000,cf
5364,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Proceeds on Sale of Assets,ProceedsFromSaleOfProductiveAssets,usd,1600000,cf
5365,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Cash Flows from Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-2305000,cf
5366,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,150000000,cf
5367,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,165000000,cf
5368,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,7732000,cf
5369,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Stock Options Activity,ProceedsFromStockOptionsExercised,usd,34000,cf
5370,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,939000,cf
5371,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Financing Fees,PaymentsOfFinancingCosts,usd,360000,cf
5372,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Cash Flows from Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-23997000,cf
5373,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-514000,cf
5374,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2020,Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,14733000,cf
5375,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Assets,Assets,usd,637461000,bs
5376,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Assets,Assets,usd,637461000,bs
5377,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Inventories,InventoryNet,usd,163451000,bs
5378,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Inventories,InventoryNet,usd,163451000,bs
5379,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,114355000,bs
5380,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,29897000,bs
5381,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,29897000,bs
5382,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Shareholders’ Equity,StockholdersEquity,usd,289846000,bs
5383,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Shareholders’ Equity,StockholdersEquity,usd,289846000,bs
5384,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Shareholders’ Equity,StockholdersEquity,usd,289846000,bs
5385,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,27375000,bs
5386,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accounts Payable,AccountsPayableCurrent,usd,26320000,bs
5387,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,304568000,bs
5388,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Goodwill,Goodwill,usd,58182000,bs
5389,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Goodwill,Goodwill,usd,58182000,bs
5390,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Long-term Debt,LongTermDebtNoncurrent,usd,168000000,bs
5391,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Accounts Receivable, Net of Allowance for Doubtful Accounts",AccountsReceivableNetCurrent,usd,92947000,bs
5392,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,24916000,bs
5393,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,108111000,bs
5394,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,108111000,bs
5395,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,17582000,bs
5396,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,17582000,bs
5397,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Current Maturities of Long-term Debt,LongTermDebtCurrent,usd,232000,bs
5398,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Current Assets,AssetsCurrent,usd,313670000,bs
5399,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,637461000,bs
5400,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,N/A,bs
5401,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Current Liabilities,LiabilitiesCurrent,usd,99268000,bs
5402,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Common Stock,CommonStockValue,usd,346000,bs
5403,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Total Liabilities,Liabilities,usd,347615000,bs
5404,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4969000,bs
5405,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4969000,bs
5406,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,19802000,bs
5407,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,19802000,bs
5408,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,42831000,bs
5409,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15068000,bs
5410,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Other Assets,OtherAssetsNoncurrent,usd,23341000,bs
5411,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Other Liabilities,OtherLiabilitiesNoncurrent,usd,62765000,bs
5412,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,150000000,cf
5413,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,(Decrease) Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-2009000,cf
5414,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Non-cash Litigation Provision,GainLossRelatedToLitigationSettlement,usd,N/A,cf
5415,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Financing Fees,PaymentsOfFinancingCosts,usd,360000,cf
5416,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Operating Lease Amortization Expense,atro:OperatingLeaseAmortization,usd,3352000,cf
5417,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,N/A,cf
5418,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,N/A,cf
5419,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,N/A,cf
5420,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-9589000,cf
5421,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-11340000,cf
5422,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-304000,cf
5423,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-63000,cf
5424,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Impairment Loss,OtherAssetImpairmentCharges,usd,87016000,cf
5425,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Impairment Loss,OtherAssetImpairmentCharges,usd,87016000,cf
5426,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Equity-based Compensation Expense,ShareBasedCompensation,usd,3924000,cf
5427,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Proceeds on Sale of Assets,ProceedsFromSaleOfProductiveAssets,usd,1600000,cf
5428,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,5575000,cf
5429,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Equity Investment Other Than Temporary Impairment,EquityMethodInvestmentOtherThanTemporaryImpairment,usd,3493000,cf
5430,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Equity Investment Other Than Temporary Impairment,EquityMethodInvestmentOtherThanTemporaryImpairment,usd,N/A,cf
5431,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Equity Investment Other Than Temporary Impairment,EquityMethodInvestmentOtherThanTemporaryImpairment,usd,N/A,cf
5432,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Deferred Tax Expense (Benefit),DeferredIncomeTaxExpenseBenefit,usd,1127000,cf
5433,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-3412000,cf
5434,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Stock Options Activity,ProceedsFromStockOptionsExercised,usd,33000,cf
5435,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,170000000,cf
5436,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,24095000,cf
5437,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,1425000,cf
5438,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,4535000,cf
5439,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Proceeds on Sale of Business,ProceedsFromDivestitureOfBusinesses,usd,N/A,cf
5440,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,224000,cf
5441,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,7732000,cf
5442,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Other,OtherNoncashIncomeExpense,usd,-6622000,cf
5443,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-6474000,cf
5444,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,"Acquisition of Business, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
5445,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-29484000,cf
5446,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Non-cash Severance Expense,SeveranceCosts1,usd,3007000,cf
5447,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-3975000,cf
5448,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,-53604000,cf
5449,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Net (Loss) Income,NetIncomeLoss,usd,-95796000,cf
5450,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Net (Loss) Income,NetIncomeLoss,usd,-95796000,cf
5451,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Net (Loss) Income,NetIncomeLoss,usd,-95796000,cf
5452,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-12316000,cf
5453,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Inventories,IncreaseDecreaseInInventories,usd,19807000,cf
5454,Astronics Corp,0000008063,ATRO,Aerospace,Q3,2020,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,31513000,cf
5455,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,(Decrease) Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,30729000,bs
5456,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,"Accounts Receivable, Net of Allowance for Estimated Credit Losses",AccountsReceivableNetCurrent,usd,98701000,bs
5457,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Inventories,InventoryNet,usd,155254000,bs
5458,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,25552000,bs
5459,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Current Assets:,AssetsCurrent,usd,310236000,bs
5460,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,104931000,bs
5461,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,17750000,bs
5462,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Other Assets,OtherAssetsNoncurrent,usd,8813000,bs
5463,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,105930000,bs
5464,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Foreign Currency Translation,Goodwill,usd,58297000,bs
5465,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Total Assets,Assets,usd,605957000,bs
5466,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accounts Payable,AccountsPayableCurrent,usd,22216000,bs
5467,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,4856000,bs
5468,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,40723000,bs
5469,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,27407000,bs
5470,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Total Current Liabilities,LiabilitiesCurrent,usd,95202000,bs
5471,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Long-term Debt,LongTermDebtNoncurrent,usd,173000000,bs
5472,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,15415000,bs
5473,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Other Liabilities,OtherLiabilitiesNoncurrent,usd,62036000,bs
5474,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Total Current Liabilities,Liabilities,usd,345653000,bs
5475,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Common Stock,CommonStockValue,usd,347000,bs
5476,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-16653000,bs
5477,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,276610000,bs
5478,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Shareholders' Equity,StockholdersEquity,usd,260304000,bs
5479,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,605957000,bs
5480,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Net Loss,NetIncomeLoss,usd,-11909000,cf
5481,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,7453000,cf
5482,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,1269000,cf
5483,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Equity-based Compensation Expense,ShareBasedCompensation,usd,2097000,cf
5484,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Deferred Tax (Benefit) Expense,DeferredIncomeTaxExpenseBenefit,usd,-51000,cf
5485,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Operating Lease Non-Cash Expense,atro:OperatingLeaseNonCashExpense,usd,1185000,cf
5486,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Impairment Loss,OtherAssetImpairmentCharges,usd,N/A,cf
5487,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Other,OtherNoncashIncomeExpense,usd,-1315000,cf
5488,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,6010000,cf
5489,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Inventories,IncreaseDecreaseInInventories,usd,-430000,cf
5490,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,-4171000,cf
5491,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-685000,cf
5492,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,-961000,cf
5493,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Customer Advance Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,2915000,cf
5494,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-246000,cf
5495,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-1307000,cf
5496,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-109000,cf
5497,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,-6863000,cf
5498,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,1905000,cf
5499,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Cash Flows from Investing Activities:,NetCashProvidedByUsedInInvestingActivities,usd,-1905000,cf
5500,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,N/A,cf
5501,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,N/A,cf
5502,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
5503,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,501000,cf
5504,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Cash Flows from Financing Activities:,NetCashProvidedByUsedInFinancingActivities,usd,-553000,cf
5505,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-362000,cf
5506,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,(Decrease) Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-9683000,cf
5507,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2021,"Proceeds of Stock Options Exercised, Net Of Taxes Remitted",atro:ProceedsOfStockOptionsExercisedNetOfTaxesRemitted,usd,-52000,cf
5508,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,7003000,bs
5509,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,7003000,bs
5510,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accounts Payable,AccountsPayableCurrent,usd,30615000,bs
5511,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,19043000,bs
5512,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,19043000,bs
5513,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-15604000,bs
5514,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Current Liabilities,LiabilitiesCurrent,usd,99057000,bs
5515,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,102095000,bs
5516,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,99683000,bs
5517,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,99683000,bs
5518,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Assets,Assets,usd,602495000,bs
5519,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Assets,Assets,usd,602495000,bs
5520,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Shareholders’ Equity,StockholdersEquity,usd,254851000,bs
5521,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Shareholders’ Equity,StockholdersEquity,usd,254851000,bs
5522,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Shareholders’ Equity,StockholdersEquity,usd,254851000,bs
5523,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,26061000,bs
5524,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,15245000,bs
5525,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,15245000,bs
5526,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,270108000,bs
5527,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Long-term Debt,LongTermDebtNoncurrent,usd,173000000,bs
5528,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Current Assets,AssetsCurrent,usd,315702000,bs
5529,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,"Accounts Receivable, Net of Allowance for Estimated Credit Losses",AccountsReceivableNetCurrent,usd,98161000,bs
5530,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Other Liabilities,OtherLiabilitiesNoncurrent,usd,60342000,bs
5531,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Goodwill,Goodwill,usd,58329000,bs
5532,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Goodwill,Goodwill,usd,58329000,bs
5533,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Liabilities,Liabilities,usd,347644000,bs
5534,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Assets Held for Sale,AssetsOfDisposalGroupIncludingDiscontinuedOperation,usd,3760000,bs
5535,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,37851000,bs
5536,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,602495000,bs
5537,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,33587000,bs
5538,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,33587000,bs
5539,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Common Stock,CommonStockValue,usd,347000,bs
5540,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Inventories,InventoryNet,usd,154133000,bs
5541,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Inventories,InventoryNet,usd,154133000,bs
5542,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Other Assets,OtherAssetsNoncurrent,usd,7643000,bs
5543,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,23588000,bs
5544,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,5000000,cf
5545,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-8000,cf
5546,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Contingent Consideration Liability Fair Value Adjustment,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-2200000,cf
5547,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Operating Lease Non-Cash Expense,atro:OperatingLeaseNonCashExpense,usd,2343000,cf
5548,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,14879000,cf
5549,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Equity-based Compensation Expense,ShareBasedCompensation,usd,3701000,cf
5550,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Payments for Long-term Debt,RepaymentsOfLongTermDebt,usd,5000000,cf
5551,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,-51000,cf
5552,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,-3566000,cf
5553,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Non-cash Severance Expense,SeveranceCosts1,usd,N/A,cf
5554,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Deferred Tax (Benefit) Expense,DeferredIncomeTaxExpenseBenefit,usd,-153000,cf
5555,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
5556,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Impairment Loss,OtherAssetImpairmentCharges,usd,N/A,cf
5557,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Impairment Loss,OtherAssetImpairmentCharges,usd,N/A,cf
5558,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,-2338000,cf
5559,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,5281000,cf
5560,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-2606000,cf
5561,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Proceeds on Sale of Assets,ProceedsFromSaleOfProductiveAssets,usd,N/A,cf
5562,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-946000,cf
5563,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,3566000,cf
5564,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,(Decrease) Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-6825000,cf
5565,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,854000,cf
5566,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Financing Fees,PaymentsOfFinancingCosts,usd,N/A,cf
5567,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Supplemental Retirement and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-199000,cf
5568,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Net Loss,NetIncomeLoss,usd,-20008000,cf
5569,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Net Loss,NetIncomeLoss,usd,-20008000,cf
5570,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Net Loss,NetIncomeLoss,usd,-20008000,cf
5571,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Other,OtherNoncashIncomeExpense,usd,-2105000,cf
5572,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Stock Options Activity,atro:ProceedsOfStockOptionsExercisedNetOfTaxesRemitted,usd,-59000,cf
5573,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Inventories,IncreaseDecreaseInInventories,usd,-720000,cf
5574,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Equity Investment Other Than Temporary Impairment,EquityMethodInvestmentOtherThanTemporaryImpairment,usd,N/A,cf
5575,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-913000,cf
5576,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Non-cash Litigation Provision,GainLossRelatedToLitigationSettlement,usd,N/A,cf
5577,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,4210000,cf
5578,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,2145000,cf
5579,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,70000,cf
5580,Astronics Corp,0000008063,ATRO,Aerospace,Q2,2021,Customer Advance Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-927000,cf
5581,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Other Liabilities,OtherLiabilitiesNoncurrent,usd,26283000,bs
5582,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Deferred Income Taxes,DeferredIncomeTaxLiabilitiesNet,usd,1421000,bs
5583,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Supplemental Retirement Plan and Other Liabilities for Pension Benefits,PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent,usd,31199000,bs
5584,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Long-term Debt,LongTermDebtNoncurrent,usd,163000000,bs
5585,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Treasury Stock, 3,808,060 Shares at December 31, 2021 and 2020",TreasuryStockValue,usd,108516000,bs
5586,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-14495000,bs
5587,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accounts Payable,AccountsPayableCurrent,usd,34860000,bs
5588,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,95236000,bs
5589,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,95236000,bs
5590,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,95236000,bs
5591,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Operating Right-of-Use Assets, Net",OperatingLeaseRightOfUseAsset,usd,16169000,bs
5592,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Operating Right-of-Use Assets, Net",OperatingLeaseRightOfUseAsset,usd,16169000,bs
5593,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Assets,Assets,usd,609138000,bs
5594,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Assets,Assets,usd,609138000,bs
5595,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,94320000,bs
5596,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Current Assets,AssetsCurrent,usd,339861000,bs
5597,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Current Liabilities,LiabilitiesCurrent,usd,118613000,bs
5598,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,609138000,bs
5599,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Shareholders’ Equity,StockholdersEquity,usd,256604000,bs
5600,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Shareholders’ Equity,StockholdersEquity,usd,256604000,bs
5601,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accrued Payroll and Employee Benefits,EmployeeRelatedLiabilitiesCurrent,usd,19607000,bs
5602,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,6778000,bs
5603,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,6778000,bs
5604,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,29757000,bs
5605,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,29757000,bs
5606,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Total Liabilities,Liabilities,usd,352534000,bs
5607,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,12018000,bs
5608,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,12018000,bs
5609,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Retained Earnings,RetainedEarningsAccumulatedDeficit,usd,287225000,bs
5610,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,45089000,bs
5611,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Other Assets,OtherAssetsNoncurrent,usd,5270000,bs
5612,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accrued Income Taxes,AccruedIncomeTaxesCurrent,usd,2621000,bs
5613,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Goodwill,Goodwill,usd,58282000,bs
5614,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Goodwill,Goodwill,usd,58282000,bs
5615,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Goodwill,Goodwill,usd,58282000,bs
5616,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Customer Advanced Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,27356000,bs
5617,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Other Accrued Expenses,OtherAccruedLiabilitiesCurrent,usd,27391000,bs
5618,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Additional Paid-in Capital,AdditionalPaidInCapitalCommonStock,usd,92037000,bs
5619,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Accounts Receivable, Net of Allowance for Estimated Credit Losses",AccountsReceivableNetCurrent,usd,107439000,bs
5620,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Accounts Receivable, Net of Allowance for Estimated Credit Losses",AccountsReceivableNetCurrent,usd,107439000,bs
5621,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Inventories,InventoryNet,usd,157576000,bs
5622,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Inventories,InventoryNet,usd,157576000,bs
5623,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,901000,cf
5624,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,901000,cf
5625,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Restructuring Activities,RestructuringCosts,usd,267000,cf
5626,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,30000000,cf
5627,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Stock Award and Employee Stock Purchase Plan (“ESPP”) activity,atro:ProceedsOfStockOptionsExercisedNetOfTaxesRemitted,usd,3396000,cf
5628,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,14832000,cf
5629,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Customer Advanced Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-235000,cf
5630,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Cash Flows From Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-7505000,cf
5631,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-404000,cf
5632,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,6034000,cf
5633,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,6034000,cf
5634,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Deferred Tax (Benefit) Expense,DeferredIncomeTaxExpenseBenefit,usd,-441000,cf
5635,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Deferred Tax (Benefit) Expense,DeferredIncomeTaxExpenseBenefit,usd,-441000,cf
5636,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,(Decrease) Increase in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-10655000,cf
5637,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,8610000,cf
5638,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Other,OtherNoncashIncomeExpense,usd,-3912000,cf
5639,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Other Investing Activities,PaymentsForProceedsFromOtherInvestingActivities,usd,N/A,cf
5640,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Income Taxes (Refunded) Paid, Net of Refunds",IncomeTaxesPaidNet,usd,-1250000,cf
5641,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,N/A,cf
5642,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Contingent Consideration Liability Fair Value Adjustment,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,usd,-2200000,cf
5643,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Acquisitions of Businesses, Net of Cash Acquired",PaymentsToAcquireBusinessesNetOfCashAcquired,usd,N/A,cf
5644,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Net Gain on Sales of Assets,GainLossOnSaleOfOtherAssets,usd,5083000,cf
5645,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Proceeds from Sale of Businesses and Assets,ProceedsFromDivestitureOfBusinesses,usd,9213000,cf
5646,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Inventories,IncreaseDecreaseInInventories,usd,5150000,cf
5647,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-5037000,cf
5648,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Operating Lease Non-cash Expense,atro:NoncashOperatingLeaseExpense,usd,5198000,cf
5649,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,-5530000,cf
5650,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Interest Paid,InterestPaidNet,usd,5951000,cf
5651,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Net (Loss) Income,NetIncomeLoss,usd,-25578000,cf
5652,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Net (Loss) Income,NetIncomeLoss,usd,-25578000,cf
5653,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Net (Loss) Income,NetIncomeLoss,usd,-25578000,cf
5654,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Net (Loss) Income,NetIncomeLoss,usd,-25578000,cf
5655,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Impairment Loss,AssetImpairmentCharges,usd,N/A,cf
5656,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Impairment Loss,AssetImpairmentCharges,usd,N/A,cf
5657,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Impairment Loss,AssetImpairmentCharges,usd,N/A,cf
5658,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Provision for Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,3942000,cf
5659,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,3179000,cf
5660,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,29005000,cf
5661,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,29005000,cf
5662,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,10677000,cf
5663,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,10677000,cf
5664,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,"Net Gain on Sale of Businesses, Before Taxes",GainLossOnSaleOfBusiness,usd,10677000,cf
5665,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Equity Investment Other Than Temporary Impairment,EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount,usd,N/A,cf
5666,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Purchase of Outstanding Shares for Treasury,PaymentsForRepurchaseOfCommonStock,usd,N/A,cf
5667,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Income Taxes Payable/Receivable,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,156000,cf
5668,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-799000,cf
5669,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Prepaid Expenses and Other Current Assets,IncreaseDecreaseInPrepaidExpense,usd,-20000,cf
5670,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Deferral of Federal Payroll Taxes,atro:DeferredIncomeTaxExpenseBenefitFederalPayrollTaxes,usd,N/A,cf
5671,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Equity-based Compensation Expense,ShareBasedCompensation,usd,6460000,cf
5672,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Non-cash 401K Contribution,DefinedContributionPlanIncreaseDecreaseCost,usd,4199000,cf
5673,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-6036000,cf
5674,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,20000000,cf
5675,Astronics Corp,0000008063,ATRO,Aerospace,FY,2021,Accrued Litigation Claim,GainLossRelatedToLitigationSettlement,usd,-8374000,cf
5676,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,24015000,bs
5677,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,24015000,bs
5678,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Shareholders’ Equity,StockholdersEquity,usd,260082000,bs
5679,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Shareholders’ Equity,StockholdersEquity,usd,260082000,bs
5680,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,93028000,bs
5681,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Property, Plant and Equipment, Net of Accumulated Depreciation",PropertyPlantAndEquipmentNet,usd,93028000,bs
5682,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Accounts Receivable, Net of Allowance for Estimated Credit Losses",AccountsReceivableNetCurrent,usd,117495000,bs
5683,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Other Liabilities,OtherLiabilitiesNoncurrent,usd,59240000,bs
5684,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Intangible Assets, Net of Accumulated Amortization",IntangibleAssetsNetExcludingGoodwill,usd,90504000,bs
5685,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Assets,Assets,usd,588471000,bs
5686,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Assets,Assets,usd,588471000,bs
5687,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Common Stock,CommonStockValue,usd,354000,bs
5688,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Operating Right-of-Use Assets,OperatingLeaseRightOfUseAsset,usd,14736000,bs
5689,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Current Liabilities,LiabilitiesCurrent,usd,121185000,bs
5690,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Current Assets,AssetsCurrent,usd,325929000,bs
5691,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Long-term Operating Lease Liabilities,OperatingLeaseLiabilityNoncurrent,usd,10964000,bs
5692,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Inventories,InventoryNet,usd,166088000,bs
5693,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Inventories,InventoryNet,usd,166088000,bs
5694,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accumulated Other Comprehensive Loss,AccumulatedOtherComprehensiveIncomeLossNetOfTax,usd,-14325000,bs
5695,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Other Shareholders’ Equity,atro:OtherShareholdersEquity,usd,274053000,bs
5696,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Liabilities,Liabilities,usd,328389000,bs
5697,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Goodwill,Goodwill,usd,58313000,bs
5698,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Goodwill,Goodwill,usd,58313000,bs
5699,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Total Liabilities and Shareholders’ Equity,LiabilitiesAndStockholdersEquity,usd,588471000,bs
5700,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Long-term Debt,LongTermDebtNoncurrent,usd,137000000,bs
5701,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Other Assets,OtherAssetsNoncurrent,usd,5961000,bs
5702,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Prepaid Expenses and Other Current Assets,PrepaidExpenseAndOtherAssetsCurrent,usd,18331000,bs
5703,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Customer Advance Payments and Deferred Revenue,ContractWithCustomerLiabilityCurrent,usd,27198000,bs
5704,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accounts Payable,AccountsPayableCurrent,usd,43400000,bs
5705,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Current Operating Lease Liabilities,OperatingLeaseLiabilityCurrent,usd,6095000,bs
5706,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accrued Expenses and Other Current Liabilities,OtherLiabilitiesCurrent,usd,44492000,bs
5707,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Operating Lease Non-Cash Expense,atro:OperatingLeaseNonCashExpense,usd,1424000,cf
5708,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Debt Acquisition Costs,PaymentsOfDebtIssuanceCosts,usd,771000,cf
5709,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Proceeds from Long-term Debt,ProceedsFromIssuanceOfLongTermDebt,usd,17925000,cf
5710,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Effect of Exchange Rates on Cash,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,usd,-173000,cf
5711,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accrued Expenses,IncreaseDecreaseInAccruedLiabilities,usd,-1380000,cf
5712,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Net Loss,NetIncomeLoss,usd,-3101000,cf
5713,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Net Loss,NetIncomeLoss,usd,-3101000,cf
5714,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Net Loss,NetIncomeLoss,usd,-3101000,cf
5715,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Supplemental Retirement Plan and Other Liabilities,IncreaseDecreaseInEmployeeRelatedLiabilities,usd,-109000,cf
5716,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Equity-based Compensation Expense,ShareBasedCompensation,usd,2101000,cf
5717,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Cash Flows from Operating Activities,NetCashProvidedByUsedInOperatingActivities,usd,316000,cf
5718,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Operating Lease Liabilities,atro:IncreaseDecreaseInOperatingLeaseLiabilities,usd,-1724000,cf
5719,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accounts Payable,IncreaseDecreaseInAccountsPayable,usd,8625000,cf
5720,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Cash Flows from Financing Activities,NetCashProvidedByUsedInFinancingActivities,usd,-26686000,cf
5721,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Inventories,IncreaseDecreaseInInventories,usd,9015000,cf
5722,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Customer Advance Payments and Deferred Revenue,IncreaseDecreaseInContractWithCustomerLiability,usd,-113000,cf
5723,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Decrease in Cash and Cash Equivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,usd,-5742000,cf
5724,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Income Taxes,IncreaseDecreaseInAccruedIncomeTaxesPayable,usd,16492000,cf
5725,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Other,OtherNoncashIncomeExpense,usd,-513000,cf
5726,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Depreciation and Amortization,DepreciationDepletionAndAmortization,usd,7088000,cf
5727,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Finance Lease Principal Payments,FinanceLeasePrincipalPayments,usd,23000,cf
5728,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Net Gain on Sale of Business, Before Taxes",GainLossOnSaleOfBusiness,usd,11284000,cf
5729,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Net Gain on Sale of Business, Before Taxes",GainLossOnSaleOfBusiness,usd,11284000,cf
5730,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,"Net Gain on Sale of Business, Before Taxes",GainLossOnSaleOfBusiness,usd,11284000,cf
5731,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Capital Expenditures,PaymentsToAcquireProductiveAssets,usd,1160000,cf
5732,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Provisions for Non-Cash Losses on Inventory and Receivables,atro:ProvisionForNonCashLossesOnInventoryAndReceivables,usd,175000,cf
5733,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Other Current Assets and Liabilities,IncreaseDecreaseInOtherOperatingCapitalNet,usd,363000,cf
5734,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Cash Flows from Investing Activities,NetCashProvidedByUsedInInvestingActivities,usd,20801000,cf
5735,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Non-Cash Accrued 401K Contribution,PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash,usd,1011000,cf
5736,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Accounts Receivable,IncreaseDecreaseInAccountsReceivable,usd,10024000,cf
5737,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Proceeds from Sale of Businesses,ProceedsFromDivestitureOfBusinesses,usd,21961000,cf
5738,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Deferred Tax Benefit,DeferredIncomeTaxExpenseBenefit,usd,N/A,cf
5739,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Stock Award Activity,atro:ProceedsPaymentsFromStockAwardActivity,usd,108000,cf
5740,Astronics Corp,0000008063,ATRO,Aerospace,Q1,2022,Principal Payments on Long-term Debt,RepaymentsOfLongTermDebt,usd,43925000,cf
